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 Summary 
 
i 
Summary 
This doctoral thesis covers the use of advanced analytical techniques (UHPLC-QTOF, UHPLC-QqQ-
MS/MS and LC-LTQ-Orbitrap) and computational software (Artificial Neural Networks, Sieve, 
MsXelerator) from the prediction of chromatographic retention time to the qualitative screening and 
quantification of pharmaceuticals and illicit drugs (PIDs) in wastewater (WW) and surface water (SW). 
It is divided into three sections and consists of six scientific articles and one review article (Scientific 
Article 1).   
The first section consists of three research articles and deals with the use of high resolution mass 
spectrometry (HRMS) in the screening and occurrence of PIDs in environmental waters of three 
countries: Colombia, Italy and Spain. The use of different HRMS instruments (QTOF and LTQ-
Orbitrap) combined with in-house and online databases of up to thousands of compounds enabled 
numerous compounds to be detected and identified. A continuously-updated in-house database of 
more than 1000 PIDs and metabolites was made incorporating their exact mass, and also adduct 
formation, fragment ions and retention time when a standard was available. This entire database was 
used for the first work, investigating influent and effluent WW as well as SW samples from Bogotá, 
Colombia, leading to the identification of 40 compounds across all samples (Scientific Article 2). A 
subset of approximately 100 of the most commonly identified compounds was used in the next work, 
looking at the use of two HRMS instruments (QTOF and Orbitrap) in the suspect screening of WW 
and SW samples from Italy and Spain, with up to 28 compounds at least detected (Scientific Article 
3). Finally, a non-target screening approach was made using two advanced deconvolution software 
and incorporating two databases: one of 250 PIDs and the ChemSpider database, with more than 20 
compounds being tentatively identified (Scientific Article 4). 
The second section consists of two research articles and covers the development and utilisation of 
two retention time prediction approaches in the identification of PIDs in waste and environmental 
water samples. Initially, a very simple approach was made, using only logKow and a combined in-house 
and Waters database of 595 reference standards. This led to a prediction accuracy of approximately 
70-80% within a retention time window of ±2 minutes. A comparison was made to see whether 
reducing the mass extraction window incrementally from 50mDa to 5mDa would result in more peaks 
being removed than the prediction method. 
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It was found that even at the narrowest window investigated, this prediction method resulted in almost 
one quarter of all chromatographic peaks able to be removed as false positives (Scientific Article 5). 
While this simple approach showed itself quite useful, a more precise method was hoped to aid in the 
identification of transformation products for which no reference standards are available. Artificial 
neural networks were thus investigated and found to be much more precise, with up to 95% of all 
compounds being within a ±2 minute window, leading to the tentative identification of ten metabolites 
and transformation products and several other compounds for which standards were unavailable 
(Scientific Article 6).  
Finally, the third section consists of one research article on the quantitative analysis of new 
psychoactive substances (NPS) using UHPLC-QqQ-MS/MS. Ten NPS were chosen, based on their 
current (ab)use and prevalence in toxicological and wastewater-based epidemiological approaches. 
This method was based on offline solid phase extraction (SPE) using mixed cation exchange (MCX) 
cartridges due to the basic nature of the NPS. A study was also made on the stability of the compounds 
in influent wastewater (both at natural pH and pH=2), with the compounds maintaining their stability 
for up to 7 days in acidified influent wastewater. This method was fully validated and tested on samples 
from throughout Europe – Utrecht, The Netherlands; Oslo, Norway; Bristol, United Kingdom; Milan, 
Italy; Copenhagen, Denmark; Brussels, Belgium, Zurich, Switzerland and Castellon, Spain – with 
mephedrone, methylone and methylenedioxypyrovalerone (MDPV)  able to be identified (Scientific 
Article 7).   
 Resumen 
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Resumen 
Esta tesis doctoral abarca el uso de técnicas avanzadas de análisis (HPLC-QTOF, HPLC-QqQ-
MS/MS y LC-LTQ-Orbitrap) y software computacional (Artificial Neural Networks, Sieve, 
MsXelerator) desde la predicción de tiempo de retención cromatográfico a la detección cualitativa y 
cuantitativa de productos farmacéuticos y drogas ilícitas (PIDs) en aguas residuales (WW) y 
superficiales (SW). Se divide en tres secciones y consta de seis artículos científicos y un artículo de 
revisión.  
La primera sección consta de tres artículos de investigación y se ocupa de la utilización de la 
espectrometría de masas de alta resolución (HRMS) en el “screening” de PIDs en aguas ambientales 
de tres países: Colombia, Italia y España. El uso de diferentes instrumentos de HRMS (QTOF y LTQ-
Orbitrap) combinado tanto con bases de datos internas como en línea de hasta miles de compuestos 
ha permitido la detección e identificación de numerosos compuestos. Se ha desarrollado una base de 
datos que se actualiza de manera continua, con más de 1000 PIDs y  metabolitos que incluye su masa 
exacta, así como la formación de aductos, los iones fragmento así como el tiempo de retención cuando 
se contaba con un patrón. Esta base de datos se utilizó para el primer artículo, la investigación de 
influentes y efluentes de WW, así como muestras de SW de Bogotá, Colombia, que permitió la 
identificación de hasta 40 compuestos en todas las muestras (Scientific Article 2). Una base de datos 
reducida, conteniendo un subconjunto de aproximadamente 100 de los compuestos más comúnmente 
identificados, se utilizó en el siguiente artículo, evaluando la utilización de dos instrumentos HRMS 
(QTOF y Orbitrap) para el “suspect screening” de muestras WW y SW de Italia y España, con un 
máximo de 28 compuestos detectados (Scientific Article 3). Por último, un método combinado de 
“suspect” y “non-target” se ha llevado a cabo mediante dos programas de deconvolución avanzada y 
la incorporación de una pequeña base de datos de 250 PIDs para “suspect screening” y la base de 
datos generalista ChemSpider para el “non-target screening”, con casi 20 compuestos  identificados 
tentativamente (Scientific Article 4). 
La segunda sección consta de dos artículos de investigación que incluyen el desarrollo y la utilización 
de dos enfoques distintos para la predicción del tiempo de retención cromatográfico en la 
identificación de PIDs en muestras de aguas residuales y ambientales. Inicialmente, se realizó un 
enfoque muy simple, utilizando sólo logKow pero combinando una base de datos interna y otra de 
Waters, lo que permitió emplear los datos de 595 patrones de referencia. Esto condujo a una exactitud 
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en la predicción de aproximadamente el 70-80% de todos los compuestos dentro de una ventana de 
tiempo de retención de ±2 minutos. Se llevó a cabo una comparación reduciendo la ventana de 
extracción de masa desde 50mDa a 5mDa para evaluar si conllevaría la eliminación de más picos 
cromatográficos que el método de predicción de tiempo de retención. Se observó que incluso con la 
ventana más estrecha investigada, este método de predicción de tiempo de retención permitió eliminar 
casi un cuarto de todos los picos cromatográficos como falsos positivos (Scientific Article 5).  Si bien 
este enfoque simple se mostró bastante útil, se requiere un método más exacto para ayudar en la 
identificación de los productos de transformación para los que no hay patrones de referencia 
disponibles. Se investigó el uso de las redes neuronales artificiales (ANNs), resultando ser mucho más 
precisas, con hasta un 95% de todos los compuestos dentro de una ventana ±2 minutos, dando lugar 
a la identificación tentativa de diez metabolitos y productos de transformación así como otros 
compuestos para los que los patrones de referencia no estaban disponibles (Scientific Article 6). 
Finalmente, la tercera sección consiste en un artículo de investigación para el análisis cuantitativo de 
nuevas sustancias psicoactivas (NPS) utilizando HPLC-QqQ-MS/MS. Diez NPS fueron elegidos, en 
función de su (ab)uso actual y prevalencia tanto toxicológica como en epidemiología de aguas 
residuales. Este método se basa en un tratamiento previo de extracción en fase sólida (SPE), usando 
cartuchos de modo mixto de intercambio catiónico (MCX), debido a la basicidad de los NPS 
investigados. También se realizó un estudio sobre la estabilidad de los compuestos en agua residual 
influente a pH natural y a pH 2, resultando estables durante un máximo de 7 días en el agua residual 
acidificada. Este método fue totalmente validado y evaluado en muestras procedentes de toda Europa 
- Utrecht, Países Bajos; Oslo, Noruega; Bristol, Reino Unido; Milan, Italia; Copenhague, Dinamarca; 
Bruselas, Bélgica, Zurich, Suiza y Castellón, España – identificando en las muestras mefedrona, 
metilona y methylenedioxypyrovalerone (MDPV) (Scientific Article 7) 
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3 
Objectives  
The main objective of this doctoral thesis was to investigate licit and illicit drugs and metabolites in 
waste and surface water using advanced analytical techniques. To reach this aim, retention time 
prediction, suspect, non-target and target screening strategies have been applied. Different 
instrumental configurations have been investigated, including low resolution tandem mass 
spectrometry (MS) using triple quadrupole (QqQ) and high resolution MS using quadrupole time-of-
flight (QTOF) and linear ion trap Orbitrap (LTQ Orbitrap) mass analysers.  
In order to reach this general objective, several specific objectives have been established: 
1) Application of a qualitative analytical methodology based on ultra-high performance liquid 
chromatography (UHPLC) coupled to QTOF MS in MSE mode, allowing rapid wide-scope 
screening for a large number of compounds based on a large in-house database. This 
methodology was to be applied to a number of water samples (influent and effluent wastewater 
and surface water) from different geographic origins and countries (Colombia, Italy and 
Spain).  
2) Development of a simple retention time prediction approach that can easily be applied during 
the suspect screening of pharmaceuticals and illicit drugs to aid in their identification. A 
comparison with mass extraction window width was also to be tested.  
3) Development of a second, more complex and precise retention time prediction approach that 
could be applied in the identification of metabolites and transformation products for which 
standards are unavailable. 
4) Development and application of a combined suspect and non-target screening workflow using 
advanced deconvolution software following injection in LTQ-Orbitrap. 
5) Development of an analytical strategy for quantification of new psychoactive substances 
(NPS) in influent wastewater based on offline solid phase extraction (SPE) followed by LC-
MS/MS measurement with a triple quadrupole mass analyser. A comparative direct injection 
method was also performed. Target compounds were selected based on consumption and 
prevalence in previous toxicological and wastewater samples.  
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4 
Working Plan 
 
This entire doctorate was supported by the Marie Curie funded International Training Network, 
SEWPROF (more in Chapter 1), which made it possible to perform research stays at several 
international institutes. 
 
The working plan followed in order to achieve the objectives outlined above was as follows: 
 
Qualitative Screening with Liquid Chromatography coupled with High Resolution Mass 
Spectrometry 
The work in this section was performed at three different institutes: University Jaume I, Mario Negri 
Institute for Pharmacological Research and KWR Watercycle Research Institute and the specific 
working plans within each institute is summarised below: 
Working Plan for work performed at University Jaume I (Spain) 
1. Continued upkeep of an in-house database developed by our group for the qualitative 
screening of pharmaceuticals and illicit drugs. This meant including (at least) the name and 
molecular mass, with the exact mass of fragment ions added when known.  
2. Manual collection of surface water samples from different areas in the Valencian region. This 
entailed physically collecting samples in high density polyurethane bottles, transporting them 
to the laboratory and storing them at 4°C. 
3. Sample treatment of wastewater and surface water samples following previously developed 
solid phase extraction techniques employed in our laboratory. 
4. Injection of samples in UHPLC-QTOF in MSE mode, thereby allowing simultaneous 
collection of low and high energy full-spectrum accurate mass data.  
5. Data analysis on specialised software, Chromalynx (Within MassLynx, version 4.1, Waters 
Corporation) which facilitates wide-scope screening analyses by automatically extracting the 
exact mass of a compound at low energy (and high energy in the cases of fragment ions) in 
the form of an extracted ion chromatogram (XIC).  
6. Further data analysis performed on the raw data for parent compounds and fragment ions to 
ensure no compounds are erroneously not detected or identified. 
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Working Plan for work performed at Mario Negri Institute for Pharmacological Research 
(Italy) 
1. Initial training with LTQ-Orbitrap based on theory and practice. 
2. Injection of samples in the LTQ-Orbitrap in data-dependent acquisition (DDA) mode, 
meaning that when a peak passed a certain pre-set threshold, MS/MS scans were made to 
acquire fragment ions. 
3. Data analysis on specialised software (TraceFinder EFS, Thermo Scientific) based on the same 
database used at University Jaume I where “positive” findings are based on the exact mass of 
the protonated molecule together with isotopic pattern, fragment ions and a library search (the 
latter two only when available). 
4. For closer examination of “positive” compounds, the samples were reinjected in the LTQ-
Orbitrap in MS/MS mode, based on a target list of the “positive” compounds to give 
information on product ions.  
5. Further data analysis performed on the raw data (in QualBrowser, Themo Scientific) for parent 
compounds and fragment ions to ensure no compounds are erroneously not detected or 
identified. 
 
Working Plan for work performed at KWR Watercycle Research Institute (The 
Netherlands) 
1. Injection of samples in the LTQ-Orbitrap in data-dependent acquisition (DDA) mode, 
meaning that when a peak passed a certain pre-set threshold, MS/MS scans were made to 
acquire fragment ions. 
2. Data analysis on specialised software for non-target (MsXelerator (MsMetrix) and Sieve 2.1 
(Thermo Scientific)) analysis.  
3. A hidden target screening was made after initial peak-picking parameters were set and the 
same database as in previous studies was used to detect compounds within the samples.  
4. Addtionally, following initial peak-picking, the ChemSpider database was used to detect 
compounds. 
Objectives and Working Plan    
 
6 
5. All samples were reinjected in MS/MS mode in the LTQ-Orbitrap based on a target list from 
the combined detected compounds found by both suspect and non-target analysis, to help 
initiate fragmentation. 
6. Analysis of samples within QualBrowser (Thermo Scientific) was made to compare fragment 
ions observed experimentally with those found in literature or in online mass spectral 
databases for tentative identification.  
Retention Time Prediction 
Retention Time Prediction based on logKow  
1. Bibliographic revision of the current trends and means of retention time prediction. 
2. Development of database based on reference standards in our laboratory and a Waters 
database. 
3. SMILES codes found for all compounds in the database. 
4. Predicted logKow values found using VCCLabs freeware, experimental values found in 
literature and online databases. 
5. Linear regression made between logKow values (both experimental and predicted) and 
retention time; different subsets based on chemical family also made to improve correlation. 
6. Investigation and comparison of the impact of a logKow predicted retention time and 
narrower extraction windows in the removal of false positive peaks for the detection of 
emerging contaminants (with reference standards available) in environmental waters. 
 
Retention Time Prediction based on Artificial Neural Networks (in collaboration with  
Leon Barron, King’s College London) 
1. Bibliographic revision of current means of retention time prediction based on artificial 
neural networks (ANN). 
2. Additional descriptors required for ANN approach found on Parameter Client (VCC Labs) 
3. Optimisation of ANN method based on implementing different training:verification:blind 
set ratios, as well as different architectures and model types. 
4. Investigation of the impact of ANN-based predicted retention times on the exclusion of 
false positive peaks for the detection of emerging contaminants (with reference standards 
available) in environmental waters. 
 Objectives and Working Plan 
 
7 
5. Investigation of ANN-based predicted retention times in the tentative identification of 
metabolites and transformation products for which reference standards are unavailable 
 
Quantitative Determination of Selected New Psychoactive Substances in Influent 
Wastewater Samples 
1. Selection of target new psychoactive substances (NPS) based on literature revision 
2. Optimisation of MS and MS/MS parameters by injection of a mixture of all 
compounds in solvent. 
i. Acquisition of full-scan MS spectra to establish the most appropriate 
ionisation mode and cone voltage of the precursor ion. 
ii. Improve formation of the protonated molecule by using additives in the 
mobile phase (i.e. formic acid and ammonium acetate).  
iii. Following optimisation of cone voltage of the precursor ion, collision energy 
is then optimised in order to select the most appropriate product ions, taking 
into account sensitivity and specificity (i.e. avoid non-specific transitions such 
as loss of water). 
iv. Selection of at least two MS/MS transitions per compound: one for 
quantification and at least one other for confirmation.  
3. Selection of chromatographic conditions by injecting standard solutions, with mobile 
phase altered using additives to improve the chromatographic peak shape and 
separation. 
4. Study of the SPE process (comparing different SPE cartridges to gain an idea of the 
best for the study) using blank samples spiked before and after the SPE step. 
5. Study the possibility of direct injection for this method. 
6. Evaluate filtration recoveries for both vacuum and syringe filters. 
7. Evaluate stability of all compounds at different temperatures (-20ºC, 4ºC and 20ºC) 
for up to 7 days (30 days at -20ºC).  
8. Validation of the optimised methods by evaluating linearity, accuracy and precision 
from recovery experiments at different concentration levels. Estimation of the limits 
of quantification and detection of all studied compounds.  
9. Application of the developed, validated method to the analysis of wastewater samples.
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Objetivos 
El objetivo principal de esta tesis doctoral fue investigar drogas (lícitas e ilícitas) y metabolitos en aguas 
residuales y superficiales utilizando técnicas analíticas avanzadas. Para alcanzar este objetivo, se han 
aplicado tanto la predicción del tiempo de retención, como las estrategias de “screening” de “suspect”, 
“non-target” y “target”. Diferentes configuraciones instrumentales han sido investigadas, incluyendo 
analizadores de masas con baja resolución usando espectrometría de masas en tándem (MS/MS) de 
triple cuadrupolo (QqQ) y alta resolución MS utilizando el cuadrupolo - tiempo de vuelo (QTOF) y 
la trampa de iones lineal - Orbitrap (LTQ Orbitrap).  
Para alcanzar este objetivo general, se han establecido varios objetivos específicos: 
1) Aplicación de una metodología de análisis cualitativo basada en cromatografía líquida de ultra-
alta resolución (UHPLC) acoplada a QTOF MS en el modo de MSE, lo que permite el 
“screening” amplio y rápido de un gran número de compuestos apoyado en una gran base de 
datos interna. Esta metodología se aplica a una serie de muestras de agua (influente y efluente 
de aguas residuales así como aguas superficiales) de diferentes orígenes y países (Colombia, 
Italia y España). 
2) El desarrollo de una aproximación sencilla para la predicción del tiempo de retención que 
pueda ser fácilmente aplicada durante el “suspect screening” de productos farmacéuticos y 
drogas ilícitas para ayudar en su identificación. Se realiza una comparación con la anchura de 
la ventana de extracción de masa. 
3) El desarrollo de una segunda aproximación de predicción de tiempo de retención, más 
compleja y precisa, que se puede aplicar en la identificación de los metabolitos y productos de 
transformación para la que no están disponibles los patrones. 
4) El desarrollo y aplicación de un flujo de trabajo combinado “suspect” y “non-target screening” 
mediante un software avanzado de deconvolución tras la inyección en LTQ-Orbitrap. 
5) El desarrollo de una estrategia de análisis cuantitativo para nuevas sustancias psicotrópicas 
(NPS) en aguas residuales influentes basada en la extracción en fase sólida (SPE), seguida de 
la determinación medfiante LC-MS/MS con un analizador de masas de triple cuadrupolo. 
También se comparan los resultados frente a un método de inyección directa. Los compuestos 
de interés se seleccionan en función del consumo y la prevalencia en los estudios previos 
toxicológicos y de epidemiología de aguas residuales. 
Objetivos y Plan de Trabajo    
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Plan de Trabajo 
 
Esta Tesis Doctoral se enmarca dentro de las Redes Internacionales de Formación (ITN) Marie Curie, 
en concreto la Red SEWPROF financiada por la Unión Europea (más información en el Chapter 1), 
lo que hizo posible la realización de diversas estancias de investigación en varios institutos 
internacionales. 
 
El plan de trabajo seguido con el fin de alcanzar los objetivos señalados anteriormente es el siguiente: 
 
Screening Cualitativo mediante Cromatografía Líquida de Alta Resolución acoplada a 
Espectrometría de Masas 
El trabajo en esta sección se realizó en tres institutos diferentes: Universitat Jaume I, Mario Negri 
Institute for Pharmacological Research y KWR Watercyle Research Institute y los planes de trabajo 
específicos dentro de cada instituto se resumen a continuación: 
Plan de trabajo en la Universitat Jaume I (España) 
1. Mantenimiento continuado de la base de datos interna desarrollada por nuestro grupo para la 
detección cualitativa de productos farmacéuticos y drogas ilícitas. Esto implicaba incluir (al 
menos) el nombre y la masa molecular, junto con la masa exacta de los iones fragmento cuando 
se conozca. 
2. Toma de muestras de aguas superficiales procedentes de diferentes zonas de la región 
valenciana. Esto implicó físicamente la toma de muestras en botellas de poliuretano de alta 
densidad, transportarlas al laboratorio y almacenarlas a 4°C. 
3. Tratamiento de las muestras de aguas residuales y de aguas superficiales siguiendo la técnica 
de extracción en fase sólida previamente desarrollada y empleada en nuestro laboratorio.  
4. Inyección de los extractos de muestra en UHPLC-QTOF en modo MSE, lo que permite 
simultáneamente la recogida de datos de masa exacta de baja y alta energía. 
5. Análisis de los datos mediante un software especializado, ChromaLynx (MassLynx, versión 
4.1, Waters Corporation), que facilita la realización de un análisis de “wide-scope screening” 
mediante la extracción automática de la masa exacta de un compuesto a baja energía (y de alta 
energía en el caso de los iones fragmento) en forma de un cromatograma de iones extraídos 
(XIC). 
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6. Un análisis más detallado se realiza sobre los datos brutos para compuestos intactos e iones 
fragmento para asegurar que ningún compuesto es no detectado o identificado erróneamente. 
 
Plan de trabajo en el Mario Negri Institute for Pharmacological Research (Italia) 
1. Formación inicial teórico-práctica sobre LTQ-Orbitrap. 
2. Inyección de muestras en el LTQ-Orbitrap en modo de adquisición dependiente de los datos 
(DDA), lo que significa que cuando un pico supera un cierto umbral preestablecido, se realizan 
barridos en modo MS/MS para adquirir iones producto. 
3. Análisis de los datos mediante un software especializado (TraceFinder EFS, Thermo 
Scientific) basado en la misma base de datos utilizada en la Universitat Jaume I, donde los 
resultados "positivos" se basan en la masa exacta de la molécula protonada junto con el patrón 
isotópico, los fragmentos de iones y una búsqueda en la biblioteca (los dos últimos sólo cuando 
esté disponible esta información). 
4. Para un examen más detallado de los compuestos "positivos", se inyectaron las muestras en el 
LTQ-Orbitrap en modo MS/MS, sobre la base de una lista de “target” de los compuestos 
"positivos" para obtener información sobre los iones producto. 
5. Un análisis más profundo se lleva a cabo sobre los datos en bruto (con el QualBrowser, 
Thermo Scientific) para compuestos intactos y los iones producto para asegurar que ningún 
analito no es detectado o identificado por error. 
 
Plan de trabajo en el KWR Watercycle Research Institute (Paises Bajos) 
1. Inyección de muestras en el LTQ-Orbitrap en modo de adquisición dependiente de los datos 
(DDA), lo que significa que cuando un pico supera un cierto umbral preestablecido, se realizan 
barridos MS/MS para adquirir iones producto. 
2. Análisis de datos con el software especializado para tanto “suspect” (Ms Xcelerator 
(MsMetrix) y Sieve 2.1 (Thermo Scientific)) como “non-target” análisis (Sieve 2.1 (Thermo 
Scientific)). 
Objetivos y Plan de Trabajo    
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3. Para el análisis “hidden target”, después de que se establecen los parámetros iniciales de “peak-
picking”, se utiliza la misma base de datos, como en estudios previos, para detectar 
compuestos dentro de las muestras. 
4. Además tras el “peak-picking” inicial, se utiliza la base de datos ChemSpider para detectar 
compuestos. 
5. Todas las muestras se reinyectan en modo MS/MS en el LTQ-Orbitrap generando una lista 
de “target” combinando los compuestos detectados tanto en análisis “suspect” como “non-
target”, para favorecer la fragmentación. 
6. También se realiza un análisis de las muestras mediante QualBrowser (Thermo Scientific) para 
comparar los iones fragmentos observados experimentalmente con los encontrados en la 
literatura o en bases de datos de espectros de masas, para la identificación tentativa de los 
positivos. 
 
Predicción de Tiempo de Retención 
Predicción de Tiempo de Retención basado en logKow  
1. Revisión bibliográfica de las tendencias y los métodos de predicción de tiempo de retención 
actuales. 
2. Desarrollo de una base de datos de tiempos de retención basada en patrones de referencia 
tanto de nuestro laboratorio como de la empresa Waters. 
3. Obtener los códigos SMILES para todos los compuestos de la base de datos. 
4. Los valores de logKow teóricos se generan mediante el software gratuito de VCCLabs 
mientras que los valores experimentales se encuentran en la literatura y en bases de datos en 
línea. 
5. Se realiza una regresión lineal entre los valores de logKow (tanto experimentales como 
teóricos) y el tiempo de retención; diferentes subconjuntos, basados en distintas familias 
químicas se evalúan para mejorar la correlación. 
6. Investigación y comparación del impacto de un tiempo de retención predicho mediante 
logKow y la anchura de las ventanas de extracción sobre la eliminación de picos de falsos 
positivos en la detección de contaminantes emergentes (con patrones de referencia 
disponibles) en aguas ambientales. 
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Predicción de Tiempo de Retención basado en Redes Neuronales Artificiales (en 
colaboración con Leon Barron, King’s College London) 
1. Revisión bibliográfica de los métodos de predicción de tiempo de retención actuales basados 
en redes neuronales artificiales (ANN) 
2. Los descriptores moleculares adicionales requeridos por la aproximación ANN se generan 
mediante el software Parameter Client (VCC Labs) 
3. Optimización del método ANN basado en la aplicación de diferentes proporciones de los 
conjuntos de training:verification:blind, así como diferentes arquitecturas y tipos de modelo. 
4. Investigación del impacto de los tiempos de retención predichos mediante ANN en la 
exclusión de los picos de falsos positivos en la detección de contaminantes emergentes (con 
estándares de referencia) en aguas ambientales. 
5. Investigación de tiempos de retención predichos mediante ANN en la identificación 
tentativa de metabolitos y productos de la transformación para los que no se dispone de 
patrones de referencia. 
 
Determinación Cuantitativa de Nuevas Sustancias Psicoactivas Seleccionadas en Muestras 
Influente de Aguas Residuales 
1. Selección de nuevas sustancias psicotrópicas (NPS) basada en revisión de la literatura 
2. Optimización de los parámetros de MS y MS/MS a partir de una mezcla de patrones 
en disolvente. 
i. Adquisición de espectros de masas en modo “full-scan” para establecer el 
modo de ionización y el voltaje de cono más apropiado para el ión precursor. 
ii. Mejorar la formación de la molécula protonada mediante el uso de aditivos en 
la fase móvil (es decir  ácido fórmico y acetato de amonio). 
iii. Después de la optimización del voltaje de cono del ión precursor, la energía de 
colisión se optimiza a continuación a fin de seleccionar los iones producto más 
adecuados, teniendo en cuenta la sensibilidad y la especificidad (es decir, evitar 
transiciones no específicos tales como la pérdida de agua). 
iv. La selección de al menos dos transiciones MS/MS por compuesto: una para la 
cuantificación y al menos otra para la confirmación. 
Objetivos y Plan de Trabajo    
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3. Selección de las condiciones cromatográficas óptimas mediante la inyección de 
soluciones estándar, modificando la fase móvil con aditivos para mejorar la forma del 
pico cromatográfico y/o la separación. 
4. Estudio del proceso SPE (comparación de diferentes cartuchos SPE) usando muestras 
blanco enriquecidas antes y después del paso por la SPE. 
5. Estudiar la posibilidad de inyección directa para este método. 
6. Evaluar las recuperaciones de filtración para ambos filtros de vacío y jeringa. 
7. Evaluar la estabilidad de todos los compuestos a diferentes temperaturas (-20ºC, 4ºC 
y 20ºC) durante un máximo de 7 días (30 días a -20ºC). 
8. Validación de los métodos optimizados mediante la evaluación de la linealidad, 
exactitud y precisión de los experimentos de recuperación a diferentes niveles de 
concentración. Estimación de los límites de cuantificación y detección de todos los 
compuestos estudiados. 
9. Aplicación del método desarrollado y validado para el análisis de muestras de aguas 
residuales. 
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1.1 Emerging Contaminants in Water 
Water is the most important resource on the planet, essential for all life and covers more than two-
thirds of the Earth’s surface; however, less than 3% of that is freshwater, able to be used for drinking.  
It is therefore crucial to ensure that this great minority of freshwater is kept clean, which is being 
achieved thanks to the introduction of wastewater and drinking water treatment plants. However, 
despite these measures, it is impossible to remove all unwanted compounds, resulting in them entering 
effluent, surface water and even in drinking water. Many of these unwanted compounds belong to the 
group called emerging contaminants (ECs), a wide group of compounds that are not yet regulated 
despite their wide presence in the environment. 
The occurrence of ECs in water is a cause for concern. ECs encompass a wide variety of everyday, 
well-consumed anthropogenic and natural products including pharmaceuticals, drugs of abuse, 
pesticides, personal care products and industrial chemicals. With burgeoning populations, new 
chemicals being made and used combined with the impossibility of wastewater treatment plants 
(WWTPs) to completely remove all ECs, they can be detected in effluent wastewater, and more 
worryingly,  surface waters.  In the early 1990s, reports began marking their appearance in groundwater 
and drinking water and it was found that WWTPs were the major source of these ECs (Ferrer and 
Thurman, 2013). In the early days of environmental analytical chemistry the focus was on the 
contaminants emitted at higher concentrations, such as polychlorinated biphenyls (PCBs) and 
dichlorodiphenyltrichloroethane (DDT), due to instrumental limitations.  But now, with instrumental 
and analytical improvements, more ECs can be detected and identified at the trace levels that they are 
commonly present at, albeit as a real analytical challenge.  
This thesis is primarily concerned with two subsets of ECs: pharmaceuticals and illicit drugs (PIDs). 
PIDs still encompass a huge number of compounds, with approximately 3000 pharmaceuticals alone 
and almost 600 illicit drugs and new psychoactive substances (Richardson and Ternes, 2014; UNODC, 
2014). In spite of these huge numbers, little is known about their individual use (or abuse), let alone 
their environmental impact. The big question, alluded to throughout this section, is whether the 
relative low concentrations of PIDs found in the environment (~ng/L) would cause adverse effects 
to either humans or wildlife. Environmental and public health organisations periodically revise their 
priority lists of contaminants based on health effect and occurrence in environmental waters. In the 
United States, the Environmental Protection Agency has recently included one antibiotic 
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(erythromycin) and nine natural and synthetic hormones (17α-ethinylestradiol, 17α-estradiol, 17β-
estradiol, equilenin, equilin, estriol, estrone, mestranol, and norethindrone) as priority drinking water 
contaminants. The European Commission have included two pharmaceuticals (diclofenac and 
ibuprofen) and two hormones (17α-ethinylestradiol and 17β-estradiol) in their directive (Richardson 
and Ternes, 2014). In spite of these findings, it is important to note that it is not just these ~3600 
parent compounds to investigate, but also their metabolites and transformation products (TPs), giving 
altogether a huge list of compounds of concern in the aquatic environment. 
As a means to investigate illicit drug use, wastewater-based epidemiology (WBE), first surmised by 
Daughton (Daughton, 2001) and first employed four years later (Zuccato et al., 2005) has become a 
very interesting and continually-widening area of research.  
1.1.1 Wastewater-based Epidemiology 
Traditionally, surveys and interview data have been used to estimate the number of illicit drug 
consumers within a society. However, this comes with distinct biases and is open for conjecture. 
Coupled with the ever-changing world of drug use, a more real-time approach was needed, first 
theorised in 2001 (Daughton, 2001).   WBE was first introduced in 2005 in Italy (Zuccato et al., 2005) 
and has been particularly utilised in Europe (Ort et al., 2014; Thomas et al., 2012) but has since 
expanded into China (Du et al., 2015; Khan et al., 2014), Hong Kong (Lai et al., 2013b), South Korea 
(Kim et al., 2015) Australia(Irvine et al., 2011; Lai et al., 2013a), Canada (Metcalfe et al., 2010) and the 
United States (Banta-Green et al., 2009; Subedi and Kannan, 2014).  
WBE initially focussed on the consumption of illicit drugs (conventionally cocaine, amphetamine, 
methamphetamine,  cannabis and MDMA (ecstasy))(Ort et al., 2014; Thomas et al., 2012), but has 
since moved, together with the drug users, to more current drugs such as new psychoactive substances 
(NPS)(Kinyua et al., 2015) and other lifestyle biomarkers such as caffeine, nicotine (Senta et al., 2015) 
and alcohol (Reid et al., 2011). Recently, further population biomarkers such as F2-isoprostanes 
(Daughton, 2012; Ryu et al., 2015) and health and exposure biomarkers including pesticides, 
pharmaceuticals and steroids have also been postulated (Thomas and Reid, 2011; Venhuis et al., 2014).   
This approach is based on the knowledge that illicit drugs consumed by an individual may be excreted 
either unchanged or as one (or a number of) metabolites. From the excretion and metabolism data, 
the parent drug (in the case of amphetamine, methamphetamine and MDMA) or a metabolite 
(benzoylecgonine for cocaine and THC-COOH for cannabis) can be chosen as the biomarker. It can 
be assumed that if a biomarker is sufficiently stable in water and is conveyed efficiently to the WWTP, 
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the amount collectively excreted in a given timeframe should be reflected by the amount reaching the 
WWTP in the corresponding interval. (van Nuijs et al., 2011)  
This approach provides objective, quantitative, near real-time profiles of illicit drug consumption by 
monitoring selected drug biomarkers entering the municipal sewage system. The concentration of 
these illicit drug biomarkers measured in influent wastewater (IWW) can be used to back-calculate the 
mass loads of the parent drugs and/or metabolites. These loads, together with knowledge of the drug 
metabolism and excretion can be used to estimate drug consumption which can then be extrapolated 
to the population served by the WWTP by dividing the drug consumption by the population.  
While this approach sounds simple, there are a lot of underlying assumptions and limitations, including 
sampling procedure, characteristics of the sewer system, and the biomarker chosen (Burgard et al., 
2014; Castiglioni et al., 2013). The biomarker selected should have a known excretion rate, be stable 
in wastewater (under a variety of weather conditions) for an extended period of time and be unique 
for the drug of interest. The first of these issues can be helped with toxicological information, leading 
to great collaborations between chemists and toxicologists within the WBE field (see Section 1.4 for 
more information on these collaborations). The second of these issues is one that has recently been 
reviewed and readers are advised to refer to McCall et al. (McCall et al., 2016). Finally, the third issue 
can be very troublesome.  For example, amphetamine is a metabolite of methamphetamine; while 
MDMA and amphetamine are enantiomeric, so differentiating excreted and dumped drugs needs 
advanced and expensive enantiomeric profiling (Emke et al., 2014). Furthermore, in spite of heroin 
being one of the most concerning drugs of abuse, it’s analysis for WBE is very complex, as it’s major, 
stable, metabolite is morphine, which is in itself a well-known prescribed drug. However, the exclusive 
metabolite, 6-monoacetyl morphine has a low excretion rate, low in-sample stability and can easily 
transform to morphine. A reliable, unbiased biomarker for heroin has thus not yet been found (McCall 
et al., 2016).  In spite of these limitations, WBE is a rapidly expanding field, with research spanning 
the world, and the traversing chemical fields: from pure analytical chemists to toxicologists, engineers, 
epidemiologists, statisticians, environmental chemists and computational chemists. With such a 
diverse range of fields and (so far) very promising and interesting results, the future is looking bright 
for WBE.  
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1.2 Analytical Strategies 
WBE approaches are normally quantitative, focussing on a small number of target compounds, for 
which low resolution but highly sensitive LC-MS/MS approaches are perfect. However, as WBE grew, 
so did the knowledge that there are thousands of potential compounds of interest in any given sample, 
changing the focus to  high resolution mass spectrometry (HRMS) instruments, capable of performing 
suspect screening methods based on in-house databases containing hundreds if not thousands of 
compounds. These instruments lead researchers beyond WBE, and into the environmental field, 
determining the existence of compounds in environmental matrices.  Beyond suspect screening is 
non-target screening, which has become a significant aspect of environmental analytical chemistry, 
where HRMS again is a prerequisite and theorises that no previous information on potential 
compounds of interest is available.  
1.2.1 Liquid Chromatography coupled to Mass Spectrometry 
Liquid Chromatography (LC) is an affinity-based chromatographic separation technique. Simply put, 
it is used to separate the components of a mixture present in a sample into its individual constituents. 
This is based on the polarity each individual component has, and their affinity to the stationary and 
mobile phases. Those components that are strongly retained by the sorbent particles of the stationary 
phase move slowly with the flow of the liquid mobile phase, and vice versa. This difference in “retention 
time” separates the samples into its individual parts, which can then be analysed quantitatively or 
qualitatively. 
The most common LC technique for the analysis of environmental samples is reversed phase (RP), 
although normal phase (NP) also has some applications as well as the intermediary hydrophilic 
interaction LC (HILIC). NP chromatography is used for the separation of more non-polar 
compounds, based on their affinity for a more polar stationary phase (i.e. silica) with a non-polar 
mobile phase (i.e. hexane, chloroform) used to separate those compounds more readily soluble in 
non-polar solvents. RP chromatography is far more common, incorporating an aqueous mobile phase 
and more non-polar column (based on silica stationary phases, which has been surface-modified to 
include long alkyl chains (e.g. C8H17, C18H37; called C8 and C18 columns respectively). Finally, HILIC 
chromatography provides improved separations and detection for highly polar compounds. The 
stationary phase is polar, similar to NP, incorporating silica, amino or cyano, but the mobile phase is 
similar to those employed in RP. HILIC also allows the analysis of charged substances, as in ion 
chromatography (Buszewski and Noga, 2012).  In spite of its complex retention mechanisms, HILIC 
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is suitable for analysing compounds that elute near the void in RP, which has led some groups to use 
it for analysing polar contaminants in the environment. (van Nuijs et al., 2011)  
The latter two chromatographic techniques also incorporate buffer solutions or additives to improve 
chromatographic peaks. The most common are small organic acids such as formic and acetic acid. 
Their widespread use is based on two fundamental reasons. First, many chromatographic separations 
benefit in terms of retention and/or peak shape under acidic conditions, because any silanol activity 
is suppressed. Second, most mass spectrometric measurements are done in positive ion mode, which 
is accomplished by the addition of a proton to form the protonated molecule [M+H] +. Organic acids 
have the necessary acidity and volatility to provide an excess of protons for this purpose. This volatility 
is necessary because one of the functions of the LC-MS interface is to vaporise the mobile phase, 
meaning that these acids are preferred to the popular but non-volatile LC-UV phosphate buffers. 
Although organic acids are the most common mobile phase additive, it may be necessary under certain 
circumstances to use more neutral conditions, either because the analytes are sensitive to acids, do not 
exhibit optimal resolution at low pH or because ionization in negative mode is used. When acids are 
not suitable, volatile salts such as ammonium formate and ammonium acetate may be the additives of 
choice.  
High performance liquid chromatography (HPLC) and ultra-high performance (or pressure) liquid 
chromatography (UHPLC) have both been used for the determination of emerging contaminants in 
water, with the latter being more highly utilised since its introduction in 2004. UHPLC has 
revolutionised LC, with HPLC methods able to be easily transferred. This, combined with a reduction 
in analysis time, has made it a powerful technique (Guillarme et al., 2010). More information relating 
to the use of HPLC and UHPLC in combination with high resolution mass spectrometry (HRMS) for 
the investigation of PIDs is found in Scientific Article 1.  
The interface between the LC and mass spectrometer is one of the most important aspects of LC-MS. 
Electrospray ionisation (ESI) is almost exclusively used in the analysis of emerging contaminants in 
environmental waters. The electrospray interface produces singly or multiply charged ions directly 
from an aqueous–organic solvent system by creating a fine spray of highly charged droplets in the 
presence of a strong electric field, with the assistance of heat or pneumatics. The successful formation 
of ions using ESI requires two steps: the transfer of the compound of interest into the gas phase and 
the addition of a charge to the analyte if it is not already in a charged state (Taylor, 2005). This interface 
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can work in both positive mode ([M+H]+, where the analyte gains a proton and becomes positively 
charged; i.e. basic compounds) and negative mode ([M-H]-, where the analyte loses a proton and 
becomes negatively charged; i.e. acidic compounds).  
The second part of an “LC-MS” instrument, mass spectrometry (MS), is the means for identification 
of a compound, where, after a compound has been separated chromatographically, it can be identified 
based on its mass. The interface converts components of the sample into rapidly moving gaseous ions, 
which the MS can then measure the mass-to-charge (m/z) ratio of, either in space or time, in the form 
of mass spectra. As most emerging contaminants are small molecules, the charge is almost exclusively 
1, meaning the m/z is simply the mass of the compound, with an extra proton or less a proton, 
depending on whether positive or negative ionisation was used (i.e. [M+H]+ or [M-H]-).  
The different mass spectrometers are differentiated based on their mass analysers, all of which have 
their own advantages and disadvantages. Some of the most common are quadrupole (Q), ion trap 
(IT), time-of-flight (TOF), Orbitrap and Fourier-transformed ion cyclotron resonance (FT-ICR). The 
main criteria used to distinguish the mass analysers are the resolution (R) (the ability to separate two 
peaks of similar m/z) and mass accuracy (the error associated with the measured m/z). Table 1.1 
(adapted slightly from (Krauss et al., 2010)) compares the parameters of these instruments. In order 
to improve sensitivity and to provide greater information than a single MS alone, the combination of 
two MS analysers has become prevalent, giving rise to triple quadrupole (QqQ), linear ion trap-
Orbitrap (LTQ-Orbitrap) and quadrupole-time-of-flight (QTOF), all of which were utilised in the 
work carried out for this thesis.  
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Table 1.1: Comparison of commercial mass analysers in LC-MS instruments. Typical values for an m/z 
range of 300-400 are given; specific instruments or configurations might have improved figures 
Mass 
Spectrometer 
Resolving 
Powera 
(FWHM) 
Mass accuracy 
(ppm) 
Linear dynamic 
range 
Sensitivityc 
(absolute mass) 
QqQ Unit resolutionb 50 104 fg-pg 
QIT 10,000 50 103 fg-pg 
TOF 20,000 3 102-103 pg (full scan) 
Orbitrap 100,000 2 103-104 fg-pg (full scan) 
FT-ICR 1,000,000 ≤1 104 pg (full scan) 
a: Resolving power depends on m/z range and scan speed on most instruments 
b Unit mass resolution is the resolution for standard quadrupole instruments; with special hyperbolic quadrupole 
instruments a resolving power of 5,000 and a mass accuracy of 5 ppm can be achieved without a major loss of signal 
intensity  
c fg (femtogram, 10-15g), pg (picogram, 10-12g) 
 Sensitivity depends strongly on the ionization efficiency of the compound in the ion source  
Within low resolution mass analyzers, the triple quadrupole (QqQ) is the most popular at present, and 
the choice for the majority of analytical environmental chemistry methods, especially because of its 
high sensitivity – required for the trace analysis of emerging contaminants in environmental waters – 
and robustness. It consists of two quadrupole mass analysers (Q) in series, with a non-mass-resolving 
radio frequency only quadrupole (q) in between to act as a collision cell, to aid in collision induced 
dissociation (CID). CID occurs based on the collision between an ion that is selected in the first 
quadrupole (Q1) and an inert gas. The fragment ions produced are then passed through to the second 
quadrupole (Q2) where they may be filtered or scanned. Each quadrupole can be operated 
independently in either full-scan or selected ion monitoring (SIM) mode. The objective of the analysis 
influences which mode is used by each Q, with the four most common being product ion scan, neutral 
loss scan, precursor ion scan and selected reaction monitoring (SRM) mode, all of which will be briefly 
explained below.      
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i) Product ion scan 
In the product ion scan, Q1 is set to select an ion of a certain mass which is fragmented in the q. Q2 is 
then set to scan the full m/z range, giving information on fragment ions of the selected precursor ion. 
The information obtained from this scan can be useful for the elucidation of the structure of the 
original ion, but is commonly used to identify the transitions used for a subsequent quantitative 
analysis in the method development.  
 
ii) Neutral loss scan 
In this scan, both Q1 and Q2 are scanned together but Q2 has a mass offset equal to that of a neutral 
loss (i.e. H2O, CO, NH3). This allows the selective detection of all ions which, by fragmentation in q, 
lead to the loss of a given neutral fragment. This technique is useful in the screening of closely related 
classes of compounds in a mixture or unknown samples.  
 
 
 
 
 
Q1 q Q2
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Q1 q Q2
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iii) Precursor ion scan 
When utilizing a precursor ion scan, a certain product ion is selected in Q2, and the precursor masses 
are scanned in Q1. This method used for the detection of structural homologues that have a common 
fragment ion. 
iv) Selected reaction monitoring 
 
When employing selected reaction monitoring (SRM) mode, both Q1 and Q3 are set at a specific mass, 
allowing only a distinct fragment ion from a certain precursor ion to be detected. This is normally 
known as a “transition” when working in tandem MS. This working mode results in increased 
sensitivity, and is the approach typically used in quantitative analysis as in Scientific Article 7.  
The use of QqQ instruments for quantitative, small scale studies does hold promise and should be a 
mainstay in environmental analytical chemistry laboratories. The use of these instruments in LC-
MS/MS methods is nowadays the most common way to determine priority (polar) contaminants in 
the aquatic environment. However, with only a limited number of compounds able to be quantified 
in this way due to the acquisition time of each transition and the related instrumental limitations, it is 
insufficient for a complete overview of contaminants present in the samples.  
High Resolution MS transcends these limitations and enables the detection of a theoretically limitless 
number of compounds, even without the need of reference standards. This is made possible with the 
Q1 q Q2
Ar(g)
Ion source
Q1 q Q2
Ar(g)
Ion source
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combination of full-spectrum data with high mass resolution and mass accuracy. More information 
on these instruments, combined with UHPLC is given in Scientific Paper 1.   
1.2.2  Matrix Effects 
The main limitation of LC-MS/MS quantitative strategies interfaced with ESI is matrix effects, which 
occur when matrix interferences coeluting with the compound(s) of interest alter the ionisation 
efficiency, resulting in signal enhancement or suppression. Matrix effects are the result of competition 
between nonvolatile matrix components and analyte ions for access to the droplet surface for transfer 
to the gas phase (Taylor, 2005). The magnitude of these effects are influenced by analyte and matrix 
properties such as proton affinity, surface activity, and polarity, as well as the ratio of analyte to matrix 
mass and instrument parameters including the desolvation temperature and ionization polarity of the 
mass spectrometer and the flow rate of the HPLC (Backe and Field, 2012).  
In order to count for matrix effects, appropriate correction means are necessary, which include the 
use of isotope-labelled isotopic standards (ILIS), matrix-matched calibration, sample dilution, further 
sample clean-up and treatment and standard addition. These have all been evaluated and contain 
various advantages and disadvantages (Niessen et al., 2006; Stahnke et al., 2012; Taylor, 2005). It is 
important to take into account the specific matrix being analysed, before deciding the appropriate 
means of correction. For example, matrix-matched calibration or standard addition, common in 
pesticide residue analysis are less suitable for the analysis of drugs in wastewater. This is primarily due 
to the availability of a suitable “blank” sample being very difficult to obtain, let alone one that is 
representative of the samples.  
For the analysis of illicit drugs in water samples, alternative approaches are applied to compensate for 
matrix effects. Most common is sample pretreatment, where solid-phase extraction (SPE) is 
performed to selectively retain and pre-concentrate the analytes of interest while removing interfering 
compounds.  However, this may also lead to a pre-concentration of interfering compounds, which 
has led to some utilising online SPE or large volume injection (Anumol and Snyder, 2015; Farré et al., 
2012; Vazquez-Roig et al., 2013). A simple approach to reduce matrix effects is sample dilution or to 
use smaller injection volumes. In this way, the amount of matrix introduced in the ion source is 
reduced, thereby decreasing signal enhancement/suppression problems generated by the interferences 
(Bijlsma et al., 2014; Stahnke et al., 2012).  
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The preferred method to compensate for matrix effects is the use of internal standards. An isotopically 
labelled internal standard (ILIS) is considered to be the ideal internal standard, as it shows (almost) 
identical behaviour to the target analyte in both sample pre-treatment, chromatography, and analyte 
ionization. Unfortunately, ILIS are available for only a limited number of target analytes, they are 
expensive, and often difficult to obtain for other target compounds, especially with sufficient isotopic 
purity with respect to the non-labelled variant (Niessen et al., 2006). This makes multiresidue methods 
troublesome, especially if some target analytes do not have an ILIS, and must therefore share with an 
ILIS of another compound that has a similar structure or retention time. In spite of the assurances of 
ILIS, even with their availability, in complex matrices it is generally recommended to also incorporate 
an additional means of matrix effect reduction, such as a pretreatment step in order to gain maximum 
sensitivity and precision.  
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1.2.3 Target, Suspect and Non-Target Screening 
 
 
Figure 1.1: Workflow for target, suspect and non-target screenings. Each method has its own individual colour: target 
(green), suspect (blue) and non-target (orange), with each step specific for any particular method coloured respectively. 
Steps concerning more than one method are in grey, while levels of confidence of identity obtained are in yellow.  
 
Target screening is the common approach when using the SRM mode of LC-MS/MS QqQ 
instruments, described above. In this method, a limited number of compounds are selected in advance, 
their specific transitions monitored and their presence in samples quantified based on their respective 
reference standards. The big limitation of this method is that there are many other compounds 
potentially present in samples being ignored. Some authors have proposed the term pre-target analysis 
for the methods based on QqQ, where the analytes must be selected before analysis, and therefore 
data acquisition is analyte-specific (Hernández et al., 2005).  
The limitation in the number of compounds to be investigated by QqQ, has led to a shift from the 
traditional LC-MS/MS pre-targeted approach to HRMS (QTOF and Orbitrap) suspect and non-target 
approaches. These two methods rely on the high resolution, exact mass capabilities of these 
instruments, as no reference standards are needed, at least in the initial stages. As well as HRMS 
instruments, these methods also require powerful deconvolution software.  
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As in the famous Donald Rumsfeld speech, these three screening methods can be thought of as 
analysing known knowns (target), known unknowns (suspect) and unknown unknowns (non-target). 
In other words, target methods are specific, analysing compounds that are being deliberately searched 
for; suspect methods search for a much larger range of compounds (i.e. through the use of a database) 
but it is not known which of these compounds will be encountered in the samples; finally in non-
target methods it is not known which compounds are in the samples or are being searched for. The 
steps associated with each method are shown in Figure 1.1.  
Suspect analyses investigate a list of compounds that are potentially present in samples on the basis 
of a database, containing name, molecular formula (or exact mass), as a minimum requirement. Further 
information, such as fragment ions and adduct formation can also be added. The main difference with 
pre-target analysis is that availability of reference standards is not a prerequisite, as the information 
acquired is the accurate-mass full-spectrum, which implies that HRMS is needed. In this way, the 
selection of analytes to be searched in the samples can be made after mass data acquisition, a reason 
why some authors have named it as a post-target screening (Hernández et al., 2005). The data 
acquisition is a very important aspect of suspect analyses, with simultaneous low- and high-energy 
acquisition highly recommended. This HRMS acquisition is known as MSE, all-ions MS/MS or all-
ions fragmentation, depending on the manufacturer, and means that in a single run, data can be 
acquired relating to the parent compound (low energy) and fragment ions (high energy).  
After data acquisition by HRMS, specialised, manufacturer-specific software such as ChromaLynx 
(Waters), TraceFinder (Thermo Scientific), DataAnalysis (Bruker) and MassHunter PCDL Manager 
(Agilent Technologies) incorporates the database and extracts all “positive” findings based on the 
user-set parameters in the form of extracted ion chromatograms (XICs).   In the cases where reference 
standards are available, the suspect compounds can be identified based on a comparison of the parent 
ion (at exact mass), fragment ions (for confirmation, where possible) and retention time.  
As reference standards are not necessarily available for all compounds, further steps can be used to 
gain tentative identification.  Initially, the mass accuracy of the HRMS instruments can be utilised, 
with accuracy possible down to <5ppm giving great confidence to (at least) the molecular formula of 
a compound within the database. However, there is a distinct possibility of isobaric compounds (e.g. 
with the same exact mass), depending on the width of the extraction window used within the software, 
and even at a certain m/z there is a chance of an isomeric compound within the XIC. Isotopic pattern 
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fitness or retention time prediction can then be used to gain further identification confidence. 
Alternatively, fragment ions can be searched and compared with literature or online mass spectral 
databases. Even though reference standards may be unavailable, a high degree of confidence in the 
“tentative” identification can be found, based on fragment ions and their comparability and 
compatibility with literature and possible chemical structure, respectively.   
Some groups have introduced confidence levels for the detection and identification of compounds 
(Schymanski et al., 2014). However, for the sake of clarity and continuity within this thesis, the criteria 
set out in Scientific Article 2 are followed: 
Detection: based on the presence of one accurate mass ion and retention time agreement (with 
reference standard)  
Confirmation of the identity (shortened to confirmation), with at least two accurate mass ions and 
retention time agreement (with reference standard) 
Tentative identification: with at least two accurate mass ions justified by literature data and/or 
compatibility with candidate chemical structure 
In all cases, the isotope pattern observed must fit the theoretical expected from the presence in the 
molecule of relevant atoms such as carbon, chlorine, bromine, among others. The parameters for mass 
error may differ depending on instrument used, with Orbitrap tending to have better mass accuracy 
and therefore the acceptable mass error may be smaller than that of a QTOF. However, within QTOF 
instruments, depending on the vendor as well as the age and use of the instrument, maximum allowed 
mass errors may differ from 20ppm (Kinyua et al., 2015) down to 5ppm, the latter being used in all 
works performed in this Thesis (Scientific Articles 2 and 3).   
With the ever-improving manufacturer-specific software, it is becoming more feasible to perform 
non-target analyses (such as the identification of metabolites or TPs) on a single platform, such as 
Metabolynx (Waters), Sieve (Thermo Scientific), Metabolite Tools (Bruker) and Metabolite ID 
(Agilent). However, it is impossible to include all necessary parameters in a single software, with 
complementary programs commonly sought.   
Non-target analyses begin with a simple hypothesis: “I do not know anything about this sample and 
the possible contaminants therein, but I want to know which compounds are there.”  While this does 
indeed sound simple and achievable, in practice it is very complex. Unlike the previous two methods, 
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where some sort of a priori knowledge is used in the development of the “target” or “suspect” lists, in 
non-target analysis, there is no previous knowledge at all, as implied by the name. To begin the analysis 
procedure, the chromatographic peaks need to be picked (i.e. which peaks are the most important). 
This determination can be made based on the end result: if the analyst wants to look for compounds 
of a high concentration, a high threshold will be given for the peaks requiring further analysis, thereby 
removing all peaks under the set threshold. Alternatively, if the analyst is searching for compounds, 
TPs or metabolites of a likely low concentration, a low threshold will be set. Nevertheless, for both 
methods, a subtraction based on a (procedural) blank sample is made to remove peaks known to not 
belong to the sample.  
Once the peaks for further investigation are found, molecular formulae are given, based on various 
heuristic filters (Kind and Fiehn, 2007). These can then be searched in databases such as ChemSpider, 
PubChem, NIST and DAIOS to give an idea of the possible compound of interest (Bletsou et al., 
2015; Little et al., 2012; Müller et al., 2011). When searching databases based on a molecular formulae, 
there is a high likelihood of isomers and therefore a ranking system is necessary to determine which 
the compound of interest is. This can be made based, simply, off the number of available sources 
(with the higher number of sources indicating a more common/known compound), or by utilising 
the HRMS data originally obtained, i.e. the fragment ions generated. A very useful non-target tool has 
been developed for this purpose, MetFusion. This software takes the fragment ions obtained for a 
specific peak and those computationally derived from its sister software MetFrag, compares them with 
the online mass spectra database, MassBank, and gives a ranked list of possible candidates based on 
spectral similarity (Gerlich and Neumann, 2013). The candidates given, based on either the ranking 
system or through the use of fragment ions can then be compared with literature data to give tentative 
identification or lead to the purchase or synthesis of standards can lead to confirmation.  
While the methodology seems straightforward, there are distinct difficulties associated with non-target 
analyses. The most complex problem is that the compounds traditionally searched for using this 
approach are those of lower concentration and not necessarily known or incorporated into suspect 
databases. The peaks would therefore be in the “noise” range of most chromatograms, so powerful 
software is required to help deconvolute the chromatograms.  Furthermore, even after distinct masses 
are found, there is a very high probability that there is more than one compound relating to any one 
specific m/z, and even isomers. For these reasons, non-target approaches are a real analytical challenge, 
very time-consuming and may only yield limited results. Nevertheless, this approach is gaining in 
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scientific interest, and with advances in the sensitivity of high resolution instruments combined with 
even more powerful software, they could become a routine part of environmental analytical chemistry.   
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1.3 Scientific Article 1 
INVESTIGATION OF PHARMACEUTICALS AND 
ILLICIT DRUGS IN WATERS BY LIQUID 
CHROMATOGRAPHY-HIGH-RESOLUTION MASS 
SPECTROMETRY 
F. Hernández *, M. Ibáñez, R. Bade, L. Bijlsma, J.V. Sancho 
Trends in Analytical Chemistry (2014) 63: 140-157 
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Abstract 
Mass spectrometry (MS) coupled to chromatography has been increasingly used in the environmental 
field, as it allows the best performance currently attainable for the investigation of a wide range of 
organic pollutants. When dealing with emerging contaminants, there is a clear trend towards the use 
of liquid chromatography-mass spectrometry (LC-MS) techniques, from tandem (low-resolution) MS 
to high-resolution (HR) MS. HRMS allows targeted and untargeted analysis, thanks to full-spectrum 
acquisition at high mass accuracy with good sensitivity. With the same instrument, target, suspect and 
non-target screening can be performed, as can retrospective analysis and discovery of 
transformation/degradation products. This article gives a general overview on the use of HRMS in 
LC-based methods directed towards the investigation of illicit drugs and pharmaceuticals in the 
aqueous environment. We consider time-of-flight and Orbitrap mass analyzers, and we discuss the 
benefits of using ultra-high-performance liquid chromatography (UHPLC) in combination with 
HRMS. 
 
 
Keywords 
Emerging contaminant; High-resolution mass spectrometry (HRMS); Illicit drug; LC-HRMS; Liquid 
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1. Introduction 
The increasing number of emerging contaminants, such as pharmaceuticals (both human and veterinary) and 
personal-care products (PPCPs), or illicit drugs, detected in the water cycle can be attributed to the growth of 
the human population, the shift towards the use of more hydrophilic compounds in consumer applications, 
and undoubtedly the improvements in selectivity and sensitivity of modern analytical techniques. 
Pharmaceuticals and illicit drugs (PIDs) are continuously excreted or discarded into the sewer systems as the 
unaltered parent compounds or their metabolites. Subsequently, they often end up in environmental waters, as 
a consequence of incomplete elimination by wastewater-treatment plants (WWTPs) [1]. There is justified 
concern over the possible impact of these pharmacologically-active compounds on the environment, especially 
over the long-term toxicological effects on living organisms and the combined effect of exposure to multiple 
compounds, particularly antibiotics [2]. In addition, a large number of transformation products (TPs), in many 
cases unknown, can be formed in the water cycle and need to be taken into account to know the overall 
contribution of these contaminants in the environment [1]. The presence of PIDs and their metabolites in water 
and sediments has spurred researchers to set up monitoring studies to evaluate their fate [2] and [3], and their 
removal and transformation in WWTPs [4], [5] and [6]. An interesting field that has emerged from the analysis 
of wastewater is the so-called sewage-based epidemiology (SBE), directed towards the estimation of illicit drug 
use of a population on the basis of the determination of appropriate biomarkers in influent wastewater. SBE is 
a promising, complementary tool to existing population surveys and other conventional approaches to 
estimating illicit drug use. SBE requires the application of sophisticated analytical methodologies able to 
quantify illicit drugs accurately in urban raw wastewater [7], [8] and [9]. 
The very low concentrations generally found for PIDs and/or their metabolites (commonly sub-µg/L levels), 
in combination with the complexity and the unknown composition of the different aqueous matrices to be 
analyzed, makes it necessary to use highly sensitive, selective analytical methodologies. The majority of the 
methods developed have been based on liquid chromatography (LC) coupled to tandem mass spectrometry 
(LC-MS/MS), particularly with triple quadrupole (QqQ) analyzers [2] and [10]. The medium-high polarity of 
most PIDs justifies the predominance of this technique. The use of MS/MS under selected-reaction monitoring 
(SRM) mode facilitates the accurate quantification of target analytes at trace levels. Furthermore, the acquisition 
of two SRM transitions, together with retention-time data and measurement of ion-intensity ratios, gives 
sufficient information for safe identification. Typically, the most sensitive transition is selected for 
quantification and at least one additional transition is acquired to render a reliable confirmatory method. 
However, the MS source and the conditions of the analyzer need to be optimized for determination, carefully 
considering the specificity of transitions to avoid potential false negatives or positives [11]. 
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The current trend in analytical chemistry is the development of LC-MS based methods that seek the 
simultaneous determination of many compounds in a single run, providing considerable information about 
their occurrence, and reducing analysis time and cost [10], [12], [13] and [14]. In spite of the high sensitivity and 
selectivity reached, LC-MS/MS has some limitations regarding multi-class analysis, especially when broadening 
the scope of the method to a large number of compounds. In MS/MS methods, the acquisition time of each 
transition restricts the number of target analytes that can be monitored. Although latest-generation QqQ 
instruments have low dwell times and allow notable increase in the number of transitions acquired within a run, 
there is still a limitation when dealing with thousands of contaminants that may potentially be present in waters. 
Thus, the application of target LC-MS/MS methods is clearly insufficient to achieve a realistic, extensive 
overview of pollutants present in the samples. This is because, in target LC-MS/MS methods, compounds 
other than the selected analytes are commonly ignored, even if they are present at high levels in the sample. 
High-resolution MS (HRMS) transcends this major limitation of targeted MS/MS analysis. HRMS instruments 
[e.g., time-of-flight (TOF) and Orbitrap] provide high-quality information by combining sensitive full-spectrum 
data with high mass resolution and mass accuracy [15] and [16]. In theory, the presence of an unlimited number 
of compounds can be investigated, without requiring the pre-selection of analytes or even without having 
reference standards available. 
With the ever-improving technology of LC-MS systems, it is easy to overlook the equally important aspect of 
chromatography. However, an efficient chromatographic separation is essential to avoid or to minimize matrix 
interferences, and to get reliable identifications. Ultra-high-performance (pressure) LC (UHPLC) has emerged 
as an innovative, powerful separation technique based on the use of columns containing stationary-phase 
packing with particle sizes smaller than those of conventional HPLC [17]. It has led to evident improvements 
in chromatographic separations, an important and relevant aspect in LC-MS analysis. Shorter chromatographic 
run times and improved sensitivity are common advantages derived from the use of UHPLC, but some other 
aspects may also be considered, as highlighted in this review. This article discusses the application of LC-HRMS 
for the investigation of PIDs and metabolites/TPs in water samples, and the role that UHPLC can play within 
this field of analysis. 
2. High-resolution mass spectrometry 
HRMS circumvents the main drawback of targeted SRM analysis (i.e., missing non-pre-selected compounds 
even if they are present at high concentrations in the samples). HRMS instruments (e.g., TOF and Orbitrap) 
provide high-quality data by combining sensitive full-spectrum mass data with high mass resolution and mass 
accuracy. Since acquisition is not targeted, any ionizable compound in the sample can be, in principle, detected 
and investigated. Furthermore, hybrid instruments, such as quadrupole-TOF (QTOF) and Linear Trap 
Quadrupole Orbitrap (LTQ-Orbitrap), offer additional information on compound confirmation and/or 
structure elucidation [18]. 
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Several studies employ a post-targeted approach, which involves an initial data inspection, based on the use of 
the exact mass of known substances in a customized database. Hundreds of compounds can be investigated 
on the basis of their theoretical exact mass, compared with the accurate-mass measurements, which greatly 
increase the reliability of identification [19]. Moreover, the presence of compounds initially not considered, 
such as new substances and TPs, can be investigated from full-scan accurate-mass data acquired at any time 
without the need for additional analysis [20], [21], [22] and [23]. This ability is advantageous, as, in many 
occasions, the samples may already have been discarded or the analytes degraded, so additional sample 
injections may not be possible. This retrospective analysis enables the screening to be further widened, by 
reprocessing only raw data. The main benefit of using HRMS is that it eschews the need for reference standards, 
as tentative identifications of suspect compounds can be made on the basis of the information provided by this 
technique. Obviously, reference standards are required for ultimate confirmation, but they may be acquired in 
a final stage when solid well-founded evidence exists on the presence of the compound in the sample. In this 
way, laboratories do not need to acquire all reference standards before analysis, with the subsequent problems 
of availability (e.g., TPs), costs and expiry dates [24]. 
Non-target analysis may also be explored when using HRMS. A true “unbiased” non-target screening, without 
any a priori information on the compounds to be detected, is an analytical challenge, as the process needs 
expertise, and is complex and time-consuming [15], [25] and [26]. An intermediate situation between target and 
true non-target analysis is the application of “biased” non-target approaches, where, for example, the formation 
of “unknown” TPs from a given parent compound is computationally predicted [27] and [28], or tentatively 
identified by performing laboratory experiments [22], [29], [30], [31] and [32]. Other options (e.g., searching for 
common fragments or mass-defect filtering) are also feasible and useful in investigating the presence of related 
compounds. Here, the number of chemically meaningful structures, which can be assigned to an unknown peak, 
is limited to structures showing a close relationship with the parent compound [15]. 
Krauss et al. gave an overview of the state of the art and future trends of LC-HRMS applied to the 
environmental analysis of polar micropollutants [15], showing illustrative systematic workflows for different 
approaches: quantitative target analysis with reference standards; suspect screening without reference standards; 
and, non-target screening of unknowns (Fig. 1). 
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Fig. 1: Comparison of systematic workflows for (a) quantitative target analysis with reference standards, (b) suspects screening without reference 
standards, and (c) non-target screening of unknowns in environmental samples by using liquid chromatography-high resolution (tandem) mass 
spectrometry [LC-HRMS(MS)]. *Note that the m/z range of the extraction window for the exact-mass filtering depends on the mass accuracy 
and the resolving power of the mass spectrometer used. {Reproduced from [15] with permission}. 
After a compound (based on a suspect or non-target approach) is discovered, the next step is to confirm its 
identity. Usually, this process involves acquisition of full product-ion spectra after re-analyzing the sample by 
MS/MS systems (i.e. hybrid QTOF or LTQ-Orbitrap), in order to match the observed accurate-mass product 
ions with the chemical structure of the suspect or candidate(s). In order to obtain fragmentation information 
in a single run, some hybrid analyzers allow acquisition of full-scan spectra with and without applying collision 
energy in a sequential fashion. Using this acquisition mode, named MSE by Waters, or high-collision dissociation 
(HCD) by Thermo [33] and [34], two separate acquisition functions are sequentially measured in full-scan mode. 
The first, without applying collision energy in the cell (LE), obtains a conventional full spectrum, where intact 
(de)protonated molecules/adducts are commonly observed, followed by a second (HE), where a fixed or 
collision-energy ramp is applied in order to induce ion fragmentation. In this way, fragmentation information 
is obtained in advance for all compounds in a single run without the need to re-inject the sample in MS/MS 
mode. 
Despite its qualitative potential, HRMS typically shows lower sensitivity than QqQ instruments operating in 
SRM mode, and quantitative LC-HRMS applications are more limited. However, Orbitrap and the latest TOF 
instruments show improved sensitivity and wider linear dynamic range, similar to that of QqQ, so prompting 
their use for quantification and identification/confirmation in a single run [20], [35] and [36]. 
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3. Contributions of UHPLC 
UHPLC is the most important development in LC in recent years. This technique uses chromatographic 
columns packed with particles with diameters below 2 µm, which significantly increase efficiency, even at high 
mobile-phase flow rate, achieving faster separations [17] and [37]. Conventional HPLC runs can be relatively 
long, particularly to avoid or to minimize co-elution of matrix interferences that may lead to difficulties in terms 
of identification. To this end, UHPLC can be of additional value. First, it shortens the run time, and, second, 
it facilitates attaining sufficient chromatographic resolution to minimize co-elution of compounds with close 
m/z values. In addition, a remarkable increase in detectability can be achieved as a consequence of the narrower, 
higher peaks provided by this technique. 
The combination of UHPLC with MS appears to be a suitable approach that fulfils sensitivity, selectivity and 
peak-assignment certainty. However, due to the very narrow peaks produced by UHPLC (commonly 1–6 s), 
coupling with MS devices may be critical. For this reason, specific quadrupole-based instruments that show 
improved acquisition rates were launched for UHPLC coupling. The short dwell times (low-ms range) offered 
by modern QqQ instruments allow easy coupling to UHPLC due to the narrow chromatographic peaks 
obtained. 
Initially, UHPLC found many applications in pesticide residues, where a large number of pesticides could easily 
be separated and measured by MS/MS in less than 10 min [38], [39] and [40]. Obviously, UHPLC-MS/MS has 
also been applied in other fields, including the quantitative determination of PIDs in water [14], [41], 
[42] and [43]. 
Aside from triple quadrupole (QqQ) mass analyzers, TOF instruments afford fast full-spectral acquisition rates 
at good sensitivity and high mass-resolution (10,000–40,000 FWHM depending on the instrument) with high 
mass accuracy (typically lower than 5 ppm). The scan speed attainable by recent accurate-mass TOF analyzers 
falls in the range of 10–100 scans/s, more than enough to follow the narrow chromatographic peaks obtained 
under UHPLC separations, without compromising mass resolution and sensitivity. 
Modern TOF analyzers represent a promising alternative, particularly for screening purposes, to the well-
established QqQ instruments, as TOF can deal with the large number of compounds to be searched in 
environmental research. The improved chromatographic resolution and detectability achieved by UHPLC 
separations were particularly essential when using QTOF mass analyzers in MSE acquisition mode. As 
fragmentation is promoted in HE function, without pre-selecting any precursor ion, recognizing which ions are 
fragment ions and which are not becomes essential to avoid spectral interferences that would complicate the 
identification process. With this aim, UHPLC has become a valuable tool for choosing ions obtained from the 
HE function that perfectly co-elute with the intact (de)protonated molecule from the LE function, and 
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assigning them as potential fragment ions. In this way, an additional MS/MS acquisition can be avoided, 
speeding up the screening and confirmation steps following the MSE approach. 
In order to illustrate the benefits of UHPLC separations along this process, Fig. 2a shows the LE and HE mass 
spectra for a wastewater-sample extract obtained after solid-phase extraction (SPE). The LE mass spectrum 
(bottom) shows several abundant ions, which are expected to be the “precursor ions” of the fragments, 
observed in the HE mass spectrum (top). In order to correlate the potential (de)protonated molecules with 
their fragment ions, extracted ion chromatograms (XICs) were obtained for all ions (at LE and HE) and 
chromatographic peak shapes and retention times were evaluated. As can be seen in Fig. 2b, two co-eluting 
compounds appeared in this sample, but, based on the improved chromatographic profile achieved by UHPLC, 
their fragment ions could be easily differentiated. Thus, the fragment ions observed in HE with m/z 119 and 
m/z 91 were assigned to the “precursor” m/z 192, while the ions m/z 207 and m/z 159 were assigned to m/z 
297. 
 
 
 
Fig. 2: (a) Low-energy (LE) and high-energy (HE) (Q)TOF mass spectra for a wastewater-sample extract after SPE; (b) XICs for the 
protonated molecule (at LE) and main fragment ions (at HE) for two co-eluting compounds. 
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A new type of HRMS analyzer, Orbitrap, was invented by Alexander Makarov in 2003 [44] and [45]. This device 
shows high mass resolution (>100,000 FWHM), high mass accuracy (<5 ppm) and acceptable dynamic range 
(103). The main drawback is its scanning speed, which is inverse of mass resolution. For example, only 1 scan/s 
can be acquired when using a resolution of 100,000. This limitation obviously affects the number of points per 
chromatographic peak and therefore its correct chromatographic peak shape when coupled to UHPLC, where 
peak widths are only a few seconds. By contrast, when a faster scanning speed is selected (e.g., 10 scans/s), 
resolution decreases dramatically (e.g., 10,000 FWHM). Thus, a compromise between achievable resolution and 
adequate chromatography must be found [46] and [47]. Nevertheless, several examples of the use of UHPLC 
columns combined with Orbitrap mass analyzers can be found [48], [49], [50] and [51]. Unfortunately, the mass 
resolution used is not reported or the chromatographic peak widths estimated from the chromatograms shown 
are unacceptably large (20–60 s) for a genuine UHPLC separation. Apparently, only Pinhancos et al. [48] 
worked in pseudo-UHPLC conditions, reporting chromatographic peaks of around 10s width. 
In summary, so far, insufficient data have been reported to support the efficient combination of UHPLC with 
Orbitrap in this field. We expect further improvements in the scan speed of these mass analyzers without 
significantly affecting the mass-resolving power in the near future, making possible successful coupling to true 
UHPLC separations. 
4. Applications of LC-HRMS 
In this section, we present different approaches to the investigation of PIDs in waters by LC-HRMS, including 
target, suspect and non-target screening, and characterization of TPs of PIDs subjected to degradation under 
laboratory-controlled conditions. 
Table 1 and Table 2 give overviews of the literature on LC-(Q)TOF-MS and LC-(LTQ)Orbitrap-MS 
applications, respectively. 
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Table 1: Literature overview on LC-QTOF-MS applications 
Author 
(year) LC Compound (no.)a 
T/S/NT/D
a Matrixb Observationsc Ref. 
Marchese 
(2003) 
HPLC Pharmaceuticals (5) T SW Quantification and 
confirmation 
(QqQversus QTOF) 
[52] 
Stolker 
(2004a) 
HPLC Pharmaceuticals 
(13) 
T SW, GW, 
DW 
Quantification 
(QqQ) and 
confirmation 
(QqQversus QTOF) 
[56] 
Stolker 
(2004b) 
HPLC Pharmaceuticals (5) T SW, WW Quantification and 
confirmation 
(QqQversus QTOF) 
[57] 
Agüera 
(2005) 
HPLCd Diclofenac D A Elucidation of Hy 
and PhN TPs by LC-
TOF MS+GC-MS 
(13) 
[97] 
Boreen 
(2005) 
Infusiond Pharmaceuticals (5) D SW Elucidation of PhN 
TPs of sulfa drugs by 
LC-UV + TOF-
MS + FTIR + 1H 
NMR + 13C NMR (5) 
[88] 
Eichhorn 
(2005) 
HPLC Trimethoprim D WW Elucidation of Bd 
TPs (2) by LC-
QTOF-MS + LC-IT-
MS + H/D exchange. 
Quantification by 
LC-MS 
[89] 
Ibáñez 
(2005) 
HPLC Unknown 
compounds 
NT SW,GW,W
W 
Screening and 
elucidation of 
unknown 
compounds 
[25] 
Petrovic 
(2006) 
UHPLC Pharmaceuticals 
(29) 
T SW,WW Screening, 
quantification and 
confirmation 
[71] 
Pozo 
(2006) 
HPLC Antibiotics (16) T SW,GW Quantification 
(QqQ) and 
confirmation 
(QqQversus QTOF) 
[11] 
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Author 
(year) LC Compound (no.)a 
T/S/NT/D
a Matrixb Observationsc Ref. 
Martínez 
Bueno 
(2007) 
HPLCd Pharmaceuticals 
and metabolites 
(48), and other 
emerging 
contaminants (56T, 
5S) 
T, S, NT WW Quantification 
(QTRAP) and 
confirmation 
(QTRAP versusTOF) 
[64] 
Pérez 
(2007) 
UHPLC Enalapril and its 
metabolite 
enalaprilat 
D A Elucidation of PhS 
TPs (3 from 
enalapril + 1from 
enalaprilat by 
QTOF+QqLIT MS) 
[98] 
Farré 
(2008) 
UHPLC Pharmaceuticals 
(28) + phytoestroge
ns (4) 
T SW, WW Quantification and 
confirmation 
(QqQversus QTOF) 
[55] 
Ibáñez 
(2008) 
UHPLCd Organic pollutants NT SW, WW Screening and 
identification. 
Empirical library 
(104) versusTheoretica
l library (500) 
[114] 
Kosjek 
(2008) 
UHPLC Diclofenac D A, HPLC Elucidation of Bd 
TPs (4). Isotopic 
cluster analysis 
[87] 
Radjenović 
(2008) 
UHPLC Atenolol and 
glibenclamide 
D WW Elucidation of Bd 
TPs (1 from 
atenolol + 1from 
glibenclamide). 1 TP 
detected in WW by 
QqLIT-MS. 
[107] 
Ibáñez 
(2009) 
UHPLC Pharmaceuticals 
(62) 
T SW, WW Screening and 
confirmation 
[69] 
Lavén 
(2009) 
HPLC Pharmaceuticals 
(15) 
T WW Screening, 
quantification, 
confirmation and 
removal efficiency 
[72] 
Ferrer 
(2010) 
HPLC Chlorine-
containing 
compounds 
Semi-NT DW, GW, 
WW, SW, 
HPLC 
Lamotrigine and its 
metabolite (2-N-
glucuronide) detected 
[112] 
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Author 
(year) LC Compound (no.)a 
T/S/NT/D
a Matrixb Observationsc Ref. 
in DW, SW and WW 
samples. 
Quantification 
Gómez 
(2010) 
HPLC Pharmaceuticals, 
transformation 
products and 
pesticides 
NT WW, SW Screening, 
quantification and 
confirmation. 
Database containing 
pharmaceuticals 
(87) + pesticides 
(300) 
[74] 
López-
Roldán 
(2010) 
UHPLCd Pharmaceuticals 
(28) and estrogens 
(10) 
T SW Quantification 
(QqQ) and 
confirmation (TOF) 
[65] 
Magnér 
(2010) 
UHPLC Pharmaceuticals 
(10) 
T SW, MW Screening, 
quantification and 
confirmation 
[67] 
García-
Galán 
(2011) 
UHPLC Sulfamethazine D A Elucidation of TPs 
after Bd by 
fungusTrametes 
versicolor(4). Removal 
efficiency in SS by 
QqLIT-MS 
[108] 
Gómez-
Ramos 
(2011a) 
HPLC Sulfamethoxazole D n.d. Elucidation of Oz 
TPs (6) 
[105] 
Gómez-
Ramos 
(2011b) 
HPLC Pharmaceuticals, 
illicit drugs, TPs and 
other organic 
pollutants 
NT WW Screening and 
identification. 
Database containing 
147 compounds. 
Identification of 
related and 
unexpected TPs 
[115] 
Hernández 
(2011a) 
UHPLC Pharmaceutical 
metabolites (160) 
S WW Screening and 
identification 
(retrospective 
analysis) 
[21] 
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Author 
(year) LC Compound (no.)a 
T/S/NT/D
a Matrixb Observationsc Ref. 
Hernández 
(2011b) 
UHPLC Illicit drugs and 
metabolites (11 T + 
65 S) 
T, S WW Screening and 
identification 
[73] 
Nurmi 
(2011) 
UHPLCd Pharmaceuticals 
(16) and pesticides 
(68) 
T WW Screening, 
quantification and 
confirmation 
[120] 
Pérez-
Parada 
(2011) 
HPLC Amoxicillin D WW, SW Elucidation of Hy 
TPs (4). 1 TP 
detected in SW 
samples 
[91] 
Postigo 
(2011a) 
UHPLC Methadone D A, HPLC Elucidation of Hy, 
PhN and Pc TPs (6). 
1 confirmed with 
reference standard 
[100] 
Postigo 
(2011b) 
UHPLC Cocaine D A, HPLC Elucidation of Hy, 
PhN and Pc TPs (14) 
[101] 
Terzic 
(2011) 
UHPLC Polar contaminants NT Sed The aquatic sediment 
was influenced by 
pharmaceutical 
industry 
[111] 
Díaz 
(2012) 
UHPLC Pharmaceuticals, 
illicit drugs, TPs and 
other organic 
pollutants 
(231 T + 1100 S) 
T, S, NT WW Screening and 
identification 
[16] 
Eichhorn 
(2012) 
UHPLC Sildenafil (Viagra) 
and its N-
demethylated 
metabolite 
D HPLC,A,SW Elucidation of PhS 
TPs (8 from 
sildenafil + 6 from N-
demethylsildenafil) by 
LC-ESI-TOF-
MS + LC-APCI-
QqQ-MS + H/D 
exchange 
[90] 
Ferrer 
(2012) 
HPLC Pharmaceuticals 
and degradation 
products (100) 
T DW, GW, 
SW WW 
Screening, 
quantification and 
confirmation 
[36] 
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Author 
(year) LC Compound (no.)a 
T/S/NT/D
a Matrixb Observationsc Ref. 
Gonzalez-
Mariño 
(2012) 
HPLC Illicit drugs and 
metabolites 
(24 T + 130 S) 
T, S WW Screening, 
quantification and 
identification 
[35] 
Leknes 
(2012) 
UHPLCd Oseltamivir and its 
metabolite 
oseltamivir 
carboxylate 
T WW Screening, 
quantification and 
confirmation 
[66] 
Martínez 
Bueno 
(2012) 
HPLC Pharmaceuticals 
and illicit drugs 
(10 T, 1200 S) 
T, S, NT SW Screening, 
quantification and 
identification 
[116] 
Nurmi 
(2012) 
 Pharmaceuticals 
and pesticides 
(88 T + 201 S) 
T, S, NT WW Evaluation of T, S, 
NT screening with 
spiked samples. 
Application of T, S to 
real WW. Theoretical 
library (6) 
[117] 
Bijlsma 
(2013) 
UHPLC Cocaine and its 
metabolite 
benzoylecgonine 
D SW Elucidation of Hy, Cl 
and PhS TPs (16 
from cocaine + 10 
from 
benzoylecgonine). 7 
TPs detected in SW 
and WW samples by 
UHPLC-QqQ-MS 
[30] 
Boix 
(2013) 
UHPLC Omeprazole D SW Elucidation of TPs 
after Hy, Cl, PhS (17). 
4 TPs detected in SW 
and WW samples by 
UHPLC-TOF-MS 
and UHPLC-QqQ-
MS 
[22] 
Díaz 
(2013) 
UHPLC Pharmaceuticals, 
illicit drugs and TPs 
(150 organic 
pollutants) 
T SW, GW, 
WW 
Qualitative validation [121] 
Masiá 
(2013) 
UHPLC Pharmaceuticals, 
illicit drugs and 
other emerging 
T, S WW, SW Quantification (42 
pesticides by QqQ), 
confirmation (QqQ 
and QTOF) and 
[75] 
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Author 
(year) LC Compound (no.)a 
T/S/NT/D
a Matrixb Observationsc Ref. 
contaminants 
(250 T + 1100 S) 
identification 
(QTOF) 
Vergeynst 
(2013) 
UHPLC Pharmaceuticals 
(69) 
T SW Screening, 
quantification and 
confirmation 
[70] 
Boix 
(2014a) 
UHPLC Omeprazole 
metabolites (24) 
T WW, SW Retrospective 
screening of 
metabolites 
previously identified 
in metabolism study. 
9 metabolites 
detected in samples 
[23] 
Boix 
(2014b) 
UHPLC THC-COOH 
(Cannabis 
metabolite) 
D SW Elucidation of Hy, Cl 
and PhS TPs (19). 8 
TPs detected in SW 
and WW samples by 
UHPLC-QqQ-MS 
[29] 
Rodriguez-
Alvarez 
(2014) 
HPLC Ethyl sulfate 
(biomarker for 
ethanol tracing) 
T WW Quantification and 
confirmation 
(QqQversus QToF) 
[68] 
a T, Target; S, Suspect; NT, Non-Target; D, Degradation study. 
b HPLC, High-performance liquid chromatography, distilled, Ultrapure or demineralized water; SW,Surface water; 
WW, Wastewater; GW, Groundwater; DW, Drinking water; SS, Sewage sludge; A, Any artificial water matrix; 
MW, Marine environment; Sed, Sediment; n.d., Not clearly defined. 
c PhN, Photolysis with natural sunlight; PhS, Photolysis with simulated sunlight; Bd, Biodegradation; Hy, Hydrolysis; 
Pc, Photocatalysis; Cl, Chlorination; Oz, Ozonation. 
d Only TOF instrument used. 
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Table 2: Literature overview on LC-LTQ Orbitrap-MS applications 
Author (year) LC Compound (no.)a T/S/NT/Da Matrixb Observationsc Ref. 
Hogenboom 
(2009) 
HPLC Pharmaceuticals, illicit 
drugs and other 
emerging 
contaminants (3000 T) 
T, NT SW, 
WW, 
GW, 
DW 
Screening, 
quantification and 
identification 
[118] 
Hollender 
(2009) 
HPLC Emerging 
contaminants (220 T, 
including 77 
pharmaceuticals); 
known oxidation TPs 
of 5 pharmaceuticals 
(S) 
T,S WW Screening and 
removal efficiency 
for 220 pollutants 
after Oz 
degradation. 
Screening of 
known oxidation 
products of 5 
pharmaceuticals 
[85] 
Kern (2009) HPLC Plausible TPs 
assembled using 
computer-aided 
prediction (UM-PPS) 
of pesticides 
(24) + biocides 
(7) + pharmaceuticals 
(21). TPs reported in 
literature of 
pharmaceuticals (21) 
and pesticides (31). 
Total: 1794 proposed 
TPs (890 from 
pharmaceuticals) 
S SW 19 TPs identified 
in SW (7 from 
pharmaceuticals) 
→ 12 confirmed 
with reference 
standards 
[28] 
Helbling (2010) HPLC Plausible TPs 
assembled using 
computer-aided 
prediction (UM-PPS) 
of pharmaceuticals 
(6) + pesticides (6). 
Degradation study 
S, D WW 26 TPs identified 
after Bd (13 from 
pharmaceuticals). 
UM-PPS predicted 
the structures of 21 
TPs. Elucidation 
resulted in 26 TPs 
[84] 
Kern (2010) HPLC Plausible TPs 
assembled using 
computer-aided 
prediction (UM-
S WW 12 TPs identified 
after Bd. 
Application to real 
samples 
[27] 
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Author (year) LC Compound (no.)a T/S/NT/Da Matrixb Observationsc Ref. 
PPS) + TPs reported 
in literature (7) 
(quantification by 
QqQ) 
Bagnati (2011) HPLC Cocaine and 
benzoylecgonine 
T WW, 
SW 
Evaluation of 
HRMS capabilities: 
screening, 
quantification and 
confirmation 
[122] 
Pinhancos 
(2011) 
UHPLC Pharmaceuticals 
(8) + metabolite of 
caffeine 
T DW Screening, 
quantification and 
confirmation 
[48] 
Wille (2011) UHPLCd Pharmaceuticals (16) 
and pesticides (13) 
T MW Screening, 
quantification and 
confirmation 
[49] 
Bijlsma (2012) HPLC Illicit drugs and 
metabolites (24) 
T WW Quantification, 
confirmation and 
removal efficiency 
[77] 
Cahill (2012) HPLC Pharmaceuticals (5) 
and pesticides (4) 
T WW Screening, 
quantification and 
confirmation 
[78] 
Calza (2012a) HPLC Clarithromycin and 
carbamazepine 
D HPLC Elucidation of Pc 
TPs (28 from 
carbamazepine and 
29 for 
clarithromycin) 
[31] 
Calza (2012b) HPLC Lincomycin D HPLC Elucidation of Pc 
TPs(21) 
[32] 
de Jongh (2012) HPLC Pharmaceuticals and 
TPs (26) 
T SW, 
DW, 
GW 
Screening and 
quantification 
[79] 
ter Laak (2012) HPLC Pharmaceuticals, illicit 
drugs, personal care 
products and other 
organic pollutants 
(635) 
T GW Screening and 
confirmation 
[82] 
Bijlsma (2013) HPLC Illicit drugs and 
metabolites 
(24 T + 2 S) 
T, S WW Quantification and 
confirmation. 
[20] 
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Author (year) LC Compound (no.)a T/S/NT/Da Matrixb Observationsc Ref. 
Calza (2013) HPLC Lincomycin, 
clarithromycin and 
carbamazepine 
D SW Elucidation of PhS 
TPs (19 from 
lincomycin, 21 
from 
carbamazepine and 
6 from 
clarithromycin).13 
TPs detected in 
samples 
[99] 
Chiaia-
Hernandez 
(2013) 
HPLC Pharmaceuticals, 
personal-care 
products and other 
organic pollutants 
(>180 T + 80 S) 
T, S Sed Screening and 
identification 
(APPI and ESI) 
[81] 
van der Aa 
(2013) 
HPLC Illicit drugs and 
metabolites (34) 
T DW, 
SW, 
WW 
Screening and 
quantification (incl. 
QqQ, Orbitrap) 
from different 
research groups 
[123] 
Rodayan (2014) UHPLC Illicit drugs and TPs 
(7) 
D WW Elucidation of Oz 
TPs (10). Removal 
efficiency 
[50] 
Emke (2014) HPLC Amphetamine and 
MDMA 
T WW Enantiomeric 
profiling. 
Quantification and 
confirmation 
[83] 
Hug (2014) HPLC Novel micropollutants 
(98 T + 2160 S) 
T, S, NT WW Screening and 
identification 
[26] 
Kosma (2014) HPLC Pharmaceuticals and 
personal-care 
products (18) 
T,S WW Confirmation of 
positives detected 
by LC-MS. 
Removal efficiency 
by LC-MS. 
Identification of 
trimethoprim TPs 
(2). 
[80] 
Schymanski 
(2014) 
HPLCe Polar organic 
contaminants 
(364 T + ~180 S) 
T, S, NT WW Screening and 
identification 
[119] 
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Author (year) LC Compound (no.)a T/S/NT/Da Matrixb Observationsc Ref. 
Zonja (2014) HPLC Zanamivir D A, SW Identification of 
TPs after PhN and 
PhS (4). 1 TP 
confirmed with 
reference standard 
[51] 
a T, Target; S, Suspect; NT, Non-target; D, Degradation study. 
b HPLC, High-performance liquid chromatography; distilled, Ultrapure or demineralized water; SW,Surface 
water; WW, Wastewater; GW, Groundwater; DW, Drinking water; SS, Sewage sludge; A, any artificial water 
matrix; MW, marine environment; Sed, Sediment. 
c PhN, Photolysis with natural sunlight; PhS, Photolysis with simulated sunlight; Bd, Biodegradation; 
Hy, Hydrolysis; Pc, Photocatalysis; Cl, Chlorination; Oz, Ozonation. 
d Exactive instrument used. 
e Q Exactive instrument used. 
 
4.1. Screening of pharmaceuticals and illicit drugs in waters 
LC-HRMS has extraordinary potential for screening PIDs in waters. The most efficient, rapid way is to perform 
target screening of a large number of compounds on the basis of large (in-house) databases. In this target 
approach, theoretical exact masses of analytes are extracted from full-spectrum acquisition data, reconstructing 
accurate-mass chromatograms, where the presence of analytes in the samples can be depicted as a 
chromatographic peak. Mass accuracy is critical for identification purposes. Normally, mass errors below 5 ppm 
are observed in routine analysis with the new instruments commercially available. The accurate mass of the 
(de)protonated molecule (on occasions adducts), the information on characteristic fragment ion(s), the isotopic 
pattern, and retention time matching with reference standards enable unambiguous identification of PIDs in 
environmental samples. 
4.1.1. (Q)TOF-MS applications 
TOF and/or hybrid QTOF analyzers are most commonly used in this field. The first works dealing with the 
analysis of pharmaceuticals in the environment by LC-QTOF-MS were reported in 2003. Marchese et al. [52] 
compared the potential of QqQ and QTOF for the LC-MS determination of five pharmaceuticals in river-
water samples. According to the authors, the selectivity was much better on QTOF than on QqQ because of 
the high resolving power of the TOF analyzer, permitting high-accuracy fragment-ion selection and minimizing 
interferences from environmental matrices. In the same year, Ferrer et al. showed the benefits of the enhanced 
resolving power of LC-QTOF-MS when investigating polar organic contaminants in complex environmental 
matrices, as isobaric interferences could be separated from the analyte signals [53] and [54]. 
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After these pioneering works, the capability of (Q)TOF-MS for screening, quantification and/or confirmation 
of pharmaceuticals in water samples has been regularly compared to that of LC-MS/MS with QqQ [11], [55], 
[56] and [57], and that resulted in a general agreement on the strong points and the weak points of these 
techniques. The elevated mass resolution and selectivity of TOF instruments diminish the problem of isobaric 
interferences [55], making TOF-MS very useful for not only identification and confirmation purposes, but also 
studying metabolic routes and degradation pathways [57]. The main limitation of TOF instruments has 
traditionally been lower sensitivity than QqQ instruments, making QqQ more appropriate for analysis at low 
ng L−1 concentrations of analytes [11]. In terms of dynamic range and limits of detection (LODs), the 
quantitative performance of QqQ instruments still presents better features than TOF-MS [55]. 
Several reviews were published in the past decade dealing with the use of LC-HRMS for the determination of 
PIDs in environmental analysis. We recommend reading of these reviews by researchers interested in this field 
[2], [3], [10], [13], [18], [58], [59], [60], [61], [62] and [63]. 
QTOF-MS has been used for unequivocal confirmation of the identity of pharmaceuticals previously detected 
and quantified by LC-MS/MS in SRM mode using hybrid quadrupole linear ion trap (QTRAP) [64] or QqQ 
[65]. The possibility of performing retrospective analysis has allowed the revision of recorded chromatograms 
for new compounds, metabolites or TPs in the samples, increasing the scope of the method in monitoring 
programs [21] and [64]. LC-MS/MS and LC-(Q)TOF-MS can be seen as complementary techniques. On the 
one hand, LC-MS/MS is the first choice for quantification in pre-target analysis, due to its good sensitivity and 
precision. On the other hand, QTOF provides accurate-mass measurements, and is ideal for post-target 
screening and confirmation. The most suitable strategy seems to be automated screening and identification by 
LC-(Q)TOF, followed by quantification by LC-MS/MS [65]. 
The use of (Q)TOF instruments for quantification of target analytes in environmental samples has been rather 
limited; however, in the past few years, there was increased use of quantitative analysis, since the limitations of 
lower sensitivity and linear dynamic range were mostly solved. This improvement contributed to extending the 
use of LC-(Q)TOF-MS to quantitation of target pharmaceuticals [66] and [67] and drugs [35] or alcohol 
biomarkers [68] in water. 
The qualitative field is undoubtedly where HRMS can take full advantage of its capabilities derived from 
sensitive accurate-mass, full-spectrum acquisition. These capabilities offer the possibility of investigating the 
presence of compounds once sample analysis has been performed and MS data acquired (i.e., without pre-
selection of analytes), and are especially suitable for screening/identification of contaminants and confirmation 
of presumed positive samples reported by other techniques. 
LC-(Q)TOF-MS has been applied successfully to the investigation of pharmaceuticals belonging to different 
therapeutic classes in surface waters [55], [69] and [70], seawater [67] and wastewaters [55], [66], [71] and [72], 
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and also illicit drugs and their metabolites in wastewaters [35] and [73]. As a consequence of the intrinsic 
characteristics of HRMS analyzers, their use enables screening for a large number of contaminants with high 
sensitivity within one run, with the obvious restrictions derived from the chromatographic and ionization 
processes in LC-MS and from sample pre-treatment. LC-(Q)TOF-MS instruments have been applied for 
comprehensive screening of many pollutants of different chemical families, including PIDs [36], [64], 
[73] and [74] in water samples. In some cases, LC-(Q)TOF-MS has also been used as a complementary tool for 
target LC-QqQ-MS-based methods allowing the detection of analytes different to those selected in previous 
QqQ methods [75]. 
The easy review step and the useful information provided by TOF-MS gives high confidence in the 
identification of the compounds detected, even without reference standards being available. In these cases, 
tentative identification may be possible based on the presence of the (de)protonated molecule (i.e., when a 
chromatographic peak is detected at its accurate mass). Subsequently, the collision-induced dissociation (CID) 
fragments/product ions (or characteristic isotopic ions) are then evaluated [16]. For this purpose, different 
possibilities are available, such as comparing experimental MS(/MS) spectra or the main fragment ions with 
those reported in the literature (massbank, or METLIN public library), or justifying the accurate-mass 
fragments taking into account the structure of the molecule. For the latter approach, the use of specialized 
software (e.g., MassFragment) can help. 
As an example, Fig. 3 illustrates the detection and the tentative identification of veterinary anthelminthic drug 
levamisole, recently also recognized as an adulterant in cocaine, in an effluent wastewater by using UHPLC-
QTOF-MS, operating in MSE mode. The protonated molecule of levamisole was detected in the LE function 
(Fig. 3a, bottom), with 3.4-ppm mass error. As the reference standard was not available at the laboratory, the 
accurate mass of the fragment ions was justified using the MassFragment software (Waters) in order to advance 
towards a tentative identification. To minimize spectral interferences that would complicate the identification 
process, recognizing which ions are and which are not fragments became essential. To this end, UHPLC was 
valuable for choosing perfectly co-eluting ions (see chromatographic peak at 3.86 min, Fig. 3b). The elemental 
composition for the two fragments detected in the HE function (Fig. 3a, top) (m/z 178.0689 and 123.0267) 
was calculated, obtaining errors less than 1 ppm in relation to the theoretical exact masses predicted. In addition 
to all information available, tentative identification of levamisole was supported by the MS/MS product ions 
reported in the literature, where the two fragments (m/z 178 and m/z 123) observed had been previously 
reported using an LTQ-Orbitrap with a resolution of 7,500 [76]. The final acquisition of the reference standard 
allowed the ultimate confirmation of this compound in the wastewater sample. 
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Fig.3: Detection and identification of levamisole by UHPLC-QTOF-MS in effluent wastewater (the reference standard was not available at 
the laboratory at the time of analysis): (a) Low-energy (LE) (bottom) and high-energy (HE) (top) spectra of the compound eluting at 3.86 min. 
(b) Extracted-ion chromatograms (0.02 Da mass width) for the protonated molecule in LE function and different fragment ions in HE function. 
(×) indicates that this ion is not related to levamisole 
The interesting possibilities offered by hybrid QTOF-MS, including the option of working in MSE mode, have 
led to a dramatic increase in the number of contaminants being included in the search, with more than 1000 
compounds included in some cases [16] and [75] by applying suspect-screening approaches. This opens up a 
new scenario in screening strategies, favoring a wider, more realistic overview when investigating organic 
contaminants or residues in different applied fields. 
4.1.2. (LTQ) Orbitrap-MS applications 
The development of the Orbitrap analyzer in 2003 spurred researchers to explore its potential for accurate-
mass screening, identification and quantification of PIDs in wastewaters [77] and [78], surface waters [79] and 
drinking waters [48] and [79] with good recoveries and RSD values. Similarly to QTOF, Orbitrap has also been 
used for the confirmation of PIDs previously found by other techniques [80] and for wide-scope target 
screening. A multi-residue method has been developed for target and suspect screening (i.e., compounds that 
did not form a part of the original target-screening list but were expected to be present in samples) of more 
than 180 organic contaminants, including pharmaceuticals, in lake sediments [81]. Orbitrap also enables 
retrospective analysis of the full-scan data, without the need for additional analysis [20], [48] and [49]. Assessing 
steps included retention-time prediction, isotope patterns, ionization efficiency and fragmentation pattern. 
Product ions of the MS/MS spectrum of a suspect compound were compared with the spectrum of a reference 
standard or with a predicted fragmentation pattern. This allowed the tentative identification of TPs of triclosan 
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and triclocarban. In another work, 42 groundwater samples were screened for 249 known chemicals and 386 
unidentified chemicals (i.e., accurate masses and retention times) [82]. Nearly 400 chemicals were observed in 
the samples, of which 82 were known and more than 300 were of unknown identity.  
Emke et al. [83] applied enantiomeric profiling in verifying sources of MDMA and amphetamine present in 
Dutch wastewater. The results from Orbitrap analysis showed that MDMA was usually present in wastewater 
due to its consumption as MDMA enriched with the R(−)-enantiomer. The high mass loads of racemic MDMA 
detected during a sampling campaign in The Netherlands therefore seemed to proceed from the direct disposal 
of unused MDMA, possibly as the result of a police raid at a nearby illegal production facility. HPLC separation 
was successfully performed using Chiral-CBH column, 100 × 2 mm, 5 µm. Unfortunately, this approach is not 
yet feasible for UHPLC, due to the lack of chiral sub-2-µm stationary phases. 
4.2. Screening metabolites/transformation products in water samples 
After human or animal consumption, PIDs or veterinary drugs may be excreted unchanged and/or as free or 
conjugated metabolites. Some of these compounds are not completely removed during wastewater treatment 
and may finally reach surface waters and even groundwaters. Consequently, several authors have included the 
main metabolites and TPs among the compounds monitored [21], but only a few works have focused on 
screening a notable number of TPs in aquatic compartments. Different approaches have been proposed in the 
literature for the investigation of metabolites and TPs, as shown below. 
4.2.1. (Q)TOF-MS applications 
Hernández et al. [21] studied the presence of 160 pharmaceutical metabolites in wastewater samples that had 
previously been analyzed for only parent compounds using LC-QTOF-MS (MSE mode). The compounds 
investigated were selected after extensive search for TPs and metabolites reported in the literature and from 
lists of commercially available reference standards. As a first step, the presence of the metabolite ion (typically 
[M+H]+ or [M-H]-) at its accurate mass was evaluated. Different strategies were applied in the tentative 
identification: 
• when the reference standard of the parent compound was available, and therefore accurate-mass 
fragment ions of the pharmaceutical were known, the accurate-mass fragments of the suspected 
metabolite were predicted, taking into account the structural differences between both molecules; 
and, 
• when fragmentation information on the parent was not available, chemical structures of the accurate-
mass fragments were proposed using specialized software (MassFragment). 
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In this case, information reported in the literature on product ions for the suspect metabolite or for the parent 
compound was essential (based on measurements of nominal mass or accurate mass). Following this strategy, 
several metabolites, such as clopidogrel carboxylic acid and N-desmethyl clarithromycin, were tentatively 
identified and subsequently confirmed after acquisition of the reference standards. 
In a recent work, Boix et al. [23] investigated the presence of 24 omeprazole metabolites (identified in previous 
excretion tests performed with healthy volunteers) in surface water and effluent wastewater by UHPLC-QTOF-
MS and UHPLC-MS/MS. Up to nine metabolites were detected, the most frequent being an omeprazole isomer, 
which presented the same exact mass (m/z 346.1225), and also shared a major common fragment at m/z 
198.0589. By contrast, parent omeprazole was never detected in any of the water samples. The authors 
emphasized that monitoring the presence of omeprazole in the aquatic environment should focus on the main 
metabolites and some of the major TPs identified in laboratory experiments, instead of the parent compound. 
4.2.2. (LTQ) Orbitrap-MS applications 
Another strategy makes use of target lists of plausible TPs assembled using the University of Minnesota 
Pathway Prediction System (UM-PPS) for the computer-aided prediction of products of microbial metabolism 
and of metabolites and TPs reported in the literature. In this way, Kern et al. screened for potential 
biotransformation-product structures of pharmaceuticals in sludge-seeded batch reactors [27] or surface water 
[28] using HRMS (LTQ Orbitrap). These authors developed an identification procedure to examine a large 
number of proposed TPs efficiently for tentative identification without reference standards [28]. The procedure 
was based on a series of steps, with each step reducing the number of potential false-positive findings: 
(a) mass error of the measurements was <5 ppm for all compounds; 
(b) positive peak findings from the extracted chromatogram were discarded if the peak intensities in the 
extracted chromatogram were <105 (arbitrary units), or if a peak at similar retention and similar intensity was 
found in the blank sample; 
(c) experimental gradient retention times of the target TPs were tested against an upper plausible limit; 
(d) the isotope pattern of the HRMS spectra was evaluated to confirm a target molecular formula; 
(e) peaks with reasonable retention times and isotopic patterns were further checked for plausibility of a 
proposed TP in positive or negative ionization mode (e.g., compounds containing amino but no acidic groups 
were considered analyzable in positive-ionization mode only, whereas strong acids or sulfonates were expected 
to be detectable in negative mode); and, 
(f) to confirm further the presence of the target compounds in the samples, HR-MS/MS was used at higher 
energy collision-dissociation settings. 
Altogether, 19 TPs were identified [28], including some rarely reported TPs, such as biotransformation products 
of pharmaceuticals venlafaxine and verapamil. 
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In another work, Helbling et al. [84] performed a preliminary identification of TPs formed within a 
biotransformation-test system using HRMS with two independent post-acquisition data-processing approaches: 
• target screening at the exact masses of plausible TPs proposed by the UM-PPS for 12 selected parent 
compounds; and, 
• screening for compound masses formed during biodegradation experiments based on background 
subtraction and exact mass filtering. 
With this strategy, previously unreported microbial TPs were tentatively identified for several pharmaceuticals. 
Hollender et al. [85] evaluated the removal efficiency of 220 micropollutants at a municipal WWTP upgraded 
with post-ozonation treatment followed by sand filtration. Afterwards, screening was conducted for known 
ozonation TPs of diclofenac, carbamazepine, and sulfamethoxazole, and possible oxidation products of 
benzotriazole and atenolol by LC-HRMS (Orbitrap). 
4.3. Degradation/transformation under laboratory-controlled conditions 
Once PIDs enter the WWTP, they can be completely mineralized, transformed into metabolites/TPs, adsorbed 
onto the solid phase (e.g., sewage sludge), or pass through the WWTP unaltered. Similarly, once released into 
the environment via the discharge of treated wastewater, PIDs are subjected to different processes, such as 
hydrolysis and photo-degradation by natural sunlight. In order to evaluate the fate of PIDs in the water cycle, 
the removal of the parent compounds and metabolites in the WWTP must be taken into account, but also the 
possible formation of TPs. The identification of TPs is complicated, but important, not only to provide a 
comprehensive risk assessment on drug residues in the environment (TPs can be equally or even more toxic 
and dangerous than the parent pollutants), but also to design improved treatment technologies for organic 
contaminants. From the different possibilities currently available, LC-HRMS has gained popularity and has 
become one of the techniques preferred for elucidating TPs in the environment. Several reviews have focused 
on the capabilities and the potential of MS techniques to determine pharmaceutical-degradation products [4], 
[5] and [86], although very little was included on the use of HRMS, surely due to the time-frame reviewed. 
The process of identification and elucidation of unknown TPs is arduous, and commonly starts with laboratory 
experiments to study the formation of TPs under controlled conditions simulating those that occur in the 
environment. The most feasible strategy relies on MS measurement of their accurate molecular mass and 
subsequent determination of the empirical formula, considering low mass errors (e.g., <5 ppm). The maximum 
and minimum parameters considered in the elemental composition calculation may be restricted on the basis 
of the structure of the parent compound, and the number of halogen atoms selected according to the observed 
isotopic pattern. Further accurate MS/MS measurement and observation of characteristic fragmentation 
pattern of the precursor ion provide valuable information for identifying TPs. In some cases, HRMS alone is 
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insufficient to identify the exact position of transformation, to differentiate isomers, or to provide the precise 
structure of TPs. Thus, LC-HRMS can be combined with other techniques, such as nuclear magnetic resonance 
(NMR), or hydrogen/deuterium-exchange (H/D-exchange) for the final characterization of TP candidates of 
PIDs [87]. Although these techniques have little applicability in the environmental field, as they require high 
concentrations of analyte for measurement, they might be useful in laboratory experiments, where higher 
concentrations can be used. 
Considerable time and effort are required to interrogate the intensive LC-HRMS data to identify unknowns. 
However, normally, the TPs are not complete unknowns as they hold a certain structural relationship with their 
parent compound. Some works only focus the research on the peaks visible in the total ion chromatogram 
(TIC), which implies that other invisible peaks, which may correspond to TPs, would be lost. To avoid this 
problem, detection can be improved by applying spectral and chromatographic search algorithms [e.g., 
MetaboLynx (Waters), Analyst/MetaboliteID (Applied Biosystems), Xcalibur/MetWorks (Thermo Fisher) or 
MassHunter (Agilent)]. Such algorithms search XICs for expected metabolites based on predicted or 
unpredicted molecular changes relative to the parent compound, and thus aid in the detection and identification 
of TPs, particularly those buried in spectral noise. The software compares mass spectral chromatograms of a 
control sample versus an analyte sample (i.e. metabolized, stressed or treated sample), and automates detection, 
identification and reporting of metabolites [88], [89] and [90]. 
PIDs can be degraded in natural environments or in WWTPs by both abiotic (advanced oxidation, photolysis 
and hydrolysis) or biotic (biodegradation) processes [87]. Different degradation/transformation experiments 
have been performed under laboratory-controlled conditions, trying to simulate the probable processes 
occurring in the aquatic environment and/or in WWTPs. Some representative examples are discussed below. 
4.3.1. Hydrolysis experiments 
Hydrolysis is a process occurring naturally in the environment. Pérez-Parada et al. [91] performed solely 
hydrolysis degradation experiments on amoxicillin in both alkaline and acidic aqueous media. Four compounds 
were identified as main TPs by LC-QTOF-MS. Data showed that although this antibiotic is not present as such 
in environmental samples, different TPs might occur. However, most papers reported on hydrolysis, studied 
this process together with other degradation experiments [22], [29] and [30]. 
4.3.2. Photodegradation experiments 
Photodegradation by sunlight may constitute a relevant natural attenuation process for pollutant residues that 
have been discharged from WWTPs. It is one of the most important processes responsible for the degradation 
of contaminants in environmental systems [92], [93] and [94]. Understanding the degradation pathways is 
essential to predict the fate and the environmental impact of organic contaminants in waters. Photolytic 
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reactions lead to multiple reaction products that may be more toxic than the parent compound [95], retain the 
properties of the parent compound (e.g., antibiotic activity) [96], or lose antimicrobial activity and/or toxicity 
[95]. 
LC-TOF-MS has been used to elucidate the photo-TPs of several pharmaceuticals in water exposed to direct 
solar irradiation. Analytes studied included sulfa-drugs containing six-membered heterocyclic substituents (i.e., 
sulfamethazine, sulfamerazine, sulfadiazine, sulfachloropyridazine, and sulfadimethoxine) [88] and non-
steroidal anti-inflammatory drug diclofenac [97]. For diclofenac, the authors combined LC-TOF-MS with GC-
MS to detect and to identify a complete range of TPs, as both techniques provided complementary information. 
Similarly, the photochemical fate of prodrug enalapril and its active metabolite, enalaprilat [98], and sildenafil 
(Viagra) and its human metabolite, N-demethylsildenafil [90], have been investigated in aqueous media under 
the influence of a sunlight simulator. To postulate plausible chemical structures for several photo-TPs, accurate-
mass measurements were combined with complementary data sets from different instruments: 
• a QTRAP mass spectrometer exploiting its MS3 capabilities [98]; and, 
• LC-APCI-QqQ MS and H/D-exchange experiments [90]. 
The aqueous environmental fate of pharmaceuticals has also been studied using LTQ Orbitrap MS. Calza et al. 
[31] and [32] investigated the degradation of antibiotics lincomycin and clarithromycin, and antiepileptic drug 
carbamazepine, whereas Zonja et al. [51] evaluated the phototransformation of antiviral zanamivir in surface 
waters using simulated and natural sunlight. Several species were formed under irradiation, and were 
characterized by evaluating MS and MSn spectra. Fig. 4 shows an MS2 spectrum of a dihydroxyl derivative of 
lincomycin. The presence of a product ion at m/z 407.1836, due to the loss of methanol from the N-
hydroxymethyl moiety, combined with m/z 142.1219, indicates the existence of a hydroxyl group in the ortho 
position, and this allowed tentative structure elucidation. In the end, eight TPs from carbamazepine, three from 
clarithromycin, and two from lincomycin were detected in natural river water [99]. 
S
c
ie
n
ti
fi
c
 A
rt
ic
le
 1
 
Hernández et al. Trends in Analytical Chemistry 63 (2014) 140-157 
62 
 
 
Fig. 4: MS2 spectrum of a dihydroxy derivative of lincomycin. {Reproduced from [32] with permission}. 
Illicit drugs have also been subjected to degradation experiments, although they have been studied less than 
pharmaceuticals. Postigo et al. described the transformation of synthetic opioid methadone [100] and cocaine 
[101] in distilled water and simulated effluent wastewater after natural solar irradiation and two solar 
photocatalytic processes: 
• heterogeneous photocatalysis with titanium dioxide; and, 
• homogeneous photocatalysis by photo-Fenton. 
Phototransformation intermediates generated during each treatment were investigated and characterized by 
UHPLC-QTOF-MS/MS. Identity confirmation was possible for some of them with the analysis of 
commercially available analytical standards. 
The group of Hernández et al. performed laboratory-controlled degradation experiments for several PIDs in 
surface water. Hydrolysis, photo-degradation under ultraviolet (UV) irradiation and simulated sunlight, and 
chlorination experiments, were carried out. The TPs formed were investigated by LC-QTOF in MSE mode. 
Studies were directed towards the degradation of cocaine and its main metabolite benzoylecgonine [30], THC-
COOH (the main metabolite of cannabis and commonly selected as biomarker for the investigation of its 
consumption) [29] and omeprazole (one of the most consumed pharmaceuticals world-wide for treating gastric 
diseases) [22]. Six TPs from cocaine and 10 TPs from benzoylecgonine were tentatively identified. Regarding 
THC-COOH, one hydrolysis, eight chlorination, three UV photo-degradation and seven sunlight photo-
degradation TPs were tentatively identified. In addition, 17 TPs were identified for omeprazole. In a subsequent 
step, samples of influent and effluent sewage water, and surface water, were retrospectively screened using 
UHPLC-QTOF-MS and UHPLC-QqQ MS for the TPs previously identified in the laboratory experiments. In 
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addition to some known compounds, several TPs that had not been reported in the literature were found in 
the samples, illustrating the usefulness of the degradation experiments performed. 
As an illustrative example, Fig. 5 shows the detection and the identification of an omeprazole photo-TP (OTP 
5) after 14 days of solar irradiation of spiked surface water. A chromatographic peak was observed at 5.68 min 
(Fig. 5a, bottom), while it was absent in the blank control sample (Fig. 5a, top). According to its accurate mass 
(m/z 330.1284, Fig. 5b, bottom), the elemental composition of the protonated molecule was assigned as 
C17H20N3O2S+ (+2.4 ppm mass error), which would imply the loss of one oxygen atom from the omeprazole 
molecule. The fragment ions at m/z 297.1497 (C17H19N3O2+•, 6.7 ppm mass error) and m/z 282.1240 
(C16H16N3O2+, −1.1 ppm) (Fig. 5b, top) were assigned to thiol [•SH] and subsequent methyl [•CH3] radical 
losses, respectively, and were related to the presence of a sulfide group [23]. Thus, an oxygen loss from the 
sulfur atom in the original omeprazole structure was suggested for this TP. This compound, identified in 
laboratory experiments, was later found in the water samples analyzed. 
 
Fig. 5: Detection and identification of a TP of omeprazole (OTP 5) by LC-QTOF-MS (MSE) resulting from photodegradation. (a) XIC 
at m/z 330.1276 (0.02-Da mass-window width) for analyte-sample (bottom) and control-sample (top), after 14 days of solar irradiation. (b) 
Low-energy (LE) (bottom) and high-energy (HE) (top) spectra and justification of fragment ions observed. 
4.3.3. Advanced oxidation processes (AOP) experiments 
Great efforts were made in recent years to develop additional (or alternative) processes for wastewater 
treatment. An interesting review on removal of pharmaceuticals from water was recently published, and is 
recommended for additional information on this issue [102]. Although ozonation leads to the elimination of 
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many organic compounds in aqueous solution, this is not necessarily accompanied by total mineralization [103]. 
In most cases, degradation by-products generated in the process persist after the parent compounds have been 
totally eliminated. Recently, it was reported that ozonation may release oxidation intermediates with enhanced 
toxicity for aquatic life [104] and [105]. This hypothesis highlights the need to characterize reaction mixtures in 
order to identify persistent and possibly toxic compounds. 
Gómez-Ramos et al. [105] identified six TPs using LC-QTOF-MS after ozonation of antibiotic 
sulfamethoxazole under different operational conditions. In a recent study [50], several illicit drugs were 
subjected to ozonation to estimate their removal as a function of ozone dose and to identify the significant 
oxidation TPs. Once the potential TPs were identified by LC-LTQ-Orbitrap, their structures were elucidated 
by carrying out HRMSn experiments (up to MS4). 
4.3.4. Biodegradation experiments 
The use of membrane bioreactor (MBR) technology for wastewater treatment presents advantages over the 
conventional activated sludge (CAS) process, such as enhanced biological performance, complete retention of 
solids, and smaller footprint [106]. 
To date, a number of abiotic PID degradation products have been identified, but published studies dealing with 
the structural elucidation of these degradates resulting from microbial transformation are still scarce. UHPLC-
QTOF-MS has been used for screening and structural elucidation of biodegradation products, previously 
generated in small-scale laboratory batch reactors, of β-blocker atenolol and hypoglycemic agent glibenclamide 
[107], antimicrobial trimethoprim [89] and analgesic diclofenac [87]. In some cases, QTOF-MS has been 
combined with multiple-stage fragmentation studies and H/D-exchange experiments using IT-MS for final 
elucidation [89] or with HPLC-QqLIT-MS for confirmation of bio-TPs in wastewater samples [107]. For 
diclofenac, pre-processing based on isotopic cluster analysis was performed, since the parent compound 
contained two chlorine atoms in its chemical structure. In this way, the number of resulting peaks could be 
reduced to only those attributed to chlorinated diclofenac bio-TPs [87]. 
Helbling et al. [84] used HRMS Orbitrap data from a single bioreactor to identify compound masses formed 
during the biotransformation experiment. For each sample, a two-dimensional matrix of masses (m/z versus 
intensity) was found and their corresponding intensities were extracted. A script in Visual Basic was written to 
compare the mass-intensity matrices between t = 0 (sample withdrawn immediately after spiking with the 
compound of interest) and each t > 0 (samples withdrawn from the reactors at time points), and used a series 
of mass filters to reduce the number of extracted masses to a list of masses of candidate TPs. Candidate TP 
masses were further confirmed or rejected following manual inspection of MS spectra for the relative 
abundance of 13C and/or 37Cl monoisotopic masses and/or adduct masses. Also, data-dependent MS/MS 
acquisitions were triggered when peaks were detected in full-scan mode at the exact masses of any parent 
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compound or candidate TP. Comparison of MS/MS fragments between each parent compound and TP further 
confirmed or rejected each candidate mass as a TP. Following this strategy, a dehydrogenation product of 
bezafibrate (not predicted by UM-PPS) was tentatively identified. 
Degradation of sulfamethazine by white-rot fungus Trametes versicolor was also assessed. Four degradation 
intermediates produced by fungal cultures or purified laccase were identified using UHPLC–QTOF-MS [108]. 
4.4. Non-target analysis of water samples 
4.4.1. Unbiased non-target analysis 
The fact that HRMS provides full-spectrum acquisitions at accurate masses opens up the possibility of 
investigating non-target compounds in environmental samples. A genuine non-target analysis pursues the 
investigation (i.e., detection and identification or elucidation) of unknowns, which means that the analyst does 
not have any information on the compounds to be investigated (i.e., an unbiased analysis is pursued). The term 
“unknown” does not necessarily mean that the compound discovered in the analysis is new or not previously 
reported. It may be a very well-known compound that was not specifically searched for in analysis, so it was 
treated as an unknown [109]. 
It was early recognized that non-target analysis in environmental waters using LC-HRMS is a challenging task 
and successful identification of non-targets relies heavily on the (free) availability of chemical databases for 
finding candidates [25]. Two unidentified components in the pioneer work reported by Ibáñez et al. [25] were 
subsequently characterized thanks to the use of commercial chemical database SciFinder to find the candidate 
chemical structures [110]. 
A non-target analysis would require a visual inspection of the TIC to find potential components that might be 
present in the sample. Following this idea, Terzic et al. [111] developed a comprehensive analytical procedure 
based on UHPLC-QTOF-MS for the identification of non-target polar contaminants in aquatic sediments from 
a small water course greatly influenced by wastewater discharges from the pharmaceutical industry. The 
chromatograms, recorded in TIC mode, were systematically examined by manually generating mass spectra of 
each individual chromatographic peak. Only major peaks (>10% of the full scale intensity) were subjected to 
the identification process as non-target analytes. The first identification step was calculation of the possible 
elemental composition of the (de)protonated molecules from the mass spectra recorded, followed by a database 
search [using Chemspider, Merck Index and European chemical Substances Information System (ESIS), and 
an in-house database] for possible candidate compounds. For some contaminants, for which a reference 
standard was available, the information on accurate mass and information on retention time were sufficient for 
a reliable identification. For unknown compounds, the ultimate assignment of their identity was achieved by 
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MS/MS experiments, followed by comparing the observed fragmentation patterns with the main product ions 
expected for the selected candidates. Different pharmaceuticals were successfully identified and confirmed with 
reference compounds. However, eight prominent peaks remained unidentified. 
One of the limitations of non-target analysis is that compounds of low abundance may not be apparent by 
visual inspection or, to the contrary, intense peaks may not necessarily be associated with a single component 
or “relevant” organic contaminants. Powerful software with chromatographic peak-deconvolution capabilities 
is required to detect multiple components and to produce pure spectra for each individual component. The 
non-target analysis workflow commonly starts with automated peak detection by exact-mass filtering from the 
chromatographic run, followed by assignment of an elemental formula to the exact mass of interest, and a 
subsequent search of plausible structures in available chemical databases for the elemental formula determined 
[15]. This is a laborious, difficult, time-consuming task when the unknown compounds are present at trace 
levels in complex-matrix samples. 
4.4.2. Biased non-target analysis 
An intermediate situation between target and non-target analysis is what some authors call a semi-non-target 
approach, based, for example, on the use of a chlorine mass-filter technique in accurate-mass and high-
resolution systems [112]. Following this strategy, which only applies to the investigation of chlorine-containing 
compounds, antidepressant lamotrigine and its major metabolite (2-N-glucuronide) were identified in 
environmental water samples [112]. 
In non-target analysis, the use of large mass spectra libraries can notably facilitate the identification of unknowns. 
The main difficulty is the lack of LC-MS standardized libraries, as a consequence of the differences in the 
ionization efficiency between the existing interfaces together with variability in the results depending on the 
mobile-phase composition or the cone voltage applied. Under these circumstances, it is more convenient to 
build home-made libraries to simplify searching. Obviously, the higher the number of compounds included in 
the library, the wider the possibilities to detect as many contaminants as possible in the samples. With the 
software currently available, it is possible to build both empirical and/or theoretical libraries [16], 
[113] and [114]. Home-made empirical libraries offer the possibility to include fragmentation and retention-
time information, which greatly aid the identification process. However, commonly, not many compounds are 
included, due to the need to inject reference standards. Instead, theoretical mass spectra libraries, based on a 
database with solely the molecular formulae, can easily be built including a large number of compounds. Díaz 
et al. [16] and [113] combined UHPLC-QTOF-MS (MSE) with specialized software (ChromaLynx) for non-
target screening of environmental water and wastewater. After chromatographic peak deconvolution, the 
software discriminated ions coming from organic compounds present in the sample from background ions. In 
a second step, a library search was performed to match the experimental deconvoluted mass spectra with the 
existing entries in the available libraries (theoretical and empirical). Finally, the formula from the library hit was 
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submitted to an elemental composition calculator and the most intense ions were either confirmed or rejected 
based on accurate-mass criteria and isotopic pattern. 
In a similar way, Gómez-Ramos et al. [115] proposed a systematic strategy to simplify the identification of 
organic-contaminant TPs, based on characteristic fragmentation undergone by the parent compound during 
MS/MS fragmentation, and on the relationship with the transformations experienced by these chemicals in the 
environment or during water-treatment processes. A database containing accurate-mass information of 147 
compounds (including pharmaceuticals, drugs and some relevant metabolites) and their main fragments 
generated by MS/MS was created using LC-QTOF-MS/MS. This database was applied to the tentative 
identification of TPs and related unexpected compounds in eight wastewater effluent samples. The approach 
comprised three stages: 
(a) automatic screening, consisting of extraction of compounds using a “molecular feature extraction” algorithm 
and database search; 
(b) identification of possible TPs (those reported compounds that yielded a good match in accurate mass but 
presented different retention times were initially considered as potential TPs or fragments of potential TPs); 
and, 
(c) confirmation by MS/MS analysis of the TPs tentatively identified in the previous step. 
Eight degradation products, from pharmaceuticals acetaminophen, amoxicillin, carbamazepine, erythromycin 
and azithromycin, were tentatively identified. Three of them were confirmed by analysis of the corresponding 
analytical standards. 
4.4.3. The “All-in-One” approach 
In recent years, there has been a move towards the “All-in-One” approach, which involves the combination of 
suspect and non-target screening with (quantitative) target analysis. Thus, LC-QTOF-MS has been proposed 
for simultaneous quantitative screening of target analytes and qualitative analysis of non-target compounds 
[116]. For 10 target compounds, the use of specialized software allowed mass spectral data to be processed 
using LC retention time, accurate mass (error) and spectral purity score. Satisfactory results were obtained in 
terms of sensitivity and linearity. A second identification approach was presented based on library searching 
for compounds not included in the analytical method as target, but which were present in a commercial 
accurate-mass MS/MS library (including ~1200 pharmaceuticals and personal-care products). The spectra 
acquired were automatically searched by spectral comparison using the MS/MS library to assist in compound 
identification. Following this, ketorolac, trazodone, fluconazole, metformin and venlafaxine could be identified 
in river-water samples. Furthermore, other compounds not included in the library were also identified by 
screening the peaks of highest intensity in the samples and by analysis of the full-scan TOF-MS, isotope pattern 
and MS/MS spectra. This was the case for histaminergic loratadine. 
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Nurmi et al. [117] evaluated the performance of UHPLC-TOF-MS in the identification of emerging 
contaminants in spiked wastewater, using target and non-target analysis. The method was satisfactory for target 
analysis with information about retention times. For those compounds lacking retention time (suspect 
screening), a four-stage process for identification was developed: the number of candidate compounds was 
reduced by using the accurate mass of selected compounds in two steps (30 mDa nw-XIC (stage 1) and ±5 mDa 
mass error (stage 2)), structure–property relationships [i.e., retention-time prediction (stage 3)] and isotope 
patterns of the analytes (stage 4). Non-target analysis was tested by applying a theoretical mass spectra library 
for a wastewater sample spiked with six pharmaceuticals. The results showed a large number of false 
identifications. In addition, manual processing of the data was considered laborious and ineffective. Finally, 
target analysis was applied to a real wastewater sample. The analysis revealed the presence of six compounds 
that were afterwards confirmed with reference standards. Three psycholeptics (nordiazepam, oxazepam and 
temazepam) could be tentatively identified. 
Hogenboom et al. applied similar approaches but using an LTQ-Orbitrap mass spectrometer [118]. Full-scan 
accurate-mass measurements were compared with theoretical exact masses of known environmental 
microcontaminants and/or with their self-created accurate-mass MS and MSn database, containing ~3000 water 
pollutants. The database included theoretical mass, retention time, retention time relative to two internal 
standards and elemental composition of product ions. For accurate masses not found in the mass database, a 
(possible) elemental composition was proposed, and searched in databases, such as Chemfinder or Chemspider, 
to find out whether the unknown compound was ever patented, studied or commercialized. MSn measurements 
were performed to obtain information on the fragment ions generated in the LIT (nominal mass of product 
ions) within the same analysis. The structures found in the libraries were evaluated based on the fragmentation 
patterns observed in the product-ion spectra acquired simultaneously. Confirmation of identity was done by 
comparing retention time and fragmentation pattern to those of a reference standard. If no information on the 
reference standard was available, the theoretical log Kow was calculated based on the proposed structure and 
compared to the retention time of the compound detected. 
Very recently, Schymanski et al. [119] developed and applied a three-fold approach: 
• (semi)-quantitative target analysis for 364 target compounds; 
• suspect screening, demonstrated for sulfur-containing surfactants [evidence used to support (or 
reject) the tentative suspect identification included expected retention time behavior and 
interpretation of the MS/MS spectra]; and, 
• non-target screening, to perform a comprehensive characterization of polar compounds in 
wastewater effluents. 
A non-target mass list for each sample was compiled with the enviMass software. Isotope and adduct grouping 
of these non-target masses was subsequently performed using the “non-target” R package. Finally, non-target 
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identification was performed on selected masses from the top 30 most intense peaks. The program system 
MOLGEN-MS/MS (MOLecular structure GENeration) was used to calculate molecular formulas from the 
exact mass and isotope patterns from the MS and MS/MS fragmentation information, if available. MetFusion 
was used to perform parallel searches of compound databases and spectral libraries and to perform in silico 
fragmentation of the candidate structures. The number of references per compound, retrieved from 
Chemspider, was also used to rank candidates. 
Systematic strategies with automated approaches are required to filter the suspect compounds to be searched 
and to select “relevant” peaks on which the identification efforts should focus. Hug et al. [26] established a 
screening procedure based on LC-HRMS to detect site-specific, suspected and formerly unknown 
contaminants in a WWTP effluent. First, the effluent was screened for the 98 target compounds using known 
retention time, exact mass and fragment ions. Some 15 target compounds were detected and quantified, 
including seven pharmaceuticals. Second, accurate-mass ion chromatograms and peak lists were generated from 
full-scan data using MZmine. For suspect screening, an initial list of 2160 site-specific and reported water 
contaminants was reduced to those amenable to LC-HRMS. Thus, only suspects containing at least one atom 
of nitrogen, phosphorus, oxygen, sulfur or any metal(loid) were considered ionizable by ESI. After searching 
MZmine peak lists for the exact masses of suspects (only those with intensity higher than 105 a.u.), presumably 
false positive detections were stepwise excluded by retention-time prediction, evaluation of isotope patterns, 
ionization behavior, and HRMS/MS spectra. Finally, in non-target analysis, masses for identification were 
selected using the R package “non-target” based on distinctive isotope patterns (containing 37Cl, 81Br, 34S or 
15N isotope peaks) and intensity (>106 a.u.). For the remaining masses, all possible formulae were calculated 
and checked using the Seven Golden Rules to reduce the number to one or two molecular formulae, which 
were searched in the Chemspider database, generating candidate lists for each formula. Only candidates 
with >10 data sources were considered of commercial importance and necessitated an automated HRMS/MS 
evaluation using MetFrag software. To confirm tentative identifications of compounds further, deuterium-
exchange experiments were also conducted. Six suspected and five non-target chemicals were identified, of 
which two had not been previously reported as environmental pollutants. However, another five non-target 
compounds could not be confirmed by the reference standard of the most likely candidate structure. 
5. Conclusions and future trends 
HRMS provides high-resolution, accurate-mass and high full-scan sensitivity and selectivity, making it very 
attractive for both target and non-target screening. Other advantages are the possibility of performing 
retrospective data examination and tentative identification of compounds when reference standards are 
unavailable. HRMS is also very powerful in the identification of degradation products or TPs in laboratory 
experiments and the elucidation of unknown compounds. 
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Recent developments in HRMS have allowed improvement of analytical methodologies applied in 
environmental MS. The search for the “All-in-One” method and instrument will continue in the coming years, 
as combining all desired features in just one method and instrument is an exciting issue: qualitative and 
quantitative analysis, with possibilities for structural elucidation of unknowns. Some recent configurations 
appearing in the market in the past few years (e.g., Triple TOF from AB Sciex, Xevo G2 QTOF from Waters, 
and Q Exactive from Thermo) are trying to meet this purpose: high sensitivity and selectivity, accurate mass, 
sufficient fragmentation to provide information on ion fragments, and satisfactory linear dynamic range. In the 
near future, rapid growth in HRMS applications will surely occur, in not only environmental research but also 
other fields, such as food safety, toxicology and doping-control analysis. 
UHPLC has become a very popular technique, replacing HPLC separations in the most recently developed 
methods. It has been successfully coupled to MS(/MS) analyzers working at nominal mass and to HR-TOF-
MS analyzers, with evident advantages deriving from its superior performance: short chromatographic runs, 
better sensitivity and more efficient separations. However, its coupling to Orbitrap is still problematic due to 
the low scan rates attainable when selecting high resolving power. 
The expected developments of HRMS will surely relate to improvement in scan speed for Orbitrap, which will 
allow coupling to UHPLC and certainly increase the number of applications, and in mass resolving power for 
TOF. Advances in accurate-mass full-acquisition data processing using more powerful, user-friendly software 
are also likely. New hybrid analyzers incorporating ion-mobility spectrometry (IMS), before or between mass 
analyzers, are appearing in the market, adding an orthogonal separation mechanism to classical m/z ratio. IMS 
will probably improve identification of co-eluting isomers or confirmation of suspect compounds in complex 
samples. 
 
Acknowledgements 
This work was developed with the financial support provided by the Plan Nacional de I+D+I, Ministerio de 
Economía y Competitividad (Project Ref. CTQ2012-36189). The authors also acknowledge financial support from 
Generalitat Valenciana (Group of Excellence Prometeo 2009/054; Collaborative Research on Environment and 
Food Safety ISIC/2012/016). 
Richard Bade acknowledges the European Union's Seventh Framework Programme for research, technological 
development and demonstration under Grant Agreement No. [Marie Curie-FP7-PEOPLE Grant #317205] 
for his Early Stage Researcher (ESR) contract. 
 Chapter 1: General Introduction 
 
71 
References 
[1] S.D. Richardson Environmental mass spectrometry: emerging contaminants and current issues Anal. Chem, 
84 (2012), pp. 747–778 
[2] P. Vázquez-Roig, C. Blasco, Y. Picó Advances in the analysis of legal and illegal drugs in the aquatic 
environment Trends Anal. Chem, 50 (2013), pp. 65–77 
[3] B. Petrie, E.J. McAdam, M.D. Scrimshaw, J.N. Lester, E. Cartmell Fate of drugs during wastewater treatment 
Trends Anal. Chem, 49 (2013), pp. 145–159 
[4] T. Kosjek, E. Heath, M. Petrović, D. Barceló Mass spectrometry for identifying pharmaceutical 
biotransformation products in the environment Trends Anal. Chem, 26 (2007), pp. 1076–1085 
[5] M. Petrovic, D. Barceló LC-MS for identifying photodegradation products of pharmaceuticals in the 
environment Trends Anal. Chem, 26 (2007), pp. 486–493 
[6] A. Agüera, M.J. Martínez Bueno, A.R. Fernández-Alba New trends in the analytical determination of 
emerging contaminants and their transformation products in environmental waters Environ. Sci. Pollut. Res. 
Int, 20 (2013), pp. 3496–3515 
[7] S. Castiglioni, K.V. Thomas, B. Kasprzyk-Hordern, L. Vandam, P. Griffiths Testing wastewater to detect 
illicit drugs: state of the art, potential and research needs Sci. Total Environ, 487 (2014), pp. 613–620 
[8] K.V. Thomas, L. Bijlsma, S. Castiglioni, A. Covaci, E. Emke, R. Grabic, et al. Comparing illicit drug use in 
19 European cities through sewage analysis Sci. Total Environ, 432 (2012), pp. 432–439 
[9] S. Castiglioni, L. Bijlsma, A. Covaci, E. Emke, F. Hernández, M. Reid, et al. Evaluation of uncertainties 
associated with the determination of community drug use through the measurement of sewage drug biomarkers 
Environ. Sci. Technol, 47 (2013), pp. 1452–1460 
[10] M. Petrovic, M. Farré, M. Lopez de Alda, S. Perez, C. Postigo, M. Köck, et al. Recent trends in the liquid 
chromatography–mass spectrometry analysis of organic contaminants in environmental samples J. Chromatogr. 
A (2010), pp. 4004–4017 
[11] O.J. Pozo, C. Guerrero, J.V. Sancho, M. Ibáñez, E. Pitarch, E. Hogendoorn, et al. Efficient approach for 
the reliable quantification and confirmation of antibiotics in water using on-line solid-phase extraction liquid 
chromatography/tandem mass spectrometry J. Chromatogr. A, 1103 (2006), pp. 83–93 
S
c
ie
n
ti
fi
c
 A
rt
ic
le
 1
 
Hernández et al. Trends in Analytical Chemistry 63 (2014) 140-157 
72 
[12] D.R. Baker, B. Kasprzyk-Hordern Multi-residue determination of the sorption of illicit drugs and 
pharmaceuticals to wastewater suspended particulate matter using pressurised liquid extraction, solid phase 
extraction and liquid chromatography coupled with tandem mass spectrometry J. Chromatogr. A, 1218 (2011), 
pp. 8036–8059 
[13] M. Farré, M. Holčapek, P.J. Schoenmakers, L. Kantiani, M. Petrovic, S. Pérez, et al. Achievements and 
future trends in the analysis of emerging organic contaminants in environmental samples by mass spectrometry 
and bioanalytical techniques J. Chromatogr. A, 1259 (2012), pp. 86–99 
[14] E. Gracia-Lor, J.V. Sancho, F. Hernández Multi-class determination of around 50 pharmaceuticals, 
including 26 antibiotics, in environmental and wastewater samples by ultra-high performance liquid 
chromatography-tandem mass spectrometry J. Chromatogr. A, 1218 (2011), pp. 2264–2275 
[15] M. Krauss, H. Singer, J. Hollender LC-high resolution MS in environmental analysis: from target screening 
to the identification of unknowns Anal. Bioanal. Chem, 397 (2010), pp. 943–951 
[16] R. Díaz, M. Ibáñez, J.V. Sancho, F. Hernández Target and non-target screening strategies for organic 
contaminants, residues and illicit substances in food, environmental and human biological samples by UHPLS-
QTOF-MS Anal. Methods (2012), pp. 196–209 
[17] R. Plumb, J. Castro-Pérez, J. Granger, I. Beattie, K. Joncour, A. Wright Ultra-performance liquid 
chromatography coupled to quadrupole-orthogonal time-of-flight mass spectrometry Rapid Commun. Mass 
Spectrom, 18 (2004), pp. 2331–2337 
[18] F. Hernández, J.V. Sancho, M. Ibáñez, E. Abad, T. Portolés, L. Mattioli Current use of high-resolution 
mass spectrometry in the environmental sciences Anal. Bioanal. Chem, 403 (2012), pp. 1251–1264 
[19] A. Kaufmann, P. Butcher, K. Maden, S. Walker, M. Widmer Comprehensive comparison of liquid 
chromatography selectivity as provided by two types of liquid chromatography detectors (high resolution mass 
spectrometry and tandem mass spectrometry): “where is the crossover point?” Anal. Chim. Acta, 673 (2010), 
pp. 60–72 
[20] L. Bijlsma, E. Emke, F. Hernández, P. de Voogt, F. Hernandez Performance of the linear ion trap Orbitrap 
mass analyzer for qualitative and quantitative analysis of drugs of abuse and relevant metabolites in sewage 
water Anal. Chim. Acta, 768 (2013), pp. 102–110 
[21] F. Hernández, M. Ibáñez, E. Gracia-Lor, J.V. Sancho Retrospective LC-QTOF-MS analysis searching for 
pharmaceutical metabolites in urban wastewater J. Sep. Sci, 34 (2011), pp. 3517–3526 
 Chapter 1: General Introduction 
 
73 
[22] C. Boix, M. Ibáñez, J.V. Sancho, W.M.A. Niessen, F. Hernández Investigating the presence of omeprazole 
in waters by liquid chromatography coupled to low and high resolution mass spectrometry: degradation 
experiments J. Mass Spectrom, 48 (2013), pp. 1091–1100 
[23] C. Boix, M. Ibáñez, T. Zamora, J.V. Sancho, W.M.A. Niessen, F. Hernández Identification of new 
omeprazole metabolites in wastewaters and surface waters Sci. Total Environ, 468–469 (2014), pp. 706–714 
[24] M. Ibáñez, J.V. Sancho, L. Bijlsma, A.L.N. van Nuijs, A. Covaci, F. Hernández Comprehensive analytical 
strategies based on high-resolution time-of-flight mass spectrometry to identify new psychoactive substances 
Trends Anal. Chem, 57 (2014), pp. 107–117 
[25] M. Ibáñez, J.V. Sancho, Ó.J. Pozo, W. Niessen, F. Hernández Use of quadrupole time-of-flight mass 
spectrometry in the elucidation of unknown compounds present in environmental water Rapid Commun. Mass 
Spectrom, 19 (2005), pp. 169–178 
[26] C. Hug, N. Ulrich, T. Schulze, W. Brack, M. Krauss Identification of novel micropollutants in wastewater 
by a combination of suspect and nontarget screening Environ. Pollut, 184C (2014), pp. 25–32 
[27] S. Kern, R. Baumgartner, D.E. Helbling, J. Hollender, H. Singer, M.J. Loos, et al. A tiered procedure for 
assessing the formation of biotransformation products of pharmaceuticals and biocides during activated sludge 
treatment J. Environ. Monit, 12 (2010), pp. 2100–2111 
[28] S. Kern, K. Fenner, H.P. Singer, R.P. Schwarzenbach, J. Hollender Identification of transformation 
products of organic contaminants in natural waters by computer-aided prediction and high-resolution mass 
spectrometry Environ. Sci. Technol, 43 (2009), pp. 7039–7046 
[29] C. Boix, M. Ibáñez, L. Bijlsma, J.V. Sancho, F. Hernández Investigation of cannabis biomarkers and 
transformation products in waters by liquid chromatography coupled to time of flight and triple quadrupole 
mass spectrometry Chemosphere, 99 (2014), pp. 64–71 
[30] L. Bijlsma, C. Boix, W.M.A. Niessen, M. Ibáñez, J.V. Sancho, F. Hernández Investigation of degradation 
products of cocaine and benzoylecgonine in the aquatic environment Sci. Total Environ, 443 (2013), pp. 200–
208 
[31] P. Calza, C. Medana, E. Padovano, V. Giancotti, C. Baiocchi Identification of the unknown transformation 
products derived from clarithromycin and carbamazepine using liquid chromatography/high-resolution mass 
spectrometry Rapid Commun. Mass Spectrom, 26 (2012), pp. 1687–1704 
S
c
ie
n
ti
fi
c
 A
rt
ic
le
 1
 
Hernández et al. Trends in Analytical Chemistry 63 (2014) 140-157 
74 
[32] P. Calza, C. Medana, E. Padovano, F. Dal Bello, C. Baiocchi Identification of the unknown transformation 
products derived from lincomycin using LC-HRMS technique J. Mass Spectrom, 47 (2012), pp. 751–759 
[33] K.P. Bateman, J. Castro-perez, M. Wrona, J.P. Shockcor, K. Yu, R. Oballa, et al. MS E with mass defect 
filtering for in vitro and in vivo metabolite identification Rapid Commun. Mass Spectrom, 21 (2007), pp. 1485–
1496 
[34] Y. Zhang, S.B. Ficarro, S. Li, J.A. Marto Optimized Orbitrap HCD for quantitative analysis of 
phosphopeptides J. Am. Soc. Mass Spectrom, 20 (2009), pp. 1425–1434 
[35] I. González-Mariño, J.B. Quintana, I. Rodriguez, M. González-Díez, R. Cela Screening and selective 
quantification of illicit drugs in wastewater by mixed-mode solid-phase extraction and quadrupole-time-of-
flight liquid chromatography–mass spectrometry Anal. Chem, 84 (2012), pp. 1708–1717 
[36] I. Ferrer, E.M. Thurman Analysis of 100 pharmaceuticals and their degradates in water samples by liquid 
chromatography/quadrupole time-of-flight mass spectrometry J. Chromatogr. A, 1259 (2012), pp. 148–157 
[37] J. Sherma, D. John, F.H. Larkin UPLC: Ultra-performance liquid chromatography J. AOAC Int, 88 (2005), 
pp. 63A–67A 
[38] M. Mezcua, A. Agüera, J.L. Lliberia, M.A. Cortés, B. Bagó, A.R. Fernández-Alba Application of ultra 
performance liquid chromatography-tandem mass spectrometry to the analysis of priority pesticides in 
groundwater J. Chromatogr. A, 1109 (2006), pp. 222–227 
[39] C.C. Leandro, P. Hancock, R.J. Fussell, B.J. Keely Comparison of ultra-performance liquid 
chromatography and high-performance liquid chromatography for the determination of priority pesticides in 
baby foods by tandem quadrupole mass spectrometry J. Chromatogr. A, 1103 (2006), pp. 94–101 
[40] O.J. Pozo, M. Barreda, J.V. Sancho, F. Hernández, J. Ll Lliberia, M.A. Cortés, et al. Multiresidue pesticide 
analysis of fruits by ultra-performance liquid chromatography tandem mass spectrometry Anal. Bioanal. Chem, 
389 (2007), pp. 1765–1771 
[41] B. Kasprzyk-Hordern, R.M. Dinsdale, A.J. Guwy Multi-residue method for the determination of 
basic/neutral pharmaceuticals and illicit drugs in surface water by solid-phase extraction and ultra performance 
liquid chromatography-positive electrospray ionisation tandem mass spectrometry J. Chromatogr. A, 1161 
(2007), pp. 132–145 
 
 Chapter 1: General Introduction 
 
75 
[42] M. Gros, S. Rodríguez-Mozaz, D. Barceló Fast and comprehensive multi-residue analysis of a broad range 
of human and veterinary pharmaceuticals and some of their metabolites in surface and treated waters by ultra-
high-performance liquid chromatography coupled to quadrupole-linear ion trap tandem J. Chromatogr. A, 1248 
(2012), pp. 104–121 
[43] A.L.N. van Nuijs, S. Castiglioni, I. Tarcomnicu, C. Postigo, M. Lopez de Alda, H. Neels, et al. Illicit drug 
consumption estimations derived from wastewater analysis: a critical review Sci. Total Environ, 409 (2011), pp. 
3564–3577 
[44] M. Hardman, A.A. Makarov Interfacing the orbitrap mass analyzer to an electrospray ion source Anal. 
Chem, 75 (2003), pp. 1699–1705 
[45] Q. Hu, R.J. Noll, H. Li, A. Makarov, M. Hardman, R. Graham Cooks The Orbitrap: a new mass 
spectrometer J. Mass Spectrom, 40 (2005), pp. 430–443 
[46] M. Kellmann, H. Muenster, P. Zomer, H. Mol Full scan MS in comprehensive qualitative and quantitative 
residue analysis in food and feed matrices: how much resolving power is required? J. Am. Soc. Mass Spectrom, 
20 (2009), pp. 1464–1476 
[47] A. Makarov, M. Scigelova Coupling liquid chromatography to Orbitrap mass spectrometry J. Chromatogr. 
A, 1217 (2010), pp. 3938–3945 
[48] R. Pinhancos, S. Maass, D.M. Ramanathan High-resolution mass spectrometry method for the detection, 
characterization and quantitation of pharmaceuticals in water J. Mass Spectrom, 46 (2011), pp. 1175–1181 
[49] K. Wille, M. Claessens, K. Rappé, E. Monteyne, C.R. Janssen, H.F. De Brabander, et al. Rapid 
quantification of pharmaceuticals and pesticides in passive samplers using ultra high performance liquid 
chromatography coupled to high resolution mass spectrometry J. Chromatogr. A, 1218 (2011), pp. 9162–9173 
[50] A. Rodayan, P.A. Segura, V. Yargeau Ozonation of wastewater: removal and transformation products of 
drugs of abuse Sci. Total Environ, 487 (2014), pp. 763–770 
[51] B. Zonja, C. Gonçalves, S. Pérez, A. Delgado, M. Petrovic, M.F. Alpendurada, et al. Evaluation of the 
phototransformation of the antiviral zanamivir in surface waters through identification of transformation 
products J. Hazard. Mater, 265 (2014), pp. 296–304 
 
 
S
c
ie
n
ti
fi
c
 A
rt
ic
le
 1
 
Hernández et al. Trends in Analytical Chemistry 63 (2014) 140-157 
76 
[52] S. Marchese, A. Gentili, D. Perret, D. Ascenzo, F. Pastori Quadrupole time-of-flight versus triple-
quadrupole mass spectrometry for the determination of non-steroidal antiinflammatory drugs in surface water 
by liquid chromatography/tandem mass spectrometry Rapid Commun. Mass Spectrom, 17 (2003), pp. 879–
886 
[53] I. Ferrer Liquid chromatography/time-of-flight/mass spectrometry (LC/TOF/MS) for the analysis of 
emerging contaminants Trends Anal. Chem, 22 (2003), pp. 750–756 
[54] I. Ferrer, E.M. Thurman Liquid chromatography/mass spectrometry, MS/MS and time of flight MS: 
analysis of emerging contaminants ACS Symp. Ser, 850 (2003), pp. 1–13 
[55] M. Farré, M. Gros, B. Hernández, M. Petrovic, P. Hancock, D. Barceló Analysis of biologically active 
compounds in water by ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry 
Rapid Commun. Mass Spectrom, 22 (2008), pp. 41–51 
[56] A.A.M. Stolker, W. Niesing, E.A. Hogendoorn, J.F.M. Versteegh, R. Fuchs, U.A.T. Brinkman Liquid 
chromatography with triple-quadrupole or quadrupole-time of flight mass spectrometry for screening and 
confirmation of residues of pharmaceuticals in water Anal. Bioanal. Chem, 378 (2004), pp. 955–963 
[57] A.A.M. Stolker, W. Niesing, R. Fuchs, R.J. Vreeken, W.M.A. Niessen, U.A.T. Brinkman Liquid 
chromatography with triple-quadrupole and quadrupole-time-of-flight mass spectrometry for the 
determination of micro-constituents – a comparison Anal. Bioanal. Chem, 378 (2004), pp. 1754–1761 
[58] M. Petrović, M.D. Hernando, M.S. Díaz-Cruz, D. Barceló Liquid chromatography–tandem mass 
spectrometry for the analysis of pharmaceutical residues in environmental samples: a review J. Chromatogr. A, 
1067 (2005), pp. 1–14 
[59] M. Petrović, D. Barcelo Application of liquid chromatography / quadrupole time-of-flight mass 
spectrometry (LC-QqTOF-MS) J. Mass Spectrom, 41 (2006), pp. 1259–1267 
[60] D. Barceló, M. Petrovic Challenges and achievements of LC-MS in environmental analysis: 25 years on 
Trends Anal. Chem, 26 (2007), pp. 2–11 
[61] F. Hernández, J.V. Sancho, M. Ibáñez, C. Guerrero Antibiotic residue determination in environmental 
waters by LC-MS Trends Anal. Chem, 26 (2007), pp. 466–485 
[62] C.S. Wong, S.L. MacLeod JEM spotlight: recent advances in analysis of pharmaceuticals in the aquatic 
environment J. Environ. Monit, 11 (2009), pp. 923–936 
 Chapter 1: General Introduction 
 
77 
[63] I. Ferrer, M.E. Thurman Analysis of pharmaceuticals in drinking water, groundwater, surface water, and 
wastewater M. Petrovic, S. Perez, D. Barcelo (Eds.), Comprehensive Analytical Chemistry, vol. 62, Analysis, 
Removal, Effects and Risk of pharmaceuticals in the water cycle: occurrence and transformation in the 
environment (electronic book) (2013), pp. 91–128 Elsevier 
[64] M.J. Martínez Bueno, A. Agüera, M.J. Gómez, M.D. Hernando, J.F. García-Reyes, A.R. Fernandez-Alba 
Application of liquid chromatography/quadrupole-linear Ion trap mass spectrometry and time-of-flight mass 
spectrometry to the determination of pharmaceuticals and related contaminants in wastewater Anal. Chem, 79 
(2007), pp. 9372–9384 
[65] R. López-Roldán, M.L. de Alda, M. Gros, M. Petrovic, J. Martín-Alonso, D. Barceló Advanced monitoring 
of pharmaceuticals and estrogens in the Llobregat River basin (Spain) by liquid chromatography–triple 
quadrupole-tandem mass spectrometry in combination with ultra performance liquid chromatography–time of 
flight-mass spectrometry Chemosphere, 80 (2010), pp. 1337–1344 
[66] H. Leknes, I.E. Sturtzel, C. Dye Environmental release of oseltamivir from a Norwegian sewage treatment 
plant during the 2009 influenza A (H1N1) pandemic Sci. Total Environ, 414 (2012), pp. 632–638 
[67] J. Magnér, M. Filipovic, T. Alsberg Application of a novel solid-phase-extraction sampler and ultra-
performance liquid chromatography quadrupole-time-of-flight mass spectrometry for determination of 
pharmaceutical residues in surface sea water Chemosphere, 80 (2010), pp. 1255–1260 
[68] T. Rodríguez-Álvarez, R. Rodil, R. Celz, J.B. Quintana Ion-pair reversed-phase liquid chromatography-
quadrupole-time-of-flight and triple-quadrupole-mass-spectrometry determination of ethyl sulfate in 
wastewater for alcohol consumption tracing J. Chromatogr. A (2014), pp. 35–42 
[69] M. Ibáñez, C. Guerrero, J.V. Sancho, F. Hernández Screening of antibiotics in surface and wastewater 
samples by ultra-high-pressure liquid chromatography coupled to hybrid quadrupole time-of-flight mass 
spectrometry J. Chromatogr. A, 1216 (2009), pp. 2529–2539 
[70] L. Vergeynst, H. Van Langenhove, P. Joos, K. Demeestre High-resolution time-of-flight mass 
spectrometry for suspect screening and target quantification of pharmaceuticals in river water Commun. Agric. 
Appl. Biol. Sci, 78 (2013), pp. 9–14 
[71] M. Petrovic, M. Gros, D. Barceló Multi-residue analysis of pharmaceuticals in wastewater by ultra-
performance liquid chromatography-quadrupole-time-of-flight mass spectrometry J. Chromatogr. A, 1124 
(2006), pp. 68–81 
S
c
ie
n
ti
fi
c
 A
rt
ic
le
 1
 
Hernández et al. Trends in Analytical Chemistry 63 (2014) 140-157 
78 
[72] M. Lavén, T. Alsberg, Y. Yu, M. Adolfsson-Erici, H. Sun Serial mixed-mode cation- and anion-exchange 
solid-phase extraction for separation of basic, neutral and acidic pharmaceuticals in wastewater and analysis by 
high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry J. Chromatogr. A, 1216 
(2009), pp. 49–62 
[73] F. Hernández, L. Bijlsma, J.V. Sancho, R. Díaz, M. Ibáñez Rapid wide-scope screening of drugs of abuse, 
prescription drugs with potential for abuse and their metabolites in influent and effluent urban wastewater by 
ultrahigh pressure liquid chromatography-quadrupole-time-of-flight-mass spectrometry Anal. Chim. Acta, 684 
(2011), pp. 96–106 
[74] M.J. Gómez, M.M. Gómez-Ramos, O. Malato, M. Mezcua, A.R. Férnandez-Alba Rapid automated 
screening, identification and quantification of organic micro-contaminants and their main transformation 
products in wastewater and river waters using liquid chromatography–quadrupole-time-of-flight mass 
spectrometry with an accurate-mass J. Chromatogr. A, 1217 (2010), pp. 7038–7054 
[75] A. Masiá, M. Ibáñez, C. Blasco, J.V. Sancho, Y. Picó, F. Hernández Combined use of liquid 
chromatography triple quadrupole mass spectrometry and liquid chromatography quadrupole time-of-flight 
mass spectrometry in systematic screening of pesticides and other contaminants in water samples Anal. Chim. 
Acta, 761 (2013), pp. 117–127 
[76] H. Horai, M. Arita, S. Kanaya, Y. Nihei, T. Ikeda, K. Suwa, et al. MassBank: a public repository for sharing 
mass spectral data for life sciences J. Mass Spectrom, 45 (2010), pp. 703–714 
[77] L. Bijlsma, E. Emke, F. Hernández, P. de Voogt Investigation of drugs of abuse and relevant metabolites 
in Dutch sewage water by liquid chromatography coupled to high resolution mass spectrometry Chemosphere, 
89 (2012), pp. 1399–1406 
[78] M.G. Cahill, B.A. Dineen, M.A. Stack, K.J. James A critical evaluation of liquid chromatography with 
hybrid linear ion trap-Orbitrap mass spectrometry for the determination of acidic contaminants in wastewater 
effluents J. Chromatogr. A, 1270 (2012), pp. 88–95 
[79] C.M. de Jongh, P.J.F. Kooij, P. de Voogt, T.L. ter Laak Screening and human health risk assessment of 
pharmaceuticals and their transformation products in Dutch surface waters ad drinking water Sci. Total 
Environ (2012), pp. 70–77 
[80] C.I. Kosma, D.A. Lambropoulou, T.A. Albanis Investigation of PPCPs in wastewater treatment plants in 
Greece: occurrence, removal and environmental risk assessment Sci. Total Environ, 466–467 (2014), pp. 421–
438 
 Chapter 1: General Introduction 
 
79 
[81] A.C. Chiaia-Hernandez, M. Krauss, J. Hollender Screening of lake sediments for emerging contaminants 
by liquid chromatography atmospheric pressure photoionization and electrospray ionization coupled to high 
resolution mass spectrometry Environ. Sci. Technol, 47 (2013), pp. 976–986 
[82] T.L. ter Laak, L.M. Puijker, J.A. van Leerdam, K.J. Raat, A. Kolkman, P. de Voogt, et al. Broad target 
chemical screening approach used as tool for rapid assessment of groundwater quality Sci. Total Environ, 427–
428 (2012), pp. 308–313 
[83] E. Emke, S. Evans, B. Kasprzyk-Hordern, P. de Voogt Enantiomer profiling of high loads of amphetamine 
and MDMA in communal sewage: a Dutch perspective Sci. Total Environ, 487 (2014), pp. 666–672 
[84] D.E. Helbling, J. Hollender, H.-P.E. Kohler, H. Singer, K. Fenner High-throughput identification of 
microbial transformation products of organic micropollutants Environ. Sci. Technol, 44 (2010), pp. 6621–6627 
[85] J. Hollender, S.G. Zimmermann, S. Koepke, M. Krauss, C.S. McArdell, C. Ort, et al. Elimination of organic 
micropollutants in a municipal wastewater treatment plant upgraded with a full-scale post-ozonation followed 
by sand filtration Environ. Sci. Technol, 43 (2009), pp. 7862–7869 
[86] J. Radjenović, M. Petrović, D. Barceló Advanced mass spectrometric methods applied to the study of fate 
and removal of pharmaceuticals in wastewater treatment Trends Anal. Chem, 26 (2007), pp. 1132–1144 
[87] T. Kosjek, D. Žigon, B. Kralj, E. Heath The use of quadrupole-time-of-flight mass spectrometer for the 
elucidation of diclofenac biotransformation products in wastewater J. Chromatogr. A, 1215 (2008), pp. 57–63 
[88] A.L. Boreen, W.A. Arnold, K. McNeill Triplet-sensitized photodegradation of sulfa drugs containing six-
membered heterocyclic groups: identification of an SO2 extrusion photoproduct 
Environ. Sci. Technol, 39 (2005), pp. 3630–3638 
[89] P. Eichhorn, P.L. Ferguson, S. Pérez, D.S. Aga Application of ion trap-MS with H/D exchange and 
QqTOF-MS in the identification of microbial degradates of trimethoprim in nitrifying activated sludge Anal. 
Chem, 77 (2005), pp. 4176–4184 
[90] P. Eichhorn, S. Pérez, J. Aceña, P. Gardinali, J.L. Abad, D. Barceló Identification of phototransformation 
products of sildenafil (Viagra) and its N-demethylated human metabolite under simulated sunlight J. Mass 
Spectrom, 47 (2012), pp. 701–711 
[91] A. Pérez-Parada, A. Agüera, M.D.M. Gómez-Ramos, J.F. García-Reyes, H. Heinzen, A.R. Fernández-Alba 
Behavior of amoxicillin in wastewater and river water: identification of its main transformation products by 
S
c
ie
n
ti
fi
c
 A
rt
ic
le
 1
 
Hernández et al. Trends in Analytical Chemistry 63 (2014) 140-157 
80 
liquid chromatography/electrospray quadrupole time-of-flight mass spectrometry Rapid Commun. Mass 
Spectrom, 25 (2011), pp. 731–742 
[92] T.E. Doll, F.H. Frimmel Fate of pharmaceuticals – photodegradation by simulated solar UV-light 
Chemosphere, 52 (2003), pp. 1757–1769 
[93] D.E. Latch, B.L. Stender, J.L. Packer, W.A. Arnold, K. McNeill Photochemical fate of pharmaceuticals in 
the environment: cimetidine and ranitidine Environ. Sci. Technol, 37 (2003), pp. 3342–3350 
[94] A.L. Boreen, W.A. Arnold, K. McNeill Photodegradation of pharmaceuticals in the aquatic environment: 
a review Aquat. Sci, 65 (2003), pp. 320–341 
[95] M. DellaGreca, A. Fiorentino, M.R. Iesce, M. Isidori, A. Nardelli, L. Previtera, et al. Identification of 
phototransformation products of prednisone by sunlight: toxicity of the drug and its derivatives on aquatic 
organisms Environ. Toxicol. Chem, 22 (2003), pp. 534–539 
[96] B. Halling-Sørensen, G. Sengeløv, J. Tjørnelund Toxicity of tetracyclines and tetracycline degradation 
products to environmentally relevant bacteria, including selected tetracycline-resistant bacteria Arch. Environ. 
Contam. Toxicol, 42 (2002), pp. 263–271 
[97] A. Agüera, L.A. Pérez Estrada, I. Ferrer, E.M. Thurman, S. Malato, A.R. Fernández-Alba Application of 
time-of-flight mass spectrometry to the analysis of phototransformation products of diclofenac in water under 
natural sunlight J. Mass Spectrom, 40 (2005), pp. 908–915 
[98] S. Pérez, P. Eichhorn, D. Barceló.Structural characterization of photodegradation products of enalapril 
and its metabolite enalaprilat obtained under simulated environmental conditions by hybrid quadrupole-linear 
ion trap-MS and quadrupole-time-of-flight-MS Anal. Chem, 79 (2007), pp. 8293–8300 
[99] P. Calza, C. Medana, E. Padovano, V. Giancotti, C. Minero Fate of selected pharmaceuticals in river waters 
Environ. Sci. Pollut. Res. Int, 20 (2013), pp. 2262–2270 
[100] C. Postigo, C. Sirtori, I. Oller, S. Malato, M.I. Maldonado, M. López de Alda, et al. Photolytic and 
photocatalytic transformation of methadone in aqueous solutions under solar irradiation: kinetics, 
characterization of major intermediate products and toxicity evaluation Water Res, 45 (2011), pp. 4815–4826 
[101] C. Postigo, C. Sirtori, I. Oller, S. Malato, M.I. Maldonado, M. López de Alda, et al. Solar transformation 
and photocatalytic treatment of cocaine in water: kinetics, characterization of major intermediate products and 
toxicity evaluation Appl. Catal. B Environ, 104 (2011), pp. 37–48 
 Chapter 1: General Introduction 
 
81 
[102] J. Rivera-Utrilla, M. Sánchez-Polo, M.Á. Ferro-García, G. Prados-Joya, R. Ocampo-Pérez 
Pharmaceuticals as emerging contaminants and their removal from water. A review Chemosphere, 93 (2013), 
pp. 1268–1287 
[103] M. Klavarioti, D. Mantzavinos, D. Kassinos Removal of residual pharmaceuticals from aqueous systems 
by advanced oxidation processes Environ. Int, 35 (2009), pp. 402–417 
[104] R.F. Dantas, M. Canterino, R. Marotta, C. Sans, S. Esplugas, R. Andreozzi Bezafibrate removal by means 
of ozonation: primary intermediates, kinetics, and toxicity assessment Water Res, 41 (2007), pp. 2525–2532 
[105] M.D.M. Gómez-Ramos, M. Mezcua, A. Agüera, A.R. Fernández-Alba, S. Gonzalo, A. Rodríguez, et al. 
Chemical and toxicological evolution of the antibiotic sulfamethoxazole under ozone treatment in water 
solution J. Hazard. Mater, 192 (2011), pp. 18–25 
[106] J. Radjenović, M. Matošić, I. Mijatović, M. Petrović, D. Barceló Membrane Bioreactor (MBR) as an 
advanced wastewater treatment technology Hdb. Env. Chem, 5 (2008), pp. 37–101 in: D. Barceló, M. Petrovic 
(Editors), Water Pollut., Springer Berlin Heidelberg, Berlin, Heidelberg 
[107] J. Radjenović, S. Pérez, M. Petrović, D. Barceló Identification and structural characterization of 
biodegradation products of atenolol and glibenclamide by liquid chromatography coupled to hybrid quadrupole 
time-of-flight and quadrupole ion trap mass spectrometry J. Chromatogr. A, 1210 (2008), pp. 142–153 
[108] M.J. García-Galán, C.E. Rodríguez-Rodríguez, T. Vicent, G. Caminal, M.S. Díaz-Cruz, D. Barceló 
Biodegradation of sulfamethazine by Trametes versicolor: removal from sewage sludge and identification of 
intermediate products by UPLC-QqTOF-MS Sci. Total Environ, 409 (2011), pp. 5505–5512 
[109] F. Hernández, J.V. Sancho, M. Ibáñez, T. Portolés TOF and QTOF-MS for identifying unknown 
contaminants and degradation products in the environment R.A. Meyers (Ed.), Encycl. Anal. Chem, John Wiley 
& Sons, Ltd., Chichester (2011) 
[110] A.H. Grange, M.C. Zumwalt, G.W. Sovocool Determination of ion and neutral loss compositions and 
deconvolution of product ion mass spectra using an orthogonal acceleration time-of-flight mass spectrometer 
and an ion correlation program Rapid Commun. Mass Spectrom, 20 (2006), pp. 89–102 
[111] S. Terzic, M. Ahel Nontarget analysis of polar contaminants in freshwater sediments influenced by 
pharmaceutical industry using ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass 
spectrometry Environ. Pollut, 159 (2011), pp. 557–566 
S
c
ie
n
ti
fi
c
 A
rt
ic
le
 1
 
Hernández et al. Trends in Analytical Chemistry 63 (2014) 140-157 
82 
[112] I. Ferrer, E.M. Thurman Identification of a new antidepressant and its glucuronide metabolite in water 
samples using liquid chromatography/quadrupole time-of-flight mass spectrometry Anal. Chem, 82 (2010), pp. 
8161–8168 
[113] R. Díaz, M. Ibáñez, J.V. Sancho, F. Hernández Building an empirical mass spectra library for screening 
of organic pollutants by ultra-high-pressure liquid chromatography/ hybrid quadrupole time-of-flight mass 
spectrometry Rapid Commun. Mass Spectrom, 25 (2011), pp. 355–369 
[114] M. Ibáñez, J.V. Sancho, D. McMillan, R. Rao, F. Hernández Rapid non-target screening of organic 
pollutants in water by ultraperformance liquid chromatography coupled to time-of-light mass spectrometry 
Trends Anal. Chem, 27 (2008), pp. 481–489 
[115] M.D.M. Gómez-Ramos, A. Pérez-Parada, J.F. García-Reyes, A.R. Fernández-Alba, A. Agüera Use of an 
accurate-mass database for the systematic identification of transformation products of organic contaminants in 
wastewater effluents J. Chromatogr. A, 1218 (2011), pp. 8002–8012 
[116] M.J. Martínez Bueno, M.M. Ulaszewska, M.J. Gómez, M.D. Hernando, A.R. Fernández-Alba 
Simultaneous measurement in mass and mass/mass mode for accurate qualitative and quantitative screening 
analysis of pharmaceuticals in river water J. Chromatogr. A, 1256 (2012), pp. 80–88 
[117] J. Nurmi, J. Pellinen, A.-L. Rantalainen Critical evaluation of screening techniques for emerging 
environmental contaminants based on accurate mass measurements with time-of-flight mass spectrometry J. 
Mass Spectrom, 47 (2012), pp. 303–312 
[118] A.C. Hogenboom, J.A. van Leerdam, P. de Voogt Accurate mass screening and identification of emerging 
contaminants in environmental samples by liquid chromatography–hybrid linear ion trap Orbitrap mass 
spectrometry J. Chromatogr. A (2009), pp. 510–519 
[119] E.L. Schymanski, H.P. Singer, P. Longrée, M. Loos, M. Ruff, M.A. Stravs, et al. Strategies to characterize 
polar organic contamination in wastewater: exploring the capability of high resolution mass spectrometry 
Environ. Sci. Technol, 48 (2014), pp. 1811–1818 
[120] J. Nurmi, J. Pellinen Multiresidue method for the analysis of emerging contaminants in wastewater by 
ultra performance liquid chromatography-time-of-flight mass spectrometry J. Chromatogr. A, 1218 (2011), pp. 
6712–6719 
[121] R. Díaz, M. Ibáñez, J.V. Sancho, F. Hernández Qualitative validation of a liquid chromatography-
quadrupole-time of flight mass spectrometry screening method for organic pollutants in waters J. Chromatogr. 
A, 1276 (2013), pp. 47–57 
 Chapter 1: General Introduction 
 
83 
[122] R. Bagnati, E. Davoli Analytical methods for the detection of illicit drugs in wastewaters and surface 
waters S. Castiglioni, E. Zuccato, R. Fanelli (Eds.), Illicit Drugs in the Environment: Occurence, Analysis and 
Fate Using Mass Spectrometry, John Wiley & Sons, Inc (2011), pp. 55–67 
[123] M. van der Aa, L. Bijlsma, E. Emke, E. Dijkman, A.L.N. van Nuijs, B. van de Ven, et al. Risk assessment 
for drugs of abuse in the Dutch watercycle Water Res, 47 (2013), pp. 1848–1857 
 
 
S
c
ie
n
ti
fi
c
 A
rt
ic
le
 1
 
  
 
 
 
 Chapter 1: General Introduction 
 
85 
1.4 Marie Curie SEWPROF ITN  
This work has been made as part of the European Union funded Marie Curie International Training 
Network (ITN) SEWPROF: A new paradigm in drug use and human health risk assessment: Sewage 
profiling at the community level. This ITN is multi-disciplinary and multi-institutional, covering 
subjects from analytical chemistry to statistics and epidemiology and includes eleven institutions in 
nine countries (Norway, Denmark, Germany, United Kingdom, The Netherlands, Belgium, 
Switzerland, Italy and Spain). Eleven Early Stage Researchers (ESRs) and four Experienced 
Researchers (ERs) from all over the world were recruited for this project. The main objective of this 
project is to “advance knowledge of the epidemiology of (illicit) drug use and to bridge gaps in the 
available expertise with the ultimate goal of applying this cutting edge interdisciplinary approach within 
epidemiological studies of societal health” (http://sewprof-itn.eu/).  
The interdisciplinary nature of this project is exemplified by the institutes and departments involved: 
from toxicologists (Toxicological Centre, University of Antwerp and Department of Experimental 
and Clinical Toxicology, University of Saarland) to water and environmental research institutes (KWR 
Watercycle Research Institute, Department of Environmental Health Sciences (Mario Mario Negri 
Institute of Pharmacological Research), Ecotoxicology and Risk Assessment (Norwegian Institute for 
Water Research  and Research Institute of Pesticides and Water (University Jaume I)), engineers 
(Department of Environmental Engineering (Technical University of Denmark) and Urban Water 
Management (Swiss Federal Institute of Aquatic Science and Technology)), epidemiologists (Centre 
for Drug and Addiction Research (University of Oslo), drug identification agencies (TICTAC 
Communications Ltd.) and pure chemists (Department of Chemistry (University of Bath).  
As implied from the title “International Training Network”, research stays for training and research 
purposes are mandatory. Research stays were thus performed by the PhD candidate at Mario Negri 
Institute of Pharmacological Research, Milan, Italy; KWR Watercycle Research Institute, Nieuwegein, 
The Netherlands; University of Saarland, Homburg, Germany; and University of Antwerp, Belgium.  
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Research stays and brief statement of work undertaken: 
Mario Negri Institute of Pharmacological Research: Suspect screening of wastewater and surface water 
samples from Spain and Italy using an LTQ-Orbitrap, under supervision of Dr. Sara Castiglioni. 
Duration: 28 April – 26 May 2014.  This work resulted in Scientific Article 3.  
KWR Watercycle Research Institute: Suspect and non-target screening of wastewater samples 
following injection in LTQ-Orbitrap using advanced deconvolution software, under supervision of 
Erik Emke and Prof. Dr. Pim de Voogt. Duration: 17 August – 13 September 2014. This work resulted 
in Scientific Article 4. 
University of Saarland: in vitro metabolism studies of 3-fluorophenmetrazine, under supervision of 
Prof. Dr. Hans Maurer. Duration: 1-18 June 2015.This work resulted in a co-authored paper (M. 
Mardal, B.  Miserez, R.  Bade, T.  Portolés, M.  Bischoff, F.  Hernández, M. R. Meyer; “3-
Fluorophenmetrazine, a fluorinated analogue of phenmetrazine: studies on in  vivo metabolism in rat 
and human, in vitro metabolism in human CYP isoenzymes and microbial biotransformation in 
Pseudomonas Putida and wastewater using GC and LC coupled to (HR)-MS techniques”, 
SUBMITTED) 
University of Antwerp: retention time prediction using artificial neural networks of three different LC 
columns: biphenyl, C8 and HILIC, under supervision of Dr. Alexander van Nuijs and Dr. Adrian 
Covaci. Duration: 20 July – 14 August 2015.  While this work did provide some good results, further 
research is required before a publication can be anticipated (see Future Perspectives).  
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1.5 Scientific Articles Included in this Thesis 
The core of this doctoral thesis consists of seven scientific articles published in (or submitted to) peer-
reviewed journals within the first quartile of the ranking by Impact factor (ISI web of knowledge). It 
is worth mentioning that five of these articles were made in collaboration with some internationally-
regarded scientists as part of the mandatory research stays mentioned in Section 1.4 as well as separate 
international collaborations. The role of the PhD candidate within these articles is outlined below.  
Scientific Article 2 was made in collaboration with researchers at the Universidad Nacional de 
Colombia and Universidad Antonio Nariño in Bogotá, Colombia. The PhD candidate was involved 
with the analysis of these samples in the UHPLC-QTOF as well as the data processing and writing of 
the article.  
Scientific Article 3 was the result of a collaboration with the Mario Negri Institute of 
Pharmacological Research (MN), Milan, Italy as part of a research stay within the SEWPROF project. 
Sample collection, preparation and analysis was all performed by the PhD candidate at the University 
Jaume I (using UHPLC-QTOF) while the candidate analysed the samples at MN following injection 
in LC-Orbitrap. Furthermore, the candidate drafted and revised the manuscripts. This work was 
performed independently under the supervision of Prof. Dr. Félix Hernández and Dr. Sara Castiglioni.  
Scientific Article 4 resulted from a collaboration with KWR Watercycle Research Institute, 
Nieuwegein, The Netherlands as part of two separate research stays (the first as a SEWPROF 
secondment and the second as a Short-Term Scientific Mission funded by COST ES1307). The 
experimental work (discounting sample preparation) and data analysis was entirely performed at KWR, 
independently under the supervision of Prof. Dr. Félix Hernández, Prof. Dr. Pim de Voogt and Erik 
Emke. The candidate drafted and revised the manuscripts. 
Scientific Article 6 involved a collaboration with Dr. Leon Barron and Thomas Miller of King’s 
College, London. This work was a follow-up to Scientific Article 5, with a subset of 544 compounds 
used in the development of a retention time prediction method using Artificial Neural Networks. The 
PhD candidate was involved in the initial development of the molecular descriptor selection and 
analysis and subsequent implementation for suspect analysis as well as writing and revision of the 
article. 
   
88 
Scientific Article 7 was the results of a final collaboration between eight institutions within the 
SEWPROF network. Samples from collected by all institutes and were used investigated using the 
optimised and validated method for new psychoactive substances, which was performed solely at 
University Jaume I.   The candidate performed all experimental work and drafted the initial 
manuscript, which was later revised by all co-authors.   This work was performed independently under 
the supervision of Prof. Dr. Juan V. Sancho, Dr. Lubertus Bijlsma and Prof. Dr. Felix Hernandez.  
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2.1 Introduction 
Liquid Chromatography coupled to High Resolution Mass Spectroscopy (LC-HRMS) is the 
technique of choice for the quick detection and (possible) identification of a large number of 
emerging contaminants in the aquatic environment. HRMS instruments combine full spectrum MS 
data with high mass resolution which makes them able to accurately measure the mass of any 
ionisable analyte in a sample. Theoretically, this means that there is a limitless number of 
compounds able to be detected using HRMS, given that they fit the requirements of the sample 
treatment, chromatographic treatment and MS ionisation. With the increased mass accuracy and 
resolution associated with HRMS (up to 100,000) compared to QqQ instruments, compounds of a 
similar exact mass are more easily differentiated and therefore it is very useful in the derivation of 
molecular formulae. Isobaric compounds, inseparable based on nominal mass (one decimal place) 
but containing different molecular formulae and thus exact mass (four decimal places), can hereby 
be distinguished using accurate mass measurements. 
In low resolution instruments, such as QqQ, isobaric compounds can be discriminated only by 
product ions and retention time. However, when bi-isobaric compounds co-elute or full 
chromatographic separation is not made, a false positive or negative may be reported. In HRMS, 
isobaric interferences can be discriminated by reducing the extracted ion chromatogram (XIC) 
window (down to 0.01-0.05 Da), which increases the signal-to-noise ratio by simultaneously 
decreasing the chemical noise, therefore improving the reliability and sensitivity of the data. 
(Hernández et al., 2005; Nurmi and Pellinen, 2011) 
The high quality, sensitive and accurate-mass data obtained by HRMS allows the determination of 
the elemental composition of a compound with high confidence. Because of the resolution, very 
similar masses can be differentiated by their different elemental compositions. For example, purine 
(C5H4N4) and acetophenone (C8H8O) both have the same nominal mass of 120.1, and with the 
nominal mass resolution of a QqQ, these ions would be indistinguishable. However, based on their 
different elemental compositions, they have different exact masses (120.0436 and 120.0575 
respectively), which could be easily distinguished using an instrument with a higher resolving power, 
such as a QTOF or Orbitrap. Furthermore, the characteristic isotopic patterns of carbon, bromine, 
sulphur and chlorine can be utilised to reduce the number of possibilities and help find the correct 
elemental composition.  
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All of these characteristics combined make HRMS a suitable instrument for environmental samples 
analysis, such as surface and wastewater, where there are potentially thousands of compounds 
warranting investigation. On the one hand, environmental analytical chemists can apply target 
approaches, being limited when choosing which compounds to focus on, as reference standards, 
required for quantitative analysis, can be very costly. With a reliance on sensitivity for these analyses, 
HRMS is not commonly the choice, although it has been used (Bijlsma et al., 2013; Gonzalez-
Mariño et al., 2012; Leendert et al., 2015), rather, triple quadrupole (QqQ) instruments (Farré et al., 
2012). But on the other hand, qualitative screening methods, making use of databases containing 
thousands of (known) emerging contaminants and metabolites can be used to get more of a general 
idea on which compounds are present. This can provide a quick overview of compounds present in 
the samples. However, one disadvantage associated with this approach is that even with a database 
containing thousands of compounds, there may still be peaks present that are unaccounted for.  
Alternatively, analyses could be made without reference standards or databases, but based solely on 
the data obtained from the LC-HRMS. These three ideas are, indeed, the three strategies used for 
the detection and identification of emerging contaminants in environmental analyses: target (list of 
targeted compounds to be searched, with reference standards available), suspect (list of targeted 
compounds to be searched, without reference standards available to the laboratory), and non-target 
(discovering of unknowns, without any selection of targets to be searched).  
One disadvantage of target and suspect screening is the “Matthew Effect” as noted by Daughton 
(Daughton, 2014), which basically states that compounds that have been detected/identified in 
previous studies are more likely to be included in target/suspect screening strategies. Although this 
seemingly self-fulfilling selection bias could be construed as chemical or environmental ignorance, 
there are several plausible reasons why not all compounds are able to be studied: 
 Newly registered/developed pharmaceuticals/drugs of abuse may gain rapid market 
penetration and ascend the rankings of prescription data and consumer consumption faster 
than targeted analysis are able to be developed. 
 Some compounds are not easily applicable for analytical methods, with difficulties resulting 
from their physicochemical characteristics, from polarity to stability. Therefore, some 
compounds which may be present will not (or cannot) be demonstrated.  
 Some compounds are simply ignored, due to wrongly predicted or performed environmental 
prevalence studies. Alternatively, even correctly performed predictions or studies can be 
 Chapter 2: Suspect and Non-Target Screening 
 
 
93 
confounded due to the extreme (and irreproducible) conditions associated with the transport 
from the source. 
The first of these is particularly relevant for new psychoactive substances (NPS; more in Chapter 4), 
which are readily produced and changed depending on consumers and legal regulations, with 
analytical methods often one step behind the production and user uptake.  Furthermore, with costly 
reference standards necessary for target (and ultimately, suspect) analyses, most laboratories are 
(rightly) apprehensive when it comes to purchasing new reference standards for compounds which 
may not be present in the environment or for which limited data is available.  
The second reason is one which is very important, often overlooked by environmental 
epidemiologists and non-chemists. It is impossible to make a single analytical method for all 
compounds. Even making a small, targeted method for tens of compounds is time-consuming. 
Conversely, in wide-scope suspect screening methods, a compromise is made so as to ensure that as 
many compounds as possible can be detected. This can mean that very polar and non-polar 
compounds can sometimes be overlooked. 
The last reason is difficult to foresee. It is impossible on a lab-scale to reproduce the conditions seen 
in the environment, in terms of sunlight, water, possible sorption and interaction with other 
compounds. Even with studies performed well, these unknown interactions could result in 
compounds initially not expected to be present, to be present.  
This bias and “Matthew Effect” can be overcome by using non-target analysis, where no prior 
information is known at all, so no selection or availability bias can be inputted. However, the 
compounds detected are limited by the analytical methodology, as explained above, where some 
compounds may not be able to be detected due to their particular chemical characteristics. Moreover, 
it is unrealistic to investigate the identity of every peak appearing in a total ion chromatogram (TIC), 
with the additional limitation that “relevant compounds” from the environmental or WBE point of 
views, are commonly present at very low concentration in complex unknown matrices, such as 
wastewater samples. 
It is difficult to assign one HRMS instrument (i.e. TOF or Orbitrap) as being superior, as their use 
depends on the aim of a particular study. Most recent publications include TOF MS instruments 
with mass accuracies typically less than 5ppm and mass resolving power of 20,000 - 40,000 FWHM 
depending on the instrument. The scan speed attainable in recent TOF instruments falls in the range 
of 10-100 scans/s, more than enough for UHPLC separations, leading to shorter run times, enabling 
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sufficient chromatographic resolution to minimize co-elution of compounds with close m/z values.  
One further advantage of a (Q)TOF is its ability to perform simultaneous full-scan and MS/MS 
(Martínez Bueno et al., 2012) (or “pseudo”-MS/MS(Hernández et al., 2011)), meaning that 
information pertaining to fragment ions can be collected in a single injection, rather than having to 
reinject a second time. The aforementioned “pseudo”-MS/MS mode, MSE, of the QTOF was used 
in both Scientific Article 2 and 3 for suspect screening.  The ability to acquire low-energy (LE) and 
high-energy (HE) data at the same time, without the need to preselect a precursor molecule, 
facilitated data analysis. By applying LE in the collision cell, fragmentation is minimized, and the 
information obtained corresponds normally to non-fragmented ions, related to the parent molecule. 
However, at HE, fragmentation will take place, resulting in abundant fragments (Hernández et al., 
2011; Plumb et al., 2006). The MSE approach is also known as All-Ion Fragmentation or broadband 
collision-induced dissociation, depending on the manufacturer. 
Orbitrap has a higher resolution than TOF (up to 150.000 FWHM), which gives obvious advantages 
in the analysis, particularly in samples of high complexity, and is considered better for quantitative 
analysis, as it affords a linear dynamic range of up to three-four orders of magnitude, at least one 
order of magnitude higher than the TOF instruments (Agüera et al., 2013; Krauss et al., 2010). The 
main drawback of this instrument is its scanning speed, which is inverse of mass resolution. For 
example, at a mass resolution of 100,000, a scan speed of only 1 scan/s is attainable. It can, however, 
be coupled to UHPLC, but only when using a sufficiently low mass resolution (i.e. 10,000 FWHM 
for a scan speed of 10 scans/s).  
Sample treatment associated with wide-scope screening methods is an important aspect, and can be 
a limitation when dealing with many compounds of quite different physicochemical characteristics. 
A simple sample treatment can be applied, such as SPE with Oasis HLB for pre-concentration and 
to enable detecting the analytes at the low concentration levels normally present, which can be 
thought of as “universal” and generic (Hernández et al., 2015), thereby allowing as many 
compounds as possible being detected following sample analysis.  Alternatively, to gain more 
specific information on the compounds present multiple SPE cartridges could be used (Kern et al., 
2009; Schymanski et al., 2014), or, if, in advance, a screening was made on a more specific set of 
compounds, different sample treatment can be applied – such as adding activated carbon for more 
polar compounds (Schollée et al., 2015).  
This chapter focusses on the use of both UHPLC-QTOF-MS and LC-LTQ-Orbitrap-MS in the 
detection and identification of emerging contaminants in environmental waters.  
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2.2 Scientific Articles 
This chapter includes three scientific articles, “LC-QTOF MS screening of more than 1,000 licit and illicit 
drugs and their metabolites in wastewater and surface waters from the area of Bogotá, Colombia” (Scientific 
Article 2), “Screening of pharmaceuticals and illicit drugs in wastewater and surface waters of Spain and Italy by 
high resolution mass spectrometry using UHPLC-QTOF MS and LC-LTQ-Orbitrap MS” (Scientific Article 
3) and “Facilitating high resolution mass spectrometry data processing for screening of environmental water samples: 
An evaluation of two deconvolution tools” (Scientific Article 4). They concern suspect and non-target 
screening for the identification of pharmaceuticals, illicit drugs and their metabolites in 
environmental waters of different geographic and aquatic origin. All of the studies incorporated the 
same sample treatment: with samples being filtered through a membrane filter (0.45µm) to remove 
any solid particulates, then extracted on HLB SPE cartridges. This generic sample treatment was 
employed due to the wide-scope nature of the studies. With no specific compounds under 
investigation, no specific sample treatment could be applied. 
Scientific Article 2 was envisaged as a very comprehensive initial study into the pharmaceuticals 
and illicit drugs present in waste and surface waters of Bogotá, Colombia. This was seen as a first 
step towards target analysis of the detected compounds, to get a more sensitive and quantitative idea 
of their existence. A database of more than 1000 compounds was used in the 
detection/identification process. After a simple SPE extraction with a generic polymeric cartridge as 
Oasis HLB, sample extracts were injected in MSE mode in the UHPLC-QTOF so as to gain 
information relating to parent and fragment ions in a single injection. In the end, 30 parent 
compounds and metabolites could be confirmed, based on the presence of at several ions at accurate 
mass, while a further five could not be confirmed as there was only one ion. Six compounds, were 
tentatively identified based on fragment ions, three of which were tentatively identified based on a 
common fragmentation pathway. 
A similar procedure was followed in Scientific Article 3, but employing a smaller list of compounds, 
those, which, based on previous experience, would be more likely to be found in environmental 
waters. To take this suspect analysis a step further, it was also performed on an LTQ-Orbitrap 
instrument. Because the methods and instruments were completely different, a comparison was not 
made, rather to see whether any additional compounds could be detected by employing a different 
instrument. After injection, the data was analysed using the respective vendors’ software. When one 
compound was found using one combination of instrument and software but not the other, the raw 
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data was investigated. In the end, little difference was seen between the instruments, proving that 
they are both powerful instruments, useful in the qualitative identification of emerging contaminants. 
Scientific Article 4 investigated a non-target approach for the tentative identification of 
pharmaceuticals and illicit drugs. Following injection in an LC-LTQ-Orbitrap, two software types 
were utilised for hidden target screening (MsXelerator and Sieve 2.1).  Two databases were used, one 
similar to that employed in Scientific Article 3 as well as ChemSpider, to detect possible 
compounds following automated exact mass extraction. Combining the detected compounds from 
the two hidden target methods, a target list was made for subsequent MS/MS investigation, in order 
to tentatively identify compounds based on product ions and their comparability with literature 
and/or the online mass spectral database MassBank.  
The results of these three articles have been published as follows: 
LC-QTOF MS screening of more than 1000 licit and illicit drugs and their metabolites in wastewater 
and surface waters from the area of Bogotá, Colombia F. Hernández, M. Ibáñez, A. M. Botero-Coy, R. 
Bade, M. Bustos-Lopez. J. Rincon, A. Moncayo, L. Bijlsma, Analytical and Bioanalytical Chemistry 407, 
2015, 6405-6416. 
Screening of pharmaceuticals and illicit drugs in wastewater and surface waters of Spain and Italy by 
high resolution mass spectrometry using UHPLC-QTOF MS and LC-LTQ-Orbitrap MS R. Bade, N. 
I.  Rousis, L. Bijlsma, E. Gracia-Lor, S. Castiglioni, J. V. Sancho, F. Hernández, Analytical and 
Bioanalytical Chemistry 407, 2015, 8979-8988. 
Facilitating high resolution mass spectrometry data processing for screening of environmental water 
samples: An evaluation of two deconvolution tools R. Bade, A. Causanilles, E. Emke, L. Bijlsma, J. V. 
Sancho, F. Hernandez, P. de Voogt Science of the Total Environment UNDER REVISION. 
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2.2.1  Scientifc Article 2 
LC-QTOF MS SCREENING OF MORE THAN 1,000 
LICIT AND ILLICIT DRUGS AND THEIR 
METABOLITES IN WASTEWATER AND SURFACE 
WATERS FROM THE AREA OF BOGOTÁ, COLOMBIA 
 
Félix Hernández, Maria Ibáñez, Ana-Maria Botero-Coy, Richard Bade, Martha 
Cristina Bustos-López, Javier Rincón, Alejandro Moncayo, Lubertus Bijlsma 
 
Analytical and Bioanalytical Chemistry (2015) 407: 6405-6416 
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Topical Collection: High-Resolution Mass Spectrometry in Food and Environmental Analysis   
Abstract 
A large screening of around 1,000 emerging contaminants, focused on licit and illicit drugs and their metabolites, 
has been made in urban wastewaters (both influent and effluent) and surface waters from the area of Bogotá, 
Colombia. After a simple generic solid-phase extraction (SPE) step with Oasis hydrophilic-lipophilic balanced 
(HLB) cartridges, analyses were made by ultra high-performance liquid chromatography coupled to quadrupole 
time-of-flight mass spectrometry (UHPLC-QTOF MS) under MSE mode (sequential acquisition of mass 
spectra at low energy (LE) and high collision energy (HE)). Accurate mass measurements and the information 
provided by MSE on the presence of the (de)protonated molecule and fragment ions allowed the reliable 
identification of the compounds detected, even without reference standards being available in some cases 
(tentative identification). The compounds most frequently found were acetaminophen/paracetamol, 
carbamazepine and its dihydro-dihydroxylated metabolite, clarithromycin, diclofenac, ibuprofen, gemfibrozil, 
lincomycin, losartan, valsartan, the two metabolites of metamizole (4-acetamido-antipyrine and 4-formylamino-
antipyrine), sucralose, and cocaine and its main metabolite benzoylecgonine. Caffeine, the sweetener saccharin, 
and two hydroxylated metabolites of losartan were tentatively identified in almost all samples analyzed. 
Pharmaceutical lidocaine was tentatively identified and subsequently confirmed with reference standard. For 
the first time, a general overview of the occurrence of drugs and their metabolites in the aquatic environment 
of Colombia has been reported. In the near future, target methodologies, typically based on liquid 
chromatography coupled to tandem mass spectrometry (LC-MS/MS), will need to be set up for accurate and 
sensitive quantification of the contaminants selected on the basis on the information provided in the present 
paper. 
 
Keywords 
Screening, ultra high-performance liquid chromatography, time-of-flight mass spectrometry, drugs, water, 
Colombia 
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Introduction 
Changes in industry, agriculture, and urban development present interlinked challenges to water quality [1, 2]. 
Due to the increasing use of pharmaceuticals and personal care products (PCPs) as well as veterinary drugs and 
illicit drugs, the amount of these newly emerging chemicals detected in waters raises environmental and health 
concerns. Many of these contaminants survive the passage through conventional wastewater treatment 
processes resulting in the growing discharge of these compounds into receiving waters where their presence is 
increasingly common [3, 4]. However, little information is available from Latin America despite the fact that 
this region undergoes rapid land, economical, and social changes [5] and where, in some areas, the discharge of 
raw sewage into rivers, lakes, and reservoirs is widely practiced [6–8]. Concern over the presence of these 
contaminants is well founded as these rivers not only flow through tropical areas rich in biodiversity, but also 
surface waters are also used as a source for human consumption after conventional chlorination processes or 
directly as irrigation water without any treatment. 
Monitoring licit and illicit drugs is generally based on multi-residue methodologies using liquid chromatography 
coupled to tandem mass spectrometry (LC-MS/MS) for target substances considered as harmful for human 
health or the ecosystem. Analyses are commonly focused on a limited number of priority compounds, and the 
main objective is the accurate quantification of the target analytes. However, the use of pharmaceuticals and 
veterinary drugs differs temporally and spatially between regions and countries due to different marketing, 
regulations, prescription practices, etc. [9]. Thus, drugs used in Latin America may differ from those generally 
prescribed or consumed in Europe and North America. Accordingly, target approaches applied for routine 
analysis of water samples in one country might ignore important contaminants from another country, as they 
are simply not included in the scope of the method. Therefore, a large screening of contaminants is of high 
interest in order to define priority compounds and to subsequently set up target methodologies for monitoring. 
To this end, high-resolution mass spectrometry (HRMS) plays an important role for screening of emerging 
contaminants, in relevant fields like environmental pollution [10, 11]. 
Hybrid HRMS, such as a quadrupole time-of-flight mass spectrometry (QTOF MS) in MSE or all ion MS/MS 
mode (the term depends on the manufacturer), has demonstrated its use as an advanced tool that allows the 
investigation of hundreds of compounds in the same run, making use of homemade databases [12–14]. The 
presence of compounds in samples can be investigated once the analysis has been performed and data acquired, 
without being dependent on the pre-selection of analytes. It allows detection/rapid screening for compounds 
by means of searching the exact mass of the (de)protonated molecules in the full spectra generated using 
low collision energy (LE function). Confirmation with reference standards, or tentative identification, could 
subsequently be performed searching for exact masses of fragment ions in the acquired spectra at high collision 
energy (HE), where fragmentation of the molecule is promoted. 
 Chapter 2: Suspect and Non-Target Screening 
 
 
101 
We performed a previous monitoring in the irrigate district of Usosaldaña, an important agricultural area in 
Colombia, mainly devoted to the cultivation of rice. Analysis of surface water and soil samples by TOF MS, 
coupled to both gas and liquid chromatography revealed the presence of several pesticides and metabolites in 
most of the samples. Also, some personal care products were identified [15]. However, there is little or no 
information on the presence of emerging organic contaminants in the area of Bogotá. In the present work, a 
large screening of pharmaceuticals belonging to different therapeutic groups, veterinary drugs, X-ray agents, 
PCPs (preservatives and UV filters), sweeteners, illicit drugs, and a notable number of metabolites has been 
performed in urban wastewaters (both influent and effluent) and receiving surface waters from the surrounding 
area of Bogotá. A customized database with more than 1,000 emerging contaminants was developed including 
pharmaceuticals frequently prescribed in Colombia. As far as we know, this is the first wide-scope screening 
based on HRMS that has been applied to this aim. Henceforth, future monitoring in this area can be focused 
on the compounds identified in this initial step. 
Material and methods 
Chemicals and standards 
Eight hundred and sixty-five human and veterinary pharmaceuticals including metabolites (see Electronic 
Supplementary Material (ESM), Table S1), 29 X-ray agents (ESM Table S2), 20 UV filters (ESM Table S3), 4 
preservatives (ESM Table S4), 9 sweeteners (ESM Table S5), and 130 illicit drugs including metabolites (ESM 
Table S6) were studied, of which 215 reference standards were available (asterisk in ESM Tables S1–S6). 
Reference standards of these compounds were purchased from Across Organics (Geel, Belgium), Aventis 
Pharma (Madrid, Spain), Bayer Hispania (Barcelona, Spain), Cerilliant (Round Rock, TX, USA), Fluka (Buchs, 
Switzerland), Dr. Ehrenstorfer (Augsburg, Germany), Fort Dodge Veterinaria (Gerona, Spain), LGC 
Promochem (London, UK), National Measurement Institute (Pymble, Australia), Riedel-de Haën (Seelze, 
Germany), Sigma-Aldrich (St. Louis, MO, USA), Toronto Research Chemicals (Ontario, Canada), Vetoquinol 
Industrial (Madrid, Spain), and Witega (Berlin, Germany). All reference materials had purities higher than 98 % 
(w/w), except for marbofloxacin and pefloxacin, which had purities higher than 93 %. 
HPLC-grade methanol (MeOH), HPLC-grade acetonitrile (ACN), sodium hydroxide (NaOH) (>99 % w/w), 
and formic acid (HCOOH) (>98 % w/w) were purchased from Scharlau (Barcelona, Spain). Leucine enkephalin 
was purchased from Sigma-Aldrich (Madrid, Spain). HPLC-grade water was obtained by purifying 
demineralized water in a Milli-Q plus system from Millipore (Bedford, MA, USA). Solid-phase extraction (SPE) 
cartridges used were 3-cm3 Oasis hydrophilic-lipophilic balanced (HLB) (60 mg) from Waters (Milford, MA, 
USA). 
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Samples 
Seven influent wastewater (IWW) samples and seven effluent wastewater (EWW) samples were taken from the 
Salitre wastewater treatment plant (WWTP), in Northwest Bogotá D.C., Colombia, which serves a population 
of approximately three million inhabitants. The 24-h composite samples were collected over seven consecutive 
days in March 2014 (starting on Wednesday, March 12, and ending on Tuesday, March 18) in high-density 
polystyrene bottles, immediately centrifuged, and stored in the dark at −20 °C until analysis. In addition, ten 
grab surface water (SW) samples were collected from around Bogota (Fig. 1) in July 2013, concerning areas of 
interest along the Tunjuelo River (samples 1–4) and in La Ramada Irrigation District (samples 5–10). Seven 
individual samples (250 mL) were taken for each sampling point. These were then combined to form a 
composite sample to provide a more complete overview of each area. An aliquot was then taken for the sample 
treatment and subsequent analysis. 
 
Sampling points 
Number Name/Description 
1 Landfill, Doña Juana (Tunjuelo river) 
2 San Benito (tanneries area) (Tunjuelo river) 
3 Guadalupe (slaughterhouse) (Tunjuelo river) 
4 Bosa (Tunjuelo river) 
5 Irrigation channel San Jose- La Victoria (Ramada irrigation area) 
6 Irrigation channel San Jose- Los Pinos (Ramada irrigation area) 
7 Wetland Güali-Tres Esquinas (Ramada irrigation area) 
8 Canal C. Agricultural Center, Marengo (Ramada irrigation area) 
9 Canal C. Agricultural Center, Marengo (Ramada irrigation area) 
10 Exit of swamp (Ramada irrigation area) 
11 Wastewater, Salitre WWTP 
Seven influent and seven effluent wastewater samples (one whole week) 
Fig. 1 Location of sampling sites 
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Sample treatment 
An SPE step was applied prior to analysis to pre-concentrate the sample. All samples were filtered through 
0.45-μm mixed cellulose ester membrane filter (Whatman, Dassel, Germany). SPE was performed using Oasis 
HLB cartridges (60 mg). The cartridges were conditioned by washing and rinsing with 6 mL MeOH and 6 mL 
Milli-Q water. The water samples (IWW was four times diluted with Milli-Q water, i.e., 25 mL sample in 100 mL; 
EWW and SW were 100 mL, no dilution) were loaded onto the cartridges, percolated by gravity (flow rate 
around 3 mL/min), and vacuum dried for approximately 15 min. Analytes were eluted with 5 mL MeOH. The 
extracts were evaporated to dryness at 35 °C under a gentle stream of nitrogen and reconstructed in 1 mL of 
10:90 MeOH/H2O. Analyses were performed by injecting 20 μL of the final extract into the UHPLC-QTOF 
MS. 
Instrumentation 
A Waters Acquity UPLC system (Waters, Milford, MA, USA) was interfaced to a hybrid quadrupole-orthogonal 
acceleration-TOF mass spectrometer (XEVO G2 QTOF, Waters Micromass, Manchester, UK), using a Z-
Spray electrospray ionization (ESI) interface operating in both positive and negative ion mode. The 
chromatographic separation was performed using an Acquity UPLC BEH C18 1.7-μm particle size column 
100 × 2.1 mm (Waters) at a flow rate of 300 μL/min. The mobile phases used were A = H2O with 0.01 % 
HCOOH and B = MeOH with 0.01 % HCOOH. The initial percentage of B was 10 %, which was linearly 
increased to 90 % in 14 min, followed by a 2-min isocratic period and, then, returned to initial conditions during 
2 min. The total run time was 18 min. Nitrogen was used as drying gas and nebulizing gas. The desolvation gas 
flow was set at 1,000 L/h and the cone gas at 80 L/h. TOF MS resolution was approximately 20,000 at full 
width at half maximum (FWHM) at m/z 556. 
MS data were acquired in centroid mode over an m/z range of 50–1,000 Da. Data were acquired in both positive 
and negative ionization mode in two separate runs. A capillary voltage of 0.7 and 2.5 kV was used in positive 
and negative ionizations mode, respectively. A cone voltage of 20 V was used. Collision gas was argon 99.995 % 
(Praxair, Valencia, Spain). The desolvation temperature was set to 600 °C and the source temperature to 130 °C. 
The column temperature was set to 40 °C. 
For MSE experiments, two acquisition functions with different collision energies were created: the LE function, 
selecting a collision energy of 4 eV, and the high energy (HE) function, with a collision energy ramp ranging 
from 15 to 40 eV in order to obtain a greater range of fragment ions. The scan time for both LE and HE 
function was 0.4 s. 
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For elucidation of losartan metabolites, MS/MS experiments at different collision energies (10, 20, 30, 40, and 
50 eV) were performed to promote higher fragmentation and also to ensure that fragment ions observed in 
MSE come from the parent ion. 
Data processing  
Processing of MS data was done using ChromaLynx XS application manager (within MassLynx v 4.1; Waters 
Corporation). The following parameters were used for screening: mass window 150 ppm (for positive ID 
≤5 ppm), isotope fit as well as retention time (maximum deviation of ≤2.5 %) and fragmentation, when 
available. Software-specific settings were as follows: peak width at 5 % height, 6 s; peak-to-peak baseline noise, 
1,000; and threshold absolute area, 200. 
Results and discussion 
Detection, confirmation and tentative identification 
The full-spectrum accurate mass data, generated by QTOF under MSE mode, were inspected in ChromaLynx 
XS (within MassLynx) using a homemade database containing 1,057 LC-amenable organic contaminants (see 
ESM, Tables S1–S6), which is continuously being updated. Analytes were mostly selected based on our own 
experience and on existing compound lists encountered in the literature on LC-MS methods for determination 
of organic contaminants. Empirical data (retention time, adduct information, and/or fragment ions) obtained 
from compounds of which reference standards (up to 215) were available in our laboratory was included. This 
information was used for an easier and more straightforward detection and unambiguous confirmation of the 
identity of the compound. Furthermore, pharmaceuticals frequently prescribed in Colombia were also included. 
For those compounds for which reference standards were not available at our laboratory, the only information 
included in the database was the name and elemental composition of the compounds. Here, the tentative 
identification was a manual and more time-consuming process, incorporating Internet resources, such as 
MassBank [16] or MetLin [17], to look for information about possible fragment ions. 
The confidence in HRMS-based identification is an important issue as pointed out by Schymanski et al. [18]. 
Discussion on how to best communicate confidence regarding identification for the exchange of results via 
literature and databases is ongoing, but criteria are needed and should be well reported. Criteria used in this 
study were based on the availability (detection and confirmation of the identity) or non-availability (tentative 
identification) of reference standards. The information given by QTOF MS spectra, both LE and HE accurate 
mass spectra, and retention times allowed the compounds to be distinguished using different possibilities: 
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 Detection, based on the presence of one accurate mass ion (mass error ≤5 ppm) and retention time 
agreement (maximum deviation ≤2.5 %) 
 Confirmation of the identity, with at least two accurate mass ions (≤5 ppm) and retention time (≤2.5 %) 
 Tentative identification, with at least two accurate mass ions justified by literature data and/or compatibility 
with candidate chemical structure 
For those compounds containing chlorine or bromine atoms, the characteristic isotopic profile should be 
observed. However, we considered the isotopic pattern as a prerequisite for identification, but not as valuable 
as an accurate mass fragment ion. Therefore, when only those ions corresponding to the parent compound and 
the isotopic peak were present, we considered the compound as detected, not as confirmed. 
In the case of tentative identification, reference standards and additional MS/MS experiments would be 
necessary for final unequivocal confirmation of the compounds. However, we do not need expensive reference 
standards for all 1,057 compounds in the database, only for the positive findings. From our previous experience, 
the subsequent acquisition of reference standards has allowed confirmation of nearly all tentative identifications. 
This supports the high degree of reliability of tentative identification by using this technique [19]. 
Screening of Colombian water samples 
In order to perform a large screening, a non-selective sample treatment, and a generic chromatographic 
separation were chosen to broaden the system applicability to as many compounds as possible. Due to the large 
level of dilution in these types of samples, SPE was performed, using a generic Oasis HLB cartridge for pre-
concentration and to enable detecting the analytes at the low concentration levels normally present. Using this 
analytical procedure and from the information obtained by UHPLC-QTOF MS under MSE mode, several 
compounds could be detected, confirmed, and/or tentatively identified in all type of Colombian water samples 
analyzed (Table 1). 
Samples were screened for pharmaceuticals belonging to different therapeutic groups, veterinary drugs, X-ray 
agents, PCPs (preservatives and UV filters), sweeteners, illicit drugs, and several metabolites. The compounds 
most frequently detected were the analgesics/anti-inflammatory drugs N-acetyl-p-aminophenol (commonly 
known as acetaminophen or paracetamol), diclofenac, ibuprofen, and lidocaine. The antibiotics clarithromycin 
and lincomycin, the angiotensin II antagonists valsartan and losartan, the anti-epileptic carbamazepine, the beta-
blocker metoprolol, the lipid regulator gemfibrozil, and the X-ray agent iopromide were also found. It is 
interesting to remark the detection or tentative identification of several metabolites such as those of metamizole 
(4-acetylamino-antipyrine and 4-formylamino-antipyrine), carbamazepine-10,11-dihydro-10,11-dihydroxy, and 
three metabolites of losartan (losartan carboxylic acid and two hydroxy-losartan isomers). Furthermore, the 
sweeteners acesulfame, sucralose, saccharin and the psychoactive drugs, cocaine and its main metabolite 
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benzoylecgonine, as well as caffeine were frequently detected or tentatively identified. UV filters were not 
detected, while the preservatives methylparaben and propylparaben were found, but only in wastewater samples. 
These data are consistent with studies on over-the-counter medicines in Colombia, where analgesics are most 
frequently sold (60 %), in Bogotá [20]. In addition, 11 % of the population of Bogotá has been diagnosed with 
hypertension of which 5.5 % take mainly losartan, valsartan, and metoprolol for its control [21] and regarding 
antibiotics, clarithromycin and lincomycin are most often prescribed [22]. Based on general population surveys, 
cocaine is the second most consumed illicit drug, but the main illicit psychoactive drug consumed in Colombia 
is cannabis [23]. However, the main metabolite of cannabis (11-nor-9-carboxy-Δ9-tetrahydrocannabinol (THC-
COOH)), which is commonly used as biomarker in wastewater for cannabis consumption, was not detected. 
This was probably due to the low sensitivity of the technique applied for this compound. The analytical 
problems found in the determination of this compound have been widely recognized in the literature [24–26]. 
Most compounds were found in both wastewaters (influent and effluent) and surface waters suggesting 
incomplete removal by WWTPs and possible disposal to receiving surface waters. The pharmaceuticals 
carbamazepine and its metabolite carbamazepine-10,11-dihydro-10,11-dihydroxy, acetaminophen, diclofenac, 
ibuprofen, the highly consumed caffeine, cocaine and its metabolite benzoylecgonine are widely occurring 
contaminants in the aquatic environment, having been reported to be also present in Brazilian surface waters 
[5, 7]. 
  
 
 
Table 1. Positive findings by UHPLC-(Q)TOF MS in 10 surface water samples. Results obtained in influent and effluent samples. 
COMPOUND 
SURFACE WATER (number of the sampling site) 
INFLUENT* 
(n=7) 
EFFLUENT* 
(n=7) 
1 2 3 4 5 6 7 8 9 10 
Pharmaceuticals and veterinary drugs 
4-Acetamido antipyine            
4-Formylamino antipyrine            
Acetaminophen/paracetamol            
Carbamazepine            
Carbamazepine 10,11-dihydro-10,11-
dihydroxy            
Clarithromycin            
Clindamycin             
Codeine            
Diclofenac            
Dimetridazole            
Gabapentin            
Gemfibrozil            
Ibuprofen            
Iopromide            
Irbesartan            
Ketoprofen            
Levamisole            
Lidocaine**            
Lincomycin            
Losartan            
Losartan, carboxylic acid**            
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Losartan, hydroxy (1)            
Losartan, hydroxy (2)            
Metformin            
Metoprolol            
Metronidazole            
Naproxen            
Pirantel            
Salbutamol            
Sulfamethoxazole            
Trimethoprim            
Valsartan            
Psychoactive drugs 
Benzoylecgonine            
Caffeine            
Cocaine             
Preservatives 
Methylparaben            
Propylparaben            
Sweeteners 
Acesulfame            
Saccharin            
Sucralose            
Dot (•) detected, not confirmed (one accurate mass ion <5 ppm + retention time <2.5 %), square root (√) confirmed with at least two accurate mass ions (<5 ppm) and retention time 
(<2.5 %) with reference standard, circled plus (⊕) tentatively identified (at least two accurate mass ions justified by literature data and/or compatible with the candidate chemical 
structure) aResults given for IWW and EWW correspond to seven samples (one whole week). The compounds indicated as dot, circled plus, or square root were found in at least six out 
of seven samples analyzed. b These compounds were firstly tentatively identified in the samples and afterwards confirmed with reference standards 
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In relation to surface waters, the presence of pharmaceuticals was more noticeable in samples collected from 
the Tunjuelo River (samples one to four)—a tributary of the Bogotá River—in the south of Bogotá. In this 
area, around 2.5 million inhabitants discharge their sewage directly to this river without any treatment. In 
addition, solid urban waste are located here (Doña Juana landfill, Fig. 1), and potential leaching surely 
contributes to the pollution in the area. This can explain that the profile of emerging contaminants found in 
these surface waters and in wastewaters collected from Salitre WWTP was rather similar, in both cases reflecting 
the drug consumption of a large population (2.5–3 million inhabitants). 
In contrast, the irrigation area of Ramada—supplied by the Bogotá river in its northern part—may be affected 
by industrial and urban waste, albeit with a lower population (around 600,000 inhabitants). Although these 
surface water samples (five to ten) had several contaminants in common with those samples from the Tunjuelo 
River and with wastewater samples, the number of compounds detected was notably lower. Despite this fact, 
the presence of emerging contaminants may have undesirable consequences for public health as these waters 
are mainly used for irrigation on this agricultural area. A more in-depth study would be required to quantify the 
compounds detected in water samples from this area for better knowledge and estimation of potential human 
risks. 
Below, some examples are given in detail, to illustrate the screening strategy applied in this study, which led to 
the detection, confirmation, or tentative identification of several compounds. The different possibilities 
considered in this work will be taken into account: presence/absence of reference standards in the laboratory 
and searching for known and unknown metabolites on the basis of common fragmentation pathway between 
parent compound and possible metabolites. 
1. Reference standards available  
Up to 215 reference standards were available in our laboratory and, therefore, experimental data such as 
retention time and fragment ions could be included in the homemade database. This information was used 
for easier detection and unambiguous confirmation of the identity of the compounds. Figure 2 shows the 
unequivocal confirmation in surface water of 4-acetamido-antipyrine, a metabolite of the widely used 
analgesic metamizole. The LE spectrum (Fig. 2a, top) of the peak at 3.78 min showed the m/z 
corresponding to the protonated molecule (m/z 246.1237) with a mass error of −2.4 ppm. The HE spectrum 
(Fig. 2a, bottom) also showed the remaining protonated molecule and five fragment ions with mass errors 
all below 5 ppm. In this figure, narrow-window eXtracted Ion Chromatograms (nw-XICs) for the six m/z 
ions are also depicted, with a chromatographic peak at exactly the same retention time. 
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Fig. 2 Detection and identification of metabolite 4-acetylamino-antipyrine in surface water by UHPLC-QTOF MS. (a) Low energy 
(LE, bottom) and high energy (HE, top) mass spectra for the peak at 3.78 min. (b) eXtracted Ion Chromatograms (XICs) at 150 ppm 
mass window for [M+H]+ in LE and main fragments in HE 
In a similar way, most of the detected compounds could be confirmed in the samples (see the compounds 
marked as square root in Table 1). The compounds metoprolol and codeine could not be confirmed despite 
the reference standards were available, as only the protonated molecule was observed at the corresponding 
retention time. In these cases, the compounds were marked as detected (dot in Table 1). Additional analysis 
would be required to promote the fragmentation, using higher collision energies in new MS/MS 
experiments.  
2. Reference standards not available  
When reference standards were unavailable, the only information included in the database was the name 
and elemental composition of the contaminants. Even in this situation, a tentative identification could be 
performed on the basis of the relevant information on the accurate mass of the (de)protonated molecule 
and the fragment ions offered by QTOF MSE. Figure 3 illustrates the potential of this screening approach 
with two case studies: the detection and tentative identification of lidocaine and caffeine in effluent 
wastewater. 
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Fig. 3 Tentative identification of lidocaine and caffeine in effluent wastewater by UHPLC-QTOF MS. (a) LE and HE mass spectra 
for the peaks at 3.89 and 3.98 min in positive ionization mode. (b) XICs at 150 ppm mass window for [M+H]+ of lidocaine (3.98 
min) and caffeine (3.89 min) in LE and for the fragment ions (m/z 86, 138, and 110) in HE 
The LE spectrum in ESI positive of an abundant chromatographic peak at 3.97 min showed an intense 
signal at m/z 235.1808 (Fig. 3a, bottom). This might correspond to the protonated molecule of lidocaine 
(C14H23N2O, expressed as protonated molecule), with a mass error of −0.9 ppm in relation with the 
theoretical exact mass. The LE spectrum also showed an important signal at m/z 195.0883 (retention time 
3.89 min) which could be attributed to caffeine (C8H11N4O2, 0.5 ppm mass error). The HE spectrum 
showed three fragment ions at m/z 138.0667 (C6H8N3O), 110.0716 (C5H8N3), and 86.0971 (C5H12N), all 
with mass errors below 2 ppm (Fig. 3a, top). At this point, UHPLC was a valuable tool for selecting almost 
co-eluting fragment ions that might correspond to different precursor ions. Thus, the fragments at m/z 138 
and 110 were related to caffeine, whereas the fragment at m/z 86 was related to lidocaine. The structures of 
the fragment ions were justified on the basis of their measured accurate masses, which was moreover in 
agreement with the information available in scientific literature [16, 17]. Lidocaine could be tentatively 
identified and subsequently confirmed after acquiring its reference standard (circled plus and square root in 
Table 1). The confirmation of caffeine would require the injection of the reference standard, which at the 
time of writing this paper was not available at our laboratory (we did not consider this compound relevant 
in our study). Similar situations occurred for other compounds tentatively identified, as metformin, pirantel, 
and the sweetener saccharin, due to the lack of reference standard (circled plus in Table 1).  
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3. Searching for metabolites  
A detailed discussion is made on the particular case of losartan, an angiotensin II receptor antagonist drug 
used mainly to treat high blood pressure (hypertension), and its metabolites identified making use of the 
common fragmentation pathway. 
Losartan was confirmed to be present in all the samples analyzed. The LE spectrum in ESI+ showed an 
abundant chromatographic peak at the expected retention time (10.13 min) for this pharmaceutical (m/z 
423.1695, −1.2 ppm mass error) and also presented the typical isotopic pattern of a chlorine atom 
(C22H24N6OCl, expressed as protonated molecule). The expected fragment ion at m/z 405.1590 (C22H22N6Cl, 
−1.0 ppm), due to a loss of water, was also observed in the LE spectrum, as well as a minor fragment ion 
at m/z 377.1528 (C22H22N4Cl, −1.3 ppm), corresponding to a N2 loss from m/z 405. The HE spectrum 
showed a predominant ion at m/z 207.0916 (C14H11N2) and minor peaks at m/z 235.0979 (C14H11N4), 
192.0813 (C14H10N), 190.0661 (C14H8N), and 180.0805 (C13H10N), all with mass errors below 4 ppm. These 
fragments correspond to the fragmentation at the benzylic carbon (CH2 near to the two rings) (m/z 235) 
with losses of N2 (m/z 207), N3H (m/z 192), or N3H3 (m/z 190). Losartan was also detected in negative 
mode at m/z 421.1552, showing fragment ions at m/z 187.0631 (C8H12N2OCl), 179.0868 (C14H11), 157.0529 
(C7H10N2Cl), and 127.0066 (C5H4N2Cl). With all this information, the compound detected in the samples 
was unequivocally confirmed to be losartan. 
The presence of three additional chromatographic peaks at 8.25, 9.29, and 10.47 min in all the three XICs 
at m/z 207, 235, and 190 performed at the HE function in ESI+ (for losartan, retention time 10.13 min) 
suggested that the three compounds were chemically related with this pharmaceutical (Fig. 4). The 
common fragmentation pathway strategy has been successfully applied by our group in the elucidation of 
metabolites of the new psychoactive substance methylenedioxypyrovalerone (MDPV) and of degradation 
products of cocaine and benzoylecgonine [27, 28]. This encouraged us to investigate the identity of the 
potential metabolites/transformation products of losartan from the data provided by QTOF MS. 
Firstly, the LE spectra (all showing the isotopic distribution corresponding to a chlorine atom) of these 
three possible metabolites were studied in more detail. In relation to the peak at 10.47 min, the protonated 
molecule corresponded to m/z 437.1490 (C22H22N6O2Cl, −0.7 ppm), which might be attributed to an 
oxidation of losartan. This compound might correspond to losartan carboxylic acid, the main metabolite 
reported in the literature [29]. 
Regarding the peaks at 8.25 and 9.29 min, accurate masses of m/z 439.1643 and 439.1661 were obtained, 
respectively, both corresponding to the same empirical formulae C22H24N6O2Cl with mass errors lower than 
3 ppm. This implies the presence of an extra oxygen atom with respect to losartan. Hence, these two 
compounds might correspond to hydroxylated metabolites of losartan. 
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The following step consisted on the elucidation of the structure of these three potential metabolites. For 
this purpose, MS/MS experiments were performed at different collision energies (10–50 eV). 
 
Fig. 4 Common fragmentation pathway strategy applied for the detection of metabolites of losartan. (a) eXtracted Ion Chromatograms 
(XICs) at 150 ppm mass window for [M+H]+ of losartan in LE function and (b) main fragments (m/z 207, 235, 190) in HE 
function. (c) XICs at 150 ppm mass window for [M+H]+ of possible carboxylic acid metabolite in LE function. (d) XICs at 150 ppm 
mass window for [M+H]+ of possible hydroxylated metabolites of losartan in LE function 
 
Regarding the peak at 10.47 min (m/z 437.1490, C22H22N6O2Cl, −0.7 ppm), five common product ions with 
losartan were observed at m/z 235.0982, 207.0919, 192.0816, 190.0654, and 180.0809. This compound was 
also detected in negative mode, with m/z 435.1327 (C22H22N6O2Cl, −2.1 ppm). At the lowest collision 
energy, a product ion was observed at m/z 391.1429 (C21H20N6Cl, −2.3 ppm), corresponding to a loss of 
CO2. When the collision energy was increased, product ions at m/z 363.1375 (C21H20N4Cl, this is a N2 loss 
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from 391, −0.3 ppm), 157.0530 (C7H10N2Cl, −1.9 ppm), and 113.9989 (C4H3N2Cl, 3.5 ppm) were observed. 
All these fragments fitted with the chemical structure of losartan carboxylic acid. After this careful evaluation 
and well-supported tentative identification, the reference standard of losartan carboxylic acid was acquired 
and injected, allowing the ultimate confirmation of this metabolite in the samples. 
Regarding the hydroxylated metabolite 1 (8.25 min, m/z 439.1643, C22H24N6O2Cl, −1.4 ppm), two minor 
product ions were observed at 10 eV at m/z 421.1536 (C22H22N6OCl) and 385.1772 (C22H21N6O), resulting 
from a loss of water and subsequent loss of hydrochloric acid. At higher collision energies, product ions at 
m/z 235.0978 (C14H11N4), 207.0915 (C14H11N2), 192.0806 (C14H10N), 190.0649 (C14H8N), and 180.0803 
(C13H10N) were obtained (Fig. 5a). Thus, ESI+ fragmentation advises about what is happening near to the 
tetrazol group but not about the location of the hydroxyl group. Accordingly, these fragments seem to 
indicate that the hydroxylation has occurred in the imidazole part. In negative mode, product ions at m/z 
203.0585 (C8H12N2O2Cl) and 173.0488 (C7H10N2OCl) were observed at 20 eV. When the collision energy 
was increased up to 50 eV, product ions at m/z 155.0384 (C7H8N2Cl), 127.0060 (C5H4N2Cl), 113.9991 
(C4H3N2Cl), and 100.9912 (C3H2N2Cl) were observed (Fig. 5b). Considering all this information, the –OH 
group could be placed in the benzimidazole part, being an N-oxide the most plausible candidate. Otherwise, 
if the hydroxyl group was located in the alkylic chain, a second loss of water should in principle be observed 
in ESI+. 
 
Fig. 5 MS/MS spectra at 10 eV (bottom), 20 eV (middle), and 50 eV (top) for hydroxylated metabolite 1 (8.25 min) in (a) ESI+ 
and (b) ESI− (dot) indicates the possible hydroxylation sites, as reported in the literature 
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Regarding the hydroxylated metabolite 2 (9.29 min, m/z 439.1645, C22H24N6O2Cl, −0.9 ppm), two 
important fragment ions were observed at 10 eV (ESI+) at m/z 421.1538 (C22H22N6OCl) and 403.1435 
(C22H20N6Cl) corresponding to two consecutive losses of water. At higher collision energies, the common 
fragment ions at m/z 235.0983, 207.0920, 192.0811, 190.0659, and 180.0808 were observed. The spectra in 
negative mode were different from those of losartan and the other hydroxylated metabolite (e.g., respectively, 
m/z 187/157 or 203/173 were not seen), and only two product ions at m/z 100.9908 (C3H2N2Cl) and 
131.0008 (C4H4N2OCl) were observed. The presence of the –OH group on the other N of the imidazole 
group would not explain the easy loss of water observed in ESI+. Another possibility would be the hydroxyl 
group to be located in the benzilic carbon, although this would hamper (but not prevent) the formation of 
the ions 235/207 in ESI+. 
After a literature search [29], three hydroxylated candidates were found (see the hydroxylated reported sites, 
marked as dot in Fig. 5): two metabolites are hydroxylated in the alkylic chain and the other in the benzilic 
carbon. However, on the basis of the MS/MS fragmentation, it was not possible to unequivocally locate the 
position of the –OH group. It would be very interesting to perform NMR to help identify the structure of 
these compounds. However, this was not possible due to the expected low concentrations of the discovered 
TPs together with the need for on-line coupling of UHPLC separations to NMR spectroscopy. 
Unfortunately, this type of instrumentation is not easy available in our area. 
It is interesting to remark that losartan, its carboxylic acid, and the two hydroxylated metabolites were found 
in all water samples analyzed (ten surface, seven effluent WW, seven influent WW). 
Conclusions 
The potential of UHPLC-QTOF MS for large screening of more than 1,000 licit and illicit drugs, even without 
the need of having all reference standards available, has allowed the detection of many of these compounds in 
water samples from the area of Bogotá. The screening performed in urban wastewater and surface water 
confirmed the presence of emerging contaminants, mainly pharmaceuticals, in the samples. This work provides 
new information on the occurrence of these compounds and metabolites in the Colombian water cycle. The 
availability of full-spectrum acquisition accurate mass QTOF data will also facilitate retrospective analysis of 
other contaminants in the future, not considered in this initial screening, if required. The results obtained in 
this first study may help Colombian institutions to select priority contaminants for future actions. Thus, target 
methodologies, typically based on LC-MS/MS, will need to be set up in the near future for accurate and 
sensitive quantification of the contaminants selected on the basis on the information provided in the present 
paper. 
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Abstract 
The existence of pharmaceuticals and illicit drugs (PIDs) in environmental waters has led many 
analytical chemists to develop screening methods for monitoring purposes. Water samples can contain 
a huge number of possible contaminants, commonly at low concentrations, which makes their 
detection and identification problematic. Liquid chromatography coupled with high resolution mass 
spectrometry (LC-HRMS) has proven itself effective in the screening of environmental contaminants. 
The present work investigates the use of the most popular HRMS instruments, quadrupole time-of-
flight and linear trap quadrupole-Orbitrap, from two different laboratories. A suspect screening for 
PIDs was carried out on wastewater (influent and effluent) and surface water samples from Castellón, 
Eastern Spain, and Cremona, Northern Italy, incorporating a database of 107 PIDs (including 220 
fragment ions). A comparison between the findings of both instruments and of the samples was made 
which highlights the advantages and drawbacks of the strategies applied in each case. In total, 28 
compounds were detected and/or identified by either/both instruments with irbesartan, valsartan, 
benzoylecgonine and caffeine being the most commonly found compounds across all samples. 
Keywords: Liquid chromatography, Screening, Pharmaceuticals, Illicit drugs, High resolution mass 
spectrometry 
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Introduction 
The presence of pharmaceuticals and illicit drugs (PIDs) in environmental waters has become more apparent 
in the past decade due to the improvements in selectivity and sensitivity of modern analytical techniques. PIDs 
are continuously excreted or disposed into the sewer systems as the unaltered parent compound or as 
metabolites [1]. Compounds of the most concern in the environment are those found with high concentrations 
and those that have been proven detrimental to the aquatic life; in fact, for several antibiotics, hormones and 
pharmaceuticals, some effects have been shown [2–4]. Various pharmaceuticals, antibiotics and illicit drugs and 
metabolites such as acetaminophen, carbamazepine, diclofenac, ciprofloxacin and benzoylecgonine are 
frequently detected in waters and are considered a potential threat [2, 5, 6]. 
Nowadays, data processing is often the most time-consuming step when screening a large number compounds. 
A fast screening method, referring to the easy searching of PIDs by software following full scan acquisition by 
high resolution mass spectrometry (HRMS), is therefore of great interest in order to gain a complete overview 
of possible contaminants and their fate in the aquatic environment. Another time-consuming step is sample 
preparation. Important improvements in sensitivity and specificity of recent instrumentation have facilitated 
the direct injection of the samples [7, 8]. 
HRMS instruments, such as quadrupole time-of-flight (QTOF) MS and Orbitrap MS, provide high quality data 
by combining full spectrum mass data with high mass resolution and mass accuracy [9]. Powerful deconvolution 
software is required to facilitate sample analysis for these instruments. Each manufacturer has its own software, 
such as ChromaLynx (Waters) and TraceFinder (ThermoScientific). These systems allow post-target analysis, 
whereby the presence of an unlimited number of contaminants can be investigated through the addition of 
empirical or theoretical compound databases, without depending on the pre-selection of analytes or having 
reference standards available [10]. In the processing of numerous samples and compounds, these programs 
undeniably save time and hence are a necessity for a large screening of environmental contaminants. 
It is difficult to compare the individual HRMS mass analysers (i.e. TOF and Orbitrap), but each hold distinct 
advantages. The main advantage of Orbitrap is its high mass resolving power (>100,000 full width at half 
maximum (FWHM)). In complex environmental matrices, co-elution of analytes with matrix interferences can 
result in ambiguous peaks. By utilising the ultra-high resolution capabilities, compounds with a very similar 
exact mass can be easily differentiated [11]. However, its main drawback is its slower scanning speed and inverse 
relationship to resolution. Conversely, the higher scanning speed of TOF enables it to be used with the highly 
efficient separation technique ultra-high performance liquid chromatography (UHPLC), resulting in shorter 
run times and improved sensitivity [10]. 
To achieve better performance such as higher sensitivity and mass resolving power, manufacturers have 
implemented hybrid mass spectrometers, two of which are used in the current work: QTOF and linear trap 
quadrupole-Orbitrap (LTQ-Orbitrap). The UHPLC capabilities are exemplified when QTOF is employed in 
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MSE mode, which involves the simultaneous acquisition of exact mass data at low and high collision energy 
[12]. At low energy, information pertaining to the non-fragmented (de)protonated molecule is obtained, whilst 
at high energy, information regarding the fragments is attained. This means that all required information is 
obtained in just one injection. LTQ-Orbitrap combines the tandem mass spectrometric capability of the LTQ 
with the high resolution and mass accuracy capability of the Fourier transform (FT) Orbitrap [13]. LTQ-
Orbitrap is operated in data-dependent acquisition (DDA) mode whereby MS and MSn spectra are obtained 
simultaneously; however, the number of compounds able to be acquired is limited and therefore may require 
subsequent injections. Some studies have been made on the identification of organic pollutants in water by 
QTOF MS [12, 14–16] and LTQ-Orbitrap MS [17–19]. 
This work derives from a collaborative study between two laboratories within the ITN Marie Curie SEWPROF 
network [20]. The aim was to perform a screening of PIDs in waste- and environmental waters using two 
different liquid chromatography coupled with high resolution mass spectrometry (LC-HRMS) systems 
(UHPLC-QTOF MS and Capillary-LC-LTQ-Orbitrap MS) available in our laboratories. Normally, a given 
laboratory would use just one of the instruments, but as both have a great capability for screening and 
identification, in this work, we pursued the comparison of data from the same analysed samples (samples 
collected from Spain and Italy). In addition, the complementary use allows true confirmation of the compound 
in the sample [9]. Although the same compounds were initially searched, the different acquisition modes may 
additionally detect other contaminants and widen the scope of the screening. It is worth noting that a 
comparison of the instruments or methods used was not pursued, rather their use to ratify the findings of the 
other instrument. In this way, on the basis of the results of the present paper, the methodologies applied by 
each laboratory could be validated by the results obtained by the other laboratory in terms of qualitative analysis. 
When performing the screening, four criteria were used based on the level of confidence and on the availability 
of reference standards. Numerous compounds were detected and identified from samples of different origin 
and matrix composition (influent and effluent urban wastewater, surface water). All samples, independently of 
they were collected from Spain or from Italy, were analysed by both HRMS instruments (Orbitrap in Milan and 
TOF in Castellón), which supports the feasibility and robustness of high resolution screening of PIDs in 
complex environmental samples. 
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Experimental 
Chemicals and reagents 
For information regarding the reference standards used for QTOF and LTQ-Orbitrap analysis (see Electronic 
Supplementary Material (ESM), Section 2.1). 
HPLC-grade methanol (MeOH), ammonia solution (25 %) and formic acid (HCOOH, 98–100 %) were 
acquired from Scharlau (Barcelona, Spain) and acetonitrile for LC-MS from Riedel de Haen (Seelze, Germany). 
HPLC-grade water was obtained by purifying demineralised water in a Milli-Q plus system from Millipore 
(Bedford, MA, USA). Solid phase extraction (SPE) cartridges used were Oasis HLB 3 mL (60 mg) from Waters 
(Milford, MA, USA). Mixed cellulose ester membrane filters (0.45 μm) and 1.6 μm GF/A glass microfiber 
filters were purchased from Whatman (Kent, UK). 
Samples 
Influent and effluent wastewater 
In total, 18 wastewater samples (nine influent wastewater (IWW) and effluent wastewater (EWW)) were taken 
from a wastewater treatment plant (WWTP) in Castellón, Eastern Spain and Cremona, Northern Italy. The 24-
h composite IWW and EWW samples were collected over seven consecutive days in March 2014 (Castellón) 
and two consecutive days in May (Cremona) in high-density polystyrene bottles and directly transported to the 
lab where they were immediately filtered and stored in the dark at −20 °C until analysis. 
Surface waters 
Five grab samples were taken from the Castellón region, Eastern Spain: Almenara, Burriana Clot, Nules and 
two sites in Albufera Natural Park. All samples were stored in high-density polystyrene bottles at 4 °C for less 
than 48 h, until sample treatment. 
Sample treatment 
Prior to SPE, Spanish WW samples were vacuum filtered through 0.45 μm mixed cellulose ester membrane 
filters, and the Italian samples were filtered through 1.6 μm GF/A glass microfiber filters. Surface water samples 
were not filtered. Subsequently, 100 mL of the samples (IWW was four times diluted with Milli-Q water, i.e. 25 
mL sample in 100 mL) was extracted using SPE cartridges (Oasis HLB), which were first conditioned by 
washing and rinsing with 6 mL of MeOH and 6 mL of Milli-Q water. Samples were percolated through the 
cartridges by gravity (flow rate around 3 mL min−1) and vacuum dried for approximately 15 min. After elution 
with methanol, extracts were evaporated to dryness at 35 °C under a gentle stream of nitrogen and 
reconstructed in 1 mL of 10 % methanol aqueous solution [21]. Two 0.5-mL aliquots were taken from the 
extract, one each for the QTOF and Orbitrap analyses. UHPLC-MS QTOF analyses were performed by 
 Chapter 2: Suspect and Non-Target Screening 
 
    127 
injecting 20 μL of the final extract into the system. Capillary-LC-LTQ-Orbitrap analyses were performed by 
injecting 2 μL of the final extract into the system.  
Instrumentation 
Ultra high-performance liquid chromatography-QTOF-mass spectrometry 
A Waters Acquity UPLC system (Waters, Milford, MA, USA) was interfaced to a hybrid quadrupole-orthogonal 
acceleration-TOF mass spectrometer (XEVO G2 QTOF, Waters Micromass, Manchester, UK), using a Z-
Spray ESI interface operating in positive ion mode. 
The chromatographic separation was performed using an Acquity UPLC BEH C18 1.7 μm particle size column 
100 × 2.1 mm (Waters) at a flow rate of 300 μL/min. The mobile phases used were A = H2O and B = MeOH 
(both with 0.01 % HCOOH). The total run time was 18 min. The initial percentage of B was 10 %, which was 
linearly increased to 90 % in 14 min, followed by a 2-min isocratic period and, then, returned to initial conditions 
during 2 min. Nitrogen was used as drying gas and nebulizing gas. 
MS data were acquired over an m/z range of 50–1,000. A capillary voltage of 0.7 kV and cone voltage of 20 V 
were used. Collision gas was argon 99.995 % (Praxair, Valencia, Spain). The desolvation temperature was set to 
600 °C and the source temperature to 135 °C. The column temperature was set to 40 °C. 
For MS E experiments, two acquisition functions with different collision energies were created: the low energy 
function (LE), selecting a collision energy of 4 eV, and the high energy (HE) function, with a collision energy 
ramp ranging from 15 to 40 eV in order to obtain a greater range of fragment ions. The total scan time was 0.4 
s. 
QTOF MS data was processed using ChromaLynx XS application manager (within MassLynx v 4.1; Waters 
Corporation). The following parameters were used: target RT tolerance (1.50 min) from empirical retention 
time (obtained from injecting standards), mass tolerance 0.020 Da (for positive ID 0.010 Da), peak width at 5 % 
height 6 s, peak-to-peak baseline noise 1,000 and threshold absolute area: 250 for SW and 500 for IWW and 
EWW. 
Liquid chromatography-LTQ-Orbitrap mass spectrometry 
Mass spectrometry analysis was performed on a high resolution LTQ-Orbitrap XL instrument, interfaced to 
the HPLC system through a desorption electrospray ionisation (DESI) source and used in nano-spray mode 
(Prosolia, Indianapolis, IN, USA). The instrument was operated at 60,000 resolution for full MS scans and at 
15,000 resolution for MS2 scans, after CID fragmentation in the linear ion trap cell. The scan time was 0.85 s 
and the cycle time was 4.8 s. Every sample was analysed in a DDA mode, in which the first data event was a 
full scan MS, whilst the following four data events were MS2 scans of the four most intense ions recorded in 
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the first event. A subsequent injection in MS/MS mode was made to find further fragments, based on target 
lists (see Section 3.1). 
The chromatographic separation was performed using a Zorbax SB-C18 5 μm particle size column 150 × 0.5 
mm (Agilent Technologies) at a flow rate of 10 μL/min. The mobile phases used were A: H2O (0.1 % HCOOH) 
and B: acetonitrile. The total run time was 46 min. The initial percentage of B was 1 % and was linearly increased 
to 99 % in 24 min, followed by a 10-min isocratic period and then reduced back to initial conditions in 2 min 
which were kept for 10 min (post-run) to equilibrate the column. 
Processing of the Orbitrap data was made using TraceFinder EFS and QualBrowser software (Thermo 
Scientific). The following parameters were used: [M+H]+ intensity (5,000), signal-to-noise ratio threshold (=5), 
retention time window override for confirmation (90 s), fragment intensity (1,000 with 10 ppm mass tolerance); 
isotopic pattern (60 % fit threshold, 5 ppm mass deviation, 10 % intensity deviation); and library search (20 % 
score threshold) using the Toxicology HCD 30-70-110 eV Library of Thermo Scientific. This library contained 
the information of 1,700 compounds, but not all PID compounds selected in our list were included in the 
library. 
Criteria for detection/identification 
Up to four levels were considered for detection and identification of the compounds based on the availability 
of reference standard and on the reliability of the data obtained. These levels were derived from a recent article 
exploring the means of identification of small molecules [22] and the European Commission Decision 
2002/657/EC for the confirmation of contaminants in samples of animal origin, commonly employed in 
environmental studies. The criteria used included the presence of the protonated molecule at accurate mass, 
fragment ion(s) at accurate mass, retention time and isotopic pattern. 
Selected criteria for QTOF MS 
The standards injected on each instrument were those available at the respective laboratories (see ESM Section 
2.1). They may be different; however, as explained above, a comparison between the labs is not proposed. 
Standard available (11 illicit drug and 61 pharmaceutical standards, see ESM Section 2.1) 
1. Detection: Protonated molecule [M+H]+ at accurate mass (<5 ppm) and retention time in agreement 
with reference standard (±2.5 %) 
2. Identification: Protonated molecule [M+H]+ at accurate mass (<5 ppm), at least one fragment ion, 
commonly in HE (<5 ppm), retention time agreement with reference standard (±2.5 %) 
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Standard not available 
3. Tentative detection (potential positive): Presence in the extracted ion chromatogram of the protonated 
molecule [M+H]+ at accurate mass (<10 ppm), typically in the LE function 
4. Tentative identification: Protonated molecule [M+H]+ at accurate mass (<10 ppm) and at least one 
fragment ion, commonly in HE function (<10 ppm), in agreement with data reported from literature 
or online databases 
Selected criteria for LTQ-Orbitrap MS 
Standard available (25 illicit drug and 27 pharmaceutical standards, see ESM Section 2.1) 
1. Detection: Protonated molecule [M+H]+ at accurate mass (<5 ppm), retention time agreement with 
standard (±2.5 %), isotopic pattern (60 % fit threshold, 5 ppm mass deviation, 10 % intensity deviation) 
2. Identification: Protonated molecule [M+H]+ at accurate mass (<5 ppm, intensity >5,000), at least one 
fragment ion in MS/MS (intensity > 1,000, <10 ppm), retention time agreement with standard 
((±2.5 %), isotopic pattern (60 % fit threshold, 5 ppm mass deviation, 10 % intensity deviation); library 
search (20 % score threshold) using the Toxicology HCD 30-70-110 eV Library. 
Standard not available 
3. Tentative detection (potential positive): Protonated molecule [M+H]+ at accurate mass (<10 ppm, 
intensity >5,000) 
4. Tentative identification: Protonated molecule [M+H]+ at accurate mass (<10 ppm intensity >5,000), 
at least one fragment ion (intensity >1,000, <10 ppm mass tolerance), comparable with literature or 
online databases, isotopic pattern (60 % fit threshold, 5 ppm mass deviation, 10 % intensity deviation) 
Results and discussion 
The methodologies followed for these analyses are based on the generic configuration employed by each 
laboratory. We acknowledge that the Orbitrap configuration is not optimal for screening of PIDs in water, as 
its use is primarily in the field of proteomics, which justifies the use of a capillary column and DESI source. 
Therefore, we do not intend to show a comprehensive comparison of the instruments but to determine whether 
both laboratories and instruments can detect and identify the same compounds using their individual workflows. 
Furthermore, in this work, we do not set out to perform a wide-scope screening of a huge number of 
compounds but rather to focus on a limited number of well-known, widely detected PIDs in wastewater to test 
the usefulness of the different approaches and instruments used and also to compare the countries. 
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Selection of PIDs 
The compounds to be investigated were initially based on a database similar to that made by Diaz et al. [23] but 
focussing solely on pharmaceuticals and illicit drugs. The database contained the compound name, associated 
fragments (if known), retention time (if standard was available) and molecular formula. A qualitative validation 
was previously performed using a similar analytical procedure based on LC-QTOF MS measurements, and the 
empirical screening detection limits (SDL) and limits of identification (LOI) in different type of water samples 
were established for some of the compounds included in the present work. For most compounds evaluated, 
SDLs were 0.02 or 0.1 μg/L [24, 25]. For compounds where no standards were available, the database included 
data regarding fragment ions and molecular formula from literature or online databases such as MassBank [26]. 
To ensure national significance, compounds found from previous studies of these regions were investigated 
and added to the database (Spain [27, 28]; Italy [29–31]). In total, 107 PIDs and 220 fragment ions were 
incorporated in the database (see ESM Table S1). 
As stated in Section 2.4.2, each sample was injected twice in the Orbitrap. The first injection enabled full scan 
acquisition. In this data, the original database of 107 PIDs was searched using TraceFinder and potential 
positive compounds were then selected, based on retention time and exact mass, as unfortunately the expected 
fragment ion information of the targeted compounds was not amongst the four most intense ions detected 
within the data events. These “positives” were then grouped into target lists, according to whether they were 
found in the Spanish (40 compounds) or Italian (52 compounds) samples (see ESM Tables S2 and S3). The 
second injection incorporated these target lists, thereby enabling their product ions to be seen. 
Within the software of the QTOF and Orbitrap, a threshold was given for intensity and mass error, outside 
which peaks were disregarded as noise. The majority of compounds were able to be automatically identified or 
detected thanks to the ChromaLynx and TraceFinder software. However, in some cases, some compounds 
were only able to be detected (i.e. no fragment ions found). This demonstrated the complementariness of the 
instruments: when one instrument was solely able to detect a compound (only the precursor ion found), the 
other was able to at least tentatively identify the compound with fragments. The raw data of both instruments 
was manually inspected in these situations to ratify the fragments (see Table 1). This secondary examination 
also reduced the possibility that one of the software had erroneously eliminated some compounds. The raw 
data investigations were only required for a small number of compounds, which is testament to the utility of 
the software. However, by decreasing the identification thresholds used, the need for manual inspection could 
be avoided, which is especially recommended for wide-scope screening methods incorporating thousands of 
compounds. 
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Table 1: All compounds detected/identified in wastewater and surface water samples of Spain and Italy 
 
 
Comparison of results from Spain and Italy 
Table 1 shows the number of compounds identified (according to identification criteria 2 and 4, from Section 
2.5) and detected (according to detection criteria 1 and 3, from Section 2.5) in each sample. In general, more 
compounds were able to be identified (up to 18) or detected (up to 25) in the Spanish samples than the Italian. 
However, some compounds were only able to be detected and not identified in some samples, due to low 
analyte concentration. For example, ofloxacin in Castellón IWW was identified in only three samples by QTOF 
but detected in the all, whilst it was identified in all samples by Orbitrap. In addition, trimethoprim was only 
Compound Spain IWW (n=7) Spain EWW (n=7) Spain SW (n=5) Italy IWW (n=2) Italy EWW (n=2) 
 QTOF Orbitrap QTOF Orbitrap QTOF Orbitrap QTOF Orbitrap QTOF Orbitrap 
4-aminoantipyrinea 7/1b 6/5 7/7 7/3       
Acetaminophen 7/7 7/7 (7)c     2/2 2/2 (2)   
Atorvastatin   2/0 5/0       
Benzoylecgonine 7/7 7/7 7/7 (7) 7/7 1/0  2/2 (2) 2/2   
Bezafibrate  3/3 7/0 7/7   2/1 (1) 2/2  1/1 
Caffeinea,d 7/7 6/6 7/1 7/7 4/3 5/5 2/2 2/2   
Carbamazepine 3/0 7/7 7/7 7/7   2/2 2/1 2/2 2/2 
Ciprofloxacin 7/6 (6) 6/6 6/5 (5) 6/5   2/2 (2) 2/2   
Clarithromycin  1/0 5/5 (5) 6/6   2/1 (1) 2/1 2/1(1) 2/1 
Cocaine 7/3 (3) 3/3 2/0 1/0   2/2 (2) 1/1   
Codeine 7/7 (7) 7/7 7/4 (4) 6/6   2/1 (1) 2/1 2/1(1) 1/1 
Cotininea,d 7/6  7/7  2/0  2/0    
Diclofenac  3/3 7/7 7/7   2/2  2/2 2/2 2/2 
Enalapril 1/0          
Gabapentina 5/0  6/6      2/0  
Gemfibrozil        2/0   
Irbesartana 7/7 7/7 7/7 7/7 2/1 2/2 2/2 2/2 2/2 2/2 
Ketoprofen 7/6 (6) 6/5 6/2 2/2   2/2    
Morphine 7/0 4/4 2/0 4/4   2/0 2/2 2/0 2/0 
Moxifloxacin   2/0        
Naproxen 7/7 7/7 (3) 4/0    2/1 1/1 (1)   
Ofloxacin 7/3 7/7 7/7 7/7 1/0  2/2  2/2 2/2  2/2 
Oxazepama,d  3/3 7/7 5/5    1/1  1/0 
Sulfamethoxazole 3/2 (2) 6/6 7/5 5/4   2/2 (2) 2/2 2/1(1) 2/2 
Temazepama,d 3/3 (3) 6/5 7/5 7/7    1/0  1/1 
Trimethoprim 1/0  7/0 7/0   2/0  2/0 2/0 
Valsartana 7/7 7/7 7/7 7/7 2/0 3/3 2/2 2/2 1/1 2/2 
Venlafaxinea 7/7 (6) 7/7 7/7 7/7  1/0 2/0 2/2 2/2 2/2 
           
Total  21/16 23/18 25/18 21/18 6/2 4/4 20/16 20/16 12/9 12/10 
a: no reference standard for Orbitrap analysis 
b: number of compounds detected/identified 
c: number in brackets refers to the number of samples manually checked in raw data for missing fragment ions 
d: no reference standard for QTOF analysis 
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detected in all Spanish and Italian EWW samples by both instruments. These results show that these 
compounds were likely present in all the detected samples but unable to be identified due to a combination of 
their low concentrations and the difference in MS/MS acquisition between the instruments. 
There is little national difference, with just cotinine, gabapentin, oxazepam, temazepam and a metabolite of 
metamizole (4-aminoantipyrine), not identified in the Italian samples. This is not to say that these compounds 
are not in the samples, rather that their concentration is lower than that necessary for detection or identification. 
In fact, 4-aminoantipyrine was the only compound in the aforementioned list not detected in at least one of 
the Italian samples. Metamizole (also known as dipyrone) is a non-steroidal anti-inflammatory drug. In some 
countries such as Sweden, UK, Canada or USA, metamizole has been banned or restricted for human use due 
to its association with diseases like agranulocytosis [32]. However, in many other countries including Spain and 
Italy, it can be purchased without a medical prescription [33]. Metamizole is a widely consumed pharmaceutical 
in Spain, and some years ago, it was amongst the ten most consumed pharmaceuticals (considering the amount 
of prescriptions), according to the information published by the Spanish Ministry of Health [34]. In Italy, 
metamizole is also highly consumed but is not included in the list of the most consumed pharmaceuticals [35]. 
This apparent difference in consumption could reflect the difference in its detection in the samples of Spain 
and Italy. 
The most commonly detected compounds mirrored those found in similar studies [12, 29, 30, 36]. Irbesartan, 
ofloxacin, sulfamethoxazole and valsartan were identified in IWW and EWW of both Spain and Italy. Caffeine, 
irbesartan, valsartan and venlafaxine were also found in a high enough concentration in surface water to be 
identified by at least one of the two instruments. Several previous studies have also shown that these 
compounds are not fully removed in WWTPs and can be present in surface waters [2, 5, 37, 38], which indicates 
that further investigation into their potential fate and harm to the environment is necessary. 
 
Use of QTOF and LTQ-Orbitrap 
There was little difference between the number of compounds able to be identified by QTOF and Orbitrap. 
However, there are some discrepancies between the numbers of compounds in each sample that are identified 
by each instrument. For example, naproxen is identified using the software in all seven Spanish IWW samples 
by QTOF whilst in only four by the Orbitrap. Alternatively, with Orbitrap, bezafibrate and morphine are 
identified in seven and four Spanish EWW samples, respectively, but in none by QTOF. In both cases, the 
compounds were detected and compared with standards. Figures 1 and 2 show the examples of naproxen and 
bezafibrate, respectively. 
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Fig. 1: (a): Identification of naproxen in an IWW sample by QTOF (ChromaLynx); LE spectrum shows the parent and fragment of 
naproxen (blue at 231.1017 and 185.0971).  
(b): Identification of naproxen in the same IWW sample by Orbitrap (raw data, using QualBrowser) based on the fragment of 185.0961, 
compared with the standard (left).  
The QTOF data is from the single MSE injection, while the Orbitrap data is from the second MS/MS injection. 
 
Fig. 2: (a) Detection of bezafibrate in an EWW sample by QTOF (raw data). The XICs (left) and related mass spectrum (bottom) of the 
standard show the fragments (316.1104, 276.0791 and 138.9951), and mass errors. The sample (right) shows none of the related fragments 
at a similar peak shape or retention time to the precursor (362.1159).  
(b) Identification of bezafibrate in the same EWW sample (right) by Orbitrap (QualBrowser), compared with the standard (left). The fragment 
ions of 316.1102, 276.0787 and 138.9946 are clear in both, as is the chromatographic peak at ~20.85 minutes.  
The QTOF data is from the single MSE injection, while the Orbitrap data is from the second MS/MS injection. 
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Figure 1 provides an example of raw data investigation, touched upon in Section 3.1. In an IWW sample, the 
QTOF data was searched with ChromaLynx and able to identify naproxen, without having to refer to the raw 
data (Fig. 1a). The protonated molecule (231.1017) and primary fragment ion (185.0971) were seen in the LE 
and HE spectra within the thresholds of mass error for identification. To gain further confidence in this finding, 
the Orbitrap data was searched with TraceFinder. However, the software could not identify naproxen in this 
IWW sample. A subsequent search of the raw data by QualBrowser revealed its presence (Fig. 1b). 
Figure 2 exemplifies the compatibility of the two HRMS instruments. ChromaLynx was unable to identify 
bezafibrate through the use of fragments, so the raw data was checked (Fig. 2a, right). Again, only the precursor 
was able to be found. A comparison with the standard is also made, showing the three fragments of 316.1105, 
276.0788 and 138.9947 (Fig. 2a, left). These fragments were searched in the HE spectrum of the sample, but 
no suitable peaks were found (Fig. 2a, right). It was thought that bezafibrate was below the detection threshold 
for the QTOF, which has a known relationship between intensity and mass error (i.e. at low concentration, the 
mass error would be high), and therefore at a low concentration, the fragment ions would fall outside the given 
mass error threshold. Conversely, Orbitrap is able to maintain its mass accuracy, even at low concentrations. 
Hence, for the same sample, using Orbitrap, bezafibrate was able to be identified with all three fragments (Fig. 
2b, right). 
A further example of the use of these instruments was in the identification of benzoylecgonine in an IWW 
sample. The protonated ion was seen in the QTOF data with a mass error of 0.07 ppm, a retention time of Δ 
0.01 min from that of the standard, and only one fragment with a mass error of 6.31 ppm—just outside the 
criteria used for identification (see Section 2.5). Although we were confident this was in fact benzoylecgonine, 
and did tentatively assign it as ‘identified’, it did not quite fulfil our set requirements. To appease our doubts, 
we also checked the Orbitrap data. Here, the protonated molecule and fragment ion were found within the 
threshold of 5 ppm and the retention time differed by 0.1 min from the standard. The isotopic pattern fit was 
above the 60 % threshold and the library search score of 50 %, above the threshold set. Therefore, full 
confidence in identification was gained for this compound. Although identification could also have been 
possible by manually scouring the raw data, as the fragment ion was only just outside the given threshold, it 
was thought better to compare with the Orbitrap data. 
The mere fact that further information can be gleaned from these two instruments shows their 
complementariness. The European Directorate General for Health and Consumer Protection (SANCO) 
guidelines on analytical quality control and validation procedures for pesticide residue analysis in food and feed 
[39], which are also applied for environmental samples in the absence of specific guidelines for the 
environmental field, state that ‘confirmation is the combination of two or more analyses that are in agreement 
with each other’. The use of two HRMS instruments thus follows these SANCO guidelines, and as shown in 
Section 3.3 and Table 1, confirmation (i.e. identification) of numerous compounds is made. The examples given 
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thus demonstrate the complementary use of QTOF and Orbitrap in the suspect screening of PIDs in 
environmental and wastewaters. 
Conclusions 
In this paper, two LC-HRMS instruments (QTOF and LTQ-Orbitrap) used in different laboratories were used 
to screen for PIDs in samples of wastewater and surface water from Spain and Italy. A database of compounds 
frequently detected in water was used by both instruments, incorporating compounds of national significance. 
The samples were first investigated through the use of the manufacturer’s software (ChromaLynx or 
TraceFinder), which allowed the detection of various compounds and in some cases the positive identification 
with fragment ions. Following this strategy, up to 18 compounds were identified with fragment ions across 
both instruments, whilst 28 compounds were at least detected (only the most abundant ion present) across all 
samples. In particular cases where identification was not automatic using software, the raw data was manually 
investigated. This was only necessary for a few compounds and occurred when the compound was detected 
but could not be identified. There was no significant difference between the countries, the metamizole 
metabolite, 4-aminoantipyrine, being the only compound found solely in Spanish waters. 
The screening results obtained by QTOF MS and LTQ-Orbitrap MS were very similar, with the number of 
compounds detected/identified only differing by up to four across all samples. Although the objective of this 
work was not to compare the methods, rather the results in terms of detection and reliable identification, it is 
worth noting that the LTQ-Orbitrap was able to identify a few more compounds without having to manually 
search for fragment ions. On the whole, this paper shows that these powerful instruments, used in these 
configurations, are suitable for the detection and identification of numerous environmental contaminants in 
waste and environmental waters. The general agreement in data obtained will serve to validate the 
methodologies commonly used by our laboratories for qualitative screening of emerging contaminants in waters. 
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Electronic Supplementary Material 
 
The tables “List of Compounds” (Table S1),  Compounds search in Italian samples by Orbitrap (Table S2) and 
Compounds search in Spanish samples by Orbitrap (Table S3) are too large for this thesis, but are available in 
the online edition of this article: doi:10.1007/s00216-015-9063-x 
 
2.1 Reagents 
 
2.1.1 Illicit Drugs (for QTOF) 
 
In total, 11 illicit drugs and/or main metabolites were selected: amphetamine, methamphetamine, 3,4-
methylenedioxymethamphetamine (MDMA, or ecstasy), cocaine, benzoylecgonine (BE), 11-nor-9- carboxy-
Δ9-tetrahydrocannabinol (THC-COOH), heroin, morphine, 6-monoacetylmorphine (6-MAM), codeine and 
ketamine. Reference standards of these compounds were purchased from Cerilliant (Round Rock, TX, USA) 
and the National Measurement Institute (Pymble, Australia) as solutions in methanol, acetonitrile or as salt. 
HPLC-grade methanol (MeOH), HPLC-grade acetonitrile (ACN), ammonium acetate, formic acid (>98 %) 
and primary secondary amine (PSA, 40–60 μm) sorbent were acquired from Scharlau (Barcelona, Spain). 
HPLC-grade water was obtained by purifying demineralised water in a Milli-Q plus system from Millipore 
(Bedford, MA, USA). Standard stock solutions of each compound were prepared at 100 mg/L in MeOH or 
ACN. Intermediate solutions (10 mg/L) were prepared by diluting the stock solution ten times with MeOH. 
Infusion solutions of individual standards were prepared at a concentration of 1.5 mg/L in MeOH:water (50:50, 
v/v). Mixed working solution of 25μg/L containing all analytes was prepared from intermediate solutions by 
appropriate dilution with Milli-Q water. 
 
2.1.2 Illicit Drugs (for Orbitrap) 
 
Illicit drugs and metabolites analyzed were the following: cocaine and its metabolites benzoylecgonine, 
norbenzoylecgonine, norcocaine, and cocaethylene; amphetamine, methamphetamine, 3,4-
methylenedioxyamphetamine (MDA), 3,4-methylenedioxymethamphetamine (MDMA, or ecstasy), 3,4-
methylenedioxyethamphetamine (MDEA) and MBDB; ketamine, norketamine, dehydronorketamine; codeine, 
6-aceyl codeine; oxycodone, hydrocodone; morphine, morphine-3β-D-glucuronide, 6-momoacetylmorphine (a 
metabolite of heroin); 11-nor-9-carboxy-∆9-tetrahydrocannabinol (11-nor-9- carboxy-∆9-THC), the main 
metabolite of ∆9-tetrahydrocannabinol; and methadone and its main metabolite, 2-ethylidene-1,5- dimethyl-
3,3-diphenylpyrrolidine (EDDP). Reference standards of all the substances were acquired were acquired from 
Cerilliant Corporation (Round Rock, Texas, USA). The standards, available as solutions in methanol or 
acetonitrile (1. 0.4 mg/mL or 0.1 mg/ mL), were diluted to 10 ng/µL with methanol and stored at -20 °C in 
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the dark. Working solutions containing all the substances to be analyzed were prepared before each analytical 
run. 
 
2.1.3 Pharmaceuticals (for QTOF) 
 
The pharmaceutical standard mix was made from a combination of human and veterinary pharmaceuticals 
and/or main metabolites (in alphabetical order): 
 4-Acetylamino-Antipyrine, Acetaminophen, Alprazolam, Ampicilline, Atorvastatin, Azithromycin , 
Bezafibrate, Carbamazepine, Cefotaxime, Cephalexin, Chloramphenicol, Ciprofloxacin, Clarythromycin, 
Clenbuterol, Clindamycin, Cloxacillin, Diclofenac, Dicloxacillin, Enalapril, Enrofloxacin, Erythromycin A, 
Flumequine, Furazolidone, Gabapentin, Gemfibrozil, Ibuprofen, Irbesartan, Ketoprofen, Lincomycin, 
Lorazepam, Marbofloxacin, Moxifloxacin, Naproxen, Nalidixic acid, Norfloxacin, Ofloxacin, Olanzapine, 
Oxacillin, Oxolinic acid, Oxytetracycline, Pefloxacin, Penicillin G, Pipedimic acid, Piperacillin, Pravastatin, 
Roxythromycin, Salicylic acid, Spiramycin, Sulfadiazine, Sulfadoxine, Sulfamerazine, Sulfamethazine, 
Sulfamethoxazole, Tetracycline, Thiabendazole, Temazepam. Tiamulin, Trimethoprim, Valsartan, Venlafaxine. 
All standards were purchased from Across Organics (Geel, Belgium), Aventis Pharma (Madrid, Spain), Bayer 
Hispania (Barcelona, Spain), Cerilliant (Round Rock, TX, USA), Fluka (Buchs, Switzerland), Dr. Ehrenstorfer 
(Augsburg, Germany), Fort Dodge Veterinaria (Gerona, Spain), National Measurement Institute (Pymble, 
Australia), Riedel-de Haën (Seelze, Germany), Sigma Aldrich (St Louis, MO, USA), Vetoquinol Industrial 
(Madrid, Spain), and Witega (Berlin, Germany). All reference materials had purities higher than 98% (w/w), 
except for marbofloxacin and pefloxacin, which had purities higher than 93%. 
The standard stock solutions of each compound ranged between 19 and 1200mg/L, prepared in MeOH or 
ACN. These compounds were separated into 6 separate intermediate working mixtures of 5mg/L. Prior to 
analysis, a working standard mixture of 50μg/L was made from the intermediate solutions by diluting with 
water.  
 
2.1.4 Pharmaceuticals (for Orbitrap) 
 
The following pharmaceuticals were included in the standard mix: Acetaminophen, Atenolol, Atorvastatin, 
Bezafibrate, Carbamazepine, Ciprofoxacin, Clarythromycin,   Diazepam, Diclofenac, Enalapril, Erythromycin 
A, Furosemide, Gemfibrozil, Hydrochlorothiazide, Ibuprofen, Ketoprofen, Lincomycin, Naproxen, Ofloxacin, 
Omeprazole, Oxytetracycline,  Ranitidine,  Spiramycin, Sulfamethoxazole.   
 
All reference standards were purchased from Sigma-Aldrich (Steinheim, Germany), ICN Biochemicals 
(Meckenheim, Germany) or Glaxo SmithKline (Philadelphia, USA); clarythromycin and omeprazole were 
obtained from pharmaceutical preparations for intravenous injection, respectively, from Abbott, Latina, Italy 
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(Klacid® i.v. 500 mg) and Malesci, Florence, Italy (Omeprazen®, 40 mg). All the reference standards were 
stored at 4 ◦C. 
 
Standards were dissolved in methanol (except those for intravenous injection that were dissolved in saline) up 
to a concentration of 1 mg/mL and subsequently diluted to 10 ng/L (stock solutions). Three standard mixtures, 
containing all the pharmaceuticals to be analysed, were prepared before each analytical run by diluting stock 
solutions in methanol. The stock solutions of ciprofloxacin, ofloxacin, omeprazole, oxytetracycline and 
sulfamethoxazole were renewed monthly because of their limited stability. Purity of the stock solutions was 
checked before each analytical run by HPLC–MS–MS. All stock solutions were stored at −20 ◦C in the dark. 
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2.2.3 Scientific Article 4 
FACILITATING HIGH RESOLUTION MASS 
SPECTROMETRY DATA PROCESSING FOR SCREENING 
OF ENVIRONMENTAL WATER SAMPLES: AN 
EVALUATION OF TWO DECONVOLUTION TOOLS 
Richard Bade, Ana Causanilles, Erik Emke, Lubertus Bijlsma, Juan V. Sancho, Felix 
Hernandez, Pim de Voogt 
Submitted to Science of the Total Environment  
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Abstract 
 
A screening approach was applied to influent and effluent wastewater samples. After injection in a LC-LTQ-
Orbitrap, data analysis was performed using two deconvolution tools, MsXelerator (modules MPeaks and MS 
Compare) and Sieve 2.1. The outputs were searched incorporating an in-house database of more than 200 
pharmaceuticals and illicit drugs or ChemSpider. This hidden target screening approach led to the detection of 
numerous compounds including the illicit drug cocaine and its metabolite benzoylecgonine and the 
pharmaceuticals carbamazepine, gemfibrozil and losartan. The compounds found using both approaches were 
combined, and isotopic pattern and retention time prediction were used to filter out false positives. The 
remaining potential positives were reanalysed in MS/MS mode and their product ions were compared with 
literature and/or mass spectral libraries. The inclusion of the chemical database ChemSpider led to the tentative 
identification of several metabolites, including paraxanthine, theobromine, theophylline and carboxylosartan, 
as well as the pharmaceutical phenazone. The first three of these compounds are isomers and they were 
subsequently distinguished based on their product ions and predicted retention times. This work has shown 
that the use deconvolution tools facilitates non-target screening and enables the identification of a higher 
number of compounds.  
 
Keywords: Non-target screening, peak-picking, hidden target screening, software, high resolution mass 
spectrometry, aquatic environment   
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Introduction 
The investigation of emerging contaminants has become prevalent in analytical environmental chemistry circles. 
The use of pharmaceuticals, personal care products and illicit drugs is increasing worldwide, due to the growing 
population and the rise in available products and the amount of these contaminants entering the aquatic 
environment is of concern (Fatta-Kassinos et al., 2011). There is no blanket removal process able to be 
undertaken by wastewater treatment plants (WWTPs) for all compounds, leading to poor removal rates and 
detection of many of these compounds in effluent wastewaters (EWW) and consequently in surface waters 
(Bijlsma et al., 2012; Luo et al., 2014; van der Aa et al., 2013).  
High Resolution Mass Spectrometry (HRMS) instruments, such as Time of Flight (TOF) and Orbitrap have 
revolutionized the investigation of emerging contaminants in the aquatic environment due to their high 
sensitivity in full scan mode, their increased mass accuracy and the possibility to distinguish the isotopic pattern. 
HRMS instruments have the ability to screen for unknowns due to exact mass measurements and these are 
unique characteristics compared to other mass spectrometry instruments. Hybrid systems i.e. HRMS 
hyphenated to a quadrupole or linear ion trap (LTQ), such as the LTQ-Orbitrap, combines the tandem mass 
spectrometric capability associated with the LTQ with the high mass resolving power (up to 100,000 FWHM) 
and mass accuracy capability of the Orbitrap (de Voogt et al., 2011; Makarov and Scigelova, 2010). These hybrid 
configurations based on HRMS allow reliable interpretation of MS/MS spectra and are very valuable when 
dealing with complex environmental matrices, such as wastewater, where co-elution of analytes with matrix 
interferences can result in ambiguous peaks (Hogenboom et al., 2009). By utilising the ultra-high resolution 
capabilities, isobaric compounds can easily be differentiated (Hernández et al., 2012).  
In the literature, three different approaches are described for the detection and/or identification of compounds: 
target, suspect/post-target and non-target (Aceña et al., 2015; Bletsou et al., 2015; Gago-Ferrero et al., 2015; 
Hernández et al., 2015b, 2014, 2005; Krauss et al., 2010; Leendert et al., 2015). Target methods are limited to a 
restricted number of compounds, for all of which reference standards must be obtained and, therefore, 
information on the occurrence of other unknown, relevant micropollutants may be missed. Suspect screening 
takes advantage of a database of “known” compounds, including molecular formulae, fragmentation and 
retention time, which can then be computationally correlated to spectral HRMS data to give potential positive 
compounds. As the concept of suspect screening implies that reference standards are not necessarily available, 
the tentative identification of potential positives needs to be confirmed by the use of reference standards (and 
MS/MS injections, if required) in a final step.  
The third, non-target, approach is of increasing interest but notoriously difficult to undertake, as, strictly 
speaking, no a priori information is available  (Krauss et al., 2010; Schymanski et al., 2014b; Zedda and Zwiener, 
2012). Even with the help of automated peak-picking software, thousands of peaks can be detected in an 
individual sample (Hug et al., 2014; Kern et al., 2009). Consequently, subsequent steps must then be made to 
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reduce the number of peaks to a more manageable number, including molecular formula derivation, isotopic 
pattern, mass defect analysis and retention time prediction (Gago-Ferrero et al., 2015; Helbling et al., 2010; 
Kind and Fiehn, 2007). Further confidence in the “potential positives” remaining can be gained through the 
use of fragmentation in a subsequent MS/MS injection and comparison with in silico fragmentation and/or 
mass spectral libraries (Bletsou et al., 2015; Herrera-Lopez et al., 2014; Hug et al., 2014; Little et al., 2012), with 
the latter referred to as “hidden targets” (Letzel et al., 2015). In these situations, it is of prime importance and 
for ease of the analyst to have software capable of fulfilling most (if not all) of these steps automatically. Most 
manufacturers have software specific for their instrument and data, which can automatically extract analytes of 
interest from the raw data, to facilitate suspect screening approaches. However, despite the tremendous 
advances in software for metabolite/transformation product detection and further non-target work, sometimes 
not all required information is available in one platform, leading users to manufacturer-independent software, 
such as the Eawag open-source R-code packages enviMass, enviPick, nontarget and RMassBank (Schollée et 
al., 2015; Schymanski et al., 2014a) which can enable the incorporation of additional parameters, such as the 
steps outlined above. In spite of these problems, non-target screening is necessary to identify new or unknown 
relevant pollutants, which is why efforts need to be made in developing proper software and efficient 
identification tools. 
This work portrays the combination of non-target data processing and hidden target searching of environmental 
water samples after injection in an LC-LTQ-Orbitrap. Two computational programs were utilized: MsXelerator 
(MsMetrix) and Sieve 2.1 (Thermo Scientific). An in-house database of more than 200 pharmaceuticals, 
personal care products and illicit drugs was incorporated in both programs. Additionally, Sieve 2.1 was used in 
combination with the ChemSpider search feature. The main objective was to demonstrate the utility and 
additional value of these software packages for screening.  This led to the detection of numerous compounds 
across both programs. The compounds detected by both methods were then reinjected to obtain MS/MS 
fragmentation, leading to the tentative identification of 24 compounds. Ultimately, this work shows that the 
combined use of two deconvolution tools combined with two hidden target screening approaches provides 
more information than either one used individually. 
2. Materials and Methods 
2.1 Reagents  
HPLC-grade methanol (MeOH), and formic acid (>98 % w/w) were purchased from Mallinckrodt Baker 
(Deventer, The Netherlands). The ultrapure water was obtained by purifying demineralized water in a Milli-Q 
system from Millipore (Bedford, MA, USA). SPE cartridges used were Oasis HLB 3 mL (60 mg) from Waters 
(Milford, MA, USA). Polytyrosine-1,3,6 standard used for mass axis calibration was purchased from Cs Bio Co. 
(Menlo Park, CA, USA). Mixed cellulose ester membrane filters (0.45 μm) were purchased from Whatman 
(Dassel, Germany). 
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2.2 Water samples and extraction procedure 
Seven influent wastewater (IWW) and seven effluent wastewater (EWW) 24-hour composite samples were 
collected over seven consecutive days in March 2014. They were stored in high density polystyrene bottles, 
immediately centrifuged and stored in the dark at -20°C.  Analyses were performed as soon as possible after 
collection in order to keep biotic or abiotic degradation to a minimum (Llorca et al. 2014).     
A solid phase extraction (SPE) step was applied prior to analysis to pre-concentrate the samples. All samples 
were filtered through a mixed cellulose ester membrane filter (0.45 μm). SPE was performed using Oasis HLB 
cartridges (60 mg). The water samples (EWW 100 mL, with IWW four times diluted (i.e. 25 mL sample diluted 
to 100mL by adding Milli-Q water)) were loaded onto the cartridges and reconstructed in 1 mL of 10:90 
MeOH:H2O after elution with MeOH (5 mL). A procedural blank was also made, following the steps above 
but using Milli-Q water. Analyses were performed by injecting 20 μL of the final extract (in triplicate) into the 
LC-LTQ FT Orbitrap.  For further information on the SPE procedure, see (Hernández et al., 2015a).   
2.3 Liquid Chromatography  
The HPLC system, consisted of a Surveyor auto sampler model Plus and a Surveyor quaternary gradient HPLC-
pump (Thermo Fisher Scientific, Breda, The Netherlands). Chromatographic separation of the compounds was 
made using an XBridge C18 column (150 mm × 2.1 mm I.D., particle size 3.5 µm) (Waters). The pre-column 
used was a 4.0 mm × 2.0 mm I.D. Phenomenex Security Guard column (Bester, Amsterdam, the Netherlands). 
The analytical column and the guard column were maintained at a temperature of 21ºC in a column thermostat. 
A gradient was used at a constant flow rate of 0.3 mL min−1 using Milli-Q water (Solvent A) and MeOH 
(Solvent B) both with 0.05% formic acid. The percentage of organic modifier (B) was changed linearly as 
follows: 0 min, 5%; 40 min, 100%; 45 min, 100%; 47 min, 5%. Between consecutive runs, the analytical column 
was re-equilibrated for 5 min. 
2.4 LTQ-FT Orbitrap mass spectrometry 
An LTQ FT Orbitrap mass spectrometer (Thermo Electron, Bremen, Germany) was used. The LTQ part of 
this system was equipped with a Heated Ion Max Electrospray Ionization (HESI) probe and operated in the 
positive ion mode. The conditions were: source voltage 3.0 kV, heated capillary temperature 300ºC, vaporizer 
temperature 350ºC, capillary voltage 13 V and tube lens 70 V. Products ions were generated in the LTQ trap 
at a normalized collision energy setting of 35% and using an isolation width of 2 Da. 
Full-scan accurate mass spectra (mass range from 50 to 1300 Da) were obtained at a mass resolution of 60,000. 
The total cycle time depends upon the resolution; at the selected resolution the total cycle time is 0.5 s. The 
instrument was initially set to operate in full-scan (‘survey’) mode with accurate mass measurements. When an 
ion exceeded a preset threshold, the instrument switched to product-ion scan mode in the ion trap part. Further 
details on instrument operating conditions can be found elsewhere (Bijlsma et al., 2013) 
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All data were acquired and processed using Xcalibur version 2.1 software. A second MS/MS injection was 
made by incorporating an inclusion list of masses (see Supporting Information (S.I.) Table S1 for list) with a 
retention window of ±2 minutes and collision energy of 35%. Since MS/MS fragmentation was carried out in 
the ion trap, only nominal mass was measured.  
Mass axis calibration was performed with every batch run just prior to starting the batch by using flow injection 
of a polytyrosine-1,3,6 solution ([M+H]+ 182.01170/508.20783 and 997.39781) at a flow rate of 10 µL min−1 . 
2.5 Settings of Deconvolution tools  
MsXelerator (MsMetrix) 
MS Compare and MPeaks are modules within MsXelerator. MS Compare is specifically designed for comparing 
MS spectra, whereas the MPeaks module picks peaks, with the “keep largest C13 peaks only” and the “peak 
cluster” algorithms used to help discard some, the latter performing componentization which groups together 
all peaks (i.e. isotopes and adducts) arising from a single retention time. All samples were uploaded individually 
and later investigated as triplicates, corresponding to the three triplicate injections of each sample. Procedural 
blank samples were initially processed using the optimized software settings (see below) to subtract identical 
peaks from each wastewater sample. 
The “peak picking”  was carried out by MPeaks on each individual sample using the following parameters and 
values: Base peak width =11 (arbitrary units); spike width = 5 scans; peak separation = 5 scans; peak threshold 
= 0.5% (vs. largest peak); smoothness threshold = 0.65%, signal/noise ratio = 20. The sensitivity value, which 
helps the user find more or less sensitive parameters for the previous three parameters, was set a relatively low, 
at 2 (out of a maximum setting of 6). The peaks picked using these parameters were further reduced by only 
keeping peaks relating to an [M+H] + charge state.   
 Using the second module, MS Compare, all samples were subjected to the following LC/MS settings (in 
accurate mass mode) of the module for peak picking across multiple samples: No baseline correction; FWHM 
(scans) = 3 (min) - 40 (max); min peak height = 10,000 counts; delete spikes; m/z range: 100-650; Max. shift 
between peaks for grouping: 20 scans; Time window for XIC: 0.25min; Mass accuracy: 10 ppm.  
.  
Sieve 2.1 (Thermo Scientific) 
The “control compare trend” feature of Sieve 2.1 (Thermo Scientific) was used with the following parameters: 
peak intensity threshold = 250,000 (62,500 for IWW); m/z range = 100-650; m/z width = 10ppm; retention 
time range = 3-40 minutes; maximum number of frames = 5,000; frame time width = 1.00 minute; align bypass 
= true. For the hidden target screening, either the database used in the analyses of MPeaks and MS Compare 
or ChemSpider was incorporated. 
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2.6 General workflow 
The general workflow followed in this work (pictorialized in Figure 1) falls into the “hidden target” area of 
non-target screening, hypothesized by Letzel et al. (Letzel et al., 2015), wherein non-target techniques (i.e. peak 
picking) are originally applied, but a database (i.e. in-house database or ChemSpider) is used for identification.  
All samples were injected in triplicate and the data were processed with the different software packages of 
MsXelerator or Sieve 2.1. Only peaks in all three injections were further investigated. This resulted in a list of 
chromatographic peaks, based on the accurate masses of their protonated molecules. To gain a list of potential 
positives, two hidden target identification methods were used: 1) an in-house database, containing more than 
200 parent compounds and metabolites and the online database ChemSpider. False positives were manually 
removed after investigating the isotopic pattern (for the characteristic patterns of sulfur- and chlorine-
containing species) and retention time prediction. A final “target list” was investigated by reinjecting the samples 
in MS/MS mode, to get product ions. Fragmentation was then compared with online databases and literature, 
which allowed the tentative identification of several compounds. 
 
Figure 1: Workflow for screenings using the deconvolution tools MsXelerator and Sieve. All orange levels represent specific identification 
confidence levels 
Potential Positive List
LC-LTQ-Orbitrap-MS
Hidden target screening
In-house database
ChemSpider
Non-target data processing
Software: MsXelerator (Mpeaks
and MS Compare) and Sieve
Remove false positives: retention
time prediction, isotopic pattern
Detected (Target List)
Reinject MS/MS 
Compare fragmentation with
mass spectral databases/literature
Tentative Identification
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MPeaks and MS Compare are modules within MsXelerator. Procedural blank samples were initially processed 
using the optimized software settings (Section 2.5) to subtract identical peaks from each wastewater sample. 
MS Compare is specifically designed for comparing MS spectra, whereas the MPeaks module picks peaks, with 
the “keep largest C13 peaks only” and the “peak cluster” algorithms used to help discard some, the latter 
performing componentization which groups together all peaks (i.e. isotopes and adducts) arising from a single 
retention time.  
Sieve 2.1 combines the power of the two modules from MsXelerator as described above. After an initial peak-
picking process using the settings described in Section 2.5, it compares MS spectra of the procedural blank 
samples and the studied wastewater samples. Only compounds with an m/z between 150 and 500, and only 
protonated molecules ([M+H]+) were considered. The list of potential positives were then search by either the 
in-house database or ChemSpider, which were incorporated in the software. The results of the ChemSpider 
search were exported into Microsoft Excel, and positive “hits” were considered based on their mass error (< 2 
ppm), and if the compound commercially existed i.e. hits which only represented chemical formula were 
excluded. 
3. Results and Discussion 
In this study, in order to show the progression through confidence levels of identification, the terminology 
proposed in the literature by Hernández et al. (Hernández et al., 2015) and Schymanski et al. (Schymanski et al., 
2014) were followed. It must be noted that potential positives and detected compounds, differentiated in this 
work, would both be level 3 tentative candidate in the terminology of Schymanski et al. The final, tentatively 
identified compounds are of a higher confidence level (level 2a). However, in order to have total confirmation 
(level 1), reference standards are necessary. As no reference standards were utilized in this work, this level could 
not be attained. 
3.1 Optimization of deconvolution tools 
All samples were injected and processed in triplicate, which were compared together, with only peaks in all 
three injections being further investigated.  Procedural blank samples were processed first, to subtract identical 
peaks from each subsequent IWW and EWW sample.  
The m/z range of MS Compare was made quite narrow as the compounds of interest in this study and in the 
in-house database (small pharmaceutical/drug molecules) would be within that range. The retention time range 
was reduced just to 3-40 mins to reduce the likelihood of erroneously detecting species that elute very early and 
late due to the high/low ratio of organic modifier, with the vast majority of all peaks in the total ion 
chromatogram falling within this range. In spite of the known mass accuracy capability of the Orbitrap, the 
mass accuracy was set at 10ppm to ensure that no compound would be missed. After this processing, a list of 
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masses common within each triplicate set was made, with compounds being detected using the same peak 
peaking parameters and database used in the final step of the MPeaks analysis. 
Sieve 2.1 used the same m/z range, m/z width and retention time range as MS Compare for better ease of 
results comparison. The peak intensity threshold was originally set quite high for both IWW and EWW samples, 
but it was later found that IWW gave fewer peaks, possibly due to the complexity of these samples and stronger 
matrix effects, mostly leading to ionization suppression. The threshold was thus reduced to one quarter to 
account for this. The maximum number of components was raised to 10,000 to ensure that no compounds 
would be missed, leading to more than 5,000 components being detected in the IWW and EWW samples (Table 
1). These were reduced by including compounds with only a m/z 150-500 and [M+H]+ =1.  The in-house 
database used by the previous two modules within the “Accurate Mass Identification Parameters” of Sieve was 
then used to gain a list of potential positives.  
The ChemSpider database (with 10ppm mass accuracy threshold) was also used within Sieve and was begun 
after the initial component optimization was completed (Figure 2). The threshold was made quite high, for 
optimal “hidden target” analysis, where the detected peaks should correspond to compounds which are 
commonly and/or highly used. The peak lists of both IWW and EWW results with all data pertaining to mass 
error, m/z and intensity were exported into Microsoft Excel. From these lists, several thresholds were set and 
outlying peaks removed: only compounds between m/z 150-500; only [M+H]+; mass error under 2.0ppm; all 
“hits” just representing a chemical structure, rather than a generic/known name. This final step is rather 
pragmatic but makes for a more optimal non-target screening, where the remaining compounds should be the 
more common and/or highly used, as emphasized by having a high intensity threshold. However, this could 
lead to some less intense peaks being missed and not noted as a possible emerging contaminant in the 
environment. 
Table 1: Number of components left after each step of the Sieve hidden target identification approaches. 
Step IWW components EWW components 
1. 6690 5091 
2. 5158 3528 
3. 2014 2175 
4.  18 16 
NON-TARGET SCREENING 
Number of distinct m/z (total number of compounds) 
5. 239 (437) 441 (677) 
6. 166 (362) 308 (543) 
7. 100 (150) 64 (108) 
Final 18 8 
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Figure 2: Sieve workflow for the two hidden target identification approaches.  
3.2 Identification with in-house database 
Both programs incorporated an in-house database of more than 200 pharmaceuticals, illicit drugs and 
metabolites (Table S3) to get a list of potential positives. All samples were first processed with MsXelerator 
(modules MPeaks and MSCompare) and Sieve 2.1 using the parameters outlined in Section 2.5. Table 2 shows 
the compounds detected by each.  
There was very little difference between the compounds found with Sieve and MS Compare, while MPeaks 
detected somewhat fewer compounds. This could be due to their apparent uses: MPeaks is for pick-peaking, 
MS Compare for comparing samples, while Sieve does both, resulting in the latter two have more similar results. 
The fact that all compounds detected by MPeaks were also found with MS Compare leads to the preferential 
use of the latter module for screening. However, by optimizing the peak-peaking parameters of MPeaks, 
specifically the sensitivity value, this module could also be of future use in suspect and/or non-target screening.  
Two methods were used to remove potential false positive peaks: isotopic pattern (for chlorine- and sulfur-
containing species) and retention time prediction. Only three of the above compounds (losartan, 
sulfamethoxazole and temazepam) had a chlorine or sulfur atom, giving rise to a characteristic isotopic pattern. 
1. Initial peak picking
2. m/z 150-500
3. [M+H]+ only
4. Database search 5. ChemSpider search
6. Mass error <2ppm
7. Generic/known name
Potential Positives
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Extracted ion chromatograms were extracted from the initial full-scan data of the Orbitrap and investigated 
manually. Both sulfamethoxazole and losartan showed the characteristic isotopic pattern, while temazepam did 
not. Temazepam was thus considered as a false positive and removed from further investigation. 
Table 2: All compounds detected (in at least one sample) by each program following suspect screening.  
Compound IWW  EWW 
 Sieve MSCompare Mpeaks  Sieve MSCompare Mpeaks 
4-acetylamino 
antipyrine 
       
4-formylamino-
antipyrine 
       
Acetaminophen        
Benzocaine        
Benzoylecgonine        
Caffeine        
Carbamazepine        
Cocaine        
Cotinine        
Gemfibrozil        
Ibuprofen        
Irbesartan        
Ketoprofen        
Lidocaine        
Lincomycin        
Losartan        
Metoprolol        
Naproxen        
Phenacetin        
Phenytoin        
Salbutamol        
Sulfamethoxazole        
Temazepam        
Trimethoprim        
Valsartan        
 
 Detected by the program 
 Not detected by the program 
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A retention time predictor was made, based on artificial neural networks, as in (Miller et al., 2013; Munro et al., 
2015) and in our previous work (Bade et al., 2015a).    A retention time window of ±11% of total run time was 
used to find compounds to focus on, based on the window used in our previous work. Of the 25 potential 
positives investigated, four were removed using this method (benzocaine, ibuprofen, lincomycin and 
salbutamol) with predicted retention times between 11.5-16.8 minutes (24-36% of the total run time) away from 
the experimental times. While only four compounds were removed using this technique, it does simplify the 
identification process, and provides greater confidence in the compounds remaining. 
3.3 Identification with ChemSpider 
To make a more comprehensive analysis of the samples, an investigation was made using the ChemSpider 
database search feature of Sieve (Figure 2). The introduction of ChemSpider, while removing many components, 
had the added complication of isobaric and isomeric compounds, with most distinct m/z values having more 
than one compound associated, as seen in step 5 of Table 1.  To further refine this list, the mass error was 
limited to 2ppm (step 6) and all compounds having a formula-only entry were deleted, leaving just compounds 
with generic names (step 7), leaving up to 100 components in the samples. The literature was then searched to 
determine whether or not their detection in wastewater could be expected,  leading to approximately 30 
components and up to 34 isomeric/isobaric compounds in the samples. The literature search was made using 
the Scopus database, and search terms were the generic name of interest, “HRMS”, “LC”, “environment” and 
“water”. If there were no suitable papers concerning the generic name of interest, the compound was removed 
from further investigation. To determine which of the isomeric/isobaric compounds the compound within the 
sample was, the molecular formula was manually searched on ChemSpider, with the compound having the 
highest number of references deemed to be the compound of interest. Step 7 and the literature search, while 
pragmatic, were employed to ensure that the compounds detected were those of high 
consumption/prescription and could therefore be more easily identified in the later in silico fragmentation 
comparison. Finally, eighteen (including three isomers) and eight compounds were finally deemed as potential 
positives using this non-target approach for IWW and EWW samples respectively (Table S4).    
It is worth noting that by using this approach, most of the same compounds were found as with the in-house 
database (Table 2 and S4). With such great similarities between the set of potential positive compounds, only 
2-hydroxy carbamazepine, desvenlafaxine, adenosine, albendazole, phenazone and the three isomers 
theophylline, paraxanthine and theobromine required further investigation. Albendazole was the only 
compound that required an investigation of isotopic pattern as it contains one sulfur atom, which was 
inconsistent with the mass spectrum, leading to its removal as a false positive. The remaining seven compounds 
were subjected to retention time prediction based on the time given by Sieve 2.1, and all were found within the 
set ±11% of total run time retention time window.  
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3.4 Tentative identification  
Table 3: All compounds tentatively identified, together with retention time and fragment ions 
The parent ions were recorded at accurate mass (full-scan mode) while the fragment ions were recorded as part of a 
product ion scan in the ion trap part with nominal mass measurement.  
1 Information on fragment ions from Hernández et al (Hernández et al., 2015a) 
2 Information on fragment ions from MassBank (Horai et al., 2010) 
3 Information on fragment ions from Bade et al (Bade et al., 2015c)  
4 Information on fragment ions from Gómez et al (Gómez et al., 2010) 
 
The potential positives found using both hidden target screening approaches were combined, less those 
removed in previous steps, leaving 28 compounds to investigate (Table S1). These compounds were added to 
a target list and several IWW and EWW samples were reinjected to see if fragment ions from these compounds 
Compound m/z RT Fragment ions IWW  EWW  
        
4-acetylaminoantipyrine1 246.1234 9.43 228.1 204.1  X X 
4-formylaminoantipyrine2 232.1086 9.29 214.1 204.1  X X 
Acetaminophen3 152.0706 6.09 110.1 134.0  X X 
Adenosine2 268.1035 3.58 136.0    X 
Benzoylecgonine2 290.1385 12.22 168.1   X X 
Caffeine1 195.0876 10.4 138.1   X X 
Carbamazepine3 237.1022 22.56 194.1 152.9  X X 
Carboxylosartan1 437.1480 26.94 207.1 235.1 365.3 X X 
Cocaine2 304.1543 13.84 182.2   X  
Ketoprofen3 255.1014 16.78 237.1 209.1  X X 
Lidocaine1 235.1807 10.12 86.1   X  
Losartan1 423.1695 25.58 405.0 207.2 377.2 X X 
Metoprolol2 268.1908 13.71 218.1 191.1 159.1 X  
Naproxen3 231.1016 27.24 185.1   X X 
Paraxanthine2 181.0721 7.98 124.1   X X 
Phenacetin2 180.1030 17.22 138.1 110.0  X X 
Phenazone2 189.1022 12.15 161.2 146.1 131.1 X X 
Sulfamethoxazole2 254.0594 12.41 235.8 188.1 156.1 X X 
Theobromine2,4 181.0721 6.28 163.1 137.1 138.1 X X 
Theophylline2,4 181.0721 8.37 124.1   X X 
Trimethoprim2 291.1454 9.91 230.2 123.2 261.1 X X 
Valsartan2 436.2341 28.96 335.1 265.2 155.1 X X 
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could give further confidence to their identification. Metfusion and MassBank were used to help provide further 
confidence to the fragment ions. As has been mentioned in previous suspect and non-target studies (Agüera et 
al., 2013; Herrera-Lopez et al., 2014; Zedda and Zwiener, 2012), the use and improvement of mass spectral 
databases, such as MassBank, is extremely important in the tentative identification of compounds for which 
standards are unavailable. In the end, 22 compounds were able to be tentatively identified (Table 3) with at least 
one fragment ion, while the other six were removed as false positives due to having incorrect fragment ions. 
One interesting finding was the detection of three isomers (paraxanthine, theobromine and theophylline). These 
three isomers are all metabolites of caffeine, accounting for 80%, 11% and 4% of total metabolism, respectively 
(Miners and Birkett, 1996). Conventionally, isomeric compounds, separated chromatographically, would be 
distinguished by retention time. However, as no standards were available, the best way to order the peaks was 
with retention time prediction. The approach outlined in Section 3.3 predicted retention times of 8.48 min, 9.34 
min and 9.41 min for theobromine, paraxanthine and theophylline, respectively. While these times are 1-2 
minutes from the experimental retention time, they do provide an idea for the order of the isomers. To give 
more confidence to this information, the fragment ions were checked. As seen in Figure 3, the peak at 6.27 min 
had fragment ions of m/z 163 and 138 while the peaks at 7.98 and 8.37 both had one major peak of m/z 124.  
These fragment ions were checked and compared with MassBank and the literature (Bianco et al., 2009; Gómez 
et al., 2010; Horai et al., 2010).. Theobromine was found to have fragment ions of m/z 163 and 138, while both 
paraxanthine and theophylline were found to have a main fragment ion of m/z 124. The losses leading to each 
fragment ion is defined in Figure 3. To differentiate the latter two, the initial retention time predictions led to 
paraxanthine being the larger peak at 7.98 min and theophylline the small peak at 8.37 min.  
While 22 compounds were tentatively identified using the workflow outlined throughout this paper, it must be 
noted that even incorporating the false positive removal strategies of retention time prediction and isotopic 
pattern as well as fragment ions, the final confirmation of the identity of compounds requires the use of 
reference standards.  Nevertheless, the addition of advanced deconvolution tools (MsXelerator and Sieve) to 
the HRMS data of the Orbitrap has been shown to be of great value, and the results show how far one can go 
without the need to purchase reference standards. The information obtained with this strategy circumvents the 
cost and problems associated with the storage and expiry dates of standards in the laboratories, as the purchase 
can be directed only towards those compounds that have been previously tentatively identified in the samples. 
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Figure 3: Tentative identification of theobromine (top left), paraxanthine (bottom left) and theophylline (bottom right), with chromatographic 
peaks (top right). The generic structure has been shown in the top right corner, where R1, R2 and R3 differ for the metabolites as follows: 
theobromine: R1 =CH3, R2 = CH3 and R3 = H; theophylline: R1 =H, R2 = CH3 and R3 = CH3; paraxanthine: R1 =CH3, R2 = H and 
R3 = CH3 
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Conclusion 
This work has shown that, following initial unbiased, non-target oriented deconvolution using two tools 
(MsXelerator and Sieve), allowed relevant peaks of interest to be attained. The complementary use of an in-
house database or ChemSpider facilitated detection and enabled the identification of more compounds than 
using just one of these databases.  
The combination of deconvolution tools and high resolution mass spectrometry, without the use of any 
reference standards, has enabled 22 compounds to be tentatively identified in environmental water samples. 
The majority of compounds that were identified in wastewater samples were pharmaceuticals, including the 
metabolites 4-formylamino antipyrine, 4-acetylamino antipyrine, theobromine, theophylline, paraxanthine and 
carboxylosartan.  
It is worth noting that the two hidden target approaches primarily found the same compounds, with some 
exceptions. Furthermore, when applying small databases it is often easier to analyse the raw data directly. 
Whereas, when a much larger database is incorporated, these software tools will facilitate searching as well as 
reducing processing time. With further improvements to these computational programs non-target analysis will 
become more enticing and easier for laboratories to use in everyday screening methods. 
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Supporting Information 
Table S3, “All compounds and respective m/z used for the suspect analysis” is too large for this thesis, 
however all other supporting tables are included here.  
Table S1: All target compounds used for final MS/MS analysis 
Compound m/z 
2-hydroxy-carbamazepine 271.1080 
4-acetylamino antipyrine 246.1234 
4-formylamino-antipyrine 232.1086 
Acetaminophen 152.0706 
Adenosine 268.1035 
Benzoylecgonine 290.1385 
Caffeine 195.0876 
Carbamazepine 237.1022 
Carboxylosartan 437.1480 
Cocaine 304.1543 
Cotinine 176.0939 
Desvenlafaxine 264.1958 
Gemfibrozil 250.1564 
Irbesartan 428.2320 
Ketoprofen 255.1014 
Lidocaine 235.1807 
Losartan 423.1695 
Metoprolol 268.1908 
Naproxen 231.1016 
Paraxanthine/Theobromine/Theophylline 181.0721 
Phenacetin 180.1030 
Phenazone 189.1022 
Phenytoin 252.0888 
Sulfamethoxazole 254.0594 
Trimethoprim 291.1454 
Valsartan 436.2341 
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Table S2: Non-target workflow for MPeaks, impact of each algorithm to the number of peaks remaining in each 
sample 
 
  
Samples Default parameters, less 
procedural blank peaks, 
charge state 1, across 
triplicate 
Keep largest 13C peak Cluster 
analysis 
Keep 
largest 
peak from 
cluster 
IWW 
1 502 500 459 292 
2 419 417 389 243 
3 415 415 389 238 
4 457 457 420 262 
5 418 417 385 236 
6 379 374 343 209 
7 482 481 445 267 
      
EWW 
1 277 276 250 182 
2 303 303 263 184 
3 415 415 360 227 
4 407 407 357 224 
5 378 378 323 210 
6 398 397 338 226 
7 660 658 576 339 
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 Table S4: Compounds detected in IWW and EWW using ChemSpider-lookup feature of Sieve 
Compounds detected in IWW Compounds detected 
in EWW 
2-hydroxy-carbamazepine Adenosine 
Benzoylecgonine Albendazole 
Caffeine Benzoylecgonine 
Carbamazepine Carboxylosartan 
Carboxylosartan Losartan 
Cocaine Paracetamol 
Desvenlafaxine Phenazone 
Ibuprofen Valsartan 
Lidocaine  
Losartan  
Metoprolol  
Naproxen  
Paracetamol  
Theophylline/Paraxanthine/ Theobromine  
Trimethoprim  
Valsartan  
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2.3 Discussion of Results  
All of the articles in this section exemplify the utility of suspect and/or non-target screening. As 
explained previously, suspect screening incorporates a number of compounds far larger than those 
available in target screenings. The big advantage of this strategy is that a much wider variety of 
compounds can be included and there is no need to initially have the reference standards available. 
Scientific Article 2 included a database of more than 1000 parent compounds and metabolites, while 
Scientific Articles 3 and 4 used a database of 107 and 250 parent compounds and metabolites, 
respectively. These databases contained compounds of diverse chemical families: drugs of abuse, 
antibiotics and both human and veterinary pharmaceuticals. While reference standards are commonly 
purchased to supplement and confirm tentatively identified compounds, the reliability of the tentative 
identification is high.    
The idea of suspect screening is simple: incorporate a database containing a huge number of 
compounds (as molecular formulae or exact mass and, when available, fragment ions) and use 
powerful software to match “hits” between the database and injected samples. However, this simple 
approach has vast consequences for environmental analytical chemists, especially, as it enables 
compounds for which reference standards are unavailable to be tentatively identified as well as low 
abundant species which may have been overlooked by a manual inspection. In Scientific Articles 2 
and 3, a QTOF instrument was used in MSE mode which allowed the simultaneous acquisition of high 
and low collision energy accurate-mass data. These simultaneous acquisitions can be visualised in 
ChromaLynx (within MassLynx), with nw-XICs at the m/z of all compounds in the database being 
performed automatically by the software (at low energy), and fragment ions at high energy.  The 
agreement between the software and the database (and sufficiently low mass error, set by the user) 
leads to the tentative identification of compounds. 
Scientific Article 2 focussed on the investigation of surface and wastewaters from Bogotá, Colombia. 
Samples were screened for pharmaceuticals belonging to different therapeutic groups, veterinary drugs, 
X-ray agents, PCPs (preservatives and UV filters), sweeteners, illicit drugs, as well as several 
metabolites. The compounds most frequently detected were the analgesics/anti-inflammatory drugs 
acetaminophen, diclofenac, ibuprofen, and lidocaine. The antibiotics clarithromycin and lincomycin, 
the angiotensin II antagonists valsartan and losartan, the anti-epileptic carbamazepine, the beta-
blocker metoprolol, the lipid regulator gemfibrozil, and the X-ray agent iopromide were also found. 
It is also interesting to note that the metabolites of carbamazepine 10,11-dihydro-10,11-dihydroxy and 
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benzoylecgonine (the main metabolite of cocaine) were also found. One fascinating aspect of this 
work was the implementation of a common fragmentation workflow for the identification of several 
metabolites of losartan (Figure 4 in Scientific Article 2) based on three chromatographic peaks 
sharing three m/z in their respective XICs: 207, 235 and 190. Closer inspection of these peaks led to 
the identities of two hydroxyl losartan metabolites as well as losartan carboxylic acid being elucidated.  
Scientific Article 3 dealt with the analysis of environmental and wastewaters from two countries 
(Spain and Italy) using two HRMS instruments (QTOF and LTQ-Orbitrap). A small database, similar 
to that used in Scientific Article 2, containing 107 pharmaceuticals and illicit drugs and metabolites 
was used in both instruments, to allow a wider scope for the screening, based on the different 
acquisition modes of the instruments. In general, more compounds could be detected (protonated 
molecule ([M+H]+) at accurate mass and retention time data when standard available) and identified 
(at least one fragment ion and [M+H]+ and retention time data when standard available) in the Spanish 
than Italian samples, with cotinine, gabapentin, oxazepam, temazepam and a metabolite of metamizole 
(4-aminoantipyrine), not identified in the Italian samples (Table 2, Scientific Article 3). Irbesartan 
(antihypertensive), valsartan (angiotensin II antagonist) and two antibiotics ofloxacin and 
sulfamethoxazole were the most commonly identified compounds in the wastewater samples of both 
Spain and Italy, while the illicit drug cocaine and its main metabolite benzoylecgonine as well as the 
addictive opioid painkillers morphine and codeine were also identified. Caffeine, irbesartan, valsartan 
and venlafaxine (antidepressant) were also found in a high enough concentration in surface water to 
be identified by at least one of the two instruments. When looking at the results of the two instruments, 
there was little difference between those compounds found, but there was a discrepancy in the number 
of compounds identified, which shows the complementary use of two HRMS instruments. As shown 
in Figure 2 of Scientific Article 3, the antihyperlipidemic bezafibrate could not be identified (i.e. 
only the [M+H]+ at a comparable retention time to the standard was found) in an EWW sample using 
the QTOF, due to its low concentration, while in the same sample after analysis with the  Orbitrap, 
three fragment ions were also found, leading to its identification.  
In Scientific Articles 3 and 4, an LTQ-Orbitrap was used for suspect and non-target screening. With 
this instrument, simultaneous acquisition of high and low energy data was impossible, due to the 
longer cycle time of the Orbitrap compared to the QTOF. Instead, the mass spectrometer operated 
under data-dependent-acquisition (DDA) mode during the complete chromatographic run, in which 
both MS and MS2 spectra were acquired simultaneously. The instrument was initially set to operate in 
full-scan (‘survey’) mode with accurate mass measurements. When an ion exceeded a preset threshold, 
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the instrument switched to product-ion scan mode in the ion trap part. However, this only meant that 
compounds of a certain (high) intensity would have product ions recorded, and only the protonated 
molecule would be seen for lower abundant compounds. Nevertheless, the exact mass capabilities of 
this instrument did lead to the tentative identification of some compounds (as a protonated molecule), 
which later could be examined in MS/MS mode for fragment ions. The MS/MS acquisition of this 
instrument was carried out in the ion-trap, and therefore only nominal mass measurements could be 
recorded for the product ions, which can lead to some erroneous tentative identifications (furthered 
below).  Even so, this instrument does hold distinct advantages, relating to its high resolving power 
(up to 100,000 FWHM) and MSn capability, which lends itself to non-target analysis.  
It must be noted that while tentative identifications do result in fairly high confidence in identity, 
without a reference standard, it is impossible to have total confidence. This is touched upon in 
Scientific Article 4, for which only tentative identification was possible as no reference standards 
were utilised in the study. In this article, the steps applied for removing possible false positives 
included mass error evaluation, isotopic pattern fit, retention time prediction before final fragment 
ion analysis after MS/MS fragmentation. In total, 22 parent compounds and metabolites were 
tentatively identified, primarily pharmaceuticals and antibiotics, but more interestingly, also phenacetin, 
a withdrawn painkiller - now seen as a cocaine adulterant, three alkaloid metabolites of caffeine 
(theobromine, theophylline and paraxanthine), the purine nucleoside adenosine and cocaine and its 
main metabolite benzoylecgonine (Table 3, Scientific Article 4). Although some uncommon and 
unexpected compounds were found using the non-target approach, the false positive removal steps 
explained above give high confidence to their eventual tentative identification.  
One interesting aspect that was not covered in Scientific Article 4 was the implications of the 
exclusion of benzocaine from further analysis after being outside the predicted retention time 
following the suspect screening. For the article, the ANN retention time prediction approach was used 
(Scientific Article 6), with a predicted retention time of 15.83 mins. A second retention time 
prediction analysis was performed using a logKow only approach (as in Scientific Article 5), which 
predicted benzocaine would have a retention time of 13.35 mins. Using a retention time window of 
±11% (±5.5mins) neither of these values are close to the experimental value of 4.81 mins.   
There was nevertheless some doubt over the removal of benzocaine, an anaesthetic also used as a 
cocaine adulterant and as retention time prediction is not perfect, benzocaine was included in the 
target list for MS/MS analysis, to ensure that it was a false positive. As seen in Figure 2.1, there was 
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only one main chromatographic peak corresponding to the protonated mass of benzocaine (166.0863 
± 5ppm) at 4.81. In the respective product ion spectra, there was one major fragment (m/z 120.1). 
Benzocaine was checked in MassBank, for a study using a 30V collision energy (closest to the 35V of 
this study) to see what the expected product ions are, and found to be 138.3, 120.1 (major), 94.1 and 
77.0. Although one fragment ion is in the MS/MS spectrum, there is not enough confidence to assign 
benzocaine as tentatively identified.  
 
Figure 2.1: Extracted ion chromatogram of m/z 166.0863 +/- 5ppm with respective mass spectra for the peaks at 4.81 min in EWW 
(left) and IWW (right). The fragment ions associated with the tentatively identified phenylalanine are shown in the mass spectra. 
As benzocaine was found following hidden target screening, the exclusion of it based on inconsistent 
fragment ions (combined with the predicted retention time data) is enough to totally disregard it for 
further investigation and accept it as a false positive. It was also not found in the subsequent Sieve 
hidden target analysis with the in-house database, possibly due to the relatively high intensity threshold 
used (250,000 for EWW and 62,500 for IWW) and the corresponding intensities of the peak of m/z 
166.0863 seen in Figure 2.1. Nevertheless, the ChemSpider strategy was followed to determine what 
the peak may have come from. With benzocaine excluded as the source of the peak of m/z 166.0863, 
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a search was made in the ChemSpider database, based on the molecular formula of C9H11NO2. This 
formula led to more than 1000 hits, and based on the number of sources, the best candidates were 
benzocaine and phenylalanine, an amino acid that is used in the biosynthesis of proteins. It is essential 
in humans, but is not synthesised by the body and must be obtained from the diet, so could plausibly 
be found in wastewater. Using the ANN model, a predicted retention time of 7.30 mins was found, 
within the set ±11% window. A search for this compound on MassBank showed that it has one major 
fragment ion at 120.1, along with a small fragment ion at 149.1. So, phenylalanine could be tentatively 
identified, based on these fragment ions. Although both benzocaine and phenylalanine have the same 
major fragment ion (120.1), but different structures (Figure 2.2), it is impossible that the same loss 
occurred in both compounds to give these ions. Further analysis of the structures led to the findings 
that in the case of benzocaine, a loss of ethanol occurred, while for phenylalanine, it was a loss of 
formic acid. This points out a limitation of performing MS/MS within an ion trap, where only nominal 
mass is given. Although ethanol and formic acid have the same nominal mass (46), their exact masses 
are 46.0419 and 46.0055, respectively, so if an exact mass fragmentation was made, it would have been 
much easier to determine which compound gave rise to the chromatographic peak. 
 
Figure 2.2: Structures of benzocaine (left) and phenylalanine (right) 
Phenylalanine does seem a more likely tentative candidate than benzocaine, based on the retention 
time and fragment ion data. However, a literature search revealed that phenylalanine has never been 
found in environmental waters, although, being a very common amino acid, its presence should not 
be discounted. Rather than conform to the “Matthew Effect” phenylalanine can be tentatively 
assigned as the m/z of 166.0863.  
Nevertheless, the conclusions from this investigation are three-fold: 
a) The retention time prediction correctly removed benzocaine as a false positive. 
b) The workflow followed in the article was sound, and correctly led to the removal of 
benzocaine following the hidden-target analysis. As phenylalanine was not also in the database, 
O
O
NH2
OOH
NH2
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it was not initially considered. However, an additional non-target approach led to its tentative 
identification. 
c) Without a reference standard, it is impossible to have complete confidence in the identification 
of a compound. Even with retention time prediction, fragment ions, and a comparative 
fragment ion spectrum, the lack of studies finding phenylalanine in environmental waters casts 
doubt over its identification.  
One further point regarding the method employed in Scientific Article 4 is the use of the number of 
sources to determine which isomer to investigate after the ChemSpider search. This was selected, as 
explained in the article, as a means to investigate highly consumed/more common drugs and 
pharmaceuticals, to focus on those of higher commercial importance. This is a known technique to 
limit the number of possible compounds to focus on, utilised in other non-target methods (Gago-
Ferrero et al., 2015; Hug et al., 2014; Little et al., 2012). It does simplify the non-target process, 
however in doing so, many “potential positive” compounds could be ignored, and, at the same time, 
some false positives could be included. These false positives are exemplified with the six compounds 
that made it all the way to the final MS/MS measurement, only to have no comparable fragment ions 
(2-hydroxy carbamazepine, cotinine, desvenlafaxine, gemfribrozil, irbesartan and phenytoin). 
Nevertheless, this article did show a way for a non-target (and hidden target) analysis, without the 
need for any reference standards, and from the steps employed, a high confidence in the tentatively 
identified compounds was gained.  
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3.1 Introduction 
The detection and identification of emerging contaminants in the aquatic environment is of increasing 
concern. The current technique of choice for an initial wide-scope screening for qualitative detection 
and identification is liquid chromatography coupled to high resolution mass spectroscopy (LC-
HRMS). As was explained in Chapter 2, there are three screening methods: target, suspect and non-
target. In a non-target and suspect screening, either a computationally derived or a manually inputted 
list of compounds, which contains the exact mass of the compounds of interest, is used as a basis for 
detection and subsequent identification. Ideally, there would just be one peak arising from the exact 
mass of the compound of interest in the extracted ion chromatogram (XIC), however, with thousands 
of organic compounds potentially present in the aqueous environment, there is a high chance that 
isobaric and isomeric compounds are also present in the same XIC, thereby complicating 
identification. Several approaches can be used to eliminate unwanted peaks, such as mass window 
filtering, mass defect analysis and isotopic pattern fit, however, this totally ignores the initial separation 
by LC, which is also an important parameter (Croley et al., 2012).  
Retention time (tR) prediction does take this important aspect into account, and therefore should be 
used as an additional means to gain confident identification of compounds. It is best incorporated at 
the beginning of the identification process, to aid in the removal of false positive peaks and is especially 
useful in the aforementioned scenario when more than one chromatographic peak is visible at a certain 
mass. In spite of the improvements in tR prediction, it is impossible to have an absolutely precise 
method, so a time window should be incorporated to aid in the identification of possible peaks of 
interest. The width of this window depends on the initial development and optimization of the 
prediction method used. For example, a simple approach consisting of only one molecular descriptor 
would generally have a lower accuracy than a more complex Quantitative structure-retention 
relationships (QSRRs) approach, necessitating a wider window.  
Liquid chromatographic tR prediction was pioneered by Kaliszan in the late 1970s (Kaliszan, 1977) but 
only in the past two decades has the evolution and capability of computational techniques enabled 
serious research. QSRRs represent a powerful tool in chromatography (Kaliszan, 1992), which 
correlate chromatographic parameters with molecular descriptors, thereby describing the analyte’s 
chemical structure (Giaginis and Tsantili-Kakoulidou, 2012). There are many different QSRR 
approaches, with linear solvent energy relationships (LSERs) and, lately, support vector machines 
(SVM), random forests (RF) and artificial neural networks (ANNs) the most popular.   
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The current work on LSERs is based on the research of Abraham et al.,  with the following equation 
representing LSERs for LC, which describes the phase transfer of a substance between two different 
phases (Abraham et al., 2004): 
Solute property = aA +bB +sS +eE +vV + c 
where solute property can be of any kind, such as logKOW and logP. A, B, S, E and V are compound 
descriptors, while a, b, s, e and v are phase descriptors describing the matrix/solvent interactions and 
c is the intercept of the equation (Ulrich et al., 2011). The terms aA and bB represent the hydrogen 
bond interactions, representing the acidity and basicity respectively. The term sS reflects the 
dipolarity/polarizability, eE is the excess molar refraction and vV is the McGowan volume.  The 
outcome of a LSER analysis is a set of regression coefficients which provide information about which 
solute–solvent interactions significantly affect the retention process. It should be mentioned that the 
regression coefficients are interrelated and do not carry independent information. This model is 
known to contribute primarily to the general understanding of a partition process and less to optimise 
separations, but is usually not accurate enough for prediction purposes (Héberger, 2007). Another 
major problem is that all values are needed and any missing value can be problematic (Livingstone, 
2003). 
SVM, RFs and ANNs have all been utilised and compared in numerous studies (Fatemi et al., 2010; 
Goudarzi and Shahsavani, 2012; Hancock et al., 2005; Héberger, 2007; Ibáñez et al., 2016; Shinoda et 
al., 2008), but no one can be considered distinctly superior. 
SVM are a group of supervised learning methods that can be applied to classification or regression 
and have gained popularity among computational chemists, particularly for drug design. The QSRR 
application of SVM regression, however, are rare, despite its potential as a viable alternative (Ivanciuc, 
2007). The main advantage seen for SVM (particularly over ANNs) is that the strong theoretical 
background provides a high generalization capability and can avoid local minima, i.e. it has the ability 
to accurately predict for new data (Shinoda et al., 2008). On the other hand, while its predictive 
capacity is great, for simple datasets, the solution can be overfitted (Ivanciuc, 2007). 
RF is a set of individual classification and regression trees which are combined to provide a prediction 
tool with high performance, introduced by Breiman (Breiman, 2001). In the RF algorithm, each tree 
is grown on a separate training set that is a bootstrap replicate of the original data. In each bootstrap 
sample, with the same length as the original data, some of the original data is repeated, and the left 
out samples are called ‘‘out-of-bag’’. To construct a tree, at each node, a small random subset of p 
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descriptors or explanatory variables (m < p) is chosen, and the best split of the feature space is done 
using only this subset (Goudarzi and Shahsavani, 2012). Each tree is then grown to the maximum size 
and is not pruned. It has been shown that as the number of trees increases, the test error always 
converges. By using many trees, RF have the ability to identify important variables and their 
relationship with the response. The number of trees, therefore, needs to be set sufficiently high to 
allow for this convergence as well as to identify the most important variables (Goudarzi and 
Shahsavani, 2012; Hancock et al., 2005). This randomness has the effect of building new trees with 
different structures, increasing the variety of relationships modelled within the forest, which in turn 
improves the overall predictive performance and makes it robust against overfitting. However, while 
RF are good for identifying main trends, it can lead to some points being poorly predicted (Hancock 
et al., 2005). 
ANNs mimic the neurons of the human brain’s way of working in acquiring knowledge from its 
environment, by “learning” from a set of case examples in the training phase (Giaginis and Tsantili-
Kakoulidou, 2012; Kaliszan et al., 2003).  There are three phases in the optimisation of ANNs: training, 
validation and blind. In the first, training phase, a list of appropriate molecular descriptors as well as 
the true output value is needed (i.e. retention time that will be later predicted). Simultaneously, a 
second dataset of case examples is used for verification and to evaluate the overall ANN predictive 
error. In this set, the true output values are not used for learning and the number of training cycles 
can be stopped by the user or when the software determines the measured error is at its minimum. In 
many cases, this is where the optimisation and development of the ANN would end, however, 
sometimes a third, blind test, dataset can be used, where the true output value is not needed, to test 
the predictive power of the network. The main disadvantage seen for ANN is a tendency for 
overfitting (i.e. giving a misleadingly accurate set of predictions) and the need to select variables in 
advance. (Goudarzi and Shahsavani, 2012; Héberger, 2007) 
While QSRRs sound quite straightforward in theory, in practice there are some key points to consider; 
with one crucial aspect being which molecular descriptors should be used and how they should be 
calculated (Héberger, 2007). While some techniques (SVM and RF) are able to incorporate variable 
selection as well as predictive analysis, ANN and simple linear regression require prior selection of 
variables.  Simplified molecular-input line-entry system (SMILES) was developed in the late 1980s as 
a way in which to easily transfer and encode molecular structures using line notation (Weininger, 
1988). Together with mol files (Dalby et al., 1992)  they have become one of the quintessential means 
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for gaining molecular descriptors of compounds from software such as Dragon (Talete S.R.L, 2013) 
and VCCLabs (Tetko et al., 2005).   
There are thousands of potential molecular descriptors, including physicochemical, topological, 
electro-topological and energy parameters that could be used for QSRR calculations, leading to 
difficulties in deciding which to use. Physicochemical descriptors are generally strongly correlated to 
retention, and are therefore more widely used as a starting point for retention time prediction, however 
they are often not experimentally available and predicted values differ widely (Livingstone, 2003). To 
eliminate a priori knowledge from impacting on the prediction capabilities, and to derive the most 
relevant molecular descriptors, various methods can be used, such as stepwise correlation and genetic 
algorithms (Pourbasheer et al., 2015; Shen et al., 2003). Barron et al have also looked into the impact 
of various descriptors in the calculation of a retention time prediction model, with logP and pKa 
expectedly the most important (Barron et al., 2009; Miller et al., 2013).  It is imperative to note that 
the descriptors found to be of the greatest influence will differ depending on the LC system, gradient, 
additives and column.  Therefore, all descriptors will have to be rechecked if any aspect of the LC 
methodology changes.  
In order to avoid these issues, and to have a simpler, albeit less precise, tR predictor, a single descriptor 
can be used together with retention time, such as logKOW, which is known to represent a  reasonably 
good model for retention of neutral compounds on C18 columns with methanol as the organic modifier 
(Kern et al., 2009). Kow itself is a complex property, which expresses the hydrophobicity of neutral 
organic chemicals as their octan-1-ol/water partition coefficient. Ideally, for a reversed-phase liquid 
chromatography system the capacity ratio (log k’) of a compound obtained with a mobile phase 
consisting of pure water would best represent its hydrophobicity (Braumann, 1986). It has been shown 
that the relationship between log k’ and the volume fraction (φ) of the organic fraction gives the 
following equation, which can then be used as an indicator of Kow (De Voogt et al., 2012): 
log k’ = log k0 -bφ 
The slope -b represents the decrease in retention of the solute as a function of increasing organic 
modifier content. This slope depends on the chromatographic conditions (type of column, chemical 
composition, temperature, back pressure, etc.), and it can be postulated that a log k’ value obtained 
on a C18 column with a methanol-water mobile phase could be used at single value of φ (de Voogt et 
al., 2012). The robustness of the relationship between C18 retention time and logKow is shown in the 
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use of C18 columns in the Organisation for Economic Co-operation and Development (OECD) 
Guidelines for the Testing of Chemicals for the estimation of LogKow(OECD, 2004).  
This simplistic approach linearly correlates the retention time and logKOW of the studied compounds, 
giving an equation that can be used to predict further compounds. The big advantage of using this 
approach is its simplicity to implement and that fewer compounds are needed for prediction. With 
the less precision associated with this method of retention time prediction, it is generally applied as an 
additional rather than stand-alone means of detection/identification. Nevertheless, its use as a means 
of retention time prediction is not necessarily worse than incorporating multiple descriptors.  
While research on tR prediction and the detection/identification of emerging contaminants in the 
aquatic environment has been made separately, the unification of these two topics is of great current 
and future interest. Currently, tR prediction is based on a laboratory’s own chromatographic system 
and is therefore not easily transferable. However, recently, Barron and McEneff have shown that 
ANNs can be used to successfully predict the retention times of more than 1000 structurally and 
chemically diverse molecules in a range of complex matrices (Barron and McEneff, 2016), while 
PredRet has been introduced as a community-sharing approach for tR prediction, which uses a direct 
mapping approach for the prediction of tR across different chromatographic systems  (Stanstrup et al., 
2015). This shows that the future is looking bright for this area and with computational and 
instrumental advances, this research will continue to flourish.  
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3.2 Scientific Articles 
This chapter includes two articles, “Critical evaluation of a simple retention time predictor based on LogKow as 
a complementary tool in the identification of emerging contaminants in water” (Scientific Article 5) and “Suspect 
Screening of Large Numbers of Emerging Contaminants in Environmental Waters using Artificial Neural Networks 
for Chromatographic Retention Time Prediction and High Resolution Mass Spectrometry Data Analysis” (Scientific 
Article 6). The first concerns the development and evaluation of a very simple retention time 
prediction method, based solely on logKow and retention time, while the latter incorporated a more 
complex artificial neural network (ANN) approach. 
Scientific Article 5 was envisaged as an example of how a research group could initially start 
investigating and using retention time prediction. It was not proposed to be a perfect predictor, rather 
a simple approach that any and every laboratory could use. All that is needed for this approach is 
reference standards and a reliable LC instrument.  Nearly 600 standards, including pesticides, human 
and veterinary pharmaceuticals, drugs of abuse and mycotoxins were used for this work, however, 
similar works have incorporated as little as 88 (Nurmi et al., 2012) and 92 (Kern et al., 2009) standards, 
with similar results. These standards were injected in an UHPLC-QTOF instrument and the logKOW 
values were searched on the freeware ALOGPS 2.1 (Tetko et al., 2005).  Three subsets were made to 
test the predictor: all compounds (n=595), pesticides (n=350) and non-pesticides (n=245), with the 
first two showing the greatest promise and were later used to test real samples. A comparison was also 
made with mass window to see whether reducing the mass window also reduces the number of peaks 
in the extracted ion chromatogram.  
Scientific Article 6 used a slightly smaller subset (544) of the standards of Scientific Article 5 and 
an alternative, QSRR method; employing artificial neural networks (ANNs). To test network 
performance, training (n=344), verification (n=100) and blind (n=100) sets were used. For all datasets 
(n=544), 85% of all compounds could be predicted within two minutes of the measured retention 
time, while this increased to 90% for the verification set (n=344) and 95% for the blind set (n=100). 
The accuracy for the blind set was very good, leading to further blind testing with metabolites and 
compounds for which no reference standards were available, which led to the tentative identification 
of eleven compounds. As with Scientific Article 5, an investigation was made into the number of 
peaks able to be disregarded after incorporating the retention time window.  
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The results of the two studies in this section have been published: 
Critical evaluation of a simple retention time predictor based on LogKow as a complementary tool in 
the identification of emerging contaminants in water  R. Bade, L. Bijlsma, J. V. Sancho, F. Hernández, 
Talanta 139, 2015, 143-149. 
Suspect screening of large numbers of emerging contaminants in environmental waters using artificial 
neural networks for chromatographic retention time prediction and high resolution mass spectrometry 
data analysis R. Bade, L. Bijlsma, T. H. Miller, L. P. Barron, J. V. Sancho, F. Hernández, Science of 
the Total Environment 538, 2015, 934-941. 
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3.2.1 Scientific Article 5 
CRITICAL EVALUATION OF A SIMPLE RETENTION 
TIME PREDICTOR BASED ON LOGKOW AS A 
COMPLEMENTARY TOOL IN THE IDENTIFICATION 
OF EMERGING CONTAMINANTS IN WATER  
 
Richard Bade, Lubertus Bijlsma, Juan V. Sancho, Felix Hernández 
 
 
Talanta (2015) 139: 143-149  
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Abstract 
There has been great interest in environmental analytical chemistry in developing screening methods based on 
liquid chromatography-high resolution mass spectrometry (LC-HRMS) for emerging contaminants. Using 
HRMS, compound identification relies on the high mass resolving power and mass accuracy attainable by these 
analyzers. When dealing with wide-scope screening, retention time prediction can be a complementary tool for 
the identification of compounds, and can also reduce tedious data processing when several peaks appear in the 
extracted ion chromatograms. There are many in silico, Quantitative Structure-Retention Relationship methods 
available for the prediction of retention time for LC. However, most of these methods use commercial software 
to predict retention time based on various molecular descriptors. This paper explores the applicability and 
makes a critical discussion on a far simpler and cheaper approach to predict retention times by using LogKow. 
The predictor was based on a database of 595 compounds, their respective LogKow values and a 
chromatographic run time of 18 minutes. Approximately 95% of the compounds were found within 4.0 minutes 
of their actual retention times, and 70% within 2.0 minutes. A predictor based purely on pesticides was also 
made, enabling 80% of these compounds to be found within 2.0 minutes of their actual retention times. To 
demonstrate the utility of the predictors, they were successfully used as an additional tool in the identification 
of 30 commonly found emerging contaminants in water. Furthermore, a comparison was made by using 
different mass extraction windows to minimize the number of false positives obtained.  
 
Keywords: Retention Time Prediction, Liquid Chromatography, Time-of-flight mass spectrometry, Water, 
Emerging Contaminants, Pesticides 
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1. Introduction 
Many environmental chemists have focused their research on “emerging contaminants” in water, which 
encompass a wide-range of compounds including drugs for health and personal care, flame retardants, illicit 
drugs and all kinds of transformation or by-products [1]. These compounds can have some detrimental effects 
on the environment [2] and it is therefore important to perform frequent monitoring on these compounds in 
order to know their concentrations and fate in water. 
High resolution mass spectrometry (HRMS), using analyzers such as Quadrupole Time-of-Flight (QTOF)-MS 
and Linear Ion Trap (LTQ) Orbitrap MS, has revolutionized screening of emerging contaminants [3], [4], 
[5] and [6]. It offers the possibility to investigate the presence of theoretically unlimited compounds once the 
analysis has been performed and data acquired, and considering their compatibility with the requirements of 
the chromatographic separation and MS ionization. Due to their high resolution, both hybrid instruments 
provide data with high mass accuracy and frequently allow tentative identification of compounds even without 
having reference standards [7] and [8]. 
Identification of the compounds detected is obviously facilitated when reference standards are available, as 
relevant information on retention time and fragment ions is included. However, it is also possible to perform 
screening without the need for reference standards, simply on the basis of a large database, where empirical 
formulae (i.e. exact mass) are the only information required. Post-target screening without standards (i.e. 
suspect) is becoming more and more common. Here, the exact mass of the compounds of interest are gathered, 
then searched and extracted from HRMS spectra, using a narrow mass window (20 mDa), in order to find 
potential positives [5], [7], [9], [10] and [11]. The increased resolving power of modern TOF and Orbitrap allows 
an even narrower mass window, reducing matrix interferences, leading to a cleaner chromatogram. Ideally, 
there would be a single peak in the chromatogram, coming from the suspect. However, in more complex 
environmental matrices, it is likely that there is more than one peak in the eXtracted Ion Chromatogram (XIC), 
arising from various isobaric or isomeric compounds, complicating the identification of the compound of 
interest. A variety of techniques can be used to aid in the detection/identification process, such as mass window 
filtering, mass defect analysis or isotopic pattern fit. 
With the high quality data obtained by HRMS, compound separation by liquid chromatography (LC) is 
sometimes overlooked, while it is also an important parameter [12]. Retention time prediction does take this 
LC aspect into account in the identification process and can therefore be a useful technique when performing 
a wide-scope screening. Reliable information on retention time can focus the identification process solely on 
those peaks that are in agreement with the predicted retention time, ignoring other false positives that may 
appear in complex matrix samples which do not correspond to the candidate under research. 
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There are several in silico, Quantitative Structure–Retention Relationship (QSRR) methods available for the 
prediction of LC retention times, used in a variety of research [13] and [14]. The principal aim of QSRR is to 
predict retention data from the molecular structure, using descriptors such as molecular mass, polar surface 
area, log P, molar polarisability and molar volume. Linear Solvation Energy Relationship (LSER) has been also 
proposed for retention time prediction. LSERs analyze any free energy related property by five fundamental 
solute parameters: the hydrogen bond acidity and hydrogen bond basicity, excess molar refraction, 
dipolarity/polarizability and the logarithm of the gas–hexadecane partition coefficient or the characteristic 
McGowan volume [14]. The major problem for LSERs is that all terms are needed and any missing value can 
be problematic [15]. While work with LSERs in this area is ongoing, Artificial Neural Networks (ANNs), a 
predictive computing technique, has shown itself as a promising retention time predictor [16]. 
In the presented work, a free and much simpler approach was tested using only LogKow for retention time 
prediction. By utilizing this predictor, we show a way to reduce the amount of time spent poring through 
chromatograms, with many peaks in the chromatogram able to be disregarded. A critical discussion is made on 
this predictor, showing the advantages and drawbacks. The usefulness of mass window filtering as a 
complementary tool to eliminate peaks not arising from the compound of interest is also evaluated in order to 
facilitate the identification process of emerging contaminants in water in wide-scope screening procedures. 
2. Experimental 
2.1. Reagents and chemicals 
A total of 595 reference standards were used in the development of the retention time predictor. This combined 
retention times of 311 and 284 individual standards and their retention times from an in-house database and a 
Waters database (Waters, Milford, MA, USA), respectively. See Table S1 for a list of all compounds used, 
retention time and LogKow. There were some duplicates between the two sets of standards, which were used 
to ensure the consistency in retention time (see Section 3.1 for more information). 
Details relating to the standards can be found elsewhere [17]. Retention times were obtained by injecting mixed 
working standard solutions (25 μg/L or 50 μg/L, diluted from mixed standard solutions in methanol or 
acetonitrile with water). 
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2.2. Water samples 
Four influent wastewater samples (24 h composite samples) were collected from different wastewater treatment 
plants (WWTPs) of Spain and Germany, in March, 2013. In addition, grab samples were taken from 11 surface 
waters from several points located in Spain and Colombia between November, 2010 and May, 2013. All these 
samples had previously been used in different studies performed at our lab using UHPLC–QTOF MS for their 
analysis. Sample treatment was based on solid phase extraction using polymeric Oasis HLB cartridges, which 
are able to retain organic compounds within a wide range of polarity. 
2.3. UHPLC–QTOF MS 
A Waters Acquity UPLC system (Waters, Milford, MA, USA) was interfaced to a hybrid quadrupole-orthogonal 
acceleration-TOF mass spectrometer (XEVO G2 QTOF, Waters Micromass, Manchester, UK), using a ESI 
(Z-Spray) interface operating in positive ion mode. The chromatographic separation was performed using an 
Acquity UPLC BEH C18 100× 2.1  mm2, 1.7 µm particle size column (Waters) at a flow rate of 300 µl/min. 
The mobile phases used were A = H2O and B = MeOH, both with 0.01% formic acid. The initial percentage 
of B was 10%, which was linearly increased to 90% in 14 min, followed by a 2 min isocratic period and, then, 
returned to initial conditions during 2 min. The total run time was 18 min. Nitrogen was used as drying gas and 
nebulizing gas. TOF-MS resolution was approximately 20.000 at full width half maximum at m/z 556. MS data 
were acquired over an m/z range of 50–1000, at 0.4 s scan time. A capillary voltage of 0.7 kV and cone voltage 
of 20 V were used. Collision gas was argon 99.995% (Praxair, Valencia, Spain). The desolvation temperature 
was set to 600 °C, and the source temperature to 135 °C. The column temperature was set to 40 °C. MS data 
was acquired in MSE mode, selecting a collision energy of 4 eV for low energy (LE) and a ramp of 15–40 eV 
for high energy (HE) [5] and [18]. 
2.4. Data processing 
MS data processing was performed manually on MassLynx v 4.1 (Waters Corporation), looking at the raw data 
in chromatogram view, initially with a mass extraction window of 20 mDa using the retention time predictor 
developed in this study. Later, different mass extraction windows (50 mDa, 10 mDa and 5 mDa) were also 
evaluated (see Section 3.3). All peaks above an intensity of 3000 were counted. 
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3. Results and discussion 
3.1. Development of retention time predictor 
A dataset of 595 compounds was used to initially prepare the retention time predictor. The retention times for 
the compounds from the “Waters” database were obtained using the same column but a slightly different 
gradient from the one described in this paper, however the 94 common compounds between the datasets were 
compared using a linear correlation on Excel (R2=0.9279). These compounds cover the LogKow range of −1 
to 8, therefore comprising the great majority of the LogKow range for the compounds under investigation. 
The equation from this correlation was used to convert all the Waters retention times to fit our in-house 
retention times (Fig. S1). The LogKow of each of these compounds was estimated using the freely available 
ALOGPS 2.1 software (VCCLAB, 2005 [19]). A linear correlation was again made to compare the LogKow 
and retention time (Fig. 1). 
 
 
Fig. 1: Correlation between retention time and LogKow for all compounds, with 95% confidence interval 
In a similar study, Nurmi et al. [11] investigated the relationship between LogKow and retention time to help 
reduce the number of candidates in a post-target screening method, using calculated LogKow values. A linear 
regression for 88 compounds was made, giving an R2 of 0.63, and a retention time window of 5 min over the 
chromatographic run of 16 min was used. Likening this work to the current, in spite of having a far larger 
dataset, the correlation coefficient does not differ markedly. Kern et al. [9] exploited this relationship in the 
analysis of transformation products (TPs) of organic contaminants. Specific compounds were used for the 
training set, with only standards that were estimated to be predominately neutral at an elution pH of 3 deemed 
acceptable, to reduce the number of false negatives for both neutral and ionic TPs as the latter are less retained 
than their corresponding neutral species. Nevertheless, the correlation for the 92 reference standards was very 
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good, with an R2 of 0.87. However, the current work is more wide-reaching, containing nearly 600 compounds 
of differing classes and physicochemical properties and is therefore expected to have a worse correlation. 
In order to improve this correlation, the 595 compounds were subdivided, not based on physicochemical 
parameters, solely on class, into two smaller subsets: pesticides and non-pesticides. The dataset initially 
contained pesticides, drugs of abuse, antibiotics, pharmaceuticals, veterinary drugs and mycotoxins. The vast 
majority of the compounds were pesticides (345 compounds), which made up one subgroup, while all the other 
compounds made up the other (250 compounds) (Figs. S2 and S3). 
The “pesticides only” grouping did make for a scarcely better correlation (R2=0.6947), while the “non-
pesticides” had a slightly worse correlation (R2=0.6518), compared with the overall correlation (R2=0.6704). 
Although these correlations have rather large variability (especially for “non-pesticides”), it was thought to 
compare the predicted retention time (made from the equations, where “x” is the LogKow, in each of the 
figures) with the actual retention time for each compound. It was expected that there would be some deviation 
between the experimental and predicted retention times because it is difficult for the algorithm used by the 
LogKow predictor (ALOGPS 2.1) to cope with complex molecules, leading to some inaccurate LogKow values. 
Table 1 shows the differences between the predicted and actual retention times for the three cases. 
Table 1: Comparisons between predicted and actual retention times 
RT window 
(± minutes) 
Prediction for all 
compounds (% of all 
compounds found within 
RT window) 
Prediction for subsets (% of all 
compounds found within RT window) 
 All (n=595) Non-Pesticides 
(n=250) 
Pesticides 
(n=345) 
0.5 18 15 30 
1 37 34 53 
1.5 55 49 68 
2 68 65 79 
2.5 81 73 86 
3 88 83 90 
3.5 92 89 93 
4 96 90 95 
4.5 97 93 96 
5 98 95 97 
 
In spite of the variability of the data, the retention times of approximately 95% of the compounds were found 
within 4 min of their actual retention time. In the case of the subsets, 79% of the pesticides can be found within 
2 min of their actual retention time, which is 14% better than for non-pesticides. 
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From these results, it was thought to use ±2 min window (±11% of the chromatographic run) for use in real 
samples. The “pesticides only” predictor was selected for pesticides and “all compounds” for the other 
compounds, wherein approximately 80% and 70% of the compounds will be respectively found. 
This predictor was designed specifically for this precise chromatographic system, gradient and method. If 
applied to other separation systems, the correlation between LogKow and retention time for these particular 
compounds may differ widely. However, it is easy to adapt this retention time predictor to other systems using 
the methodology outlined in Section 3.1. Some groups have introduced a retention time index [6] to cope with 
this limitation. In order for a more complete predictor, training/validation sets comprising different 
compounds could be incorporated. Furthermore, the evaluation of different chromatographic conditions such 
as different columns and gradients could be carried out. 
3.2. Impact of experimental and predicted LogKow 
In an attempt to gain narrower retention time windows, a study was made on the impact of experimental versus 
predicted LogKow values. A study was made comparing the accuracy of predictive software, wherein ALOGPS 
2.1 was shown to be quite accurate and only differed from the measured values by up to 0.5 log units [15]. 
Software such as ALOGPS 2.1 is prone to systematic errors, especially for complex molecular structures, 
because correction factors for certain structural configurations might be missing [9]. To test the difference 
between experimental and predicted LogKow for the retention time predictors, “experimental” LogKow values 
were found for 280 of the pesticides in the Pesticide Manual [20] and for 52 drugs of abuse, antibiotics, 
veterinary drugs and pharmaceuticals on DrugBank [21]. 
Fig. 2 shows the difference between the experimental and predicted values for the 332 compounds at intervals 
of 0.1 log units. As seen in the figure, fewer than 2% (corresponding to 5 of the 332 compounds) had the same 
experimental and predicted LogKow. Cumulatively, 77% of the compounds had an absolute difference within 
1 log unit; however 10% still had a difference greater than 2 log units. 
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Fig. 2: Difference between experimental and predicted LogKow values and cumulative percentage of compounds within each differential interval. 
These findings alone show that while predicted values give a good estimate, the fact that some compounds had 
a difference more than two Log values shows that experimentally derived values are preferable for any latter 
retention time predictions. The 36 compounds whose values of experimental and predicted LogKow differed 
by greater than 2 log units were removed from the overall compound list to see the impact on the correlation 
coefficient. It was found that the R2 did not differ, with only a change from 0.6704 to 0.6737 following their 
removal (Fig. S4). 
The difference between experimental and predicted LogKow values had such little impact on the correlation 
between LogKow and retention time, which gives credence to the use of predicted values. Furthermore, 
experimental values are not possible for all compounds and predicted values open up the possibility to work 
with new emerging contaminants and TPs, which is of particular relevance when investigating organic 
micropollutants in waters. 
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3.3. Application of the retention time predictor to real water samples 
Fifteen influent wastewater and surface water samples were selected, representing different types of water 
sources, to test the retention time predictors. As stated previously, two predictors were used: one for pesticides 
only and one for non-pesticides. A set of 30 compounds were selected, based on their prevalence in 
environmental water samples [22], [23] and [24] and their retention times were predicted using the 
aforementioned equations with the predicted LogKow of each of the compounds (Table S2). 
A retention time window of ±2 min (from the predicted value) was given for each compound, and they were 
searched with a mass window of 20 mDa. All peaks in the narrow window (nw)-XIC for each compound were 
counted manually (above intensity of 3000), while all peaks outside the prediction window were disregarded. 
All of the 30 compounds were detected in the water samples. Of these, 20 were found in the ±2 min retention 
time window (Fig. 3). Remarkably, eight of the 20 compounds had only one peak inside the retention time 
window. In addition, the percentage of peaks outside the retention time window of ±2 min (and therefore not 
pertaining to the compound of interest) was found to be 35%, meaning that over one-third of the peaks in the 
XICs could be disregarded through retention time prediction. This retention time prediction shows a noticeable 
reduction in time spent processing data for potential positive samples. 
 
 
Fig. 3: All 20 compounds found within the ± 2 minute retention time window and their associated peak data. The compounds on the left are 
all pesticides while those on the right are pharmaceuticals. The dark grey lines represent the average number of peaks found in the XIC of each 
compound and the light grey lines represent the average number of peaks inside the retention time window.  
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3.4. Complementary use of mass chromatogram extraction window 
Using a mass window of 20 mDa, four compounds only had one peak in the XIC (Fig. 3). To complement the 
information and applicability of the retention time predictor, a comparison was made with three additional 
mass chromatogram extraction windows (50 mDa, 10 mDa and 5 mDa). An extra window of 20 mDa was used 
as a reference for these tests. 
The 10 extra compounds, whose predicted retention time fell outside of the ±2 min window, were also included 
in this test (see Table S2). The results of this comparison are shown in Table 2. As expected, the number of 
peaks observable in the XIC decreases as the extraction window decreases, from 119 (50 mDa) down to 62 
peaks (5 mDa). However, it is of note that even at the 5 mDa extraction window and within the retention time 
window, there were still unknown peaks not just pertaining to the compound of interest. In these situations, 
retention time prediction is very helpful in the reduction of false positive findings. 
 
Fig. 4 shows the influence of mass windows in XICs and the predicted retention time window for two 
compounds detected in surface water (benzoylecgonine, BE) and influent wastewater (trimethoprim). In the 
case of BE (major metabolite from cocaine), using a 50 mDa XIC, several isobaric compounds are also seen; 
however, by decreasing the mass extraction window, all of these peaks disappear, leaving just the peak of BE 
at 4.53 min and a small spike at 6.5 min. Although BE was able to be identified solely with a nw-XIC, the 
retention time fell just outside the predicted window (2.48±2 min). As stated above, the use of ±2 min retention 
time window led to a 70% success rate in the predictions for the “all compounds” group, where BE is included. 
Using a slightly wider window such as ±2.5 min to get a success rate of 80%, similar to the pesticides group 
(see Table 1) would have led to BE being inside the prediction window. In any case, it seems that improvements 
are needed in the retention time prediction in order for it to be more useful in the identification process. 
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Table 2: Number of peaks found in the chromatograms (XICs) of 50mDa, 20mDa, 10mDa and 5mDa and inside the predicted retention 
time window. The lower compounds are those whose empirical retention times fall outside the ±2minute predicted retention time window 
a : not found in this mass extraction window 
Compound 50mDa 20mDa 10mDa 5mDa 
Peaks Inside 
RTW 
Peaks Inside 
RTW 
Peaks Inside 
RTW 
Peaks Inside 
RTW 
2-hydroxyatrazine 7 3 4 2 3 2 3 2 
2-
hydroxyterbuthylazine 
5 3 3 2 2 2 1 1 
Atrazine 4 2 3 2 2 1 2 1 
Desethylterbuthylazine 3 2 3 2 2 1 2 1 
Diuron 2 1 1 1 1 1 1 1 
Simazine 3 2 3 2 3 2 3 2 
Terbuthylazine 2 1 2 2 1 1 1 1 
Terbutryn 4 2 1 1 1 1 a a 
4-Aminoantipyrine 4 3 4 4 3 2 3 2 
Bezafibrate 2 1 2 1 2 1 2 1 
Carbamazepine 4 3 5 4 2 2 2 2 
Diclofenac 2 1 2 2 2 1 1 1 
Enrofloxacin 1 1 1 1 1 1 1 1 
Irbesartan 6 3 5 3 3 2 3 2 
Lincomycin 3 2 2 1 2 1 3 2 
Ofloxacin 2 1 1 1 1 0 1 1 
Oxazepam 4 3 3 2 3 2 2 2 
Sulfamethoxazole 3 1 2 1 2 1 1 1 
Trimethoprim 7 3 6 3 6 3 4 2 
Valsartan 4 2 2 2 1 1 1 1 
         
Total peaks 76 43 57 37 45 29 39 29 
         
Carbendazim 4  3  2  2  
Desethylterbumeton 7  4  3  3  
Imazalil 4  2  2  2  
Codeine 5  5  3  2  
Paracetamol 4  4  4  4  
Temazepam 7  4  3  3  
Venlafaxine 5  5  3  3  
Benzoylecgonine 3  3  2  2  
Cocaine 3  2  2  2  
Methamphetamine 5  3  3  2  
         
Total peaks 119  90  70  62  S
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Fig. 4: TOP: XIC of Benzoylecgonine (m/z 290.139, 4.53 min) at 50mDa, 20mDa, 10mDa and 5mDa, with related predicted retention 
time window (2.48min ± 2 minutes) in surface water. BOTTOM: Trimethoprim (m/z 291.146, 3.64 min) and related retention time 
prediction window (Predicted retention time 5.61 min ± 2 minute window) at XICs of 50mDa, 20mDa, 10mDa and 5mD in influent 
wastewater. XICs at 10mDa, 20mDa and 50mDa all have been 5 times magnified (from 3 – 16 min) to highlight other peaks. 
In the case of the antibiotic trimethoprim, the peak is easily seen at 5 mDa (3.66 min); however at a larger mass 
extraction window, two isobaric compounds are observed at a much higher intensity (2.5–3.0 min). With the 
retention time window (5.61±2 min), these peaks, as well as the one at 7.6 min are removed, leaving just the 
two peaks at 3.66 and 4.6 min. The first one corresponded to trimethoprim, while the second was an unknown. 
This example shows the true utility of retention time prediction, especially in alliance with HRMS. While mass 
extraction windows can be narrowed to remove some interfering peaks, even at a 5 mDa mass window, pseudo-
isobaric interferences remain. By incorporating retention time prediction, some of these false positive peaks 
can be removed. 
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4. Conclusions 
A critical evaluation has been made on the applicability of retention time prediction based on LogKow to help 
in identification of suspect compounds in screening procedures. Two predictors were used; one based on 
pesticides only, and one for all other compounds (mainly licit and illicit drugs). Both were tested on 30 emerging 
contaminants commonly found in environmental and wastewater samples by retrospective analysis with 
QTOF-MS. In addition to help identify the compound of interest, the retention time predictors also allowed 
over one-third of isobaric chromatographic peaks to be disregarded for further analysis as they were outside 
the retention time window, thereby enabling the reduction of tedious data processing. This is relevant when 
applying wide-scope screening for a large number of compounds (e.g. emerging contaminants and pesticides) 
or when investigating the presence transformation products, where many of the required reference standards 
are not available at the laboratory. In addition to the retention time prediction, the impact of extracted mass 
windows was investigated as a complementary tool for the screening. A smaller mass extraction window also 
removed unwanted peaks from the chromatogram. However, in some cases, even at a narrow mass extraction 
window of 5 mDa, some isobaric peaks still appeared. 
The combination of this simple retention time predictor with extracted mass windows facilitated the removal 
of many false positives. In this work, 70–80% of compounds studied were able to be found in a ±2 min window, 
but a ±5 min window was needed for ≥98% confidence. Our present research is focused on alternate and more 
sophisticated retention time predictors in order to improve the precision. This would allow the use of narrower 
time windows, thereby simplifying data processing due to fewer peaks needing to be investigated in the 
chromatograms. 
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Supporting Information 
 
The table “All 595 Compounds used in retention time predictor, empirical retention time and predicted Log 
Kow” (Table S1), is too large for this thesis, but are available in the online edition of this article: 
doi:10.1016/j.talanta.2015.02.055. However the other supporting information tables and figures are included 
here. 
 
Table S2: Predicted retention time, empirical retention time and parent ion ([M+H]+) m/z for all 30 compounds. Those in 
bold fall outside the retention time window of +/-2 minutes used for the analysis but used in Section 3.3 
 
Type of Compound Compound RT (pred) RT (emp) [M+H]+  
Pesticides 2-hydroxyatrazine 2.66 2.79 198.1355 
2-hydroxyterbuthylazine 3.95 5.76 212.1511 
Atrazine 9.93 9.34 216.1016 
Carbendazine 7.47 3.42 192.0773 
Desethylterbuthylazine 8.47 7.91 202.0859 
Desethylterbumeton 8.95 5.72 198.1355 
Diuron 9.11 8.78 233.0248 
Imazalil 11.20 8.19 297.0561 
Simazine 8.71 8.14 202.0859 
Terbuthylazine 9.99 10.51 230.1172 
Terbutryn 10.72 9.91 242.1439 
Pharmaceuticals/ 
Antibiotics 
 
4-Aminoantipyrine 4.38 3.52 204.1137 
Bezafibrate 10.98 10.86 362.1159 
Carbamazepine 7.93 7.36 237.1028 
Codeine 6.45 2.75 300.1600 
Diclofenac 10.38 12.17 296.0245 
Enrofloxacin 5.56 4.58 360.1723 
Irbesartan 12.60 10.36 429.2403 
Lincomycin 4.93 3.56 407.2216 
Ofloxacin 4.19 4.08 362.1516 
Oxazepam 9.68 9.77 287.0587 
Paracetamol 4.90 2.44 152.0711 
Sulfamethoxazole 5.22 3.91 254.0599 
Temazepam 7.77 10.09 301.0744 
Trimethoprim 5.61 3.64 291.1457 
Valsartan 10.06 10.56 436.2349 
Venlafaxine 9.50 7.23 278.2120 
Drugs of Abuse Benzoylecgonine 2.48 4.53 290.1392 
Cocaine 7.80 4.66 304.1549 
Methamphetamine 7.88 3.05 150.1282 
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Figure S1: Correlation of in-house and Waters data 
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Figure S2: Correlation between retention time and LogKow for all non-pesticides (250 compounds) with 95% confidence interval 
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3.2.2 Scientific Article 6 
SUSPECT SCREENING OF LARGE NUMBERS OF 
EMERGING CONTAMINANTS IN ENVIRONMENTAL 
WATERS USING ARTIFICIAL NEURAL NETWORKS 
FOR CHROMATOGRAPHIC RETENTION TIME 
PREDICTION AND HIGH RESOLUTION MASS 
SPECTROMETRY DATA ANALYSIS 
 
Richard Bade, Lubertus Bijlsma, Thomas H. Miller, Leon P. Barron, Juan V. Sancho, 
Felix Hernández 
 
 
Science of the Total Environment (2015) 538: 934-941 
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Abstract 
The recent development of broad-scope high resolution mass spectrometry (HRMS) screening methods has 
resulted in a much improved capability for new compound identification in environmental samples. However, 
positive identifications at the ng/L concentration level rely on analytical reference standards for 
chromatographic retention time (tR) and mass spectral comparisons. Chromatographic tR prediction can play a 
role in increasing confidence in suspect screening efforts for new compounds in the environment, especially 
when standards are not available, but reliable methods are lacking. The current work focuses on the 
development of artificial neural networks (ANNs) for tR prediction in gradient reversed-phase liquid 
chromatography and applied along with HRMS data to suspect screening of wastewater and environmental 
surface water samples. Based on a compound tR dataset of > 500 compounds, an optimized 4-layer back-
propagation multi-layer perceptron model enabled predictions for 85% of all compounds to within 2 min of 
their measured tR for training (n = 344) and verification (n = 100) datasets. To evaluate the ANN ability for 
generalization to new data, the model was further tested using 100 randomly selected compounds and revealed 
95% prediction accuracy within the 2-minute elution interval. Given the increasing concern on the presence of 
drug metabolites and other transformation products (TPs) in the aquatic environment, the model was applied 
along with HRMS data for preliminary identification of pharmaceutically-related compounds in real samples. 
Examples of compounds where reference standards were subsequently acquired and later confirmed are also 
presented. To our knowledge, this work presents for the first time, the successful application of an accurate 
retention time predictor and HRMS data-mining using the largest number of compounds to preliminarily 
identify new or emerging contaminants in wastewater and surface waters. 
Keywords: Retention time prediction; Artificial neural networks; Time-of-flight high resolution mass 
spectrometry; Screening of emerging contaminants 
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1. Introduction 
The number of emerging contaminants in the aquatic environment is increasing, due to urbanization and 
subsequent societal and industrial needs (Pal et al., 2014). The development of liquid chromatography–high 
resolution mass spectrometry (LC–HRMS) technologies has revolutionized the analysis of emerging 
contaminants in environmental waters, and especially for screening of large numbers of compounds (Agüera 
et al., 2013, Gómez et al., 2010, Hernández et al., 2011 and Hogenboom et al., 2009). HRMS instruments allow 
the recording of full-scan spectra with high mass accuracy and resolution, thus making it possible to search for 
any given compound based on its exact mass. 
There has been much interest in improving the confidence in the identification of small molecules with HRMS; 
from potential positives through to detection and finally confirmation (Hernández et al., 2015a and Schymanski 
et al., 2014). The main distinguishing factor between these levels is the (non-) availability of reference standards. 
Suspect screening refers to compounds tentatively identified based solely on HRMS data and comparable 
spectral libraries. Confirmation requires reference standards. An additional tool to increase the confidence in 
the tentative identification of compounds for which standards are unavailable is reliable and accurate tR 
prediction. This is of particular relevance in the case of degradation/transformation products (TPs), which can 
reach the aquatic environment in high concentrations, but commonly for which reference standards are less 
accessible. Chemical risk assessment is therefore significantly challenging for such compounds. 
Prediction of tR plays an important role in the qualitative identification of emerging contaminants. Many 
different approaches to tR prediction exist and range from the simple ( Kern et al., 2009 and Nurmi et al., 2012) 
to the complex ( Goryński et al., 2013, Ji et al., 2009, Kaliszan et al., 2003 and Ukić et al., 2014a). For example, 
logKow models can be derived using freely accessible data from chemical databases such as ChemSpider and 
PubChem, as well as freeware prediction sources such as VCCLABS. Its use in tR prediction is extremely simple 
to implement. It is frequently used in environmental studies for the description of the fate of various pollutants 
and as a simple tR predictor for TPs (Kern et al., 2009) and emerging contaminants (Bade et al., 2015 and Nurmi 
et al., 2012). Alongside simple algorithms, other and more complex in silico approaches now exist which are 
based on quantitative structure–retention relationship (QSRR) modeling, including artificial neural networks, 
support vector machines and random forests ( Giaginis and Tsantili-Kakoulidou, 2012 and Héberger, 2007). 
The principal aim of QSRR is to predict retention data from the molecular structure and its physicochemical 
properties, using a range of input descriptors and measured tR data. One QSRR method gaining recent attention 
for broad screening using high resolution techniques is the use of artificial neural networks (ANNs), a predictive 
computing technique that has shown itself as a promising tR predictor with potentially higher accuracy than 
classical models ( Miller et al., 2013 and Ukić et al., 2014b). The design of ANNs were inspired by the human 
brain and differ from classical computer programs in that they generally employ non-linear learning techniques 
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using a set of case examples (i.e. a training dataset) ( Kaliszan et al., 2003). In the training phase, the ANN 
requires a range of suitable molecular descriptors as well as the true output value (in this case, measured tR) to 
use for comparison with predicted values. At the same time, a second dataset of case examples is often used 
for verification and to assess overall ANN predictive error. The true output values in the verification set are 
generally not employed for learning, but the number of training cycles can be stopped by the user or the 
software when the overall measured error across all cases is at its minimum. Therefore, ANN learning is 
generally an iterative process and once an acceptable number of training cycles is reached, the optimized ANN 
can be applied to predict the output where experimentally derived data are unavailable (Miller et al., 2013). In 
some cases, a third dataset can be used after the model has been finalized to ‘blind test’ the predictive power 
of the network. Its use is even more pertinent for analyses where large number of new analytes are expected to 
occur and with potentially high variance from sample to sample, such as in environmental and municipal water 
samples. Therefore, since information from the sample includes chromatographic tR as well as HRMS data, it 
makes this interpretation of suspect occurrence more accessible in the first instance. 
The aim of this work was to develop and evaluate ANN for predictions of unknown chromatographic tR in 
suspect screening of environmental waters. To the best of our knowledge, this method includes the largest 
range of physicochemically diverse compounds for this purpose (n = 544 in total) and includes both neutral 
and charged compounds eluted under gradient reversed-phase LC conditions. Lastly, this work aimed to 
improve upon a recent logKow-based tR prediction approach (Bade et al., 2015) using the ANNs as an 
alternative. This work, for the first time, presents the use of ANN for identification of additional suspect 
compounds (including metabolites and TPs) in wastewater and surface water samples both with and without 
reference standards. 
2. Experimental 
2.1. Reagents and chemicals 
A total of 544 analytical grade reference materials were used for preparation of model solutions at 25 μg/L or 
50 μg/L (diluted from mixed standard solutions in methanol or acetonitrile with water) for ANN modeling of 
tR. These included pesticides, drugs of abuse, human/veterinary pharmaceuticals and mycotoxins (See 
Supplementary Information (SI) Table S1 for all compounds used in this study). These covered a large range 
of molecular hydrophobicity (logKow − 3 to 9). Information relating to 595 standards was available (Bade et 
al., 2015), however after transforming the compounds using SMILES codes, some errors were observed, leading 
to incomplete data, and a further 42 were removed from the initial ANN method development (Section 3.1) to 
use in a subsequent blind test (Section 3.2). Further details relating to these compounds can be found elsewhere 
(Bade et al., 2015 and Hernández et al., 2015b). 
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2.2. Water samples for suspect identification 
A total of 44 composite (24-h) influent and effluent wastewater (IWW and EWW) samples and grab surface 
water (SW) samples were used to demonstrate the application of the developed ANN model. All these samples 
were previously used in different studies performed at our lab using the same analytical instrumentation for 
analysis (Hernández et al., 2015a). All measured tR data herein were generated using ultra-high pressure liquid 
chromatography coupled to quadrupole-time of flight mass spectrometry (UHPLC–QTOF-MS). 
2.3. UHPLC-QTOF MS 
A Waters Acquity UPLC system (Waters, Milford, MA, USA) was interfaced to a hybrid quadrupole-orthogonal 
acceleration-TOF mass spectrometer (XEVO G2 QTOF, Waters Micromass, Manchester, UK), using a 
electrospray ionization (ESI) Z-Spray interface operating in positive mode. The chromatographic separation 
was performed using an Acquity UPLC BEH C18 100 × 2.1 mm, 1.7 μm particle size column (Waters) at a 
flow rate of 300 μl/min. Gradient elution was performed using mobile phases of A = H2O and B = MeOH, 
both containing 0.01% HCOOH. The initial percentage of B was 10%, which was linearly increased to 90% in 
14 min, followed by a 2 min isocratic period and, then, returned to initial conditions during 2 min. The total 
run time was 18 min. Nitrogen was used as the drying gas and nebulizing gas. 
MS data were acquired over an m/z range of 50–1000. A capillary voltage of 0.7 kV and cone voltage of 20 V 
were used. Collision gas was argon 99.995% (Praxair, Valencia, Spain). The desolvation temperature was set to 
600 °C, and the source temperature to 135 °C. The column temperature was set to 40 °C. MS data was acquired 
in MSE mode, selecting a collision energy of 4 eV for low energy (LE) and a ramp of 15–40 eV for high energy 
(HE). The LE and HE functions settings were for both a scan time of 0.4 s (Hernández et al., 2011 and Ibáñez 
et al., 2013). 
Processing of MS data was made using ChromaLynx XS application manager (within MassLynx v 4.1; Waters 
Corporation). The following parameters were used: mass window 0.020 Da (for positive ID ≤ 0.010 Da), peak 
width at 5% height: 6 s, peak-to-peak baseline noise: 1000 and threshold absolute area 500. When manually 
searching the data for all peaks in an eXtracted Ion Chromatogram (XIC), a chromatographic peak was thought 
viable when above an intensity threshold of 3000 counts. 
2.4. Molecular description and neural network optimization procedures 
Compound logD data (for a mobile phase of pH = 3.2) were generated using Percepta PhysChem Profiler 
(ACD Laboratories, ON, Canada) and for all other descriptors, Parameter Client freeware was used (Virtual 
Computational Chemistry Laboratory, Munich, Germany). Canonical simplified molecular line entry system 
strings (SMILES) were created using ChemSpider freeware (Royal Society of Chemistry, UK) for 544 
compounds and from these 16 molecular descriptors (as ANN inputs) were generated including the number of 
double and triple bonds (nDB or nTB), the number of carbon and oxygen atoms (nC or nO), the number of 
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4–9 membered rings (nR04-nR09), unsaturation index (UI), hydrophilic factor (Hy), Moriguchi and Ghose–
Crippen logP (MlogP and AlogP respectively) as well as with software predicted logKow data (Tetko et al., 
2005). Prediction of tR (as the designated single output) via neural networks was performed using Trajan 
version 6.0 neural network simulator (Trajan Software Ltd., Lincolnshire, U.K.) and compared with 
experimentally determined tR via correlation graphs as well as assessment of residual errors. Table S1 has all 
compounds and their respective predicted and experimental tR and ANN subset. 
3. Results and discussion 
In a previous study, we developed a simple tR prediction model based on logKow of nearly 600 compounds, 
predicted using freeware (Bade et al., 2015). This resulted in approximately 70% of all compounds being 
predicted within 2 min of the measured tR, and 95% within 4 min. This technique was simple to implement and 
facilitated the removal of several false positives. However, when investigating unknowns and compounds for 
which reference standards were unavailable, it was concluded that a more robust, accurate and precise 
methodology was still needed. In this vein, ANNs were considered as an alternative. Recent work successfully 
used ANN for a similar purpose, albeit using a much smaller set of compounds of 86 and 166 compounds in 
either study and focused only on pharmaceuticals (Miller et al., 2013 and Munro et al., 2015). It is unlikely that 
this fully represents the breadth of alternative compound classes and chemistries potentially occurring 
simultaneously in environmental waters. However, these models successfully predicted tR for a range of blind 
test drug compounds in wastewater and urine to warrant further investigation here using a much larger case 
dataset. 
3.1. Prediction of tR using Artificial Neural Networks (ANNs) 
The molecular descriptors chosen were based on the previous work wherein more than 200 descriptors were 
evaluated (Miller et al., 2013). As the same type of reversed-phase column and LC system were used in both 
studies, the same descriptors were hoped to provide similar results. These descriptors were used again to also 
assess the possibility for transferring the model to another laboratory and to extend the prediction to a much 
larger set of chemically diverse compounds. Collinearity data for all molecular descriptors and retention time 
are given in the SI. Higher Pearson correlations were observed for hydrophobicity-based descriptors with 
retention time as was perhaps expected (maximum R = 0.823 with logKow). Similarly, these descriptors also 
showed some collinearity with each other (R ≤ 0.889) which prevented strong conclusions to be drawn 
regarding their relative importance to an ANN model. As molecular descriptors selected were from previous 
investigations, there is also the possibility that additional descriptors may have had more importance to 
retention prediction on this system. For example, retention on reversed-phase media is not only dependent on 
hydrophobic interactions, but also steric and shape effects. Large molecules may not interact with the stationary 
phase well and thus show reduced retention (Wilson et al., 2002). A simple Pearson correlation was examined 
for a selection of potentially relevant additional descriptors covering charge states, geometrical, topological and 
S
c
ie
n
ti
fi
c
 A
rt
ic
le
 6
 
Bade et al Science of the Total Environment 538 (2015) 934-941 
212  
physicochemical properties. Overall, most of these descriptors showed weak relationships < 0.5 except for the 
descriptor BTLA96 which showed a negative Pearson coefficient of − 0.649. 
Over 100,000 network architectures for each model type were initially investigated for their predictive ability 
across five different ANN model types including 3- and 4-layer multi-layer perceptrons (MLPs), generalized 
regression neural networks (GRNNs), radial basis functions (RBFs), linear neural networks and probabilistic 
neural networks (PNN). For training, 344 cases were used along with 100 cases for both verification and blind 
testing of network performance. Cases were randomly assigned at the beginning of each network test to prevent 
any bias from pre-selection. Upon selection of the ‘best’ model statistics (minimum/maximum values, 
interquartile ranges, standard deviations, medians and means) were generated to ensure that a fair representation 
of cases and descriptors were present in each dataset subset (see SI). The diversity of ANN types and 
architectures tested was balanced against the error generated. For network design and testing the omission of 
input descriptors was included as an option. One hundred of the best networks (software selected) were 
retained for further investigation which mainly comprised of MLPs, GRNNs and RBFs. Overall for this 
separation system, the best correlations of predicted versus experimentally measured tR were observed using 
MLPs in comparison to all other types and these correlations were in agreement with previous works despite 
different compounds being used for training, verification and blind testing ( Barron et al., 2009, Miller et al., 
2013 and Munro et al., 2015). The finalized network was found to be a 4-layer 16-19-9-1 MLP using all 16 
molecular descriptors as inputs (Fig. 1). The source code (in C) for this ANN has been attached in the SI. 
Reducing the number of descriptors further worsened predictive accuracy of the blind test set in general. This 
ANN type and architecture was chosen based on the lowest absolute errors (i.e. predicted tR -measured tR) in 
the training, verification and blind test sets across all networks. Therefore, ANN architecture was based on 
performance and the software designer tool was used to optimize the number and composition of hidden 
layers. The coefficients of determination (R2) were between 0.86 and 0.90 between the three sets, which was 
already a marked improvement on that obtained from our previous study at R2 = 0.67. Furthermore, the root-
mean-squared error (RMSE) of the blind set of compounds (1.03 min) is less than half that of our previous 
work (2.19 min) (Bade et al., 2015). 
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Fig. 1: TOP: Correlation of measured and predicted tR for all compounds. The worst outliers in each set are also shown: A=atenolol (training 
set, error of -6.21 minutes); B=levamisole (verification set, +5.19 minutes); C=metosulam (blind set, +3.56 minutes). BOTTOM: Residual 
errors for all compounds in each dataset. For training, verification and blind test sets, n=344, 100 and 100 compounds respectively. 
 
The maximum measured tR on this chromatographic system was 16.50 min (narasin; an antibiotic) and the 
lowest was 0.86 min (methamidophos; an organophosphate insecticide). For all compounds within this 
retention window of 15.64 min, the mean error in tR prediction was < 6% using this ANN approach for all 
compounds. Overall, the mean absolute errors and standard deviations were recorded as 0.97 ± 0.95 min  
(training set); 0.79 ± 0.85 min (verification set); 0.79 ± 0.69 min (blind test set); and 0.91 ± 0.89 min (all sets 
combined). When focussing specifically on the blind test set which was used to simulate a true application of 
the approach, 95% of compounds had predicted tR values within 2.00 min of the measured value and the 
maximum error was 3.56 min for metosulam (Fig. 1). However, across the other datasets some larger errors 
were recorded in isolated cases.  Table 1 shows that for all datasets, 90% of all 544 compounds could be 
predicted to within 2.00 min of the measured tR value. Upon sub-division of the datasets, 85% of the 
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compounds in the training and verification sets and 95% of compounds in the blind test set were predicted to 
within two minutes of the measured value. The maximum error recorded within the training set was + 6.25 
min (for the beta blocker atenolol; measured tR = 2.49 min); within the verification set was + 5.19 min (for the 
anti-helminthic drug levamisole; measured tr = 3.02 min) and within the blind test set was + 3.56 min (for the 
pesticide, metosulam; measured tr = 7.54 min). 
Table 1: Summary of predicted tR errors for all ANN test sets. Numbers given in italics are those which fall below the proposed 2-min window 
limit 
Percentile of compounds  50 55 60 65 70 75 80 85 90 95 
Predicted tR error/min           
All sets (n=544) 0.66 0.75 0.85 0.97 1.05 1.19 1.39 1.56 1.96 2.80 
Training set (n=344) 0.70 0.81 0.89 1.02 1.13 1.24 1.45 1.70 2.21 2.87 
Verification set (n=100) 0.51 0.59 0.64 0.76 0.89 0.99 1.35 1.44 1.60 2.43 
Blind test set (n=100) 0.70 0.78 0.84 0.89 1.01 1.08 1.16 1.34 1.63 1.99 
 
Prediction errors for all cases were investigated again with respect to any apparent trends and it was found that 
a very slight over-estimation existed for poorly retained compounds, as well as the converse for strongly 
retained compounds. Recent work focussing on modeling a smaller number of compounds in wastewater also 
revealed a similarly slight bias, but used a different network type (a GRNN) (Munro et al., 2015). When 
examining those compounds with absolute errors > 2.00 min (54 compounds in total across all sets), these were 
spread across the entire compound retention range (mean measured tR = 7.81 ± 3.93). However, a slight over-
estimation was again apparent for 29 compounds with tR from 1.34–5.38 min (mean measured tR = 2.97 min). 
Reduced under-estimation was observed for the remaining 25 compounds eluting between 5.38–16.30 min 
(mean measured tR = 10.67 min for these compounds). Seventeen compounds eluting < 5.38 min were over-
estimated and tR for eleven were under-estimated when eluting > 10.00 min. 
The contribution of each descriptor towards the final prediction output was investigated using the ANN 
software sensitivity analysis tool. In this test, each molecular descriptor is removed and treated as missing by 
the ANN. A new predicted tR is generated and a ratio calculated between the network error with a given input 
omitted to the error of the network with a complete input dataset. Ratios > 1 indicated higher importance in 
the prediction. Perhaps not surprisingly for a reversed-phase chromatography system, the most important 
molecular descriptors and their measured error ratios were: logD (1.443), logKow (1.182), AlogP (1.114), nO 
(1.096), UI (1.006) MlogP (1.023), Hy (1.017), nDB (1.012), nR04-nR09 (all 1.000–1.063), nTB (1.004) and nC 
(1.002) Hydrophobicity-based descriptors are likely to show importance as retention on reversed-phase media 
is primarily by van der Waals interactions. Again, while these descriptors together show their combined 
importance to the network, moderate collinearity between them means relative error ratios should be treated 
with caution for these descriptors (Table SI). However, such collinearity should not adversely affect predictive 
ability of the model. The lowest ratio was observed for nR04 with a ratio of 1.000 meaning no change in 
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network performance was measured for its removal. Within the dataset, only 14 compounds had 4-membered 
rings (amoxicillin, ampicillin, cefaclor, cefadroxil, cefalexin, cefotaxime, cefquinome, cefuroxime, cloxacillin, 
dicloxacillin, heptenophos, oxacillin, oxasulfuron, and penicillin G). Inclusion of nR04 still resulted in better 
performance in comparison to any other type or architecture investigated during the network optimization 
stage and so was retained as a descriptor in the final ANN model. Error ratios discussed above represent that 
of the entire dataset (training, verification and blind test). Sensitivity analysis (see SI) of each set separately 
revealed excellent consistency across all sets, showing that predictive accuracy was likely to be the dominant 
contributors to error ratios rather than over-fitting of the training set alone. 
3.2. Use of ANN as a tR predictor in environmental water samples 
In wide-scope screening methods, where thousands of compounds are searched, it is of great importance to 
have secondary techniques for aid in the identification process. While reference standards can unequivocally 
confirm the identification of a compound, purchasing and maintaining standards for all compounds is 
prohibitively expensive. Data acquired from MS fragmentation of suspect compounds may also direct 
investigations. Furthermore, for many TPs, reference standards are not available and therefore alternate means 
for confidence in detection/identification are necessary. Although it is not comparatively informative as mass 
spectra, tR prediction models can be very helpful in gaining more confidence in the obtained data and reducing 
time-consuming data processing. Most importantly, the application of tR prediction is not to replace the use of 
reference standards, but to help (along with MS/MS data) to direct synthesis efforts for confirmation in the 
usual manner. Prediction of tR is best used at the beginning of this process and is especially useful when at a 
certain exact mass (i.e. (de)protonated molecule of a suspect compound), more than one chromatographic peak 
appears in the corresponding XIC. 
Along these lines, and to test the “blind” skills of the ANN in a real environmental application, the 100 blind 
compounds as well as an additional set of compounds from our previous study not initially used into the ANN 
method (a total of 142 compounds), including primarily metabolites and TPs were searched. None of these 
compounds were in the training or verification sets used for ANN development. From this list of 142 
compounds, 46 were finally selected and searched in 44 water samples (EWW, IWW and SW) using 
ChromaLynx and the ANN predicted tR, based on their possible occurrence in the environment (Table S2)       
(Gracia-Lor et al., 2010, Gracia-Lor et al., 2011, Hernández et al., 2015a and Zuccato et al., 2006). For further 
confidence, and to see how many false positive chromatographic peaks (above the intensity threshold) could 
be disregarded, fragment ions were also included in the detection process (Table S3). When a compound was 
identified on the basis of the accurate mass of the (de)protonated molecule and at least one fragment ion in at 
least one sample it was included in this test, leaving 26 compounds of various chemical classes and including 
nine metabolites, for only some of which standards were available in our laboratory (Table 2). A tR window of 
2 min was used in this section, as 95% of all compounds in the ANN blind set were within this window, thereby 
giving high confidence that almost all compounds should be found. The only compound found to have a tR 
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outside that of the ANN predicted 2 minute window was codeine. The incorporation of the ANN predicted tR 
allowed almost half (49%) of all chromatographic peaks to be ignored, and even after removing codeine from 
the calculation, 48% could be disregarded. Furthermore, all but three compounds had a reduction in the median 
number of potential positive peaks, while 11 compounds had a median value of only one chromatographic 
peak remaining after the introduction of the ANN predicted window. 
In this section, examples are shown in the identification of losartan (originally tentatively identified with tR 
prediction before a reference standard was purchased) and the tentative identification of the metabolites 10,11-
dihydroxy carbamazepine and O-desmethyl venlafaxine (no reference standard available). 
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Table 2: All compounds used for testing ANN predicted tR, together with the number of samples each compound was detected, average number 
of peaks in the XIC and the ±2 minute window and the predicted and sample tR 
Compound  Detection 
rate out of 44 
samples 
Median peaks 
per XIC 
(range)  
Median peaks 
inside ±2 min tR 
window (range) 
 Predicted 
tR (min) 
Sample tR 
(min) 
Inaccuracy in 
predicted tR 
(min) 
10,11-dihydroxy 
carbamazepinea 
30 2 (1-4) 1 (1-3)  6.29 6.66 0.37 
2-hydroxy-
terbuthylazineb 
6 6 (4-8) 2 (1-3)  4.24 5.50 1.26 
4-desmethoxy 
omeprazolea 
33 1 (1-2) 1 (1-2)  8.15 6.29 -1.86 
4-formylamino-
antipyrineb,c 
37 2 (1-8) 2 (1-4)  3.53 3.70 0.17 
a-hydroxy 
metoprolola 
17 5 (2-10) 3 (2-4)  2.73 3.30 0.57 
Benzoylecgonineb 40 3 (1-6) 2 (1-5)  4.11 4.65 0.54 
Bezafibrateb 2 6 (4-7) 1 (1-1)  10.80 10.78 -0.02 
Caffeinea 40 3 (1-6) 1 (1-3)  3.17 3.83 0.66 
Carbamazepineb 40 3 (1-10) 3 (1-5)  7.73 8.82 1.09 
Carboxy losartana 35 2 (1-3) 1 (1-1)  10.75 10.44 -0.31 
Codeineb 25 5 (1-7) 1 (0-3)  4.85 2.46 -2.39 
Cotininea 32 10 (4-14) 5 (3-7)  2.00 1.81 -0.19 
Diazinonb,c 4 3 (2-5) 2 (1-2)  11.64 12.50 0.86 
Diclofenacb 13 1 (1-2) 1 (1-1)  11.71 12.17 0.46 
Gemfibrozilb 13 4 (3-7) 2 (1-4)  12.29 13.34 1.05 
Lidocainea 40 5 (1-11) 2 (1-4)  5.21 4.24 -0.97 
Lincomycinb,c 14 4 (2-8) 2 (1-4)  4.28 3.73 -0.55 
Losartanb 42 2 (1-4) 2 (1-3)  9.95 10.13 -0.18 
Metoprolola 24 3 (1-9) 1 (1-3)  4.07 5.44 1.37 
Naproxenb 32 7 (4-11) 2 (1-4)  10.06 10.54 0.48 
O-
desmethylvenlafaxinea 
29 3 (2-5) 3 (1-5)  5.76 4.68 -1.08 
Paraxanthinea 39 7 (2-12) 3 (2-4)  2.03 2.97 0.94 
Ranitidinea 23 4 (2-6) 1 (1-1)  3.03 2.10 -0.93 
Terbuthylazineb,c 4 1 (1-3) 1 (1-2)  9.60 10.78 1.18 
Trimethoprimb 32 7 (2-10) 4 (1-6)  3.11 3.52 0.41 
Valsartanb 39 2 (1-7) 1 (1-3)  10.90 11.24 0.34 
a: Standard not available in laboratory Sample tR was based on HRMS data and the incorporation of fragment 
ions 
b: Standard available in laboratory 
c: Compound in blind set of ANN 
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3.2.1. Assignment with reference standards 
Losartan is a pharmaceutical used to treat hypertension that has been both predicted (Howard and Muir, 2013 
and Oosterhuis et al., 2013) and detected in environmental waters (Hernández et al., 2015a and Matsuo et al., 
2011). Its presence in a suspect list is thus warranted, and its exact mass was incorporated into our HRMS 
database. When screening WW and SW samples, XICs at the exact mass of losartan (m/z 423.1700) resulted 
in two chromatographic peaks (4.63 and 10.13 min) (Fig. 2, bottom left). The ANN tR predictor was used and 
calculated a tR of 9.95 min. This is almost exactly the tR of one of the peaks, but it is worth noting than even 
after incorporating a ± 2 minute window only one peak warranted further investigation. Nevertheless, both 
peaks could have conceivably corresponded to losartan, therefore further research was conducted. 
The LE and HE mass spectrum of the peak at 10.13 min was investigated for fragment ions: m/z 207.0917 
(C14H11N2, − 2.4 ppm), 377.1552 (C22H22N4Cl, + 5 ppm) and 405.1590 (C22H22N4Cl, − 2.3 ppm) (Fig. 
2, right). Literature (Hernández et al., 2015a) and the mass spectral database MassBank (Horai et al., 2010) were 
also searched to aid in the confidence of these fragment ions. It was found that these three fragment ions did 
indeed correspond to losartan. As seen in the figure, all associated fragments corresponded to the peak at 10.13 
min, following the assertion of the tR predictor. Furthermore, it is clearly seen that none of the fragment ions 
correspond with that of the other peak in the LE (4.63 min). A standard was later purchased and injected, 
unequivocally confirming that the peak at 10.13 min did correspond to losartan. 
 
Fig. 2: LEFT: eXtracted Ion Chromatograms (XICs) of losartan in an EWW sample, together with ANN tR prediction (9.95 min) and 
associated ±2 minute window (dotted lines; centre dashed line is the ANN-predicted value). RIGHT: Mass spectra from LE (bottom) and 
HE (top), showing fragment ions (423.158, 377.156, 207.092).    
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3.2.2. Tentative identification of metabolites without standard reference materials 
The elimination of false positives in suspect analysis is challenging, especially the environmental matrices 
investigated herein (SW and WW) as thousands of compounds may be present. Suspect screening, by definition, 
does not rely on reference standards (Krauss et al., 2010). While the exact mass capability of HRMS has gone 
some way to avoid false positives, even at narrow mass window chromatograms, matrix inferences can be 
present, thereby hindering confident identification (Bade et al., 2015 and Croley et al., 2012). A precise tR 
predictor can therefore be a great additional means of identification. 
Most research of emerging contaminants in the environment has focused on parent compounds, however many 
compounds can be at least partially metabolized or degraded in natural conditions (Jakimska et al., 2014). In 
this respect, the tentative identification of two major metabolites of carbamazepine and venlafaxine were 
explored: 10,11-dihydroxy carbamazepine and O-desmethyl venlafaxine (Fig. 3a). More than one 
chromatographic peak was observed at the exact mass of each protonated molecule. The ANN tR predictor 
was then used to try to help minimize the number of peaks to be analyzed, with the predicted tR calculated to 
be 6.29 and 5.76 min for 10,11-dihydroxy carbamazepine and O-desmethyl venlafaxine, respectively. 
 
Fig. 3: Tentative identification of 10,11-dihydroxy carbamazepine (a) and O-desmethyl venlafaxine (b) in an IWW and EWW sample 
respectively, together with ANN prediction and ± 2 minute window. 
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Two large (~ 4.00 and 6.66 min) and one small (~ 4.90 min) peaks are seen in the LE XIC of 10,11-dihydroxy 
carbamazepine (m/z = 271.1080). The predicted tR was calculated to be 6.29 min and by including a ± 2 minute 
window as in Section 3.2.1, the large peak at ~ 4.00 min could be disregarded, leaving the peaks at 6.66 and ~ 
4.90 min. The ability to focus on fewer peaks is the primary aim and benefit of tR prediction in environmental 
screening applications for unknowns. While having only one (correct) peak remaining is ideal, being able to 
disregard some peaks gives credence to the use of tR prediction in the identification process. To aid in the 
differentiation of these peaks, fragment ions were sought in literature, whereby one group performed an 
MS/MS experiment with a QTOF instrument to find the fragment ions of 10,11-dihydroxy carbamazepine 
(271.1080, 236.0706, 210.0913 and 180.0808) ( Ferrer and Thurman, 2012). As the XICs in the figure show, all 
fragment ions have the peak at 6.65 min in common. This provides great confidence that this peak is indeed 
from 10,11-dihydroxy carbamazepine, however for unequivocal identification, a standard would still have to be 
purchased. 
The example of O-desmethyl venlafaxine represented the worst case scenario, where no peaks could be 
removed after application of the ± 2 minute limit window. However, it must be noted that this was a rare case 
and only occurred for three of 26 compounds. In the LE XIC, two large (4.69 and 5.00 min) and two small 
peaks (~ 4.20 and 6.50 min) are seen. Even after incorporating the ANN predicted tR and associated window 
(5.76 ± 2 min), all four peaks are still of interest. With the peaks being so close together, even using a ± 1.3 
minute window (corresponding to ~ 80% of compounds being successfully inside this window) would result 
in the correct elimination of only one small peak. In this situation, fragment ions have to be used to gain further 
information on the identity. Fragment ions were thus searched in literature (Herrera-Lopez et al., 2014) and 
investigated in the HE. Fig. 3b shows all ions corresponding to the peak at 4.69 min. While the ANN predicted 
tR and associated window did include O-desmethyl venlafaxine, all other peaks in the LE XIC were also inside, 
meaning that no further confidence could be gained by tR prediction, rather through the investigation of 
fragment ions. Nevertheless, the combination of ANN predicted tR and fragment ions led to the tentative 
identification of this compound. 
While the examples explained here show the successful assignment of chromatographic peaks, it is impossible 
to have total confidence with tR prediction. In cases where there is more than one peak in the XIC, and the 
predicted peak is found to be incorrect, the peaks slightly outside the prediction window will also have to be 
investigated. Nevertheless, with data processing nowadays being the most time consuming part of 
environmental screening methods, the time saved by incorporating tR prediction outweighs the possibility of 
false negatives (and positives). 
These examples clearly show the utility of ANN as a tR predictor, not just for its ability to disregard some false 
positive peaks, but also for its accuracy and subsequent confidence for tentatively identified compounds. It is 
therefore recommended when performing large scope (e.g. > 1000 compounds) screening of environmental 
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samples to include accurate tR prediction in the strategy used for identification. This is particularly useful in the 
investigation of metabolites and TPs, for which standards can be very costly or unavailable. 
4. Conclusions 
This work showed the development and use of a tR predictor based on artificial neural networks. In particular, 
a four layer multilayer perceptron successfully modeled retention of 544 compounds under these separation 
conditions. Overall, 90% of all compounds eluted within 2.00 min of the predicted value and for 100 blind test 
compounds, 95% were predicted within this window. The network was applied to additional suspect compound 
occurrence in wide-scope screening based on the use of LC-HRMS, demonstrating that it can reduce the 
number of false negatives or positives. This saves time and effort in the tentative identification of the 
compounds detected, as only those chromatographic peaks that fit the predicted tR need to be focused on. 
Several representative examples are given to illustrate the usefulness of the complementary use of precise tR 
prediction in large suspect screening of emerging contaminants. It is recommended to include this prediction 
for the identification of suspect compounds, particularly in the investigation of metabolites and TPs of organic 
contaminants, for which reference standards are commonly less accessible. 
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Supporting Information 
The tables in the supporting information: A All compounds used for the initial ANN predictions, including 
experimental tR, predicted tR, absolute error and subset (Table S1),  All 46 compounds investigated in the 
samples, including predicted tR  and exact mass (m/z) of their protonated molecule (Table S2), All compounds 
searched in the secondary blind test, together with exact mass (m/z) of protonated  molecules and fragment 
ions (Table S3) as well as information relating to the descriptors used, collinearity tests and ANN sensitivity 
analysis are too large for this thesis, but are available in the online version: doi: 10.1016/j.scitotenv.2015.08.078.  
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3.3  Discussion of Results 
These two scientific articles have shown the potential of tR prediction: from an initial, very simple 
approach based solely on logKow to a more complex, computational, QSRR method based on ANN.  
The investigation into tR prediction was begun because of the ever-increasing number of compounds 
able to be detected based on high-resolution mass spectrometry in our laboratory. With the expense 
associated with purchasing reference standards and the expiration date of stock solutions, a 
complementary means of tentative identification would give more confidence to detected peaks before 
having to purchase standards. Moreover, for degradation and metabolism studies, where reference 
standards are oftentimes impossible to obtain, a secondary means of confidence would be of great 
use.  
Initially, a simple approach was advised, which any laboratory could also do without having to buy 
expensive software: the logKow only approach. This approach was indeed very simple, from a 
computational point of view, being based on a single descriptor and the retention times of all the 
reference standards we had previously injected into our UPLC-QTOF MS as well as a set from Waters, 
which had been run on the same instrument using a slightly different gradient. LogKow was decided 
upon as the descriptor of choice as it mimics the processes involved in reversed phase as well as being 
known to have a good correlation with tR for C18 columns with methanol as the organic modifier. This 
was shown to be the case, however with almost 600 compounds from differing chemical families and 
physicochemical properties, an R2 of slightly under 0.70 was the best that could be achieved. This 
imperfect correlation meant that the tR window would have to either be made wide (i.e. ±4 minutes)  
to have a statistically significant 90-95% of the compounds being found or be made small enough to 
be analytically relevant (i.e. ±2 minutes) with the related prediction error leading to 70-80% of all 
compounds being found. The latter was chosen, with the associated disadvantages described in 
Scientific Article 5. While this approach did succeed in its initial goal to produce a simple and free tR 
predictor, a more precise approach was sought. 
An approach was made to Leon Barron at King´s College, London, who had successfully applied 
ANN for tR prediction for anti-doping screening of urine, for a collaboration using our compilation 
of almost 600 reference standards. It turned out that using the same fifteen descriptors they had used 
(Miller et al., 2013) as well as logKow led to a very good prediction, with up to 95% of all compounds 
found within two minutes of their experimental tR. As shown in Scientific Article 6 this enabled its 
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use in the tentative identification of compounds, metabolites and transformation products for which 
reference standards were unavailable.  
To compare the two approaches, Figure 3.1 shows the use of both tR prediction methods in the 
detection of three common emerging contaminants: bezafibrate (a), trimethoprim (b) and codeine (c), 
using the tR window of ± 2 minutes as in both scientific articles. These three examples portray three 
specific cases: when the compound is within the two minute window of the simple logKow only 
approach (a); when the compound is outside the window of the logKow only but inside that of the 
ANN approach (b); and finally where the compound is neither within the logKow only nor ANN 
windows (c). 
The first example (a) shows the utility of the simple logKow only approach, where the predicted tR (± 
2 minutes) includes the peak of bezafibrate (10.91), whilst also enabling all other chromatographic 
peaks to be disregarded. The second example (b) is one typical of suspect screening, with more than 
one large peak inside the XIC. While the logKow prediction is unable to remove (or include) either of 
the large peaks, the ANN prediction includes the peak of benzoylecgonine. The final example is very 
uncommon and unwanted: where both approaches fail. The tR prediction windows do not include any 
of the three peaks of the XIC, where the predictions from logKow (6.46 mins) and ANN (4.85 mins) 
are nowhere near the three peaks in the XIC, let alone the peak of codeine (2.46 mins). This final case 
is one which, albeit rare, can happen; as explained in both scientific articles, whereby not 100% of all 
compounds can be found within two minutes. In order to improve the chance of the compounds 
being within the tR window, it may be necessary to widen the window, which can have the adverse 
effect of increasing the number of potential peaks needing to be later analysed. However, as has been 
shown, especially for the ANN approach, a window of ±2 minutes is more than enough for the vast 
majority of compounds.  
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Figure 3.1: Extracted ion chromatograms of three compounds; bezafibrate (a), benzoylecgonine (b) and codeine (c) at a mass 
extraction window of 10mDa and incorporating  the retention time predictions of both the logKow only approach (blue), ANNs 
(yellow), while green is the peak of actual compound.  
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While the examples of Figure 3.1 do show the advantages and disadvantages of tR prediction in terms, 
all had reference standards, so it was straightforward to finally identify the compounds. However, 
when investigating new compounds, metabolites and transformation products, for which standards 
may not be available, it is imperative to have a complementary means of identification; a precise tR 
predictor such as ANNs alongside conventional mass spectrometric fragment ion analysis. Figure 3 
in Scientific Article 6 shows two examples of 10,11-dihydroxy carbamazepine and O-desmethyl 
venlafaxine, the first of which shows the perfect example of the utility of a precise tR predictor, able 
to remove three peaks from later analysis, while the latter shows the situation of two almost co-eluting 
peaks which are unable to be distinguished solely with tR prediction. A further example is shown in 
Figure 3.2, of carboxy losartan, a metabolite of the antihypertensive, losartan. It is clear to see in the 
low energy XIC (where solely the parent compound should be seen) there are two peaks, one small 
one at ~8 minutes and a second, larger one at 10.45 minutes. While some analysts performing suspect 
screening may (sometimes erroneously) assume that the larger peak is their compound of interest, the 
introduction of  tR prediction (10.75 mins) immediately removes the smaller peak from further 
investigation, vindicated by the fragment ions relating solely to the peak at 10.45 mins.  
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Figure 3.2: Tentative identification of carboxy losartan following the introduction of ANN optimised tR prediction 
The previous examples have shown the way toward tentative identification using tR prediction as the 
initial point of call. However, this is not necessarily always the case, with some laboratories performing 
mass spectral analysis (i.e. common fragmentation pathways) first to determine the fragment ions 
relating to metabolites of a known parent compound. This can provide some idea of which 
chromatographic peaks give rise to which metabolite. Figure 3.3 shows the common fragmentation 
pathway route for the tentative identification of six metabolites of the antihypertensive diltiazem 
(Ibáñez et al., 2016) with no reference standards being available to aid in their identification. To 
provide further confidence to their identification, tR prediction was used. As can be seen, all predictions 
were within the ±2 minute window used in previous examples, most within one minute.  
One interesting aspect of this diltiazem example is the observance of isomers, which are notoriously 
difficult to distinguish based solely on mass spectral analysis. Without spending further analysis time 
and expense in synthesising standards, to help differentiate the isomers, tR prediction could be used. 
As tR prediction is based on the chemical structure, isomers can have slightly different properties, 
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giving rise to different tR. While total confirmation cannot be made with tR prediction, a qualitative 
idea on the elution order of the isomers is possible. This is shown perfectly where the two sets of 
isomers: O-deacetyl-O-desmethyldiltiazem and O-deacetyl-N-desmethyldiltiazem and O-desmethyl 
diltiazem and N-desmethyl diltiazem could not be distinguished based on mass spectral analysis. 
Although the predicted tR were similar, the metabolites were able to be assigned based on the elution 
order (i.e. 6.23, 6.48, 7.06, 7.52 for the aforementioned metabolites, respectively).  
 
 
Figure 3.3: Tentative identification of diltiazem and six metabolites using common fragmentation pathways and tR prediction. 
The solid lines are the predicted tR while the circled peaks are those found based on common fragmentation with the colours relating 
to the colour of the borders of the compounds. Adapted from (Ibáñez et al., 2016).  
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In spite of the advances made using the ANN approach, it is impossible to have an absolutely precise 
means of prediction, not least due to reproducibility of liquid chromatography instruments, especially 
with respect to the stationary phase and the composition of the mobile phase as well as the matrix 
involved. Furthermore, as explained in Scientific Article 6, QSRR models are usually based solely on 
one laboratory´s chromatographic instrument and its associated parameters, making it very difficult 
to transfer to other instruments and even slightly different parameters. As collaboration and 
information-sharing is very important in academia, it is therefore pertinent find a way to make 
retention time prediction models transferable and easy for anyone to use. Stopping short of insisting 
all laboratories use one instrument with all the same parameters, two possible solutions are: 
i) Indexing compounds, similar to the way Kovat’s Index works in gas chromatography. This 
could be based on compounds not found in nature (i.e. deuterated standards) which cover 
the entire retention time range.  
ii) Performing retention time prediction on a range of columns and under different 
chromatographic conditions. This could then provide information on relevant descriptors 
needed for optimal prediction, which can be utilized by all laboratories. 
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4.1 Introduction 
New psychoactive substances (NPS) are emerging narcotic or psychotropic drugs that are not 
controlled by the 1961 Single Convention on Narcotic Drugs or the 1971 Convention on Psychotropic 
Substances, but which may pose a public health threat. It must be noted that here the term ‘new’ does 
not necessarily refer to new inventions but to substances that have been recently become available in 
the market (UNODC, 2014). While the use of NPS appears to be limited overall, over the past ten 
years, the pace of emergence of new drugs has not diminished. Reports to the EU Early Warning 
System indicate that both the variety and quantity of NPS on Europe’s market are increasing. In 2014, 
more than 100 NPS were detected in Europe alone for the first time, and it is interesting to note how 
the new drugs on the market, mainly synthetic cannabinoids, stimulants, hallucinogens and opioids, 
mirror the established substances (i.e. cannabis, amphetamine, methamphetamine and cocaine) 
(EMCDDA, 2015). Initially not controlled under drug misuse legislation, NPS are easily available via 
the internet and “head shops”, described as ‘bath salts’ and ‘plant foods’ marketed as not for human 
consumption but which are indeed intended for recreational use.  
The trouble with NPS is that they are continually changing due to the impact of legislation, with 
regulated compounds becoming “illicit drugs”, meaning possession and consumption is forbidden. 
New substances then fill this gap, and the process repeats.  This means that determining which 
compounds to focus on for WBE approaches is very difficult, with there being a distinct possibility 
that the NPS in the methods are not found in any analysed samples. However, this may not be because 
the NPS are not being used, but rather the wrong biomarker is being searched. Little research has 
been made into the metabolism of NPS, and even when metabolism studies have been performed 
(Caspar et al., 2015; Chimalakonda et al., 2012; Mardal and Meyer, 2014; Moran et al., 2011), the 
standards (let alone deuterated standards) are sometimes difficult to obtain. This has led to WBE 
studies of NPS incorporating (predominantly) the parent compounds. (Borova et al., 2015; Kinyua et 
al., 2015a; Senta et al., 2015) 
Between 2008-2013, the majority of NPS reported to the United Nations Office on Drugs and Crime 
were synthetic cannabinoids (28%), synthetic cathinones (26%) and phenethylamines (17%) 
(UNODC, 2014), on which NPS-based WBE approaches have been focusing.  
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Figure 4.1: Structures of some synthetic cannabinoids  
Synthetic cannabinoids are functionally but not necessarily structurally related to Δ9-
tetrahydrocannabinol (THC), the active compound of cannabis, binding to the same cannabinoid 
receptors. They have become extremely popular as legal alternatives to cannabis and many have greater 
binding potency for CB1 and CB2 receptors than Δ9-THC and are full rather than partial agonists. 
(Hill and Thomas, 2016). They are sold as ‘legal’ smoking mixtures, containing many different 
compounds, some of which are non-psychoactive such as vitamin E, added in an attempt to ‘mask’ 
the active components. There has been much publicity around the synthetic cannabinoids, marketed 
as ´K2´and ‘Spice’ in the past ten years, with the European Monitoring Centre for Drugs and Drug 
Addiction convening an expert meeting on them in 2009 (EMCDDA, 2009). With legislation being 
introduced to halt the popularity of these mixtures, new analogues are being introduced as substances 
become restricted. Thus, the detection and identification of these compounds is very difficult and 
necessitate the use of HRMS to be able to differentiate the analogues (Grabenauer et al., 2012; Ibáñez 
et al., 2013). Nevertheless, for the most common synthetic cannabinoids (such as AM2201, JWH-018 
and JWH-073, Figure 4.1), metabolism studies have been made (Chimalakonda et al., 2012; Moran et 
al., 2011), with the described metabolites used in quantitative WBE methods (Reid et al., 2014).   
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Figure 4.2: Structures of cathinone and the synthetic cathinone derivatives 
Synthetic cathinones such as naphyrone, butylone, mephedrone, N-ethylcathinone, methedrone, 
methylone and methylenedioxypyrovalerone (MDPV) are structurally related to cathinone (Figure 
4.2), a natural compound found in the khat plant (Catha edulis), which is commonly chewed by people 
originating from countries around East Africa and the Arab Peninsula. They form a large family of 
compounds produced by substitutions at three locations of the cathinone molecule: phenyl ring, 
amino group and propanone terminus. Alkyl, alkoxy, alkylenodioxy, haloalkyl, cyclic groups and 
halides may be introduced to the molecule (Fornal, 2013).  This has led to copious synthetic cathinones 
being developed and sold to the public in mixtures, with numerous synthetic cathinones currently 
identified and known (Ibáñez et al., 2014; Leffler et al., 2014; National Alliance for Model State Drug 
Laws, 2012; Zancajo et al., 2014). Due to the known toxicity of synthetic cathinones, legislation has 
been enacted in some countries, leading to a decrease in their use, however, in spite of these legal 
controls, some synthetic cathinones are still commonly abused (German et al., 2014; Hill and Thomas, 
2016).  
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Figure 4.3: Structures of the “2C” phenethylamines 
The N-2-methoxybenzyl phenethylamine (NBOMe) set of compounds are derived from a class of the 
well-known potent hallucinogenic phenethylamines, the so-called 2Cs (Maurer, 2010). Thus, they 
have a high potential for hallucinogenic effects with the risk of serotonergic toxicity. Among others, 
2-(4-bromo-2,5- dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25B-NBOMe), 2-(4-
chloro-2,5-dimethoxyphenyl)-N-[(2 methoxyphenyl)methyl]ethanamine (25C-NBOMe), and 2-(4-
iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) (Figure 4.3) 
have been sold and consumed as so-called research chemicals. Among the NBOMe derivatives, 25I-
NBOMe seems to be the most commonly used drug, seen as a ‘legal’ alternative to LSD. (Caspar et 
al., 2015; EMCDDA, 2015) These drugs may serve as replacements for the previously popular beta-
keto derivatives of amphetamine – methcathinone and methedrone – as well as the methylenedioxy 
ring derivatives similar to MDMA (Ecstasy), methylone and methylenedioxypyrovalerone (MDPV), 
which are now controlled substances in Europe and the USA (Gibbons, 2012).   
The metabolism of 25I-NBOMe has been studied (Caspar et al., 2015), with more than 60 metabolites 
found, including 26 in a human urine sample. With deuterated analogues of these metabolites very 
difficult to obtain, the parent compound is generally used for qualitative and quantitative analyses, and 
have been attributed to fatal intoxications (Kinyua et al., 2015b; Poklis et al., 2014; Tang et al., 2014).  
The main difficulty associated with the quantitative analysis of new psychoactive substances (NPS) is 
the extremely low analyte concentration in the aquatic matrix. Within the context of WBE, traditional 
illicit drugs such as cocaine, MDMA, amphetamine and methamphetamine are found in the low ppb 
– ppt range, however, NPS are at even lower concentrations, due to their niche markets and ever-
evolving compounds. This results in the need for very sensitive instrumentation, combined with 
specific sample pretreatment to minimise matrix effects. Furthermore, the complex nature of influent 
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wastewater requires filtration or centrifugation of samples prior to pretreatment. Filtration is generally 
made using glass fibre filters to remove any solid particulates. Due to the basicity of NPS, SPE is 
normally performed using cartridges with cationic exchange sorbents (e.g. Oasis MCX), with samples 
acidified (pH 2-3) prior to extraction. Comparisons have been made between the more generic Oasis 
HLB cartridges and the MCX, at differing pH, with MCX at pH 2-3 giving far better recoveries for 
the more basic synthetic cathinones and phenethylamines (Kinyua et al., 2015a; Senta et al., 2015; van 
Nuijs et al., 2013) while MCX has also been used for synthetic cannabinoids(Reid et al., 2014).   
With the diverse range and ever-changing environment of NPS, one all-encompassing method has yet 
to be developed for their quantitative analysis in wastewater. In fact, a single LC technique has also 
yet to be decided upon, with both RP and HILIC used for their analysis. Within RP LC separation, 
various columns have been used, based on the NPS being analysed: from the generic C18 for the 
conventional illicit drugs and the NPS mephedrone, methylone and MDPV (Kankaanpää et al., 2014; 
van Nuijs et al., 2013) to the less hydrophobic C8 for the analysis of synthetic cannabinoids (Reid et 
al., 2014), pentafluorophenyl column for the analysis of synthetic cannabinoids, cathinones and 
amphetamines (Borova et al., 2015) and the polar ether-linked phenyl column for synthetic cathinones 
and amphetamines (Senta et al., 2015). Interestingly, HILIC has also been used for the analysis of the 
very polar phenethylamine-based compounds, which are retained well on HILIC columns (Kinyua et 
al., 2015a).  
Nevertheless, the mobile phases utilised for all separations incorporate an aqueous and organic phase 
(typically methanol or acetonitrile). As mentioned previously, the addition of specific additives or 
buffers can enhance the chromatographic separation or influence the ionisation. The aqueous phase 
usually consists of acidified water (using 0.05-0.2% formic or acetic acid) and ammonium formate or 
ammonium acetate (5-10mM). The acidification improves the ionisation of the NPS, which are best 
ionised in positive ion mode.   
As explained previously, sensitive determination of NPS is necessary for WBE, leading QqQ to be 
the instrument of choice, typically in SRM mode. This requires the preselection of all analytes, and all 
MS parameters are then optimised individually, such as cone voltage and collision energy. First of all, 
the ionisation mode and cone voltage are optimised, to define the precursor ion. Next, using the 
defined cone voltage and ionisation mode, variable collision energies are applied to determine product 
ions. At least two transitions (i.e. precursor ion > product ion) are necessary: one for quantification 
and one for confirmation. Typically the most abundant and sensitive transition is used for 
quantification. However, for oxygen-containing ephedrine-, cathinone- and phenethylamine-like NPS, 
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the most abundant transition corresponds mainly to the loss of water, which is a relatively non-specific 
transition.  This can result in some matrix interferences, particularly in the complex matrix that is 
wastewater, which is full of organic hydroxyl-containing compounds. For such compounds, the 
second, less abundant, but specific transition should be used for quantification. In these cases, it is 
advisable to monitor additional transitions that can also be used for confirmation.  
This chapter focusses on the use of UHPLC-QqQ-MS for the quantitative determination of NPS in 
influent wastewater.  
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4.2 Scientific Articles 
This chapter includes one scientific article, “Ultra-high performance liquid chromatography-tandem mass 
spectrometry determination of selected new psychoactive substances including synthetic cathinones and phenethylamines in 
influent wastewater” (Scientific Article 7).  
Scientific Article 7 presents a sensitive method for the quantification of ten NPS (N-ethylcathinone, 
methylone, butylone, MDPV, naphyrone, mephedrone, methedrone, 25-B-NBOMe, 25-I-NBOMe 
and 25-C-NBOMe) in influent wastewater. An investigation was made into the best extraction 
technique, with HLB and MCX SPE cartridges used, with MCX deemed to be superior for these basic 
compounds. Furthermore, the stability of these compounds was tested for up to 30 days at 20ºC, 4ºC 
and -20ºC at both natural pH and pH 2. This method was used on wastewater samples from 
throughout Europe, with mephedrone, methylone and MDPV identified in several of the wastewater 
samples analysed.   
 
These results have been written in the following article, submitted for publication: 
Ultra-high performance liquid chromatography-tandem mass spectrometry determination of selected 
new psychoactive substances including synthetic cathinones and phenethylamines in influent 
wastewater of eight European cities R.Bade, L. Bijlsma, J. V. Sancho, J. A. Baz-Lomba, S. Castiglioni, E. 
Castrignanò, A.Causanilles, E. Gracia-Lor, B. Kasprzyk-Hordern, J. Kinyua, A.-K. McCall, A. L.N. van Nuijs, 
C.Ort, B. G. Plósz, P. Ramin, N. I. Rousis, Y. Ryu, K.V. Thomas, P. de Voogt, E. Zuccato, F. Hernández 
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4.2.1 Scientific Article 7 
ULTRA-HIGH PERFORMANCE LIQUID 
CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY 
DETERMINATION OF SELECTED NEW 
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Abstract 
The use of new psychoactive substances (NPS) has grown in popularity over the past few years. 
Certain NPS are still commonly and even preferentially consumed even with the introduction of 
preventative legislation. With the objective to improve the knowledge on the use of NPS a rapid and 
very sensitive method was developed for the determination of ten priority NPS (N-ethylcathinone, 
methylenedioxypyrovalerone (MDPV), methylone, butylone, methedrone, mephedrone, naphyrone, 
25-C-NBOMe, 25-I-NBOMe and 25-B-NBOMe) in influent wastewater. Sample clean-up and pre-
concentration was made by off-line solid phase extraction (SPE) with Oasis MCX cartridges. 
Isotopically labelled internal standards were used to correct for matrix effects and potential SPE losses. 
Following chromatographic separation on a C18 column within 6 minutes, the compounds were 
measured by tandem mass spectrometry (triple quadrupole) in positive ionisation mode. The method 
was optimised and validated for all compounds, with limits of quantification being 1 or 5 ng L-1, 
with the method having been fully validated in samples spiked at these levels.  An investigation 
into the stability of these compounds in influent wastewater was also performed, showing that, 
following acidification at pH 2, all compounds were relatively stable for up to 7 days. The method was 
then applied to influent wastewater samples from eight European countries, in which mephedrone, 
methylone and MDPV were detetcted.  This work reveals that although NPS use is not as extensive 
as for classic illicit drugs such as cocaine, cannabis, amphetamines, the application of a highly sensitive 
analytical procedure makes their detection in wastewater possible. The developed analytical 
methodology forms the basis of a subsequent model-based back-calculation of abuse rate in urban 
areas (i.e. wastewater-based epidemiology) in the future.  
 
 
 
 
 
 
Key Words: New psychoactive substances, Ultra high-performance liquid chromatography, Triple 
Quadrupole, Wastewater, Stability, Matrix Effects 
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1. Introduction 
New psychoactive substances (NPS) are emerging narcotic or psychotropic drugs that are not controlled by 
legislation, but which may pose a public health threat. It must be noted that in this context, the term ‘new’ does 
not necessarily refer to new inventions but to substances that have been recently become available [1]. The use 
of NPS has grown rapidly over the past decade and there have been increasing reports of the availability and 
manufacture of such substances, with the number of NPS reported globally more than doubling between 2009-
2013 (UNODC 2014). In 2014 alone, 101 NPS were for the first time reported to the EU Early Warning System 
[2]. Given the nature of the NPS market, with developers limited only by their imagination and ability to side-
step legislation [3] there is a sustained need to analyse the extent of the NPS problem. 
 
The analysis of wastewater to estimate (illicit) drug consumption based on biomarkers, has traditionally 
focussed mainly on the most commonly used illicit drugs - cocaine, cannabis, amphetamine, methamphetamine, 
3,4-methylenedioxymethamphetamine (ecstasy, MDMA) [4,5], leaving a large information gap on other illicit 
drugs and NPS. Little research has been made on NPS and their suitable biomarkers, let alone their stability. 
In the few papers that have been published until now on the determination of NPS in wastewater, the target 
analytes included are commonly the synthetic cathinones mephedrone, methylone and MDPV [6–15]. Within 
these studies, the most commonly detected NPS in wastewater are mephedrone and MDPV, generally found 
at the low ng/L range.     
 
Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) is commonly the technique of 
choice for the quantitative determination of illicit drugs in wastewater, due to the low concentrations involved 
and the high sensitivity of the instrument. When using this technique, several analytical aspects are of relevance 
in order to report accurate data. In addition to the required validation at realistic concentrations that can be 
found in the samples, relevant issues must be considered, such as the way to correct/minimize matrix effects, 
and the proper identification of the compound detected. The use of isotopically-labelled internal standards 
(ILIS) is one of the most efficient tools to correct for matrix effects as well as potential losses from solid phase 
extraction (SPE). The confirmation of identity of the compounds is essential in order to avoid reporting false 
positives. By utilising LC-MS/MS instruments in selected reaction monitoring (SRM) mode, at least two 
transitions should be incorporated in the method (one for quantification and the other(s) for confirmation). 
However, the specificity of the transitions should be taken into account, as non-specific transitions (such as the 
loss of water) can lead to false negatives due to the non-compliance of ion ratios [16].  
 
The purpose of this study was to develop and validate a sensitive LC-MS/MS method for the quantitative 
determination of a number of NPS of the synthetic cathinone and phenethylamine families: butylone, ethylone, 
methylone, naphyrone, methedrone, methylenedioxypyrovalerone (MDPV), mephedrone, 25-I-NBOMe, 25-
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C-NBOMe and 25-B-NBOMe. These compounds were selected on the basis of their frequent detection in 
analytical, forensic and toxicological studies [6–10,12,13,17–19] as well as reports from the EMCDDA [20] and 
UNODC [1].The developed method, using Oasis MCX SPE cartridges for sample pre-treatment, followed by 
UHPLC-MS/MS measurement, has been applied to influent wastewater samples from around Europe, with an 
additional study on stability being made. Special emphasis is placed on the reliable confirmation of the NPS 
detected in water, with up to three SRM transitions being acquired, which, together with ion ratios, allowed 
simultaneous detection, quantification and confirmation of positive samples.  
 
2. Experimental 
2.1 Chemicals and Materials 
Reference standards of all analytes: N-ethylcathinone, MDPV, methylone, butylone, methedrone, mephedrone, 
naphyrone, 25-C-NBOMe, 25-I-NBOMe and 25-B-NBOMe were purchased from Cerilliant (Round Rock, TX, 
USA) at a concentration of 1 mg/mL in methanol for the analytes. Standard stock solutions of each compound 
were prepared at 100 mg/L.  
Mixed working solutions containing all analytes were prepared from stock solutions at different concentrations 
by appropriate dilution with water, and were used for preparation of the aqueous calibration standards and for 
spiking samples in the validation study.  
Deuterated analogues: MDPV-d8, methylone-d3, butylone-d3, mephedrone-d3, naphyrone-d5, 25-C-NBOMe-
d3, 25-I-NBOMe-d3 and 25-B-NBOMe-d3 were also purchased from Cerilliant (Round Rock, TX, USA) at a 
concentration of 100 µg/mL in methanol. Standard stock solutions of each compound were prepared at 10 
mg/L. Mixed standard solutions containing all compounds were made with appropriate dilution with water.  
All standard solutions were stored in amber glass bottles in the dark at -20°C.  
HPLC-grade methanol (MeOH), ammonium acetate, ammonia solution (25 %) and formic acid (HCOOH, 98–
100 %) were acquired from Scharlau (Barcelona, Spain) HPLC-grade water was obtained by purifying 
demineralised water in a Milli-Q plus system from Millipore (Bedford, MA, USA).  SPE cartridges used were 
Oasis HLB 3cc (60mg) and Oasis MCX 6cc (150 mg) from Waters (Milford, MA, USA) 
2.2 Samples 
A number of different influent wastewater (IWW) samples were utilised in the development and validation of 
the present method: from Zurich, Switzerland; Copenhagen, Denmark and Castellon, Spain. The developed 
method was applied to IWW samples. The 24-h composite samples were taken in March 2015 from Zurich, 
Switzerland; Copenhagen, Denmark; Oslo, Norway; Castellon, Spain; Milan, Italy; Brussels, Belgium and 
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Utrecht, The Netherlands and Bristol, United Kingdom. All samples were collected in high density polyethylene 
bottles, transported to Castellon and stored in the dark at -20ºC until pre-treatment.  
2.3 Instrumentation 
A Waters Acquity UHPLC system (Milford, MA, USA) was interfaced to a triple quadrupole mass spectrometer 
(Xevo TQS, Waters Micromass, Manchester, UK) equipped with Z-Wave devices and an electrospray 
ionization interface (ESI) operated in positive-ion mode. The chromatographic separation was performed using 
an Acquity UPLC BEH C18 column, 1.7 μm, 50 mm × 2.1 mm (i.d.) (Waters) at a flow rate of 0.3 mL min−1. 
The mobile phases used were water with 5 mM ammonium acetate and 0.01% formic acid (solvent A) and 
MeOH with 0.01% formic acid (solvent B). The percentage of B changed linearly as follows: 0 min, 10 %; 3 
min, 90 %; 3.5 min, 90 %; 3.6 min, 10 %; 6 min 10 %, equilibration of the column. Cone gas as well as 
desolvation gas was dry nitrogen, with flows set to 150 and 800 L h−1, respectively. For operation in the 
MS/MS mode, collision gas was argon 99.995 % (Praxair, Madrid, Spain) with a pressure of 4×10−3 mbar in 
the collision cell (0.15 mL min−1). Other parameters optimized were: capillary voltage, 3.0 kV; source 
temperature, 150 °C and desolvation temperature, 650 °C. Dwell times of 0.01 s/transition were automatically 
selected. 
All data were acquired and processed using MassLynx v4.1 software (Waters, Manchester, UK). 
2.4 Sample Pre-treatment 
All water samples were acidified to pH 2 with formic acid (98%), then centrifuged for 5 minutes at 6000 rpm. 
SPE cartridges were conditioned with methanol (6mL), water (3mL) and acidified water (pH 2 with formic acid, 
3mL). The IWW samples (100mL) were spiked with mixed surrogate ILIS to give a final in sample 
concentration of 20 ng L-1, then percolated through the cartridges at ±5 mL min-1. The cartridges were then 
washed with 5 mL acidified methanol (pH 2 with formic acid) and dried under vacuum for 10 minutes. The 
analytes were eluted with 5 mL MeOH (2% ammonia), evaporated to dryness at 35ºC under nitrogen and 
reconstituted to 1mL with 10:90 methanol:water.  
Analyses were performed by injecting 3 μL of the final extract in the UHPLC-MS/MS system. 
2.5 Quantification and Method Validation 
SRM mode was used to acquire all data, with the precursor ion of each compound being the protonated 
molecule.  In general, the most abundant product ion of each target analyte was used for quantification, with 
one or two additional product ions and their ion ratios used for confirmation.  In order to confirm the 
compounds detected, LC retention time was compared to that of the reference standards (within ± 0.1 minutes). 
These steps are in line with the SANCO guidelines for analytical quality control and validation procedures [21], 
which has been utilised previously by research groups for quantification of illicit drugs in wastewater [22]. Each 
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compound was quantified using its corresponding ILIS as surrogate internal standard, except N-ethylcathinone 
and methedrone, which were quantified using butylone-d3 and methylone-d3, respectively. These ILIS were 
chosen based on their ability to correct for matrix effects as well as having similar retention times and chemical 
structures closely related to the analyte of interest.  
The performance of the method was evaluated in terms of linearity, limits of detection and quantification, 
accuracy and precision.  
The linearity was studied by analysing standard solutions in solvent in triplicate at seven concentration levels 
ranging from 0.5-100 ng L-1. Satisfactory linearity using weighted (1/X) least squares regression was assumed 
when the correlation coefficient (r) was >0.99.  
For limits of quantification and detection (LOQ and LOD), two different concentration levels (1 and 5 ng L-
1) were tested so as to provide a more accurate measure. The limit of quantification (LOQ) was established as 
the lowest level for which the method was fully validated using spiked IWW samples with satisfactory accuracy 
based on recovery experiments (between 70-120%) and precision (relative standard deviation (RSD) ≤20%). 
Furthermore, at least two MS/MS transitions were required at the LOQ level for confirmation. All recovery 
experiments were performed in quintuplicate. 
The limit of detection (LOD) was estimated using blank samples spiked at the lowest analyte concentration 
tested, based on a signal-to-noise level of three from the quantification SRM chromatogram.  
2.6 Stability experiments 
Stability experiments were performed under different conditions (IWW at natural pH and acidified to pH 2, 
filtered influent wastewater at natural pH and acidified to pH 2 and MilliQ water) and at three different 
temperatures (20ºC, 4ºC and -20ºC) for 24 hours, 48 hours, 7 days, and 30 days (at -20ºC only). The samples 
were each initially spiked at a concentration level of 100ng L-1. One mL of each sample was collected at the 
time intervals outlined above and spiked with ILIS (100 ng L-1) just before analysis.  
3. Results and Discussion 
3.1 Selection of Compounds 
Only parent compounds were selected for this study. This is based on the previous metabolism studies 
performed on the selected ten  as well as related NPS in human and rat urine [18,23–27], which showed that in 
spite of the number of metabolites identified, the parent compound could still be detected in urine, thereby 
giving credence to their inclusion as a biomarker in this method. Furthermore, it has been noted that the 
metabolic patterns of selected phenethylamine-based designer drugs have indicated rather slow metabolism 
rates, with parent drugs being the key biomarkers of consumption [8,28], somewhat expected due to their 
structural similarity to amphetamine and MDMA [5].   
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In addition, for the phenethylamine-based 25-X-NBOMe compounds, the parent compound is generally used 
in both qualitative and quantitative toxicological studies [29–31]. 
3.2 Instrument Optimisation 
Initially, all cone voltages were optimised concurrently for all compounds, using a mixed standard solution (10 
µg L-1), with the cone voltage ranging from 10-50 V at 10 V intervals. For all compounds, the precursor ion 
was [M+H]+. Collision energies were optimised for each compound independently using a collision energy 
ranging from 10-50eV at 10eV intervals. The most sensitive transition was typically selected for quantification 
(Q) while an additional one (or two) were selected for confirmation (q).  Some compounds only had two 
product ions of significant intensity, meaning that only two transitions (i.e. Q and q1 only) could be monitored 
(Table 1). Non-specific transitions such as the loss of water were avoided as much as possible (except for 
methylone, mephedrone and N-ethylcathinone where they were used as confirmation transitions) in order to 
reduce the likelihood of false positives [22]. For the three 25-X-NBOMe compounds, the same product ions 
were seen (m/z 121 and 91), corresponding to the cleavage of the methoxybenzyl moiety (m/z 121) and the 
further loss of the methoxy group producing the tropylium ion (m/z 91). These transitions are not very specific, 
and can come from any compound with a methoxybenzoyl moiety, however as there were no other transitions 
available for these compounds, they had to be used as quantification and confirmation transitions. Regarding 
the ILIS, only a single transition was monitored. 
The chromatographic separation was initially based on a mobile phase composed of water:MeOH, which 
resulted in very poor peak shapes. Different concentrations of ammonium acetate buffer and pH (formic acid) 
were investigated. The effects of pH and mobile phase ionic strength on the peak shapes, resolution and 
efficiencies were evaluated by varying the buffer concentration. An optimal mobile phase consisting of water 
with 5 mM ammonium acetate and 0.01% formic acid (solvent A) and MeOH with 0.01% formic acid (solvent 
B) was finally selected.
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Table 1: MS/MS optimised conditions for all studied compounds 
Compound 
Retention 
time 
(mins) 
Precursor 
ion 
[M+H]+ 
(m/z) 
Cone 
Voltage 
(V) 
Collision 
Energy 
(eV) 
Product 
Ions 
(m/z) 
LOQa 
(ng L-1) 
LODb 
(pg L-1) 
q/Q ratio  
(RSD %) 
         
25-B-NBOMe 3.76 380.1 40 20 121.0 1 100  
    30 91.0   0.4 (6) 
25-C-NBOMe 3.70 336.1 20 20 121.1 5 70  
    40 91.0   0.6 (6) 
25-I-NBOMe 3.86 428.1 20 20 121.0 5 100  
    50 91.0   0.5 (6) 
Butylone 2.68 222.1 20 20 174.0 5 200  
    20 146.0   0.3 (6) 
    30 131.2   0.3 (7) 
Mephedrone 2.77 178.1 30 20 145.2 5 200  
    20 119.0   0.1 (11) 
    10 160.0   1.3 (7) 
Methedrone 2.57 194.1 20 20 161.1 5 200  
    20 146.0   0.4 (4) 
MDPV 3.11 276.2 50 20 175.1 1 200  
    20 126.0   0.6 (5) 
  
 
 
    20 205.0   0.8 (9) 
Methylone 2.36 208.1 50 20 160.0 5 50  
    20 132.1   0.4 (6) 
    10 190.0   0.5 (11) 
Naphyrone 3.71 282.2 50 20 141.2 1 50  
    20 211.1   0.5 (6) 
    40 127.4   0.2 (6) 
N-ethylcathinone 2.42 178.1 20 10 130.0 5 200  
    20 117.1   1.1 (7) 
    30 160.1   0.7 (10) 
25-B-NBOMe-d3 3.76 383.3 40 20 124.0    
25-C-NBOMe-d3 3.70 339.1 20 20 124.0    
25-I-NBOMe-d3 3.86 431.1 20 20 124.0    
Butylone-d3 2.68 225.1 20 20 177.1    
Mephedrone-d3 2.77 181.1 30 20 145.2    
MDPV-d8 3.11 284.2 50 20 205.0    
Methylone-d3 2.36 211.1 50 20 163.1    
Naphyrone-d5 3.71 287.2 50 20 141.2    
aLOQ objective. Lowest concentration tested for the method being fully validated with satisfactory results. 
bLOD estimated for a signal-to-noise level of three from the quantification SRM chromatogram of blank samples spiked at the lowest analyte concentration tested.
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3.3 Optimisation of extraction procedure 
An investigation into the filtration losses of these compounds was made in samples at both natural and pH 2, 
using a vacuum filter (Whatman, 0.45μm mixed cellulose ester membrane). It was found that for naphyrone 
and the 25-X-NBOMe compounds, less than 5% of the compounds were recovered following filtration, while 
for MDPV a recovery of 55-71% was found. (Table S1) With these results, filtration was not employed in this 
method, instead we only performed centrifugation. 
Two cartridges were evaluated in the optimisation of the SPE procedure: Oasis HLB and Oasis MCX, which 
are two of the most popular cartridges for the extraction of different types of illicit drugs in environmental 
waters [32]. The backbone of the Oasis sorbents consists of apolar moieties (benzyl groups, aliphatic chains) 
and polar groups (pyrrolidone). HLB is only synthesised from these two monomers and neutral. MCX has extra 
sulfonic acid functional groups (1.01mmol g-1) implemented at a fixed location and contain permanently 
charged groups at any relevant pH. For both cartridges, 100 mL of IWW was spiked with the compounds (100 
ng L-1) before and after extraction and the recovery was used to determine the better cartridge for further 
optimisation.  No pH adjustment was made for the Oasis HLB cartridges, while for the MCX, samples were 
acidified (pH 2) in order to protonate all basic analytes, thereby enhancing their ionic interactions with the 
sorbent [8]. This led to a reduction in matrix interferences, giving higher sensitivity and peak shapes for the 
majority of the compounds (Figure 1). The SPE procedure followed for the HLB cartridges was the same as 
in previously published studies. [33,34]  
Higher recoveries were obtained when using Oasis MCX cartridges (Figure 2) and therefore these were 
selected for further optimisation. For the washing step, water, pure MeOH and acidified MeOH (pH 2) were 
tested. Drying under vacuum (or not) was also tested, to determine the optimal washing/drying steps (Figure 
2).  
As seen in Figure 2, the optimal SPE procedure involved washing with 5mL acidified methanol and drying for 
10 minutes, with recoveries ranging from 83%-93% (Figure 2, MCX 3). 
In previous methods for NPS using MCX cartridges, different percentages of ammonia in methanol have been 
used for elution, ranging from 0.5% to 4% [7,8,11,12]. A compromise of 2% was utilised in this work, and 
showed good recoveries for all compounds. An elution volume of 5mL of 2% ammonia in MeOH solution 
was finally chosen. This was based on the comparison of the recoveries of 5mL and 10mL elution volumes, 
with recoveries only 2% less for the 5mL than the 10mL.  
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Figure 4: SRM of a selection of compounds, after extraction with HLB (LEFT) and MCX (RIGHT) cartridges.  From top to bottom: 
methedrone, butylone, mephedrone, MDPV and N-ethylcathinone.  
 
 
Figure 5: Recoveries for all compounds using HLB and MCX cartridges. Legend shows different washing/drying steps used. Black lines are 
shown at the threshold limits for satisfactory recovery (70-120%) 
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3.4 Method Validation 
Before applying the developed methodology to IWW samples, the method was fully validated for linearity, 
precision and accuracy (recovery), LOD, LOQ and q/Q ratio (Tables 1 and 2). A calibration curve of seven 
points was made in solvent from 0.5-100ng L-1. Correlation coefficients were greater than 0.99 for all 
compounds, except for naphyrone and the NBOMe compounds, which had values between 0.97-0.98. For 
precision and accuracy, blank IWW samples were spiked at four concentration levels (1 ng L-1, 5 ng L-1, 10 ng 
L-1 and 50 ng L-1), and analysed in quintuplicate. These two sets corresponds to the different LOQs of some 
of the compounds (either 1 ng L-1or 5 ng L-1, see Table 1). Accuracy was measured by means of recovery, with 
all compounds showing satisfactory recovery (between 70-120%), and precision (all within RSD 20%). 
LOQs were estimated from a non-statistical point of view, utilising an LOQ objective: the lowest level in sample 
for which the method was fully validated in terms of accuracy and precision. This criterion has been utilised in 
the past in published results [22] and is used in other fields, such as pesticide residue analysis [21]. This gives a 
more realistic LOQ value, albeit generally higher than those estimated from statistical criteria (i.e. signal-to-
noise of 10 at the lowest validation level tested).  
Average intensity q/Q ratios were calculated from reference standards in solvent of different concentrations 
(Table 1). With RSD% values ≤11% for all q/Q ratios, there was high confidence that the ratios are not 
concentration dependent.  These were compared to those experimentally obtained from sample extracts spiked 
at the lowest level validated. The aim of this was to test the robustness of these values and to check for potential 
matrix interferences that could affect the q/Q ratios and consequently, the confirmation process. As Table 2 
shows, average q/Q deviations were all below 30% [21], except for 25-I-NBOMe and 25-C-NBOMe at the 
lowest level of 1ng/L. This finding returns to the previous discussion of the non-specificity of the NBOMe 
transitions, whereby although these transitions could be seen at this level, matrix interferences let the q/Q 
deviations far exceed the threshold of the SANCO guidelines, which were being followed in this work. This 
led to the LOQ for these two compounds being increased to 5 ng L-1.  
Matrix effects are a known drawback of LC-MS/MS, which can adversely affect the compounds of interest, 
leading to signal enhancement or suppression, thereby affecting the quantification process. These effects are 
most pronounced in more complex matrices, such as IWW. In this work, matrix effects were calculated by 
comparing the peak areas of Set 1 (SPE eluates (IWW previously extracted) spiked with the mixed standard 
and ILIS solutions) with Set 2 (mixed standard solution in solvent, including ILIS).  All samples were performed 
in triplicate and averaged to perform the following calculations [35]: 
Matrix effects (%) = 
average peak area (Set 1) 
average peak area (Set 2)
 ×  100  
These calculations showed the true impact of the matrix on the compounds, with all showing significant matrix 
enhancement (Table 2). To correct for these interferences, ILIS were included in the calculation: 
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Matrix effects (%) = 
average peak area (Set 1,ILIS) / average peak area (Set 2,ILIS)
average peak area (Set 1) / average peak area (Set 2)
 ×  100 
Including ILIS to the calculations led to corrected matrix effects under 10% for all compounds.   
Additional data pertaining to the use of ILIS is shown in Table 2, for SPE recovery and matrix effects, showing 
how well the ILIS are able to correct for matrix interferences. 
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Table 2:  Method validation for all compounds in IWW at 2 validation levels (all values are in %), together with recovery and matrix effects before and after correction with internal standard (n=5). Linearity is 
also shown. 
Compound 
Matrix effects 
(%)a 
q1/Q ratio q2/Q ratio SPE Recovery (%) Linearity 
   Lowb Highc Lowb Highc Lowb  Highc   
  No ILIS      No ILIS  No ILIS  
            
25-B-NBOMe -4 60 -11 (12) -9 (4) - - 121 (7) 87 (13) 83 (4) 57 (16) 0.9722 
25-C-NBOMe -7 50 -7 (8) -2 (0) - - 86 (9) 51 (14) 89 (7) 73 (15) 0.9737 
25-I-NBOMe -6 66 5 (8) -13 (1) - - 111 (9) 85 (16) 77 (6) 78 (16) 0.9722 
Butylone -6 29 -13 (12) -4 (6) 24 (26) -11 (4) 79 (10) 49 (13) 83 (4) 55 (8) 0.9923 
MDPV -7 48 6 (8) 10 (4) 17 (13) 9 (8) 122 (10) 94 (8) 74 (9) 52 (10) 0.9900 
Mephedrone -9 26 -6 (11) 12 (4) 0 (5)d 15 (4)d 71 (10) 40 (8) 94 (7) 52 (6) 0.9914 
Methedrone -10 31 -12 (4) -7 (6) - - 73 (8) 49 (7) 80 (5) 53 (7) 0.9923 
Methylone -6 30 6 (7) -1 (8) d d 71 (8) 30 (4) 89 (4) 36 (7) 0.9919 
Naphyrone -10 62 -5 (5) -7 (9) -5 (9) -13 (3) 111 (10) 75 (10) 76 (8) 50 (15) 0.9883 
N-ethylcathinone 3 27 -33 (21) 1 (7) d 5 (6)d 113 (7) 47 (12) 84 (7) 34 (5) 0.9975 
ILIS (Isotopically-labelled Internal Standard)  
a: for matrix effects, a negative value (-) denotes matrix suppression, while positive values indicate matrix enhancement.  
b: Low refers to the LOQ value of all compounds: 1 ng L-1 for MDPV, Naphyrone and 25-B-NBOMe and 5 ng L-1 for all other compounds 
c: High refers to the 10xLOQ value of all compounds: 10 ng L-1 for MDPV, Naphyrone and 25-B-NBOMe and 50 ng L-1 for all other compounds 
d: These transitions were for a loss of water. The non-specificity associated with these transitions combined with the complex IWW matrix led to some of these transitions being non-
observed/interfered. However, as they were all q2 transitions, the method could still be validated based on q1. 
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3.5 In-sample Stability 
Stability of analytes is a key matter in any analysis, particularly when dealing with very low analyte concentrations 
in complex matrices such as wastewater. It is imperative that target analytes do not degrade during the 24-hour 
composite samples collection or during their storage before extraction. Composite samples are normally 
collected at 4 °C and are stored either at that temperature, or at -20 °C, depending on the time lapsing between 
collection and extraction[8], while extraction is usually carried out at room temperature. For these reasons, the 
stability of the target analytes in this study was studied at 4 °C, -20 °C and 20 °C. The study was carried out in 
both raw and filtered wastewater (as some research groups filter their samples prior to storage) as well as in 
Milli-Q water. Furthermore, the impact of acidification was also examined, with the samples examined at both 
natural pH and at pH 2.  
In this section, low (60-100% transformation), medium (20-60% transformation) and high stability (0-20% 
transformation) is defined as by McCall et al [36], with all results being normalised to t=0. It must be stated 
that there was little difference between the filtered and unfiltered wastewater for most analytes, with the 
compounds less stable at natural pH. At 20 ºC, N-ethylcathinone and mephedrone, showed low stability after 
24 hours. However, at pH 2, all compounds exhibited high stability at all temperatures, for at least 7 days.  
The results show that if the samples are not acidified they should be refrigerated (at 4 °C), or frozen (at -20 °C), 
and analysed within 7 days to ensure no significant degradation has occurred. Alternatively, if samples are 
acidified to pH 2, all investigated compounds are more stable and can even be maintained at room temperature 
for up to 7 days. However, after 30 days, there were some distinct stability issues with some compounds: 
mephedrone, methedrone and butylone all exhibiting low stability (up to 84% transformation); N-
ethylcathinone, MDPV and methylone showing medium stability while the 25-X-NBOMe compounds and 
naphyrone still had high stability (less than 10% transformation) (Figure 3). All other results of the stability 
tests (i.e. in filtered wastewater and Milli-Q water) can be found in the supporting information (Figures S1-S3). 
These results also mirror those of the recent studies of Senta et al [8], and Reid et al [12], who investigated the 
stability of some of these compounds. 
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Figure 3: Stability of all compounds in raw IWW at (pH 2) at 20 ºC (TOP), 4 ºC (MIDDLE) and -20 ºC (BOTTOM). Transformation 
(y axis) shows the value of the analyte remaining (i.e. a value of 20% means a transformation of 80%) 
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3.6 Application to Real Samples 
A selection of samples from throughout Europe were investigated for the presence of NPS. In total, IWW 
from eight cities were investigated: Bristol, United Kingdom; Brussels, Belgium; Castellon, Spain Oslo, 
Norway; Copenhagen, Denmark; Milan, Italy; Utrecht, The Netherlands; Zurich, Switzerland, and samples 
were from weekends (Saturday and Sunday) and weekdays (Monday-Friday).   
In every sequence of analysis, water samples were injected between two calibration curves. Two quality 
control samples (QCs), i.e. a blank water sample (previously analyzed) spiked at LOQ and 10×LOQ levels, 
were also analysed. QC recoveries were considered satisfactory when they were in the range of 70–120% for 
each analyte. 
Table 3: Concentrations (in ng L-1) of investigated NPS in IWW throughout Europe (weekday/weekend) 
Compound 
South 
West UK 
Brussels Castellon Copenhagen Milan Oslo Utrecht Zurich 
N-
ethylcathinone - - - - - - - 
- 
MDPV - - - - -/3 -/2 - 6/- 
Mephedrone 61/106 d/- - 5/5 - d/d -/d -/d 
Methylone -/d - - -/12 - - 7/5 - 
Butylone - - - - - - - - 
Methedrone - - - - - - - - 
Naphyrone - - - - - - - - 
25-B-NBOMe - - - - - - - - 
25-I-NBOMe - - - - - - - - 
25-C-NBOMe - - - - - - - - 
d: detected, at a concentration below LOQ; -: not detected (<LOD) 
 
 
As shown in Table 3, mephedrone was the most commonly identified NPS, with concentrations ranging from 
<5 ng L-1 (Brussels, Oslo, Copenhagen and Utrecht) to 106 ng L-1 (South West UK). The high concentrations 
found in Bristol are similar to another study in the United Kingdom, which found concentrations up to 114 (± 
15) ng L-1. [15] These data also follow that from the UNODC, stating that mephedrone has the highest 
prevalence rate of any NPS in the United Kingdom, and behind only cannabis, cocaine and ecstasy in terms of 
drug use [1]. The only other compounds confirmed in our study were methylone and MDPV, with 
concentrations ranging from below LOQ to 12 ng L-1 (methylone) and 6 ngL-1 (MDPV), with these low 
concentration in line with previous studies in Croatia and Switzerland [7,8]. These overall results are also 
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comparable with EMCDDA seizure data, with mephedrone (20%), methylone (7%) and MDPV (9%) some of 
the most commonly seized synthetic cathinones. Furthermore, the United Kingdom had one of the most 
synthetic cathinone seizures in Europe, implying a high consumption of these NPS [20].  
  
 
Figure 4: Positive findings (from left to right) of MDPV, mephedrone and methylone in IWW of Milan, South West UK and Copenhagen, respectively. The uppermost transition for each compound is 
the confirmation (Q) transition in the QC (low, 5 ng L-1), while the lower three are all from the sample. All include three transitions, and the q/Q ratio, together with the deviation from the QC.  
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Figure 4 shows the confirmation in three IWW samples of MDPV, mephedrone and methylone. All show 
the compliance of all the necessary criteria: retention time compatibility with the standard (in the form of the 
QC in the figure), at least two transitions, and ion ratio within 30% for at least one confirmation transition. It 
must be noted that the q2/Q ratio for both MDPV and methylone are outside the accepted ±30% ion ratio 
window, but as the q1/Q ratio for both are within the window, both can be confirmed. 3.6.1 False positive 
identification 
 
3.6.1 Occurrence of false positives 
 
With quantification methods, it is easy to distinguish positive findings from negative, using strict criteria such 
as ion ratio (±30%), retention time (± 0.1 min) and at least one additional, confirmatory transition. However, 
there are some scenarios where the rulings are not so obvious.  
 
For some compounds, only one, the most sensitive, transition may be observed, but may not be confirmed 
with a subsequent transition, suggesting that the compound could be present, although only at very low 
concentrations. If criteria are not strictly adhered to, this could lead to false positive findings. This was the case 
for MDPV in a sample from Zurich (Figure 5). Within this sample, the Q transition was found at the correct 
retention time, but the two q transitions were between 0.09-0.2 minutes away. This suggests that two different 
compounds were present in the samples showing the above transitions. Even though the shift in retention time 
itself is enough to reject the detection of this compound, the ion ratios were still checked. The q1 transition 
was found within the q/Q ratio threshold (30%). Although the q2 ratio was more than 100% lower than 
expected, if the sample was not well checked, it could have been erroneously assigned as a false positive on the 
basis of one q/Q ratio accomplishment.  
 
Figure 5 also shows the curious case of butylone, which seemed to have been detected in an IWW sample 
from Bristol. As this figure shows, all three transitions can clearly be seen, albeit at a retention time 0.17 minutes 
lower than in the quality control. Although one q/Q ratio is within the ±30% threshold, the fact that the 
retention time is greater than 0.10 minutes from the standard is enough evidence to say that this is not butylone. 
However, with all the same transitions present, there is a possibility that this compound could be related to 
butylone. Due to the retention time being less than the reference standard, this compound could be a metabolite, 
which, due to its more polar characteristics would lead it to elute earlier. Alternatively, it could be a related 
cathinone-derivative, for example ethylone, which has the same fragmentation, and has been found in previous 
European samples [7]. However, more research is needed to confirm its identity.   
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Figure 5: The false positive detections of butylone in Bath (LEFT) and MDPV in Zurich (RIGHT). The uppermost transition is the 
quantification (Q) transition in the QC (low, 5ng/L), while the lowermost is the Q of the ILIS (in sample). All transitions are shown, together 
with the q/Q ratios. 
 
Conclusions 
A very sensitive analytical method based on UHPLC-MS/MS has been developed for the determination of ten 
NPS of the synthetic cathinone and phenethylamine classes in influent wastewater. The overall analytical 
procedure, based on an off-line SPE step using Oasis MCX cartridges prior to the determination by UHPLC–
MS/MS using a triple quadrupole analyzer, has been fully validated, obtaining satisfactory accuracy and 
precision. Extra emphasis was made on the SPE cartridge, clean-up step and matrix effects. An additional study 
was also made into the stability of these compounds in five matrices at -20 °C, 4 °C and 20 °C, with advice 
given on the optimal means of storage. 
The method was tested on samples from throughout Europe, with mephedrone, methylone and MDPV able 
to be identified in various samples.  These data support the applicability of the method to influent wastewaters, 
despite the very low concentrations observed, and also support the previous information available on NPS use 
in Europe, where these compounds are in agreement with prevalence and seizure data.  
In the future, with information on flow data for the IWW plants and metabolic data to correct for excretion, 
this method could be used to obtain accurate analytical concentrations which subsequently could allow the 
estimation of NPS consumption within a population.  
 
Time
2.80 2.90 3.00 3.10 3.20 3.30 3.40
%
0
2.80 2.90 3.00 3.10 3.20 3.30 3.40
%
8
2.80 2.90 3.00 3.10 3.20 3.30 3.40
%
3
2.80 2.90 3.00 3.10 3.20 3.30 3.40
%
6
2.80 2.90 3.00 3.10 3.20 3.30 3.40
%
10
NPS_RealSamples_015 1: MRM of 18 Channels ES+ 
276.2 > 175.1 (MDPV)
1.09e5
3.11
NPS_RealSamples_024 1: MRM of 18 Channels ES+ 
276.2 > 175.1 (MDPV)
1.16e5
3.10
NPS_RealSamples_024 1: MRM of 18 Channels ES+ 
276.2 > 126 (MDPV)
9.54e4
3.19
NPS_RealSamples_024 1: MRM of 18 Channels ES+ 
276.2 > 205 (MDPV)
3.07e4
NPS_RealSamples_024 2: MRM of 4 Channels ES+ 
284.2 > 205 (MDPV)
8.46e5
3.10
Time
2.40 2.50 2.60 2.70 2.80 2.90 3.00
%
0
2.40 2.50 2.60 2.70 2.80 2.90 3.00
%
7
2.40 2.50 2.60 2.70 2.80 2.90 3.00
%
3
2.40 2.50 2.60 2.70 2.80 2.90 3.00
%
0
2.40 2.50 2.60 2.70 2.80 2.90 3.00
%
6
NPS_RealSamples_015 1: MRM of 18 Channels ES+ 
222.1 > 174 (Butylone)
9.86e4
2.70
NPS_RealSamples_010 1: MRM of 18 Channels ES+ 
222.1 > 174 (Butylone)
1.19e6
2.53
NPS_RealSamples_010 1: MRM of 18 Channels ES+ 
222.1 > 146 (Butylone)
3.82e5
2.53
NPS_RealSamples_010 1: MRM of 18 Channels ES+ 
222.1 > 131.2 (Butylone)
9.62e4
2.53
NPS_RealSamples_010 2: MRM of 4 Channels ES+ 
225.1 > 177 (Butylone)
9.21e5
2.70
Q (QC low)
Q
q1
q2
Q (ILIS)
q1/Q = 0.28
q2/Q = 0.27
q1/Q =0.31 (+10%)
q2/Q = 0.08 (-108%)
q1/Q = 0.64
q2/Q = 0.82
q1/Q =0.87 (+30%)
q2/Q = 0.25 (-106%)
S
c
ie
n
ti
fi
c
 A
rt
ic
le
 7
 
Bade et al.  
268 
Contributions 
RB, LB, JVS and FH planned and designed the study. LB, JBL, SC, EC, AC, EGL, BKH, JK, AKM, AvN, 
CO, BGP, PR, NIR, YR, KVT, EZ and PdV organised the collection of the wastewater samples. RB and LB 
developed the method and RB performed the validation. RB analysed the samples and interpreted the results 
with contribution from all co-authors. RB, with significant contributions from LB, JVS and FH drafted the 
manuscript, which was critically revised by all co-authors. All authors are aware of the content, and accept 
responsibility, for the manuscript. 
 
Acknowledgements 
The authors would like to thank all the personnel of the wastewater treatment plants for their collaboration in 
providing the samples: Sociedad de Fomento Agrícola Castellonense (FACSA, Castellon, Spain), VEAS (Oslo, 
Norway), Aquiris (Brussels, Belgium), Hoogheemraadschap de Stichtse Rijnlanden (Utrecht, the Netherlands), 
Wessex Water  (South West UK), Metropolitana Milanese (Milan, Italy), Werdhölzli (Zurich, Switzerland) and 
BIOFOS (Copenhagen, Denmark).   
RB, JBL, EC, AC, JK, AKM, PR and NIR acknowledge the European Union for their Early Stage Researcher 
(ESR) contracts and EGL for her Experienced Researcher (ER) contract as part of the EU-International 
Training Network SEWPROF (Marie Curie- PEOPLE Grant #317205). 
LB acknowledges NPS-Euronet (HOME/2014/JDRUG/AG/DRUG/7086), co-funded by the European 
Union, for his post-doctoral fellowship. This publication reflects the views only of the authors, and the 
European Commission cannot be held responsible for any use which may be made of the information 
contained therein. AvN acknowledges the support of the Flanders Foundation for Research (FWO). EGL is 
also thankful for the financial support from Generalitat Valenciana (APOSTD/2015, Programa VALi+d). 
The financial support of Generalitat Valenciana (Prometeo II 2014/023) and of the Spanish Ministry of 
Economy and Competitiveness (Project ref CTQ2015-65603) is also acknowledged by the authors of University 
Jaume I. 
  
 Chapter 4: Determination of NPS 
 
269 
References 
[1] UNODC, Global Synthetic Drugs Assessment: Amphetamine-type stimulants and new psychoactive 
substances, 2014. 
[2] EMCDDA, European Drug Report: Trends and Developments, 2015. 
[3] M. Reid, K. Thomas, New Psychoactive Substances: analysis and site-specific testing, in: S. Castiglioni 
(Ed.), Assess. Illicit Drugs Wastewater Adv. Wastewater-Based Drug Epidemiol., 2016: pp. 57–65. 
[4] K. V Thomas, L. Bijlsma, S. Castiglioni, A. Covaci, E. Emke, R. Grabic, et al., Comparing illicit drug 
use in 19 European cities through sewage analysis, Sci. Total Environ. 432 (2012) 432–439. 
doi:10.1016/j.scitotenv.2012.06.069. 
[5] C. Ort, A.L.N. van Nuijs, J.-D. Berset, L. Bijlsma, S. Castiglioni, A. Covaci, et al., Spatial differences 
and temporal changes in illicit drug use in Europe quantified by wastewater analysis, Addiction. 109 
(2014) 1338–1352. doi:10.1111/add.12570. 
[6] C. Chen, C. Kostakis, R.J. Irvine, J.M. White, Increases in use of novel synthetic stimulant are not 
directly linked to decreased use of 3,4-methylenedioxy-N-methylamphetamine (MDMA), Forensic Sci. 
Int. 231 (2013) 278–283. doi:10.1016/j.forsciint.2013.06.007. 
[7] J. Kinyua, A. Covaci, W. Maho, A.-K. McCall, H. Neels, A.L.N. van Nuijs, Sewage-based 
epidemiology in monitoring the use of new psychoactive substances: Validation and application of an 
analytical method using LC-MS/MS, Drug Test. Anal. 7 (2015) 812–818. doi:10.1002/dta.1777. 
[8] I. Senta, I. Krizman, M. Ahel, S. Terzic, Multiresidual analysis of emerging amphetamine-like 
psychoactive substances in wastewater and river water, J. Chromatogr. A. 1425 (2015) 204–212. 
doi:10.1016/j.chroma.2015.11.043. 
[9] V.L. Borova, P. Gago-Ferrero, C. Pistos, N.S. Thomaidis, Multi-residue determination of 10 selected 
new psychoactive substances in wastewater samples by liquid chromatography–tandem mass 
spectrometry, Talanta. 144 (2015) 592–603. doi:10.1016/j.talanta.2015.06.080. 
[10] A. Kankaanpää, K. Ariniemi, M. Heinonen, K. Kuoppasalmi, T. Gunnar, Use of illicit stimulant drugs 
in Finland: A wastewater study in ten major cities, Sci. Total Environ. 487 (2014) 696–702. 
doi:10.1016/j.scitotenv.2013.11.095. 
[11] A.L.N. van Nuijs, A. Gheorghe, P.G. Jorens, K. Maudens, H. Neels, A. Covaci, Optimization, 
validation, and the application of liquid chromatography-tandem mass spectrometry for the analysis of 
new drugs of abuse in wastewater., Drug Test. Anal. (2013) 861–867. doi:10.1002/dta.1460. 
[12] M.J. Reid, L. Derry, K. V. Thomas, Analysis of new classes of recreational drugs in sewage: Synthetic 
S
c
ie
n
ti
fi
c
 A
rt
ic
le
 7
 
Bade et al.  
270 
cannabinoids and amphetamine-like substances, Drug Test. Anal. 6 (2014) 72–79. 
doi:10.1002/dta.1461. 
[13] E.M. Mwenesongole, L. Gautam, S.W. Hall, J.W. Waterhouse, M.D. Cole, Simultaneous detection of 
controlled substances in waste water, Anal. Methods. 5 (2013) 3248–3254. doi:10.1039/c3ay40655e. 
[14] J.A. Baz-Lomba, M.J. Reid, K. V. Thomas, Target and suspect screening of psychoactive substances 
in sewage-based samples by UHPLC-QTOF, Anal. Chim. Acta. 914 (2016) 81–90. 
doi:10.1016/j.aca.2016.01.056. 
[15] E. Castrignanò, A. Lubben, B. Kasprzyk-Hordern, Enantiomeric profiling of chiral drug biomarkers 
in wastewater with the usage of chiral liquid chromatography coupled with tandem mass 
spectrometry, J. Chromatogr. A. 1438 (2016) 84–99. doi:10.1016/j.chroma.2016.02.015. 
[16] Ó.J. Pozo, J. V. Sancho, M. Ibáñez, F. Hernández, W.M. a. Niessen, Confirmation of organic 
micropollutants detected in environmental samples by liquid chromatography tandem mass 
spectrometry: Achievements and pitfalls, TrAC Trends Anal. Chem. 25 (2006) 1030–1042. 
doi:10.1016/j.trac.2006.06.012. 
[17] S. Elliott, J. Evans, A 3-year review of new psychoactive substances in casework, Forensic Sci. Int. 
243 (2014) 55–60. doi:10.1016/j.forsciint.2014.04.017. 
[18] V. Uralets, S. Rana, S. Morgan, W. Ross, Testing for designer stimulants: Metabolic profiles of 16 
synthetic cathinones excreted free in human urine, J. Anal. Toxicol. 38 (2014) 233–241. 
doi:10.1093/jat/bku021. 
[19] M. Ibáñez, J. V. Sancho, L. Bijlsma, A.L.N. van Nuijs, A. Covaci, F. Hernández, Comprehensive 
analytical strategies based on high-resolution time-of-flight mass spectrometry to identify new 
psychoactive substances, TrAC Trends Anal. Chem. 57 (2014) 107–117. 
doi:10.1016/j.trac.2014.02.009. 
[20] EMCDDA, New psychoactive substances in Europe, EU Early Warn. Syst. (2015) 12. 
doi:10.2810/372415. 
[21] SANCO, Guidance document on analytical quality control and validation procedures for pesticides 
residues in food and feed, SANCO /12571/2013. (2013). 
http://ec.europa.eu/food/plant/pesticides/guidance_documents/docs/qualcontrol_en.pdf. 
[22] L. Bijlsma, J. V Sancho, E. Pitarch, M. Ibanez, F. Hernandez, Simultaneous ultra-high-pressure liquid 
chromatography-tandem mass spectrometry determination of amphetamine and amphetamine-like 
stimulants, cocaine and its metabolites, and a cannabis metabolite in surface water and urban 
wastewater, J. Chromatogr. a. 1216 (2009) 3078–3089. doi:10.1016/j.chroma.2009.01.067. 
 Chapter 4: Determination of NPS 
 
271 
[23] H.T. Kamata, N. Shima, K. Zaitsu, T. Kamata, A. Miki, M. Nishikawa, et al., Metabolism of the 
recently encountered designer drug, methylone, in humans and rats, Xenobiotica. 36 (2006) 709–723. 
doi:10.1080/00498250600780191. 
[24] M.R. Meyer, P. Du, F. Schuster, H.H. Maurer, Studies on the metabolism of the α-
pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and 
human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by 
GC-MS, J. Mass Spectrom. 45 (2010) 1426–1442. doi:10.1002/jms.1859. 
[25] M. Mardal, M.R. Meyer, Studies on the microbial biotransformation of the novel psychoactive 
substance methylenedioxypyrovalerone (MDPV) in wastewater by means of liquid chromatography-
high resolution mass spectrometry/mass spectrometry, Sci. Total Environ. 493 (2014) 588–595. 
doi:10.1016/j.scitotenv.2014.06.016. 
[26] M. Ibáñez, Ó.J. Pozo, J. V. Sancho, T. Orengo, G. Haro, F. Hernández, Analytical strategy to 
investigate 3,4-methylenedioxypyrovalerone (MDPV) metabolites in consumers’ urine by high-
resolution mass spectrometry, Anal. Bioanal. Chem. 408 (2016) 151–164. doi:10.1007/s00216-015-
9088-1. 
[27] A.T. Caspar, A.G. Helfer, J.A. Michely, V. Auwarter, S.D. Brandt, M.R. Meyer, et al., Studies on the 
metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-
dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine 
using GC-MS, LC-MS, and LC-HR-MS/MS, Anal Bioanal Chem. (2015) 6697–6719. 
doi:10.1007/s00216-015-8828-6. 
[28] F.Y. Lai, C. Erratico, J. Kinyua, J.F. Mueller, A. Covaci, A.L.N. van Nuijs, Liquid chromatography-
quadrupole time-of-flight mass spectrometry for screening in vitro drug metabolites in humans: 
investigation on seven phenethylamine-based designer drugs, J. Pharm. Biomed. Anal. 114 (2015) 
355–375. doi:10.1016/j.jpba.2015.06.016. 
[29] J. Kinyua, N. Negreira, M. Ibáñez, L. Bijlsma, F. Hernández, A. Covaci, et al., A data-independent 
acquisition workflow for qualitative screening of new psychoactive substances in biological samples, 
Anal. Bioanal. Chem. 407 (2015) 8773–8785. doi:10.1007/s00216-015-9036-0. 
[30] J.L. Poklis, C.R. Nanco, M.M. Troendle, C.E. Wolf, A. Poklis, Determination of 4-bromo-2,5-
dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by 
high performance liquid chromatography with tandem mass spectrometry in a case of severe 
intoxication, Drug Test. Anal. 6 (2014) 764–769. doi:10.1002/dta.1522. 
[31] M.H. Tang, C.K. Ching, M.S. Tsui, F.K. Chu, T.W. Mak, Two cases of severe intoxication associated 
S
c
ie
n
ti
fi
c
 A
rt
ic
le
 7
 
Bade et al.  
272 
with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe, 
Clin Toxicol. 52 (2014) 561–565. doi:10.3109/15563650.2014.909932.  
 [32] D.R. Baker, B. Kasprzyk-Hordern, Critical evaluation of methodology commonly used in sample 
collection, storage and preparation for the analysis of pharmaceuticals and illicit drugs in surface water 
and wastewater by solid phase extraction and liquid chromatography–mass spectrometry, J. 
Chromatogr. A. 1218 (2011) 8036–8059. doi:10.1016/j.chroma.2011.09.012. 
[33] L. Bijlsma, E. Beltrán, C. Boix, J. V Sancho, F. Hernández, Improvements in analytical methodology 
for the determination of frequently consumed illicit drugs in urban wastewater, Anal. Bioanal. Chem. 
406 (2014) 4261–4272. doi:10.1007/s00216-014-7818-4. 
[34] R. Bade, N.I. Rousis, L. Bijlsma, E. Gracia-Lor, S. Castiglioni, J. V. Sancho, et al., Screening of 
pharmaceuticals and illicit drugs in wastewater and surface waters of Spain and Italy by high resolution 
mass spectrometry using UHPLC-QTOF MS and LC-LTQ-Orbitrap MS, Anal. Bioanal. Chem. 407 
(2015) 8979–8988. doi:10.1007/s00216-015-9063-x. 
[35] B.K. Matuszewski, M.L. Constanzer, C.M. Chavez-Eng, Strategies for the assessment of matrix effect 
in quantitative bioanalytical methods based on HPLC-MS/MS, Anal. Chem. 75 (2003) 3019–3030. 
doi:10.1021/ac020361s. 
[36] A.-K. McCall, R. Bade, J. Kinyua, F.Y. Lai, P.K. Thai, A. Covaci, et al., Critical review on the stability 
of illicit drugs in sewers and wastewater samples, Water Res. 88 (2016) 933–947. 
doi:10.1016/j.watres.2015.10.040. 
  
 Chapter 4: Determination of NPS 
 
273 
Supporting Information 
 
Table S1: Filtration recovery for all compounds using vacuum filter (%) 
 
 
Compound Natural pH pH = 2 
N-ethylcathinone 98 106 
MDPV 55 71 
Mephedrone 97 102 
Methylone 88 104 
Butylone 84 104 
Methedrone 90 102 
Naphyrone 1 4 
25-B-NBOMe 1 1 
25-I-NBOMe 0 1 
25-C-NBOMe 1 1 
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Figure S1: Stability of all compounds in filtered IWW (pH2) at 20ºC (LEFT), 4ºC (MIDDLE) and -20ºC (RIGHT) 
 
Figure S2: Stability of all compounds in filtered IWW (natural pH) at 20ºC (LEFT), 4ºC (MIDDLE) and -20ºC (RIGHT) 
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Figure S3: Stability of all compounds in Milli-Q water at 20ºC (LEFT), 4ºC (MIDDLE) and -20ºC (RIGHT) 
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4.3 Discussion of Results 
Within the realm of WBE, illicit drugs (especially cocaine, methamphetamine, amphetamine, MDMA, 
and cannabis) have been the focus. The success of this approach has led researchers to explore further 
biomarkers in fields other than illicit drugs, including F2-isoprostanes, alcohol, caffeine, nicotine, 
phosphodiesterase type V inhibitors and pesticides. In the past five years, there has been a rapid 
growth in NPS, as ‘legal’ alternatives to the conventional illicit drugs outlined above. With little 
toxicological knowledge of these compounds, governments and regulators have been quick to illegalise 
these compounds. However, slight modifications can be made to get around the legislation, leading 
to more NPS hitting the market. In spite of the legislation, and the new NPS continuously reaching 
the market, some NPS have proven more popular that others (even after being deemed illegal), such 
as mephedrone (in Europe) and MDPV and methylone (mainly in the United States).  
Several research groups have developed WBE methods for various NPS (Borova et al., 2015; Kinyua 
et al., 2015a; Senta et al., 2015), while our group has previously analysed legal highs – in the form of 
herbal blends, pills, powders, drinkable solutions and truffles – to identify the NPS inside (Ibáñez et 
al., 2014). This information, combined with that from recent toxicological studies (Caspar et al., 2015; 
Kinyua et al., 2015b; Mardal and Meyer, 2014), led to the ten NPS being chosen for this study:  N-
ethylcathinone, butylone, methylone, naphyrone, MDPV, mephedrone, methedrone, 25-B-NBOMe, 
25-C-NBOMe and 25-I-NBOMe.  
Only parent compounds were selected for this study. This is based on the previous metabolism studies 
made on these and related NPS in human and rat urine (Caspar et al., 2015; Ibáñez et al., 2016; Kamata 
et al., 2006; Mardal and Meyer, 2014; Meyer et al., 2010; Uralets et al., 2014), which showed that in 
spite of the number of metabolites identified, the parent compound could be detected, thereby giving 
credence to their inclusion as a biomarker for drug consumption. Furthermore, it has been noted that 
the metabolic patterns of selected phenethylamine-based designer drugs have indicated rather slow 
metabolism rates, with parent drugs being the key biomarkers of the drug consumption(Lai et al., 2015; 
Senta et al., 2015), somewhat expected due to their structural similarity to amphetamine and MDMA, 
for both of which the parent drug is used as the biomarker for drug consumption.   
Matters are further complicated with information relating to routes of administration, dosage levels, 
habits of consumption and individual metabolism lacking. This could have a big impact on the most 
suitable biomarker, as the excretion rate can vary according to the route of administration and the 
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frequency of use of a substance(Castiglioni et al., 2016, 2013). Although back-calculation to estimate 
consumption is not (yet) the goal of identifying NPS in wastewater, knowledge of the most highly 
excreted metabolites could allow more of these NPS to be found, and can be used for future WBE 
methods. 
With the conventional WBE drugs, excretion rates of the biomarkers used range from 0.6% (THC-
COOH for cannabis) to 65 % (MDMA) (Burgard et al., 2014; Castiglioni and Gracia-Lor, 2016). The 
fact that these compounds are still utilised as the most suitable biomarkers despite the small excretion 
rates in some cases, combined with the findings of the aforementioned metabolism studies, leads the 
parent drugs to being a plausible biomarker of consumption. 
When developing this method, the first parameters to be optimised were those related to the mass 
spectrometry measurement. As with other methods incorporating these basic compounds, only 
positive ionisation mode was tested, with the [M+H]+ used as the precursor ion for all compounds 
for both quantification and confirmation transitions. Initially, all analytes were injected as a mix, with 
optimisation of the cone voltage made concurrently, with the voltage being increased from 10V-50V 
at 10V steps (example of methedrone in Figure 4.4). If the cone voltage deemed to have the greatest 
sensitivity was at 50V, higher cone voltages were applied (as in the cases of methylone and naphyrone), 
to see whether greater sensitivity could be achieved. Once the optimal cone voltage had been found, 
the collision energy was optimised for each compound individually, using the optimised cone voltage 
and the collision energy being increased from 10eV-50eV at 10eV increments. All transitions (i.e. 
precursor ion > product ion) were noted, along with their optimal collision energy and areas (to 
determine the sensitivity).  
In general, the most sensitive transition was used for quantification. The only exception was 
methylone where it corresponded to the non-specific loss of water, thus the 178.1>145.2 transition 
was used for quantification instead. For confirmation, the next most sensitive transition was selected, 
with the loss of water again overlooked due to its low specificity. However, for mephedrone, a loss of 
water (178.1>160.0) was used for confirmation due to the low sensitivity of other transitions.  
The initial UHPLC optimisation was based on a previous method of our group (Bijlsma et al., 2014). 
A mobile phase of pure milli-Q water (H2O) and methanol (MeOH) was first used, together with a 
mixed solution of the analytes (100ppb). However, due to the sensitivity of the instrument, the column 
was overloaded at such a high concentration, so subsequent injections were made at 10ppb and 1ppb. 
Furthermore, without any additives, no clear chromatographic peaks could be observed. Formic acid 
 Chapter 4: Determination of NPS 
 
279 
(FA) and ammonium formate (NH4Ac) at differing concentrations were then added in an attempt to 
improve the chromatographic peaks (Figure 4.4). As seen, there is a massive improvement as soon 
as FA is added to the aqueous phase.  
 
Figure 4.4: Cone voltage and UHPLC Optimisation of Methedrone: a = 10ppb methedrone, mobile phase of H2O and MeOH only; b = 
10ppb methedrone, mobile phase of H2O + 0.01%FA and MeOH.  
Cone voltage is shown on the left. 
 
When tweaking the mobile phase additives, it was found that the compounds most susceptible to peak 
broadening were those eluting later: naphyrone and the NBOMe compounds. While the addition of 
FA and NH4Ac to the aqueous mobile phase did improve the peak shapes of all compounds, the 
addition of FA to the organic mobile phase improved the sensitivity of all compounds, with up to a 
two-fold increase (Figure 4.5). Thus, a mobile phase of water (with 0.01% formic acid and 5mM 
ammonium acetate) and methanol (with 0.01% formic acid) was selected.  
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Figure 4.5: UHPLC Optimisation: LEFT: H2O + 0.01% FA + 5mMol NH4Ac; MeOH,  
RIGHT: H2O + 0.01% FA + 5mMol NH4Ac; MeOH + 0.01% FA 
Compounds, from top to bottom: 25-I-NBOMe, 25-B-NBOMe, 25-C-NBOMe, naphyrone 
 
Two SPE cartridges were tested for both sample treatment purposes: Oasis HLB and Oasis MCX.  
Oasis HLB is a hydrophilic-lipophilic-balanced, water wettable, reversed phase material, commonly 
used as a generic cartridge as it is ideal for acidic, basic and neutral analytes. Oasis MCX is a mixed 
mode cation-exchange sorbent, which is selective for bases. Both consist of a copolymer synthesised 
from a polar divinylbenzene and polar N-vinylpyrrolidone. HLB is only synthesised from these two 
monomers and neutral. MCX has extra sulfonic acid functional groups (1.01mmol/g) implemented at 
a fixed location and contain permanently charged groups at any relevant pH (Bäuerlein et al., 2012). 
All of the compounds in this method were basic phenethylamine- and cathinone-derivatives, so the 
MCX was expected to be superior, or at least being more specific. In order to compare the two 
cartridges, recovery experiments were made, whereby the samples were spiked before and after 
extraction.  Figure 4.6 shows the comparison between the two procedures at 10ppb in IWW, with 
the MCX giving recoveries between 80-100% for all compounds, while, using HLB, both butylone 
and methedrone had recoveries less than 80%. This led to MCX being chosen as the preferred sample 
treatment method, and further optimisation of the elution and drying was made to improve the 
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recoveries. However, as shown in Figure 2 of Scientific Article 7, the recoveries for these alternative 
steps led to recoveries greater than 120%.  
 
Figure 4.6: Comparison of SPE recoveries of Oasis HLB and Oasis MCX 
 
Matrix effects, extraction efficiency (absolute recovery) and process efficiency (relative recovery) were 
also tested for the MCX cartridges, based on the work of Matuszewski et al. (Matuszewski et al., 2003), 
where three different sets of samples were prepared. Set 1 consisted of a mixed standard solution in 
solvent, including ILIS. Set 2 consisted of IWW samples, which had previously been extracted, and 
the SPE eluates spiked with the mixed standard and ILIS solutions. Finally, in set 3, IWW samples 
were first spiked at the same concentrations as the previous sets and then extracted. All sets were 
performed in triplicate and averaged to perform calculations. Extraction efficiency was calculated by 
comparing the peak areas of set 2 and set 3; matrix effects by comparing set 2 and set 1, and total 
process efficiency by comparing set 3 and set 1, as in the calculations below, with Table 4.1 showing 
the results of these experiments: 
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Corrected Extraction Efficiency/ Absolute Recovery (%) =  
average peak area (Set 2, ILIS) / average peak area (Set 3, ILIS)
average peak area (Set 2) / average peak area (Set 3)
 𝑥 100 
Matrix effects (%) = 
average peak area (Set 1) 
average peak area (Set 2)
 𝑥 100 ; Matrix effects (%) – 1 = matrix enhancement (i.e. 
all positive figures denote matrix enhancement, all negative figures matrix suppression) 
Corrected Matrix effects (%) = 
average peak area (Set 1,ILIS) / average peak area (Set 2,ILIS)
average peak area (Set 1,) / average peak area (Set 2)
 𝑥 100 
Process Efficiency/Relative Recovery (%): = 
average peak area (Set 3) 
average peak area (Set 1)
 𝑥 100 
Corrected Process Efficiency/Relative Recovery (%) = 
average peak area (Set 3, ILIS) / average peak area (Set 1, ILIS)
average peak area (Set 3) / average peak area (Set 1)
 𝑥 100 
  
Table 4.1: Absolute recovery, matrix effects and relative recovery (%) for all compounds after SPE with MCX cartridges 
Compound 
Absolute 
recovery 
Absolute 
recovery 
(correctedb) 
Matrix 
effectsa 
Matrix 
Effects 
(correctedb) 
Relative 
recovery 
Relative 
recovery 
(correctedb) 
       
N-
ethylcathinone 
83 102 73 3 23 101 
MDPV 91 102 52 -7 44 91 
Mephedrone 85 103 74 -9 22 88 
Methylone 84 104 70 -6 25 91 
Butylone 89 99 71 -6 26 95 
Methedrone 87 97 69 -10 27 94 
Naphyrone 87 99 38 -10 54 91 
25-B-NBoMe 89 96 40 -4 53 100 
25-I-NBoMe 86 97 34 -6 57 96 
25-C-NBoMe 90 103 50 -7 45 90 
a: for matrix effects, a negative value (-) denotes matrix suppression, while positive values indicate matrix enhancement.  
b: corrected with ILIS 
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The use ILIS was imperative, as they allowed the correction of both matrix effects and losses 
associated with the sample preparation. In this respect, a deuterated analogue of each individual 
analyte would be an ideal internal standard, as it should show an identical behaviour to the sample 
analyte in sample pretreatment, chromatography and ionisation. All but two analytes had a deuterated 
analyte as an internal standard, but alternative ILIS were used for N-ethylcathinone and methedrone 
(methylone-d3 and butylone-d3, respectively) owing to their ability to correct for matrix effects and 
their similar retention times.  
A direct injection method was also attempted, as a comparison to the applied SPE method. One clear 
advantage of direct injection is that SPE is not needed, thereby cutting sample pretreatment times 
considerably, and avoiding potential losses or contaminations that may occur during this step. 
However, without any preconcentration, there is a chance that the levels able to be reached by direct 
injection are not as low as those that incorporate SPE. Furthermore, there is also a high chance of 
matrix interferences, leading to signal suppression or enhancement, which can make validation and 
quantification difficult. Normally, direct injection in this field involves large volume injection (i.e. from 
50-900µL), generally for “cleaner” samples such as drinking water and surface water; however, an 
effort was made to use an even lower injection volume, of 3µL, to reduce matrix effects further. It 
was found that the matrix effects led to signal enhancement for all the compounds (Table 4.2), and 
were influenced by their retention time, with later eluting compounds having greater matrix effects 
(two- to three-fold higher) than the earlier eluting compounds. This could be as a result of the gradient 
and the “washing” of the column at the later stages of the chromatographic run. Acceptable matrix 
effects were observed for the first five eluting compounds (from Methylone to Mephedrone), while 
they lead up to 2.5-fold signal for the last eluting compound 25-B-NBoMe. More research is needed 
in this area in order to facilitate direct injection of samples in the future (see Future Perspectives). 
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Table 4.2: Matrix effects (%) of all compounds with direct injection method 
Compound 
Retention 
Time 
Matrix 
Effectsa 
   
Methylone 2.07 25 
N-ethylcathinone 2.14 4 
Methedrone 2.31 14 
Butylone 2.44 11 
Mephedrone 2.53 7 
MDPV 2.88 86 
25-C-NBoMe 3.50 196 
Naphyrone 3.51 212 
25-B-NBoMe 3.56 240 
aMatrix effects of 0% indicate no suppression or enhancement, while all positive values indicate enhancement 
Within the development of a  direct injection method, a study was made into the recoveries of the 
compounds after filtration, both using several syringe filters (for direct injection) and a vacuum filter 
normally used in our laboratory prior to both qualitative and quantitative methods of wastewater 
(Bijlsma et al., 2014; Hernández et al., 2015). Filtration experiments were performed using IWW at 
both natural pH and acidified to pH2, after centrifugation (Tables 4.3 and 4.4). Seven syringe filters 
were tested (0.2µm Nylon; 25mm (Sarorius, only at natural pH), 0.22 µm PTFE; 13mm (Membrane 
solutions (Mieron)), 0.45µm Nylon; 17mm (Nalgene), 0.45 µm Nylon; 13mm (Scharlau), 0.2 µm 
Polypropylene; 13mm (Whatman), 0.2µm PTFE ;13mm (Teknokroma) and 0.45µm PTFE; 13mm 
(Teknokroma)) and one vacuum filter (0.45μm mixed cellulose ester membrane filters (Whatman, 
Dassel, Germany). For all experiments, the wastewater sample was spiked at 2.5ppb with mixed 
standards prior to filtration, while 2ppb (final concentration) of the ILIS was added after, to correct 
for matrix effects. 1mL of IWW was collected after filtration, in triplicate.  
 Of all of the filters investigated, only one (0.45µm Nylon, 13mm) did not retain any compounds in 
the filtration of IWW at natural pH, while at pH2, all compounds passed all syringe filters. At natural 
pH, the NBOMe compounds (especially 25-I-NBOMe) were particularly retained on the filters, 
recording recoveries less than 50% for the majority of the filters (Table 4.3) 
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Table 4.3: Filtration recoveries (%) of all compounds at natural pH 
Compound 
Membrane 
0.45µm 
(vacuum) 
Nylon 
0.20 µm 
(25mm) 
PTFE 
0.22µm 
(13mm) 
Nylon 
0.45µm 
(17mm) 
Nylon 
0.45µm 
(13mm) 
Polypropylene 
0.2 µm 
(13mm) 
PTFE 
0.2µm 
(13mm) 
PTFE 
0.45µm 
(13mm) 
N-ethylcathinone 98 96 100 92 119 97 123 114 
MDPV 55 91 97 70 121 67 95 100 
Mephedrone 97 99 118 106 140 93 106 105 
Methylone 88 96 104 101 125 99 103 102 
Butylone 84 90 98 86 115 81 102 100 
Methedrone 90 82 10% 86 115 90 104 102 
Naphyrone 1 67 75 67 106 3 64 83 
25-B-NBoMe 1 26 28 39 101 2 33 64 
25-I-NBoMe 0 0 9 18 91 0 19 50 
25-C-NBoMe 1 39 42 55 110 2 40 69 
 
One interesting aspect of this experiment was the effectiveness of the vacuum filter that is 
commonplace in qualitative and quantitative studies in our laboratory. It was found that at both natural 
pH and pH2, four compounds (naphyrone and the three NBoMe compounds) were highly retained 
(less than 5% remaining), with MDPV also being somewhat retained (29-45%) on the filter. This result 
suggests that screening methods performed using this filter will always be missing these NPS, which 
could result in their being erroneously qualified as not detected. It must be noted that because of this 
result, none of the IWW samples for the SPE method were filtered, solely centrifuged. The filter finally 
chosen for direct injection was the Nylon 13mm, 0.45µm, which had recoveries of 98-105% for all 
compounds at pH2 and was the only filter to have respectable recoveries for all compounds at natural 
pH (91-140%).  
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Table 4.4: Filtration recovery (%) of all compounds at pH 2 
 
Tables 1 and 2 in Scientific Article 7 show the results of the final validation of the SPE method 
(n=5), with precision (RSD), recovery, LOD, LOQ and linearity. The limit of quantification objective 
(LOQ) was taken as the lowest level for which the method was fully validated using spiked samples 
with satisfactory recovery (between 70-120%) and precision (relative standard deviation (RSD) ≤20%). 
Two LOQ validations (1ng/L and 5ng/L) were made to provide a more accurate measure, with 
MDPV, naphyrone and the NBOMe compounds all having LOQs as low as 1ng/L.   Recoveries were 
acceptable for all compounds, ranging between 71-113% (at 5ng/L) and 85-122% (and 1ng/L), and 
the precision (in terms of RSD) was below 20% for all compounds. Linearity was studied for all 
compounds. Two calibration curves were made: 0.5-25ng/L (five points) and 1-100ng/L (6 points), 
the first for those compounds with a lower LOQ (1ng/L). Correlation coefficients were greater than 
0.99 for all compounds, except naphyrone and the NBOMe compounds, which had values greater 
than 0.96.      
A selection of samples from throughout Europe was investigated for NPS using this method. In total, 
17 samples were investigated from Bristol, United Kingdom (1 x weekday, 1 x weekend); Brussels, 
Belgium (1 x weekday, 1 x weekend); Castellon, Spain (1 x weekend) Oslo, Norway (1 x weekday, 1 x 
weekend); Copenhagen, Denmark (1 x weekday, 2 x weekend); Milan, Italy (1 x weekday); Utrecht, 
The Netherlands (1 x weekday, 2 x weekend); Zurich, Switzerland (1 x weekday, 2 x weekend).  As 
shown in Table 3 of Scientific Article 7, only MDPV, mephedrone and methylone were found. The 
highest concentration of any compound was for mephedrone, with a concentration of 106ng/L found 
Compound 
Membrane 
0.45µm 
(vacuum) 
PTFE 
0.22µm 
(13mm) 
Nylon 
0.45µm 
(17mm) 
Nylon 
0.45µm 
(13mm) 
Polypropylene 
0.2 µm 
(13mm) 
PTFE 
0.2µm 
(13mm) 
PTFE 
0.45µm 
(13mm) 
N-ethylcathinone 106 97 97 101 96 91 98 
MDPV 71 100 89 101 101 103 103 
Mephedrone 102 102 101 105 97 100 99 
Methylone 104 103 102 104 101 98 100 
Butylone 104 101 98 102 92 96 97 
Methedrone 102 100 97 103 97 100 101 
Naphyrone 4 85 89 95 92 99 102 
25-B-NBoMe 1 74 87 99 81 104 99 
25-I-NBoMe 1 53 82 98 64 102 83 
25-C-NBoMe 1 79 87 98 87 105 101 
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in South West UK, showing its popularity is far higher in the United Kingdom than in other cities of 
continental Europe, although it was also quantified in Copenhagen and detected in Oslo and Brussels, 
although at concentrations lower than LOQ. MDPV was found in Milan, Oslo and Zurich at low 
concentrations (2-6ng/L), while methylone was found in Utrecht and Copenhagen (5-12ng/L) and 
detected in Bristol at a concentration lower than LOQ.  
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6.1 Conclusions 
The general conclusion of this thesis is that advanced analytical techniques, based on liquid chromatography 
coupled to low and high-resolution mass spectrometry, and incorporating retention time prediction and target, 
suspect and non-target analyses are of great utility for the detection and identification of emerging 
contaminants in water. The use of (hyphenated) high resolution mass spectrometry such as triple quadrupole 
(QqQ), quadrupole time-of-flight (QTOF) and Linear ion Trap (LTQ) Orbitrap, allows comprehensive 
analysis of emerging contaminants in environmental waters, through the use of target (QqQ), suspect (QTOF 
and LTQ-Orbitrap)  and non-target (LTQ-Orbitrap) analyses. Furthermore, the complementary use of 
retention time prediction made the detection of compounds (especially for which standards were unavailable) 
much less tedious and enabled higher confidence in their tentative identification.  
From the work performed in this thesis, several specific conclusions can be garnered: 
1. High resolution mass spectrometry, especially QTOF and LTQ-Orbitrap are very powerful 
instruments for the qualitative suspect and non-target screening of emerging contaminants in aquatic 
samples. 
2. QTOF in MSE mode facilitates the detection and tentative identification of pharmaceuticals, illicit 
drugs (PIDs) and their metabolites, with high energy (corresponding to fragment ions) and low 
energy (corresponding primarily to the parent molecule) information gained in a single injection. 
3. It has been shown that there is a geographic difference in the detection of PIDs, with samples from 
Colombia, Italy and Spain having been analysed. While the samples from Italy and Spain were quite 
similar - Irbesartan (antihypertensive), valsartan (angiotensin II antagonist) and two antibiotics 
ofloxacin and sulfamethoxazole were the most commonly identified compounds – in the Colombian 
samples the beta-blocker metoprolol, the lipid regulator gemfibrozil, and the X-ray agent iopromide 
as well as metabolites of losartan and carbamazepine were found.  
4. The use of non-target analyses in a hidden target approach provides a lot of information. 
Furthermore, even without reference standards, numerous compounds can be tentatively identified.  
5. Retention time prediction has been shown as a great complementary technique in the detection and 
identification of PIDs and their metabolites. 
6. A retention time prediction approach based solely on logKOW is not only cheap and simple, but also 
led to between 70-80% of all compounds having a predicted retention time within 2 minutes of their 
experimental. 
7. A more complex retention time prediction approach, based on artificial neural networks, showed a 
greater predictive capacity, with up to 95% of all compounds having a predicted retention time 
within 2 minutes of their experimental. This allowed greater confidence in the tentative identification 
of compounds for which standards were unavailable. 
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8. Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) with triple quadrupole 
mass analyser is a powerful analytical technique for the quantification of new psychoactive 
substances (NPS) in wastewater. The robustness, sensitivity and selectivity of this technique make it 
highly appropriate for the determination of these compounds at the low concentrations commonly 
found in complex-matrix samples such as urban wastewater.  
9. Additional studies of filtration are necessary to account for possible losses during sample treatment. 
Vacuum filtration (using membrane filters) was found to have under 5% recovery for the three 
NBOMe compounds as well as naphyrone. Syringe filters (of PTFE, polypropylene and nylon) were 
found to have better recoveries for all compounds, with the Nylon 13mm, 0.45µm proving to be the 
best, which had recoveries of 98-105% for all compounds 
10. Mobile phase additives, sample injection volume and desolvation and cone gas flow rates all 
contribute to optimising chromatographic peak shape and mass spectrometric optimisation. 
11. Stability is an important parameter for WBE of NPS, with acidification (to pH 2) necessary to reduce 
transformation and degradation for all NPS investigated at 20ºC, 4ºC and -20ºC for up to seven days. 
If left unacidified, samples should be analysed within 48 hours (if stored at -20ºC or 4ºC), while at 
20ºC, N-ethylcathinone and mephedrone showed low stability within 24 hours. 
12. The acquisition of two or three transitions allows the simultaneous quantification and confirmation 
of various NPS.  
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6.2 Conclusiones 
La conclusión general de esta tesis es que las técnicas analíticas avanzadas, basadas en la 
cromatografía líquida acoplada a espectrometría de masas de baja y de alta resolución, para el análisis 
“target”, “suspect” y “non-target”, incorporando la predicción del tiempo de la retención, son de 
gran utilidad para la detección e identificación de contaminantes emergentes en agua. El uso de 
espectrometría de masas de baja y alta resolución, como triple cuadrupolo (QqQ), cuadrupolo 
tiempo de vuelo (QTOF) y trampa de iones lineal (LTQ) Orbitrap, permite el análisis exhaustivo de 
los contaminantes emergentes en aguas ambientales, a través del uso del análisis “target” (QqQ), 
“suspect” (QTOF y LTQ-Orbitrap) y “non-target” (LTQ-Orbitrap). Además, el uso 
complementario de la predicción del tiempo de retención hizo la detección de compuestos 
(especialmente para los que no estaban disponibles los patrones) mucho menos tediosa y mejoró la 
confianza en su identificación tentativa. 
A partir del trabajo realizado en esta tesis, se pueden enumerar varias conclusiones específicas: 
1. La espectrometría de masas de alta resolución, especialmente QTOF y LTQ-Orbitrap, es 
una técnica muy poderosa para la detección cualitativa en análisis “suspect” y “non-target” 
de contaminantes emergente en muestras acuáticas. 
2. QTOF en el modo de MSE facilita la detección y la identificación tentativa de los productos 
farmacéuticos, drogas ilícitas (PIDs) y sus metabolitos, con la información de los espectros 
de alta energía (que corresponden a los iones fragmento) y de baja energía (que corresponde 
principalmente a la molécula intacta) obtenidos en una sola inyección. 
3. Se ha demostrado que hay una diferencia geográfica en la detección de PIDs, tras analizar 
muestras de Colombia, Italia y España. Mientras que las muestras procedentes de Italia y 
España eran bastante similares - irbesartán (antihipertensivo), valsartán (antagonista de 
angiotensina II) y dos antibióticos ofloxacina y sulfametoxazol fueron los compuestos más 
comúnmente identificadas - en las muestras colombianas se encontró el betabloqueante 
metoprolol, el regulador de lípidos gemfibrozilo, y el agente de rayos X iopromida, así como 
metabolitos de losartán y carbamazepina. 
4. El uso del análisis “non-target” (hidden target screening) proporciona mucha información. 
Por otra parte, sin los patrones de referencia, permitió que numerosos compuestos pudieran 
ser tentativamente identificados. 
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5. Se ha demostrado que la predicción del tiempo de retención es una gran técnica 
complementaria en la detección e identificación de los PIDs y sus metabolitos. 
6. Un método de predicción del tiempo de retención basado únicamente en logKow es no sólo 
barato y sencillo, sino que también condujo a que aproximadamente el 70-80% de todos los 
compuestos presentaban un tiempo de retención teórico con una tolerancia menor de 2 
minutos respecto a su valor experimental. 
7. Un método de predicción del tiempo de retención más complejo, basado en redes 
neuronales artificiales, mostró una mayor capacidad predictiva, con hasta el 95% de todos 
los compuestos con un tiempo de retención predicho dentro de 2 minutos respecto a su 
tiempo experimental. Esto permitió una mayor confianza en la identificación tentativa de los 
compuestos para los que los patrones no estaban disponibles. 
8. La cromatografía líquida acoplada a espectrometría de masas en tándem (LC-MS/MS) con 
analizador de masas de triple cuadrupolo es una técnica analítica poderosa para la 
cuantificación de las nuevas sustancias psicotrópicas (NPS) en diferentes tipos de agua. La 
robustez, la sensibilidad y la selectividad de esta técnica la hacen muy adecuada para la 
determinación de estos compuestos a las bajas concentraciones en que se encuentran 
comúnmente en las muestras de matriz compleja tales como las aguas residuales urbanas. 
9. Estudios adicionales de filtración son necesarios para tener en cuenta las posibles pérdidas 
durante el tratamiento de la muestra. Se encontró que la filtración a vacío (utilizando filtros 
de membrana) proporcionaba bjas recuperaciones (5%) para los tres compuestos NBOME 
así como la nafirona. Sin embargo, se observó que los filtros de jeringa (de PTFE, 
polipropileno y nylon) proporcionaban mejores recuperaciones para todos los compuestos, 
siendo el de Nylon de 0.45μm el mejor, ya que resultaba en recuperaciones de 98 a 105% 
para todos los compuestos. 
10. Se estudiaron los aditivos añadidos a la fase móvil, el volumen de inyección de muestra así 
como los flujos de gas de desolvatación y de cono, ya que todas estas variables contribuyen a 
la optimización tanto de la separación y forma del pico cromatográfico como al rendimiento 
de ionización en espectrometría de masas. 
11. La estabilidad es un parámetro importante a tener en cuenta para los estudios de 
epidemiología de aguas residuales en general, y para NPS en particular. La acidificación (a 
pH 2) fue necesaria para reducir la transformación y la degradación de todos los NPS 
investigados a 20ºC, 4ºC y -20ºC durante un máximo de siete días. Si no se acidifica, las 
muestras deben ser analizadas dentro de las 48 horas (si se almacenan a -20ºC o 4ºC), 
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mientras que a 20°C, la N-ethylcathinone y la mefedrona mostraron una baja estabilidad 
degradándose dentro de las primeras 24 horas. 
12. La adquisición de dos o tres transiciones SRM permite la cuantificación y la confirmación 
simultánea de diversas NPS. 
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6.3 Suggestions for Future Research 
Throughout this thesis, advanced analytical techniques including high resolution mass spectrometry, 
tandem mass spectrometry and the complementary use of retention time prediction have shown 
their potential in the detection and identification of emerging contaminants in environmental waters. 
Frustratingly, with every result come more questions and ideas for future research, which, due either 
being out of the scope of this thesis or lack of time could not be undertaken. Nevertheless, several 
suggestions for future research are outlined below: 
Screening approaches: 
More information is needed on metabolites, transformation products and NPS. While the in-house databases 
are always being added to, this needs to continue in the future, perhaps with more emphasis on metabolites 
and transformation products. 
To aid non-target approaches, collaboration is necessary. This could be in terms of uploading mass spectra to 
the online mass spectral database, MassBank, or through the sharing of in-house databases. These ideas have 
been floating around the NORMAN network, who have introduced a non-target specific working group for 
this reason, leaving the future looking bright.  
Retention time prediction: 
During the research stay at University of Antwerp, a retention time prediction method based on ANNs and 
incorporating three different columns (biphenyl, C8 and HILIC) was undertaken for 100 NPS and illicit drug 
reference standards. After optimizing the ANN, all three columns had a mean error within one minute:  0.51, 
0.68 and 0.81 respectively, however the HILIC results are skewed due to overfitting the training set. Further 
work is needed on the HILIC column, while future work could include the addition of more standards to the 
C8 and biphenyl methods as well as its use in suspect detection and identification. When future optimization 
is complete, it would be very interesting to test the retention time predictior for NPS, either in wastewater or, 
perhaps more curiously, in toxicological samples, where “new” NPS are first identified.  
A second approach could be the use of different software for retention time prediction, such as random 
forests or support vector machines. 
Furthermore, an investigation into different molecular descriptors could be carried out. More than one 
thousand descriptors are available on VCCLABS’ Parameter Client module. During the research stay at 
University of Antwerp, a brief study into the impact of different descriptors was made, but far more time is 
needed for a suitable and reliable study.  
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Further to the work done on the quantification of NPS, an investigation into their metabolism could be made. 
The parent compound is not necessarily the most abundant and appropriate biomarker, leading to a 
metabolite biomarker being more useful, and perhaps leading to more compounds being confirmed in the 
real samples.  
Further research into a direct injection approach could be made. As mentioned in Chapter 4, huge matrix 
effects were seen for the later eluting compounds in influent wastewater using direct injection. Alternative 
gradients could be investigated, perhaps performing a stepped gradient, so as to reduce the “flushing” of 
more non-polar contaminants at the end of the chromatographic run.   
Finally, an investigation into the environmental harm of NPS and their metabolites could be made. There is 
currently limited information related to the environmental harm of pharmaceuticals, with even less relating to 
NPS.  
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5.4 Sugerencias para Futuras Investigaciones  
A lo largo de esta tesis, se ha demostrado el potencial de las técnicas analíticas avanzadas, incluyendo 
la espectrometría de masas de alta resolución, espectrometría de masas tándem y el uso 
complementario de la predicción del tiempo de retención para la detección e identificación de 
contaminantes emergentes en aguas ambientales. Sin embargo, con cada nuevo resultado aparecen 
más preguntas e ideas para futuras investigaciones, las cuales, debido bien a estar fuera del alcance de 
esta tesis o por falta de tiempo no pudieron llevarse a cabo. Sin embargo, a continuación se resumen 
varias sugerencias para futuras investigaciones: 
Aproximaciones de Screening: 
Se necesita más información sobre metabolitos, productos de transformación y NPS. A pesar de que 
las bases de datos internas siempre están en continua actualización, en el futuro, tal vez se deba 
hacer más énfasis en los metabolitos y productos de transformación. 
Para avanzar en aproximaciones “non-target”, la colaboración con otros grupos es vital. Esta se 
podría llevar cabo mediante la compartición de espectros de masas en base de datos de espectros en 
línea, como MassBank, o incluso mediante el intercambio de las bases de datos internas de cada 
grupo. Estas ideas también han sido abordadas de manera recurrente en la red NORMAN, que 
finalmente han cristalizado en un grupo de trabajo específico, augurando un brillante futuro en este 
campo. 
Predicción del Tiempo de Retención: 
Durante la estancia de investigación en la Universidad de Amberes, un método de predicción del 
tiempo de retención basado en ANNs e incorporación hasta tres columnas diferentes (bifenilo, C8 y 
HILIC) se llevó a cabo empleando 100 NPS y patrones de referencia de drogas ilícitas. Después de 
la optimización de la ANN, las tres columnas tenían una media de error por debajo del minuto: 0,51, 
0,68 y 0,81, respectivamente; sin embargo, los resultados HILIC están sesgados debido a un 
“overfitting” en el conjunto de entrenamiento, por lo que es necesario seguir trabajando en la misma. 
Por otra parte, un trabajo futuro podría incluir la adición de más patrones para los métodos de C8 y 
bifenilo, así como su uso en la detección e identificación de sospechosos. Cuando se complete en un 
futuro la optimización de la ANN, sería muy interesante evaluar la predicción de tiempo de 
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retención para NPS, ya sea en las aguas residuales o, quizás más interesante, en las muestras 
toxicológicas, donde generalmente se identifican por primera vez las "nuevas" NPS. 
Una segunda aproximación podría ser el uso de diferentes software para la predicción de tiempo de 
retención, como “random forests” o “support vector machines”.  
Además, se podría llevar a cabo una investigación sobre diferentes descriptores moleculares. Más de 
un millar de descriptores están disponibles en los módulos de Parameter Client (VCC LABS). 
Durante la estancia de investigación en la University of Antwerp, se hizo un breve estudio sobre el 
impacto de los diferentes descriptores, pero se necesita mucho más tiempo para un estudio 
adecuado y fiable. 
Nuevas Sustancias Psicoactivas: 
En relación con el trabajo realizado en la cuantificación de NPS, se podría hacer una investigación 
sobre su metabolismo. El compuesto original no es necesariamente el biomarcador más abundante y 
adecuado, lo que puede llevar a que un metabolito sea el biomarcador más útil. Este hecho 
permitiría tal vez que más compuestos se confirmen en las muestras reales. 
También se podrían realizar investigaciones adicionales para implementar un método por inyección 
directa. Como se ha mencionado en el capítulo 4, se observaron grandes efectos matriz para los 
compuestos que eluían al final del gradiente para influente de aguas residuales al realizar la inyección 
directa. Se podrían investigar gradientes alternativos, p. ej. escalonados, con el fin de reducir el 
"lavado" de los contaminantes más apolares al final del cromatograma. 
Por último, se podría hacer una investigación sobre el impacto ambiental de las NPS y sus 
metabolitos. En la actualidad existe información limitada relacionada con el perjucio ambiental de 
los productos farmacéuticos,  mucho menor para el caso de los NPS. 
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